<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t7myrd7pk24p st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="Nursing Pharmacology Rollant Paulette D Hill Karen RN 1996 St Louis MO Mosby Year Book.pdf">Nursing Pharmacology Rollant Paulette D Hill Karen RN 1996 St Louis MO Mosby Year Book.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">17.4MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> Nursing Pharmacology Rollant Paulette D Hill Karen RN 1996 St Louis MO Mosby Year Book.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mosby-s-review-series">Mosby's Review Series<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mosby-s-review-series" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nursing-pharmacology">NURSING PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251221-d5931e3f.jpeg" alt="img-0.jpeg"></p>
<p>Paulette D. Rollant
Karen Y. Hill</p>
<p>Free Disks Included!</p>
<p>^{}[]</p>
<p>Mosby's Review Series</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-pharmacology">NURSING PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>blank</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mosby-s-review-series">Mosby's Review Series<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mosby-s-review-series" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nursing-pharmacology">NURSING PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Paulette D. Rollant, PhD, MSN, RN, CCRN
<em>President, Multi-Resources, Inc.</em>
<em>Grantville, Georgia</em></p>
<p>Karen Hill, RN, MSN
Assistant Professor
Southeastern Louisiana University
Hammond, Louisiana</p>
<p>Mosby
St. Louis Baltimore Boston Carlsbad Chicago Naples New York Philadelphia Portland
London Madrid Mexico City Singapore Sydney Tokyo Toronto Wiesbaden</p>
<p>Mosby
Dedicated to Publishing Excellence</p>
<p>Copyright © 1996 Mosby-Year Book, Inc.</p>
<p>All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher.</p>
<p>Permission to photocopy or reproduce solely for internal or personal use is permitted for libraries or other users registered with the Copyright Clearance Center, provided that the base fee of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>40.00</mn><mi>p</mi><mi>e</mi><mi>r</mi><mi>c</mi><mi>h</mi><mi>a</mi><mi>p</mi><mi>t</mi><mi>e</mi><mi>r</mi><mi>p</mi><mi>l</mi><mi>u</mi><mi>s</mi></mrow><annotation encoding="application/x-tex">40.00 per chapter plus </annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord">40.00</span><span class="mord mathnormal">p</span><span class="mord mathnormal">erc</span><span class="mord mathnormal">ha</span><span class="mord mathnormal">pt</span><span class="mord mathnormal" style="margin-right: 0.02778em;">er</span><span class="mord mathnormal" style="margin-right: 0.01968em;">pl</span><span class="mord mathnormal">u</span><span class="mord mathnormal">s</span></span></span></span></span>.10 per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, MA 01970. This consent does not extend to other kinds of copying, such as copying for general distribution, for advertising or promotional purposes, for creating collected works, or for resale.</p>
<p>Printed in the United States of America</p>
<p>Mosby-Year Book, Inc.
11830 Westline Industrial Drive
St. Louis, MO 63146</p>
<p>International Standard Book Number 0-8151-7245-1</p>
<p>99 / 9 8 7 6 5 4</p>
<p>REVIEWERS</p>
<p>Carol Flom, RN, BSN, MEd, MS
Nursing Instructor
Minneapolis Community College
Minneapolis, Minnesota</p>
<p>Patricia P. Shoemaker, RN, BSN, MSN
Chair, Health Technology Division
Davidson County Communication College
Lexington, North Carolina</p>
<p>.</p>
<p>To Dan, Mom, Dad, Joanne, Joe, Alan, and Amy
Paulette Rollant</p>
<p>To Bobby, B.J., and Kristopher
Karen Hill</p>
<p>vii</p>
<p>Digitized by the Internet Archive
in 2022 with funding from
Kahle/Austin Foundation</p>
<p><a href="https://archive.org/details/nursingpharmacol0000roll_g2t0" target="_blank" rel="noopener noreferrer">https://archive.org/details/nursingpharmacol0000roll_g2t0</a></p>
<p>PREFACE</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="how-can-mosby-s-review-series-be-used">HOW CAN MOSBY'S REVIEW SERIES BE USED?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-can-mosby-s-review-series-be-used" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Mosby's Review Series is designed to help you obtain the most from your preparation and study time for your nursing exams. These books should be used to review essential concepts, theory, and content prior to nursing courses, challenge, certification, or licensing examinations. The review series can be used to prepare for clinical experiences and as a quick reference when providing care of clients. Mosby's Review Series consists of five books:</p>
<ul>
<li>Maternity Nursing</li>
<li>Medical-Surgical Nursing</li>
<li>Mental Health Nursing</li>
<li>Pediatric Nursing</li>
<li>Nursing Pharmacology</li>
</ul>
<p>The series is designed to highlight important information related to the specific content. It is not meant to provide a comprehensive, in-depth coverage of the selected area of nursing. The reference list at the end of each book is a compilation of resources used to develop these books. These references as well as other texts should be consulted when a more comprehensive discussion of a particular topic is desired. Use these books to jog your memory, to reinforce what you know, to guide you to identify what you don't know, and to lead you to appropriate sources for more details. If you are in a formal education setting, these books are not intended to be considered as a substitute for attending classes or completing required reading assignments.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="used-correctly-these-books-can-help-you">Used correctly these books can help you:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#used-correctly-these-books-can-help-you" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Increase your ability to prioritize in clinical situations while using the nursing process.</li>
<li>Increase your ability to remember essential content.</li>
<li>Increase your productivity in studying to leave some time for you and your family.</li>
<li>Apply new behaviors for improvement of your testing skills.</li>
<li>Evaluate your strengths and weakness related to content areas or testing situations.</li>
</ol>
<p>ix</p>
<p>x
▼
PREFACE</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="what-is-unique-about-mosby-s-review-series">WHAT IS UNIQUE ABOUT MOSBY'S REVIEW SERIES?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#what-is-unique-about-mosby-s-review-series" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Computer disks of exams</li>
<li>Comprehensive rationales</li>
<li>Test-taking tips</li>
<li>Chapter format</li>
<li>References for further reading</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="computer-disk">Computer Disk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#computer-disk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Each book in the series has a comprehensive exam on computer disk. For your convenience, the exam is also included in the book. The answers for the comprehensive exams, like the end of the chapter questions, include the answers, comprehensive rationales, and test-taking tips.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="comprehensive-rationales">Comprehensive Rationales<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#comprehensive-rationales" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These include answers and rationales for each option in each test question.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="test-taking-tips">Test-Taking Tips<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These tips aid in your decision-making and facilitate the development of your logical thinking for the selection of the correct answers, especially if you have narrowed your choice to two options.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-format">Chapter Format<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-format" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Each chapter contains an easy-to-follow format divided into five sections:</p>
<p><strong>Study Outcomes:</strong> provides an advanced organizer approach to what is in each chapter</p>
<p><strong>Key Terms:</strong> includes the most common difficult terms to recall</p>
<p><strong>Content Review:</strong> is organized and structured by the nursing process to help you identify what is most important</p>
<ul>
<li>All information within each heading is prioritized</li>
<li>Nursing diagnoses are prioritized</li>
<li>Goals are client-centered</li>
<li>Client teaching content is focused for in-hospital and at-home clinical settings</li>
<li>Home care content is included</li>
<li>Older adult alerts are included where applicable</li>
<li>Evaluation criteria includes decision-making tools concerning which actions to take when client's clinical status shows improvement or deterioration</li>
<li>Many tables, charts, and figures contrast, cluster, and simplify information for ease of remembering</li>
</ul>
<p><strong>Review Questions:</strong> stand-alone, 4-option multiple choice</p>
<p><strong>Answers, Rationales, and Test-Taking Tips:</strong></p>
<ul>
<li>Comprehensive rationales: given for each option to explain why it is correct or incorrect</li>
</ul>
<p>PREFACE ▼ xi</p>
<p>▼ Test-taking tips: give strategies to use in situations such as when options are narrowed to two or when you have no idea of a correct answer</p>
<p><strong>References</strong></p>
<p>Current references are suggested for further study if more in-depth discussion is needed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="what-s-in-mosby-s-review-series-nursing-pharmacology">WHAT'S IN MOSBY'S REVIEW SERIES: NURSING PHARMACOLOGY?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#what-s-in-mosby-s-review-series-nursing-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><em>Mosby's Review Series: Nursing Pharmacology</em> includes basic principles of pharmacology and content about medications. The focus is on essentials needed by nurses. Within the initial four chapters, essential content such as fundamentals and principles of pharmacology, and drug therapy provide a basis for the remaining chapters. The remaining chapters are organized by major systems with the most common drug classifications as the building block within each chapter. The content is developed with priorities and most common elements written in order to meet your need for studying, reviewing, and referencing in an expedient manner.</p>
<p>^{}[]</p>
<p>I express my heartfelt gratitude to those who have endured with me throughout this publication opportunity for a nursing review series: an adventure from idea to reality.</p>
<p>I especially want to thank the following people:</p>
<p><em>Beverly Copland</em>, who thought that I had the potential to complete this project and who eagerly gave me tons of strong support in the initial and ongoing book development phases.</p>
<p><em>Laurie Muench</em>, who picked up the ball in the middle of manuscript preparation and persisted with me through the process to completion of book publication. The response “OK . . . when can I expect it?” provided silent encouragement and sometimes comic relief when my mental and physical energies ran quite low. Laurie’s thoughtfulness and guidance to help me set priorities were invaluable! I am very grateful and fortunate to work with Laurie.</p>
<p><em>Suzi Epstein</em>, who was full of enthusiasm and total support from the birth of the idea for a nursing review series to the final publication of the books. Suzi’s creativity and suggestions provided essential building blocks in the overall development of the series.</p>
<p>My coauthors, for their enormous efforts to produce manuscript content in a short period of time. Their nursing expertise was helpful for the development of the unique aspects of each book.</p>
<p>My wonderful husband, Dan, for his patience, humor, support, and love. His faith in my abilities has sustained my energies and maintained my sense of self.</p>
<p>My parents, Joseph and Mildred Demaske, for their love, encouragement, and prayers.</p>
<p>Paulette D. Rollant</p>
<p>Thanks to Bobby, B.J., and Kristopher for their love and support.</p>
<p>Karen Hill</p>
<p>^{}[]</p>
<p>CONTENTS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-1-essential-elements-for-nursing-1">Chapter 1 Essential Elements for Nursing 1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-1-essential-elements-for-nursing-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Essential Elements in Nursing 2</li>
<li>The two essential elements 2</li>
<li>Nursing incorporates these essential elements 2</li>
<li>Nursing process is the priority thread throughout nursing 2</li>
<li>Client education facilitates behavior changes in health promotion 2</li>
<li>Nursing Process 2</li>
<li>The nursing process has five steps 2</li>
<li>The initial assessment process 3</li>
<li>The selection of nursing diagnoses 4</li>
<li>The planning process 5</li>
<li>The intervention process 6</li>
<li>The evaluation process 6</li>
<li>Client Education 7</li>
<li>Client education: the process 7</li>
<li>Client assessments for education 8</li>
<li>Special needs of clients for their education 9</li>
<li>Learning theory 10</li>
<li>Tools for teaching 11</li>
<li>NANDA-Approved Nursing Diagnosis 14</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-2-fundamentals-of-pharmacology-19">Chapter 2 Fundamentals of Pharmacology 19<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-2-fundamentals-of-pharmacology-19" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Nursing process 20</li>
<li>Drug legislation within the United States 22</li>
<li>Controlled substances 22</li>
<li>Drug names 22</li>
<li>Forms of medications 22</li>
<li>Review Questions 28</li>
<li>Answers, Rationales, and Test-Taking Tips 29</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-3-principles-of-drug-therapy-31">Chapter 3 Principles of Drug Therapy 31<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-3-principles-of-drug-therapy-31" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Three reasons for medication administration 32</li>
<li>The study of pharmacology includes three areas 33</li>
<li>Pharmacokinetics 33</li>
<li>Pharmacodynamics 36</li>
</ul>
<p>xvi ▼ CONTENTS</p>
<p>Pharmacotherapeutic phase 36
Monitoring drug therapy 40
Review Questions 42
Answers, Rationales, and Test-Taking Tips 44</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-4-administration-of-medications-47">Chapter 4 Administration of Medications 47<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-4-administration-of-medications-47" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>General principles for medication administration 48
Administration by injection 49
Key principles 52
Needles 57
Three formulas for dosage calculation 57
Review Questions 59
Answers, Rationales, and Test-Taking Tips 60</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-5-drugs-affecting-the-autonomic-nervous-system-63">Chapter 5 Drugs Affecting the Autonomic Nervous System 63<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-5-drugs-affecting-the-autonomic-nervous-system-63" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Adrenergic Agents—Sympathomimetic 64
Adrenergic agonists 64
Adrenergic Blocking Agents 67
Divided into three groups 67
Alpha adrenergic blockers 67
Beta adrenergic blockers 68
Ganglionic blockers 69
Cholinergic Agents—Parasympathomimetic 70
Divided into the following 70
Direct-acting cholinergic agonists 70
Anticholinesterase agents 70
Cholinergic Blocking Agents 71
Anticholinergic agents 71
Review Questions 73
Answers, Rationales, and Test-Taking Tips 75</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-6-drugs-affecting-the-neuromuscular-system-79">Chapter 6 Drugs Affecting the Neuromuscular System 79<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-6-drugs-affecting-the-neuromuscular-system-79" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Anticonvulsants 80
To prevent or treat epilepsy/convulsive seizures 80
General information 80
Hydantoin derivatives 81
Barbiturates 81
Iminostilbenes 82
Oxazolidinediones 82
Succinimides 83
Valporic acid 83
Benzodiazepines 83</p>
<p>CONTENTS ▼ xvii</p>
<p>Antiparkinsonism Drugs 84
Parkinson's disease 84
Goals of these agents 84
Actions 84
Uses 84
Major side effects 84
Interactions 85
Nursing implications 85
Common drugs 85
Antimyasthenic Agents 85
Myasthenia gravis 85
Action 86
Uses 86
Major side effects 87
Interactions 87
Nursing implications 87
Common drugs 87
Neuromuscular Blocking Agents 88
Divided into two groups 88
General information about the classification 88
Nondepolarizing agents 88
Depolarizing agents 89
Review Questions 90
Answers, Rationales, and Test-Taking Tips 92</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-7-drugs-affecting-the-central-nervous-system-97">Chapter 7 Drugs Affecting the Central Nervous System 97<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-7-drugs-affecting-the-central-nervous-system-97" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Preanesthetics 99
Anesthetics 100
General Anesthesia 100
Three phases of anesthesia 100
Anesthesia requires critical concentration levels 100
Anesthetic agents are administered until loss of consciousness occurs 100
Inhalation anesthetics 101
Intravenous (IV) anesthetics 102
Local Anesthesia 102
General information 102
Action 103
Uses 103
Side effects 103
Nursing implications 103
Common drugs 104</p>
<p>xviii ▼ CONTENTS</p>
<p>Central Nervous System Stimulants 104
General information 104
Amphetamines and amphetamine-like drugs 104
Anorexiant agents 106
Analgetics and methylxanthines 106
Psychotropics 107
Classifications 107
Antipsychotic agents 107
Antianxiety or anxiolytic 108
Tricyclic antidepressants 109
Monoamine oxidase (MAO) inhibitors 110
Selective serotonin reuptake inhibitors (SSRI) 111
Mood stabilizers 112
Skeletal Muscle Relaxants 113
Classifications 113
General information 113
Centrally acting 113
Peripherally or direct-acting agents 114
Review Questions 115
Answers, Rationales, and Test-Taking Tips 119</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-8-drugs-affecting-sleep-127">Chapter 8 Drugs Affecting Sleep 127<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-8-drugs-affecting-sleep-127" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Sedatives and hypnotics—general considerations 128
Barbiturates 129
Benzodiazepines 130
Nonbarbiturates 131
Alcohol 131
Review Questions 133
Answers, Rationales, and Test-Taking Tips 134</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-9-drugs-that-relieve-pain-and-inflammation-137">Chapter 9 Drugs That Relieve Pain and Inflammation 137<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-9-drugs-that-relieve-pain-and-inflammation-137" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Analgesics 138
Narcotics 138
Mixed narcotic agonist-antagonist agents 140
Narcotic antagonists 140
Nonnarcotic analgesics 141
Nonsteroidal antiinflammatory drugs (NSAIDs) 142
Drugs Used to Treat Inflammation 142
Antiinflammatory/Antipyretic agents 142
Drugs Used to Treat Arthritis 143
Antirheumatic agents 143
Antigout agents 144</p>
<p>CONTENTS ▼ xix</p>
<p>Steroidal antiinflammatory agents 145
Review Questions 146
Answers, Rationales, and Test-Taking Tips 147</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-10-drugs-affecting-the-cardiovascular-system-149">Chapter 10 Drugs Affecting the Cardiovascular System 149<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-10-drugs-affecting-the-cardiovascular-system-149" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cardiac Glycosides and Similar Drugs 150</li>
<li>Actions 150</li>
<li>Uses 151</li>
<li>Major side effects 151</li>
<li>Nursing implications 152</li>
<li>Interactions 153</li>
<li>Contraindications 153</li>
<li>Common individual drugs 153</li>
<li>Antianginals 153</li>
<li>Classifications of drugs used to treat angina 153</li>
<li>Nitrates 153</li>
<li>Beta adrenergic blockers 155</li>
<li>Calcium channel blockers 158</li>
<li>Antidysrhythmic Agents 159</li>
<li>Actions 159</li>
<li>Specific actions, uses, side effects 159</li>
<li>Nursing implications 159</li>
<li>Antihypertensives 159</li>
<li>The stepped-care approach 159</li>
<li>Classifications of drugs used beyond Step 1 163</li>
<li>Diuretics 163</li>
<li>Beta adrenergic blockers 164</li>
<li>Calcium channel blockers 164</li>
<li>Angiotensin antagonists (ACE) inhibitors 165</li>
<li>Adrenergic blocking agents 166</li>
<li>Direct vasodilating agents 167</li>
<li>General nursing implications for antihypertensives 168</li>
<li>Antihyperlipidemia Agents 168</li>
<li>Therapy for high cholesterol and triglyceride levels 168</li>
<li>Cholesterol-lowering agents 168</li>
<li>Triglyceride-lowering agents 169</li>
<li>Review Questions 170</li>
<li>Answers, Rationales, and Test-Taking Tips 173</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-11-drugs-affecting-the-renal-system-179">Chapter 11 Drugs Affecting the Renal System 179<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-11-drugs-affecting-the-renal-system-179" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Diuretics 181</li>
<li>Major classifications 181</li>
</ul>
<p>CONTENTS</p>
<p>Thiazide and thiazide-like agents 181
Loop diuretics (potent diuretics) 182
Potassium sparing agents 183
Carbonic anhydrase inhibitors (weak diuretics) 184
Osmotics 185
General nursing implications for all diuretics 186
Review Questions 187
Answers, Rationales, and Test-Taking Tips 188</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-12-drugs-affecting-the-hematologic-system-191">Chapter 12 Drugs Affecting the Hematologic System 191<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-12-drugs-affecting-the-hematologic-system-191" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Anticoagulants 192
Oral anticoagulants 192
Parenteral anticoagulants 194
Thrombolytic Agents 195
Thrombolytic agents 195
Other Agents 196
Antiplatelet agents 196
Hemostatic agents 197
Hematinic Agents 197
Iron products 197
Hydroxocobalamin (vitamin B₁₂) 198
Folic acid (vitamin B₆) 199
Review Questions 200
Answers, Rationales, and Test-Taking Tips 202</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-13-drugs-affecting-the-immune-system-205">Chapter 13 Drugs Affecting the Immune System 205<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-13-drugs-affecting-the-immune-system-205" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Immunological Agents 206
General considerations 206
Passive immunity agents 210
Active immunity agents 210
Immunosuppressive and Immunomodulating Agents 211
Immunosuppressive agents 211
Immunomodulating agents 212
Review Questions 213
Answers, Rationales, and Test-Taking Tips 215</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-14-drugs-affecting-the-endocrine-system-217">Chapter 14 Drugs Affecting the Endocrine System 217<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-14-drugs-affecting-the-endocrine-system-217" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Pituitary Hormones 219
Anterior pituitary hormones 219
Posterior pituitary hormone 220
Thyroid and Parathyroid Hormones 222
Parathyroid hormone 222</p>
<p>CONTENTS ▼ xxi</p>
<p>Thyroid hormones 223
Adrenal Hormones 225
Glucocorticoids 225
Mineral corticoids 226
Drugs Used in Diabetes 227
Hypoglycemic agents 227
Hyperglycemic agents 230
Review Questions 232
Answers, Rationales, and Test-Taking Tips 234</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-15-drugs-affecting-the-respiratory-system-237">Chapter 15 Drugs Affecting the Respiratory System 237<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-15-drugs-affecting-the-respiratory-system-237" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Bronchodilators 238
Groups of drugs 238
Sympathomimetics 238
Xanthine derivatives: methylxanthines 240
Upper Respiratory Drugs 241
Decongestants 241
Antihistamines 241
Drugs Affecting Cough 242
Diluents 242
Mucolytic drugs 242
Expectorants 243
Antitussives 244
Other Respiratory Agents 244
Prophylactic asthmatic drugs 244
Antiinflammatory agents: corticosteroids 245
Review Questions 246
Answers, Rationales, and Test-Taking Tips 248</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-16-drugs-used-to-treat-cancer-251">Chapter 16 Drugs Used to Treat Cancer 251<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-16-drugs-used-to-treat-cancer-251" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Antineoplastics 252
General considerations 252
Preparation and administration 253
Major side effects and nursing implications 253
Classification of agents 254
General nursing implications 254
Review Questions 257
Answers, Rationales, and Test-Taking Tips 258</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-17-drugs-used-to-treat-infections-261">Chapter 17 Drugs Used to Treat Infections 261<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-17-drugs-used-to-treat-infections-261" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Antibiotics 262
General information 262</p>
<p>xxii ▼ CONTENTS</p>
<p>Penicillins 263
Cephalosporins 264
Tetracyclines (broad-spectrum) 265
Aminoglycosides 266
Macrolides 267
Sulfonamides (broad-spectrum) 267
Quinolones 268
Antitubercular Agents 269
Actions 269
Uses 269
Major side effects 269
Nursing implications 269
Common drugs 269
Other Agents 269
Antivirals 269
Antifungals 270
Antihelmintic agents 271
Antimalarial agents 271
Review Questions 272
Answers, Rationales, and Test-Taking Tips 273</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-18-dermatological-agents-275">Chapter 18 Dermatological Agents 275<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-18-dermatological-agents-275" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Antiseptics and disinfectants 276
Baths 277
Soaps and cleansers 277
Emollients 278
Solutions and lotions 278
Astringents 279
Skin protectants 279
Rubs and liniments 279
Protectives 280
Topical antiinfectives 280
Antiinflammatory agents 281
Antiparasitic agents 282
Keratolytics 282
Debriding agents 283
Review Questions 284
Answers, Rationales, and Test-Taking Tips 285</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-19-drugs-affecting-the-gastrointestinal-system-287">Chapter 19 Drugs Affecting the Gastrointestinal System 287<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-19-drugs-affecting-the-gastrointestinal-system-287" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Drugs Used to Treat Peptic Ulcer Disease and Gastric
Hyperacidity 288</p>
<p>CONTENTS ▼ xxiii</p>
<p>Antacids 288
H₂ histamine receptor antagonists 289
Anticholinergic agents (antispasmodics) 290
Other Gastrointestinal Agents 291
Digestants 291
Antiflatulent agents 291
Antiemetics 292
Emetics 293
Laxatives (cathartic) 293
Antidiarrheals 295
Flora modifiers 296
Review Questions 297
Answers, Rationales, and Test-Taking Tips 298</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-20-drugs-affecting-the-ear-and-eye-301">Chapter 20 Drugs Affecting the Ear and Eye 301<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-20-drugs-affecting-the-ear-and-eye-301" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Agents Used in the Eye 302
Mydriatics and cycloplegics 302
Miotics 303
Other drugs used to lower intraocular pressure (IOP) 305
Anesthetic agents 305
Antiinflammatory agents 306
Antiinfectives 306
Agents Used in the Ear 307
Antiinfective agents 307
Antiinflammatory agents 309
Anesthetic agents 309
Ceruminolytic agents 309
Review Questions 310
Answers, Rationales and Test-Taking Tips 311</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chapter-21-drugs-affecting-sexuality-and-reproduction-313">Chapter 21 Drugs Affecting Sexuality and Reproduction 313<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chapter-21-drugs-affecting-sexuality-and-reproduction-313" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Female and Male Sex Hormones 314
Estrogens 314
Progestins 315
Oral contraceptives: birth control pills 316
Contraceptives: other devices 317
Androgens 317
Ovulation stimulants 320
Drugs Used during Pregnancy 321
Uterine stimulants 321
Uterine depressants 321</p>
<p>xxiv ▼ CONTENTS</p>
<p>Lactation suppressants 322
Review Questions 323
Answers, Rationales, and Test-Taking Tips 324</p>
<p><strong>Comprehensive Exam</strong> 327
Comprehensive Exam Questions 328
Answers, Rationales, and Test-Taking Tips 337</p>
<p><strong>Bibliography</strong> 355
<strong>Index</strong> 357</p>
<p>INTRODUCTION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="how-can-i-use-this-book">HOW CAN I USE THIS BOOK?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-can-i-use-this-book" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>This book is designed to work for you—at your convenience. Read the following guidelines first to help save you time and energy during test preparation. The chapters are designed for short, quick intervals of review. Carry this book with you to catch the times when you are stuck and have nothing to do.</p>
<p>The directions will help you to:</p>
<ul>
<li>Maximize your individual performance in review and testing situations.</li>
<li>Identify your personal priorities in preparation for testing.</li>
<li>Sharpen your thinking and discrimination skills for testing.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="directions-on-how-to-review">DIRECTIONS ON HOW TO REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#directions-on-how-to-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. Identify your routine for reviewing: the best days, the best time of day</p>
<p>A. Write the days and times on the inside front cover of this book and on your personal calendar and the calendar at home. This communicates to your family or support systems that you will be unavailable to them at these times. It is also a nice reminder every week to yourself that this is important to you.
B. Refer to section V for specific directions on how to develop your routine</p>
<p>II. Scan the table of contents</p>
<p>A. Put a check mark in front of the content with which you are comfortable
B. Circle the content in which you think you are weak
C. Prioritize the weak content with #1 being the weakest content area. Put these numbers in front of your circles.
D. Prioritize the strongest content areas in the same manner</p>
<p>III. When you are feeling a high-energy day</p>
<p>A. Go to the #1 chapter of the weakest content area for review</p>
<p>IV. When you are having a low-energy day</p>
<p>A. Go to the #1 chapter of the strongest content area for review</p>
<p>XXV</p>
<p>xxvi ▼ INTRODUCTION</p>
<p>V. General guidelines for the development of a routine for reviewing
A. Develop a system of review that meets your needs
B. Set aside time when you are least tired or stressed both mentally and physically
C. Limit your review time to a maximum of 90 minutes for the most effective, efficient retention of reviewed content
D. If possible, relax and take a nap after reviewing to further place the information into long term memory. Some research reveals that sleeping for 2 to 3 hours after studying results in a 70 to 80% retention rate of content into long term memory in contrast to 30 to 40% retention when you are active after studying.
E. Use at least one relaxation technique <em>at the onset</em> and <em>at the end</em> of your review time. Deep breathing that is slow with a concentration on the air movement going in and out is one of the best ways to relax physically and mentally.
F. Use at least one relaxation technique <em>during</em> the time you review.
G. If your time is limited, use 10 to 15 minute intervals to review small portions of the content. For example, you may want to review the different aspects of hypertension in one study session.
H. Use a theme per week or per day approach. For example, if there is enough time between your test and when you begin to study, every Monday review something on sodium from the book. Then at work find clients with sodium imbalances, review their charts, and discuss their situations with colleagues or with the clients’ physicians.</p>
<p>Continue with themes for the day such as:</p>
<ol>
<li>Tuesdays are potassium</li>
<li>Wednesdays are calcium</li>
<li>Thursdays are magnesium</li>
<li>Fridays are acidosis situations</li>
<li>Saturdays are alkalosis days</li>
<li>Sundays are fun days. Don’t forget to keep one day to relax and have fun. This allows your mind to work for retention and reorganization of the content that you reviewed during the week.</li>
<li>Weekly themes also might be of help. Do one system per week such as pulmonary, endocrine and so forth.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="directions-on-how-to-use-this-book-for-success">DIRECTIONS ON HOW TO USE THIS BOOK FOR SUCCESS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#directions-on-how-to-use-this-book-for-success" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. Suggested study sequence #1 for each chapter
A. Read the objectives
B. Complete the key terms</p>
<p>INTRODUCTION ▼ xxvii</p>
<p>C. Complete the content review
D. Complete the review questions
E. Review the answers, rationales, test-taking tips</p>
<p>II. Suggested study sequence #2 for each chapter
A. Complete the review questions
B. Review the answers, rationales, test-taking tips
C. Review the missed content areas
D. Review the unfamiliar and the familiar content areas
E. Complete the key terms
F. Complete the objectives to evaluate your level of understanding</p>
<p>III. Suggested study sequence #3 after doing #1 or #2 suggested sequence
A. Complete the comprehensive exam in the book
B. Correct comprehensive exam answers with review of the rationales and test-taking tips
C. List content areas missed, then cluster them in terms of similar content
D. Prioritize these clusters with #1 being the least familiar content
E. Review additional content as directed by the questions you missed</p>
<p>IV. Suggested study sequence #4 before doing #1 or #2 suggested sequence
A. Complete the comprehensive exam in the book
B. Correct comprehensive exam answers with review of the rationales and test-taking tips
C. List content areas missed, then cluster them in terms of similar content
D. Prioritize these clusters with #1 being the least familiar content
E. Implement either sequence #1 or #2
F. Complete the computer comprehensive exam. Note that even though the questions are the same as in the book, you should evaluate how your reading of the questions and options differed as related to perception and consistent ability to identify key words, terms, age, and developmental needs.
G. Review content as needed and directed from your missed questions on your exam</p>
<p>V. Suggested techniques for use of the objectives during your review
A. Read the objectives to have them guide you where to start
B. Put a check next to the ones in which you feel the weakest
C. Prioritize them with #1 being the weakest
D. Review the weakest content first or on high-energy days
E. Review the most familiar content last or on low-energy days</p>
<p>VI. Suggested techniques for the use of the key terms, the content review section, and the exams
A. Key terms—suggested study techniques</p>
<ol>
<li>Use a 3 x 5 index card to cover the definitions of the key terms</li>
<li>State your definition out loud</li>
</ol>
<p>xxviii ▼ INTRODUCTION</p>
<ol start="3">
<li>
<p>Uncover the definition and read the given definition out loud (speaking the content as well as seeing the content will enhance your retention)</p>
</li>
<li>
<p>Write key notes in terms of a few words on a 3 x 5 card for the information you have difficulty recalling</p>
</li>
<li>
<p>Carry the card with you for a few days to review this content again. Suggestion: put the card on your survivor in the car and review it at the stoplight or if stopped in traffic.</p>
</li>
</ol>
<p>B. Content review—suggested study techniques</p>
<ol>
<li>
<p>Use a 3 x 5 card to cover the content under a major heading</p>
</li>
<li>
<p>State out loud what 3 or 4 important aspects of the content under the major heading might be or ask yourself a few questions about that content heading. Try to state the items in order of priority.</p>
</li>
<li>
<p>Uncover the content under the major heading. Check your information against that given in the book. See what you forgot or added that may or may not be important.</p>
</li>
<li>
<p>Write key notes in terms of a few words on a 3 x 5 card for the information you have difficulty recalling</p>
</li>
<li>
<p>Carry the card with you for a few days to review this content again. Suggestion: carry the card with you to review whenever you get 5 to 10 minutes free.</p>
</li>
<li>
<p>When you practice prioritizing the content you will enhance your critical thinking skills</p>
</li>
</ol>
<p>C. Exam review—suggested study techniques</p>
<ol>
<li>
<p>For all tests read all the rationales and test-taking tips for missed and correct questions. These often contain pearls of wisdom on how to remember or get a better understanding of the content.</p>
</li>
<li>
<p>Remember to do a relaxation exercise before you begin your questions and repeat the exercise about every 25 questions</p>
</li>
<li>
<p>When you miss a question ask yourself
a. Did I not know the content?
b. Did I misread the question or option(s)?</p>
</li>
<li>
<p>If you miss questions because of a knowledge deficit
a. Make a list on a 3 x 5 card for 3 to 4 days
b. Group or cluster the content according to the steps in the nursing process, the content area, or a system
c. Look up that content
d. Do not look up content after every practice test. A better approach is to cluster the content and look it all up every</p>
</li>
</ol>
<p>INTRODUCTION</p>
<p>3 to 4 days. With this approach you will have better retention into long term memory and the best recall at a later time.</p>
<p>e. Try to identify new ways to approach reading questions and their options</p>
<ol start="5">
<li>If you misread the question or the option(s)</li>
</ol>
<p>a. Try to identify what key words, timeframes, ages, and developmental stages that you may have overlooked</p>
<p>b. Try to identify new ways to approach reading the questions and their options</p>
<p>c. Practice, practice and practice doing questions</p>
<p>d. Practice, practice, and practice doing relaxation before you begin the practice exam, after every 10 to 20 questions, and then at the end of the exam to refresh your thinking and diminish your tenseness or tiredness.</p>
<ol start="6">
<li>
<p>Be sure to do a practice exam with the exact number of questions as your real exam. Note after this exam when you were the most tired, anxious, or nervous. Plan to do a relaxation exercise at these times during the real exam.</p>
</li>
<li>
<p>Your success is directly correlated to your degree of effort to review content as well as relax during the review and exam processes.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="summary">SUMMARY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is hoped that after you have completed your review with the use of this book as your major tool that you have:</p>
<ul>
<li>Maximized your individual performance in review and testing situations.</li>
<li>Identified your personal priorities in preparation for testing.</li>
<li>Sharpened your thinking and discrimination skills for testing.</li>
</ul>
<p>Let this book work for you to make it easy, enjoyable, and effective to review at times that are convenient for you. The short, condensed, and prioritized chapter content may spark new ways to develop your skills in critical thinking and content recall.</p>
<p>It is feedback from students, graduates, and practitioners in nursing that prompted the development and publication of this book. We welcome your comments. We wish you a successful career in the nursing profession and hope that Mosby's Nursing Review Series has made that success a little easier to obtain!</p>
<p>^{}[]</p>
<p>CHAPTER 1</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="essential-elements-for-nursing">Essential Elements for Nursing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#essential-elements-for-nursing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify essential elements common to all nursing specialties.</li>
<li>Discuss the priority content for each essential element.</li>
<li>Incorporate the essential elements into nursing practice.</li>
</ul>
<p>CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="client-education">Client education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#client-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Process of meeting the client's needs for the acquisition of skills, knowledge, or attitudes to deal with a pathological condition in the arenas of primary, secondary, or tertiary health promotion as based on the prior skills, knowledge, and attitudes of the client.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="nursing-process">Nursing process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Process used as the basis of nursing practice. It includes five steps: (1) assess, (2) select nursing diagnosis, (3) plan, (4) intervene, and (5) evaluate.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="essential-elements-in-nursing">ESSENTIAL ELEMENTS IN NURSING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#essential-elements-in-nursing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>I. The two essential elements
A. Nursing process
B. Client education</p>
<p>II. Nursing incorporates these common essential elements irrespective of the level, environment, or client population</p>
<p>III. The nursing process is the priority common thread throughout nursing practice</p>
<p>IV. Client education facilitates clients' behavior changes in areas of primary (preventive), secondary (early diagnosis), and tertiary (restorative, rehabilitative) health promotion</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="nursing-process">NURSING PROCESS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>I. The nursing process has five steps
A. Assess
B. Select nursing diagnosis
C. Plan
D. Intervene
E. Evaluate</p>
<p>THE NURSING PROCESS, ASSESSMENT ▼ 3</p>
<ol>
<li>Nurses follow the nursing process sequence in any initial client contact</li>
<li>Evaluation of the interventions occurs to determine effectiveness or ineffectiveness</li>
<li>If effective results, the client-nurse relationship either terminates or new priorities are set for new client problems</li>
<li>If ineffective results, nurses select the appropriate step(s); at this point in the evaluation process, the sequence of steps is a creative process by nurses as dictated by client need</li>
<li>If a client has unexpected changes during care, nurses typically do further assessment of the situation before implementing actions</li>
<li>Use of these steps is a dynamic, client-centered process</li>
<li>Communication is essential in all phases of the nursing process</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-the-initial-assessment-process">II. The initial assessment process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-the-initial-assessment-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-includes-subjective-and-objective-information">A. Includes subjective and objective information<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-includes-subjective-and-objective-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-subjective-information-elicited-by-questions-such-as">B. Subjective information: elicited by questions such as<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-subjective-information-elicited-by-questions-such-as" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>What is the one item that made you decide to seek help?</li>
<li>What is your major problem today?</li>
<li>When did this start? How long did it last? What relieved it?</li>
<li>Do I need to know any other information that can help me better care for you?</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-objective-information-elicited-through-the-senses">C. Objective information: elicited through the senses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-objective-information-elicited-through-the-senses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Inspection: done initially for the client's respiratory rate, breathing effort, color, and position</li>
<li>Inspection and touch: a handshake of the client elicits
a. Demonstration of respect for the client; reduction of client's anxiety
b. Level of consciousness and the motor ability/strength of client to initiate an appropriate response
c. Pulse assessment for rate and regularity if two-handed technique is used
d. Skin assessment for temperature, color, texture, and moisture</li>
<li>Smell for odors: done simultaneously with inspection</li>
<li>Hearing: asking the initial questions, then auscultating elicits
a. Specific information about the client's perception of the problem
b. Information about the client's emotional reaction to the situation by noting the tone and inflection of the speech</li>
</ol>
<p>CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<p>c. Degree of influence from others based on whether they answer or clarify client's answers to questions
d. Auscultation typically includes the lungs, heart sounds, bowel sounds, and then any vascular sounds such as the carotid arteries or arterio-venous (A-V) fistulas</p>
<ol start="5">
<li>Touch: commonly the approaches to other touch techniques such as percussion or palpation are completed by starting with the problem system then moving to the respiratory, cardiac, and neurological systems followed by the other systems</li>
</ol>
<p>D. In emergency situations, objective information may take precedent over subjective information</p>
<ol>
<li>Airway, breathing, and circulation, the ABCs, may dictate assessment priorities</li>
<li>Deferment of the history and physical assessment of all body systems may take a secondary focus, with priority actions aiming to support the cardiac and respiratory systems</li>
</ol>
<p>E. Subjective information is best obtained from the client, the primary source, or from secondary sources such as the caretaker, family, or friends
F. History can be obtained from prior documentation to expedite the initial contact and conserve client energy
G. Results of the client's assessment act as the foundation for selecting priority nursing diagnoses and the development of an appropriate plan of care
H. In acute- and home-care settings, nurses may limit priorities to two nursing diagnoses for a more realistic, attainable, efficient, and effective approach to client care</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-the-selection-of-nursing-diagnoses">III. The selection of nursing diagnoses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-the-selection-of-nursing-diagnoses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-nursing-diagnoses">A. Nursing diagnoses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-nursing-diagnoses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Are clinical judgments about responses of an individual or family to actual or a risk for threats to health or life situations</li>
<li>Provide the basis for the selection of nursing interventions or referrals to achieve positive outcomes for evaluation</li>
<li>Are designed with a three-part statement; however, in clinical practice the first part is consistently used, but the other parts may not be required as part of the documentation</li>
</ol>
<p>a. The three parts, also referred to as the PES format, are</p>
<p>(1) P = health problem, stated as a nursing problem
(2) E = etiological or related factors
(3) S = the defining characteristics or cluster of signs/symptoms as identified from the assessment data</p>
<p>ASSESSMENT, NURSING DIAGNOSES SELECTION ▼ 5</p>
<p>b. The words <em>related to</em> connect the health problem and the etiological factors
c. The words <em>as manifested by</em> connect the etiological factors and the signs/symptoms
d. Example: urinary elimination—altered <em>related to</em> loss of muscle tone <em>as manifested by</em> incontinence, nocturia, dribbling.
e. A health problem may be an actual or a risk for (formerly potential or high-risk) problem</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-process-to-the-selection-of-nursing-diagnoses">B. Process to the selection of nursing diagnoses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-process-to-the-selection-of-nursing-diagnoses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Assessment data are analyzed and interpreted for priorities in relation to time, for an actual or high-risk problem with respect to what interventions are accountable by nursing
a. In acute care: what needs to be accomplished
(1) In the next 30 to 60 minutes?
(2) In the next 8 hours?
(3) In the next 24 hours?
(4) By discharge from the facility?
b. In other settings such as clinic, home, and outpatient care
(1) What was the priority in the last few visits?
(2) What necessitated this visit?
(3) What has changed to require a reorganization of the priorities?</p>
</li>
<li>
<p>A diagnostic label is selected with or without the phrases <em>related to</em> and <em>as manifested by</em>; institutional documentation policies guide the specific format for each agency</p>
</li>
<li>
<p>In most situations, one or two priority nursing diagnoses are appropriate</p>
</li>
<li>
<p>The ABCs are appropriate to use as a guide for setting priorities</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-the-planning-process">IV. The planning process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-the-planning-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-blueprint-for-nursing-actions-also-called-nursing-orders-or-planned-nursing-interventions-which-are">A. Blueprint for nursing actions, also called nursing orders or planned nursing interventions, which are<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-blueprint-for-nursing-actions-also-called-nursing-orders-or-planned-nursing-interventions-which-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Based on the priorities collected or clustered from the assessment data</li>
<li>Selected in reference to time and resources available</li>
<li>Safe for the client and the nurse</li>
<li>Commonly a combination of independent, interdependent, and dependent actions</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-involves-goal-setting-for-achievement-of-client-outcomes">B. Involves goal setting for achievement of client outcomes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-involves-goal-setting-for-achievement-of-client-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<p>C. May be done cooperatively if client is able to participate
D. Commonly involves some component of education for a client knowledge deficit
E. Commonly dictates client outcomes, which need to be</p>
<ol>
<li>Achieved in a set amount of time</li>
<li>Objective</li>
<li>Realistic</li>
<li>Observable or measurable for changes in client's activity, behavior, or physical state</li>
<li>Used as a standard of measure in the evaluation process</li>
<li>Examples
a. Client outcome: within 48 hours the client will sleep through the night without the need to void
b. Planned interventions
(1) Provide use of the bedside commode before bedtime
(2) Give no liquids after 8:00 P.M.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-the-intervention-process">V. The intervention process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-the-intervention-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actual execution of the planned nursing actions
B. Incorporates supervision, coordination, or evaluation of the delivery of care
C. Includes the recording and exchange of information among different disciplines</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-the-evaluation-process">VI. The evaluation process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-the-evaluation-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Based on client outcomes as identified from the planning process
B. Determination of the degree of effectiveness or ineffectiveness of the interventions taken to achieve the stated outcomes
C. Ongoing throughout the client-nurse relationship
D. Often performed concurrently with other phases of the nursing process rather than as a distinctly individual step
E. May result in the client's reassessment to reorder priorities and set new outcomes, especially if the stated time frame has been exceeded
F. Requires documentation of the date when revisement or resolution of the health problem occurred; may be documented as ongoing
G. Requires timely, accurate, and objective documentation and communication</p>
<p>PLANNING, INTERVENTION, EVALUATION; CLIENT EDUCATION ▼ 7</p>
<p>H. Includes identification of the client’s level of knowledge and degree of willingness to change behaviors, skills, knowledge, or attitudes in any of these areas</p>
<ol>
<li>Diet</li>
<li>Activity</li>
<li>Environment</li>
<li>Equipment</li>
<li>Medications: knowledge of
a. Expected side effects
b. Side effects that are treatable
c. Side effects to report to the physician and within what time frame
d. Length for the course of treatment</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="client-education">CLIENT EDUCATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#client-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I. Client education: the process
A. Integral part of nursing care on either a formal or informal basis
B. Incorporates the use of the nursing process
C. Requires the use of teaching and learning principles
D. Varies with clients according to their life experiences, present situation, and age
E. Includes six main steps</p>
<ol>
<li>Assessment of client education needs or wants</li>
<li>Identification of priorities</li>
<li>Identification of client goals or outcomes: what is needed
a. Behavior changes
b. Skill acquisition
c. Cognitive or attitude changes</li>
<li>Development of a teaching plan
a. Development of learner objectives
b. Determination of the content required for the given situation
c. Determination of the resources and how to use them
(1) Identify the available referral support agencies
(2) Identify the materials available for teaching/learning activities
(3) Investigate whether there is money available for materials, courses, transportation to and from education classes
(4) Estimate the amount of time available versus the amount of time needed to implement the teaching plan</li>
</ol>
<p>8 ▼ CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<p>(5) Decide whether the nurse will initiate and complete the education or refer to another support service for the education</p>
<p>d. Determination of sequence and presentation approach of the content</p>
<ol start="5">
<li>
<p>Implementation of the teaching plan over a stated time frame</p>
</li>
<li>
<p>Evaluation of outcomes with revisions or reteaching as needed</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-client-assessments-for-education">II. Client assessments for education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-client-assessments-for-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1d460449">A. Client’s knowledge base. What does the client know? What does he or she want to know? Respect that some clients desire no information and document that response.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1d460449" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-readiness">B. Readiness<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-readiness" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Emotional</li>
</ol>
<p>a. Which stage of loss does client exhibit?</p>
<p>(1) Denial
(2) Anger
(3) Bargaining
(4) Depression
(5) Acceptance</p>
<p>b. If clients are in denial or anger, education will probably be ineffective; document stage of loss</p>
<ol start="2">
<li>
<p>Motivational: intrinsic motivation, stimulated from within the learner, is preferred to extrinsic motivation, stimulated from outside the learner</p>
</li>
<li>
<p>Experiential climate</p>
</li>
</ol>
<p>a. Values associated with social roles
b. Personal resources and support systems</p>
<p>(1) Family, friends
(2) Finances for medications, equipment
(3) Environmental factors: indoor plumbing, electricity
(4) Prior and current exposure to interactions with the healthcare system and providers
(5) Availability of healthcare services, time versus distance with available transportation</p>
<p>c. Developmental stage</p>
<ol start="4">
<li>Physical</li>
</ol>
<p>a. Clinical status is stable or improved
b. Functional abilities</p>
<p>(1) Hearing, attention span, listening
(2) Vision
(3) Touch and manual dexterity</p>
<p>CLIENT ASSESSMENTS FOR EDUCATION ▼ 9</p>
<p>(4) Reading, level of highest education
(5) Endurance
(6) Short-term memory
(a) Limited in its capacity
(b) Enhanced if distractions are avoided
(c) Enhanced if opportunities are given for repeating or rehearsing the information
(7) Long-term memory
(a) Unlimited in its capacity and duration
(b) Influenced by the rate at which new information is introduced: the best approach is to introduce one new item every 4 to 5 seconds
(c) Enhanced by 20% to 90% if material is incorporated into a story or real-life situation</p>
<ol start="5">
<li>Signs of client’s readiness
a. Beginning behaviors of adaption to the original problem
b. Exhibits awareness of the health problem and its implications
c. Asks direct questions
d. Presents clues that suggest client is seeking information
e. Begins to ask questions about how to handle situations at home
f. Indicators during a teaching session
(1) Client is physically comfortable; basic needs are met
(2) Client readily gives attention; eye contact is made
(3) Client turns off television or asks visitors to leave</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-special-needs-of-clients-for-their-education">III. Special needs of clients for their education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-special-needs-of-clients-for-their-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-interventions-for-low-literacy-clients">A. Interventions for low-literacy clients<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-interventions-for-low-literacy-clients" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Give only simple (basic) information</li>
<li>Present no more than three new points at a given time</li>
<li>Give the most important information first and last</li>
<li>Sequence information in the way the client will use it</li>
<li>Give information the client can use immediately</li>
<li>Use the same words when meanings are the same (e.g., medicine or drug, not both words)</li>
<li>Use small, simple words and short sentences; introduce no more than five new words in one session</li>
<li>Present information at the fifth-grade level or lower</li>
<li>Be concrete and time specific. Example: take two pills at 4:00 P.M.</li>
<li>Ask the client to repeat the information or the skill</li>
<li>Use humor appropriately; be creative</li>
</ol>
<p>CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<ol start="12">
<li>Avoid long explanations</li>
<li>Reward frequently—even for small accomplishments</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-interventions-for-older-clients">B. Interventions for older clients<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-interventions-for-older-clients" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Priority evaluations
a. Establish the degree of functional losses
b. Identify the degree of social support; lack of social support may be an important determinant in the decreased compliance of older adults
c. Identify their habit structures
d. Have an evaluation completed by social services or the business office for the availability of monies</p>
</li>
<li>
<p>Clients with impaired hearing
a. Use low-pitched voice
b. Face client when speaking
c. Use clear, concise terms</p>
</li>
<li>
<p>Clients with impaired vision
a. Use large print and a magnifying glass
b. Black on white or black on yellow paper may be easier for the older clients to read
c. Provide adequate lighting
d. Have client use prescription glasses</p>
</li>
<li>
<p>Clients with limited endurance
a. Keep sessions short (10 to 15 minutes)
b. Schedule the teaching session at a time of day when clients are comfortable and their energy levels are higher
c. Break down the information into small steps
d. The initial session should have only survival-level information</p>
</li>
<li>
<p>Clients with memory loss
a. Provide repeated exposure to same message
b. Provide cues: visual, verbal, written
c. Question frequently
d. Use advanced organizers: "I'm going to tell you 2 ways to give your insulin," "I've told you how to give your insulin by using two methods."</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-learning-theory">IV. Learning theory<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-learning-theory" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-learning-theory-for-adults">A. Learning theory for adults<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-learning-theory-for-adults" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Adult learner is defined as a self-directed, independent person who becomes ready to learn when the need to know or perform is experienced</li>
<li>Adult education is learner centered</li>
<li>Adult education is dynamic, interactive, and cooperative</li>
</ol>
<p>EDUCATION NEEDS; LOW-LITERACY, OLDER ADULTS; LEARNING THEORY ▼ 11</p>
<ol start="4">
<li>The responsibility for success of adult learners is shared by all participants</li>
<li>Adult learners
a. Like to participate in identification of their learning needs, formulation of learning objectives, and evaluation of learning
b. Expect a climate of mutual respect
c. Enter the learning situation with a life-centered, task-centered, or problem-centered approach
d. Are motivated internally to learn in order to increase self-esteem, self-confidence, or seek a better quality of life
e. See the educator as a facilitator rather than a director of the activity</li>
</ol>
<p><strong>B. Learning theory for children</strong></p>
<ol>
<li>Learning programs for children are more subject centered</li>
<li>Design of learning experiences is topic centered</li>
<li>Learning may be more of an external process with emphasis on externally sanctioned approvals for learning such as stars, happy-face stickers</li>
<li>Objective, content development, and evaluation process are teacher controlled</li>
</ol>
<p><strong>C. Factors that interfere with learning</strong></p>
<ol>
<li>Nervousness, anxiety, fear</li>
<li>Too much content at one session</li>
<li>Unfamiliar terms</li>
<li>Complexity of the task</li>
<li>Limited time with too much content, results in rushing</li>
<li>Background noise or other distractions</li>
<li>Fear of the task or information</li>
<li>Frequent interruptions</li>
<li>Inability of an educator to listen to the client</li>
<li>Absence of silence</li>
<li>Left-handed student’s learning skills with right-handed educator</li>
<li>Client is not healthcare oriented; healthcare educator is</li>
<li>Stage of development; older adults may have the attitude that they have lived more or less successfully with their present habits and there is no reason to change now</li>
</ol>
<p><strong>V. Tools for teaching</strong></p>
<p><strong>A. Types of teaching</strong></p>
<ol>
<li>One to one</li>
<li>Group</li>
</ol>
<p>12 ▼ CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<p>a. Homogeneous clients for a topic
b. Heterogeneous clients for a topic</p>
<ol start="3">
<li>Programmed instruction</li>
<li>Guided independent study</li>
<li>Lecture</li>
<li>Role playing</li>
<li>Simulation</li>
<li>Case method</li>
<li>Demonstration/return demonstration</li>
<li>Computerized instruction</li>
</ol>
<p><strong>B. Media for teaching</strong></p>
<ol>
<li>Printed materials: pamphlets, books, crossword puzzles, study guides</li>
<li>Pictorial materials: coloring books, videotapes, cartoons, flowcharts, slides, posters, overhead transparencies, computer simulations</li>
<li>Visual representations: models, actual equipment</li>
<li>Auditory: lectures, paired and small-group discussion, one-to-one interaction, role playing, cassette tapes, simulations</li>
<li>Tactile, kinesthetic: practice with real or simulated items, manipulating or constructing models, playing games, completing worksheets, drawing, preparing charts, bulletin boards, developing a calendar of activities</li>
</ol>
<p><strong>C. Factors to consider in the selection of media/support materials</strong></p>
<ol>
<li>Items readily available within acceptable costs</li>
<li>Suitability: for the purpose of the teaching, to the environment in which the teaching will take place, for the availability of ancillary equipment</li>
<li>Language: appropriate, understandable, and useful to the audience</li>
<li>Materials: accurate and relevant to the intended age group and culture</li>
<li>Print size: readable for the intended age group</li>
<li>Illustrations: accurate and related to the intended audience</li>
</ol>
<p><strong>D. Nurse as a tool of teaching: the nursing professional should</strong></p>
<ol>
<li>Show interest, empathy, and enthusiasm</li>
<li>Practice expert listening skills; listen between the lines not only to what clients say, but how they say it</li>
<li>Note clients’ verbal and nonverbal communication that occurs; be aware of your own communication style</li>
<li>Take a break when the client indicates a need; vary the schedule</li>
<li>Be creative</li>
</ol>
<p>TOOLS FOR TEACHING ▼ 13</p>
<ol start="6">
<li>Keep language simple</li>
<li>Allow enough time for demonstrations and return demonstrations</li>
<li>Summarize at the end with encouragement for any progress, no matter how small</li>
</ol>
<p>E. <strong>Evaluation tips for achievement of education outcomes</strong></p>
<ol>
<li>Evaluation is an ongoing process throughout the entire teaching session</li>
<li>If periodic reassessment of learning indicates no progress, try a different approach</li>
<li>Ask open-ended questions along with specific questions</li>
<li>Ask clients to evaluate themselves</li>
</ol>
<p>F. <strong>Intervention tips for different age groups</strong></p>
<ol>
<li>Pediatrics: the play approach works best with dolls or models; coloring, comic, or storybooks</li>
<li>Teenagers and persons in their 20s: use peer speakers, entertainment, and peer groups and keep in mind that body image and independence are a priority for these age groups</li>
<li>Persons in their 30s to mid-40s: written materials work well with follow-up time to answer questions or clarify information</li>
<li>Persons from mid-40s to early 60s: a few long, single sessions to discuss how the effects of the health problem will interfere with attainment of or plans for lifelong goals</li>
<li>Persons over mid-60s: use short, frequent, one-to-one meetings with material in larger print and keep in mind that maintaining functional abilities is a priority</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="summary">SUMMARY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A working knowledge of the content in Chapter 1, the essential elements for nursing, will enhance the application of the remainder of the content in the review series. Most nursing professionals incorporate the two elements into their practice, which is based on the changing needs of clients who pursue the acquisition of healthcare services and actions to prevent pathological deterioration of the body. The nursing process and client education are intertwined in the areas of primary (preventive), secondary (early diagnosis), and tertiary (restorative, rehabilitative) health promotion.</p>
<p>14 ▼ CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nanda-approved-nursing-diagnoses">NANDA-APPROVED NURSING DIAGNOSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nanda-approved-nursing-diagnoses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Activity intolerance</li>
<li>Activity intolerance, risk for</li>
<li>Adaptive capacity, decreased: intracranial</li>
<li>Adjustment, impaired</li>
<li>Airway clearance, ineffective</li>
<li>Anxiety</li>
<li>Aspiration, risk for</li>
<li>Body-image disturbance</li>
<li>Body temperature, altered, risk for</li>
<li>Bowel incontinence</li>
<li>Breastfeeding, effective</li>
<li>Breastfeeding, ineffective</li>
<li>Breastfeeding, interrupted</li>
<li>Breathing pattern, ineffective</li>
<li>Cardiac output, decreased</li>
<li>Caregiver role strain</li>
<li>Caregiver role strain, risk for</li>
<li>Communication, impaired verbal</li>
<li>Community coping, ineffective</li>
<li>Community coping, potential for enhanced</li>
<li>Confusion, acute</li>
<li>Confusion, chronic</li>
<li>Constipation</li>
<li>Constipation, colonic</li>
<li>Constipation, perceived</li>
<li>Coping, defensive</li>
<li>Coping, family: potential for growth</li>
<li>Coping, ineffective family: compromised</li>
<li>Coping, ineffective family: disabling</li>
<li>Coping, ineffective individual</li>
<li>Decisional conflict (specify)</li>
<li>Denial, ineffective</li>
<li>Diarrhea</li>
<li>Disuse syndrome, risk for</li>
<li>Diversional activity deficit</li>
<li>Dysreflexia</li>
<li>Energy field disturbance</li>
<li>Environmental interpretation syndrome: impaired</li>
<li>Family processes, altered</li>
<li>Family processes, altered: alcoholism</li>
</ul>
<p>NANDA-APPROVED NURSING DIAGNOSES ▼ 15</p>
<p>Fatigue
Fear
Fluid volume deficit
Fluid volume deficit, risk for
Fluid volume excess
Gas exchange, impaired
Grieving, anticipatory
Grieving, dysfunctional
Growth and development, altered
Health maintenance, altered
Health-seeking behaviors (specify)
Home maintenance management, impaired
Hopelessness
Hyperthermia
Hypothermia
Incontinence, functional
Incontinence, reflex
Incontinence, stress
Incontinence, total
Incontinence, urge
Infant behavior, disorganized
Infant behavior, disorganized: risk for
Infant feeding pattern, ineffective
Infection, risk for
Injury, perioperative positioning: risk for
Injury, risk for
Knowledge deficit (specify)
Loneliness, risk for
Management of therapeutic regimen, community: ineffective
Management of therapeutic regimen, families: ineffective
Management of therapeutic regimen, individuals: effective
Management of therapeutic regimen, individuals: ineffective
Memory, impaired
Mobility, impaired physical
Noncompliance (specify)
Nutrition, altered: less than body requirements
Nutrition, altered: more than body requirements
Nutrition, altered: risk for more than body requirements
Oral mucous membrane, altered
Pain
Pain, chronic
Parent/infant/child attachment altered, risk for</p>
<p>CHAPTER 1 ESSENTIAL ELEMENTS FOR NURSING</p>
<p>Parental role conflict
Parenting, altered
Parenting, altered, risk for
Peripheral neurovascular dysfunction, risk for
Personal identity disturbance
Poisoning, risk for
Posttrauma response
Powerlessness
Protection, altered
Rape-trauma syndrome
Rape-trauma syndrome: compound reaction
Rape-trauma syndrome: silent reaction
Relocation stress syndrome
Role performance, altered
Self-care deficit, bathing/hygiene
Self-care deficit, dressing/grooming
Self-care deficit, feeding
Self-care deficit, toileting
Self-esteem, chronic low
Self-esteem disturbance
Self-esteem, situational low
Self-mutilation, risk for
Sensory/perceptual alterations (specify) (visual, auditory, kinesthetic, gustatory, tactile, olfactory)
Sexual dysfunction
Sexuality patterns, altered
Skin integrity, impaired
Skin integrity, impaired, risk for
Sleep pattern disturbance
Social interaction, impaired
Social isolation
Spiritual distress (distress of the human spirit)
Spiritual well-being, potential for enhanced
Suffocation, risk for
Swallowing, impaired
Thermoregulation, ineffective
Thought processes, altered
Tissue integrity, impaired
Tissue perfusion, altered (specify type) (renal, cerebral, cardiopulmonary, gastrointestinal, peripheral)
Trauma, risk for
Unilateral neglect</p>
<p>NANDA-APPROVED NURSING DIAGNOSES ▼ 17</p>
<ul>
<li>Urinary elimination, altered</li>
<li>Urinary retention</li>
<li>Ventilation, inability to sustain spontaneous</li>
<li>Ventilatory weaning process, dysfunctional</li>
<li>Violence, risk for: self-directed or directed at others</li>
</ul>
<p>^{}[]</p>
<p>CHAPTER 2</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="fundamentals-of-pharmacology">Fundamentals of Pharmacology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fundamentals-of-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Discuss the use of the nursing process in drug administration.</li>
<li>Describe drug legislation within the United States.</li>
<li>Describe controlled substances with the categories for controlled agents.</li>
<li>Identify the three types of names for a given drug.</li>
<li>Discuss the various preparations of drugs.</li>
</ul>
<p>19</p>
<p>20 ▼ CHAPTER 2 FUNDAMENTALS OF PHARMACOLOGY</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Brand or trade name</strong>
The proprietary name assigned by the manufacturing company. Example: Tylenol.</p>
<p><strong>Chemical name</strong>
The chemical nomenclature. Example: N-acetyl-para-aminopenol.</p>
<p><strong>Controlled substance</strong>
Drugs that have the potential for physical or psychological dependence.</p>
<p><strong>Enteral route</strong>
By way of the gastrointestinal (GI) tract.</p>
<p><strong>Generic name</strong>
The nonproprietary name assigned by the United States Adopted Names Council. Example: acetaminophen.</p>
<p><strong>Inhalation route</strong>
By way of the respiratory tract with inspired air.</p>
<p><strong>Parenteral route</strong>
By way of any route other than in or through the digestive tract.</p>
<p><strong>Topical route</strong>
By way of a body surface part such as the skin, mucous membranes, or cornea.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-nursing-process">I. Nursing process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-nursing-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-assessment">A. Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>
<p>Obtain a drug history. Include each of the following
a. Prescription drugs
b. Over-the-counter (OTC) drugs
c. Drug specifics
(1) Name
(2) Amount
(3) Route
(4) Frequency
d. Allergies to drugs
Ask: What exactly does the medicine do?</p>
</li>
<li>
<p>Identify diseases in the body system that may affect the following
a. Drug absorption through the gastrointestinal tract, lungs, mucous membranes
b. Distribution by the circulatory system
c. Metabolism by the hepatic system
d. Excretion by the renal system</p>
</li>
<li>
<p>Assess the use of illegal drugs</p>
</li>
<li>
<p>Identify special considerations for the older adult, pediatric, and pregnant client</p>
</li>
</ol>
<p>DRUG ADMINISTRATION AND THE NURSING PROCESS ▼ 21</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-diagnosis">B. Diagnosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Identify nursing diagnosis related to the medications currently in use</li>
<li>Begin a plan of care related to the client's drug regimen, considering side effects, dietary factors, and compliance</li>
<li>Apply nursing diagnoses taken from the North American Nursing Diagnoses Association (NANDA) specific to drug therapy
a. Knowledge deficit related to drug treatment regimen
b. Noncompliance related to side effects of medication or financial difficulty
c. Risk for injury related to side effects of medication
d. Alteration in bowel elimination: constipation related to narcotic use secondary to pain</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-planning">C. Planning<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-planning" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Identify outcome criteria to document patient responses to the drug therapy</li>
<li>Determine the best schedule to administer the prescribed drugs
a. Consider drugs to be administered with and without meals
b. Plan diuretics and laxatives early in the morning to avoid unnecessary interruptions in sleep during the night
c. Identify potential drug interactions and schedule accordingly</li>
<li>Establish nursing observations and interventions for safe drug therapy</li>
<li>Identify necessary client teaching for safe drug administration at home</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-implementation">D. Implementation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-implementation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Provide drug therapy as directed on the plan of care</li>
<li>Prepare the medication with consideration to the proper technique for the ordered route and drug calculation</li>
<li>Consider the five rights of drug administration (Box 2-1)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-2-1-five-rights-of-drug-administration">Box 2-1. Five Rights of Drug Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-2-1-five-rights-of-drug-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Right Drug</li>
<li>Right Dose</li>
<li>Right Route</li>
<li>Right Time</li>
<li>Right Client</li>
</ul>
<p>CHAPTER 2 FUNDAMENTALS OF PHARMACOLOGY</p>
<ol start="4">
<li>Monitor for the effectiveness of the drug and for adverse side effects</li>
<li>Teach appropriate information for home drug therapy</li>
</ol>
<p>E. Evaluation</p>
<ol>
<li>Document the effectiveness of the drug</li>
<li>Document any side effects and the actions taken to relieve them</li>
<li>Determine the client's knowledge of the drug regimen</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-drug-legislation-within-the-united-states-table-2-1">II. Drug legislation within the United States (Table 2-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-drug-legislation-within-the-united-states-table-2-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-controlled-substances">III. Controlled substances<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-controlled-substances" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Defined as drugs that have the potential for physical or psychological dependence
B. The nurse's responsibility is to maintain accurate records of controlled-substance use in health care agencies</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-drug-names">IV. Drug names<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-drug-names" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Chemical name is the chemical nomenclature {N-Acetyl-para-aminopenol}
B. Generic name is the nonproprietary name assigned by the United States Adopted Names Council {acetaminophen}
C. Brand name is the proprietary name assigned by the manufacturing company {Tylenol}
D. Nurses should know both the generic and brand name of a drug in clinical practice and for nursing exams</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-forms-of-medications">V. Forms of medications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-forms-of-medications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Preparations</p>
<ol>
<li>Oral: solids
a. Tablets that are compressed: may be scored
b. Capsules with a dissolvable gelatin sheath
(1) Time-release or sustained-release tablets or capsules have several doses of specially coated medications that dissolve at different times. May have the suffix SA, SR, or extentab. (Box 2-2)
(2) Enteric-coated tablets or capsules dissolve in the intestine instead of in the stomach
(3) Time-release and enteric-coated tablets should not be crushed (Box 2-2)</li>
</ol>
<p>DRUG NAMES, FORMS, LEGISLATION ▼ 23</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="table-2-1-federal-drug-legislation-in-the-united-states">Table 2-1. Federal Drug Legislation in the United States<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#table-2-1-federal-drug-legislation-in-the-united-states" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Date</th><th>Title of Law</th><th>Major Provisions</th></tr></thead><tbody><tr><td>1906</td><td>Pure Food and Drug Act</td><td>Established USP and NP as official standards</td></tr><tr><td>Set standards for proper drug labeling</td><td></td><td></td></tr><tr><td>1912</td><td>Sherley Amendment</td><td>Prohibited fraudulent claims for therapeutic effects of drugs</td></tr><tr><td>1914</td><td>Harrison Narcotic Act</td><td>Legally defined term narcotic</td></tr><tr><td>Regulated and restricted importation, manufacture, sale, or use of opium, cocaine, marijuana, and other drugs likely to produce dependence</td><td></td><td></td></tr><tr><td>1938</td><td>Food, Drug, and Cosmetic Act</td><td>Maintained major provisions of previous laws</td></tr><tr><td>Required that a drug be demonstrated to be safe before it was marketed</td><td></td><td></td></tr><tr><td>Added Homeopathic Pharmacopoeia of the United States as a third standard for drugs</td><td></td><td></td></tr><tr><td>1941-1945</td><td>Amendments to Pure Food and Drug Act</td><td>Required that biologic products used as drugs (e.g., insulin or antibiotics) be certified on a batch-by-batch basis by a government agency</td></tr><tr><td>1952</td><td>Durham-Humphrey Amendment</td><td>Designated certain drugs as legend drugs (must be marked “Caution: Federal Law prohibits dispensing without prescription”)</td></tr><tr><td>Restricted right of pharmacist to distribute legend drugs</td><td></td><td></td></tr><tr><td>1962</td><td>Kefauver-Harris Amendment</td><td>Required proof of efficacy for a drug to remain on market</td></tr><tr><td>Authorized FDA to establish official names for drugs</td><td></td><td></td></tr></tbody></table>
<p>Continued.</p>
<p>CHAPTER 2 FUNDAMENTALS OF PHARMACOLOGY</p>
<p>Table 2-1. Federal Drug Legislation in the United States—cont'd</p>
<table><thead><tr><th>Date</th><th>Title of Law</th><th>Major Provisions</th></tr></thead><tbody><tr><td>1970</td><td>Comprehensive Drug Abuse Prevention and Control Act (or Controlled Substances Act)</td><td>Defined drug dependency and drug addiction</td></tr><tr><td>Classified drugs according to abuse potential and medical usefulness</td><td></td><td></td></tr><tr><td>Established methods for regulating the manufacture, distribution, and sale of controlled substances</td><td></td><td></td></tr><tr><td>Established education and treatment programs for drug abuse</td><td></td><td></td></tr><tr><td>1983</td><td>Orphan Drug Act</td><td>Offered tax relief to companies marketing orphan drugs</td></tr><tr><td>Protected companies for 7 years against competition on nonpatentable orphan drugs</td><td></td><td></td></tr><tr><td>1984</td><td>Drug Price Competition and Patent Term Restoration Act</td><td>Drugs first marketed after 1962 are eligible for abbreviated new drug application</td></tr><tr><td>Generic drugs are more easily introduced</td><td></td><td></td></tr><tr><td>Established guidelines for bioequivalence</td><td></td><td></td></tr><tr><td>Restored up to 5 years of patent protection for time used in drug development</td><td></td><td></td></tr><tr><td>1986, 1988</td><td>National Childhood Vaccine Injury Act</td><td>Private health care providers are required to keep records on adverse events following immunization</td></tr><tr><td>Covers diphtheria, measles, mumps, pertussis, poliomyelitis, rubella, and tetanus toxoids or vaccines</td><td></td><td></td></tr><tr><td>1987</td><td>Prescription Drug Marketing Act</td><td>Bans diversion of prescription drugs from legitimate channels</td></tr><tr><td>Restricts reimportation of drugs from other countries</td><td></td><td></td></tr><tr><td>1988</td><td>Food and Drug Administration Act</td><td>Establishes the FDA within the Department of Health and Human Services</td></tr><tr><td>Sets mechanism for appointing the Commissioner of Food and Drugs</td><td></td><td></td></tr></tbody></table>
<p>Clark, J, Queener, S, and Karb, V: Pharmacological basis of nursing practice, ed 4, St Louis, 1993, Mosby.</p>
<p>GUIDELINES FOR DRUG ADMINISTRATION ▼ 25</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="box-2-2-drug-forms-that-should-not-be-crushed-or-chewed">Box 2-2. Drug Forms That Should Not Be Crushed or Chewed<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-2-2-drug-forms-that-should-not-be-crushed-or-chewed" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Enteric-coated tablets</li>
<li>Sustained-release forms. These often have the following suffixes attached to the drug name:</li>
<li>Dur (Duration)</li>
<li>SR (Sustained Release)</li>
<li>CR (Controlled or Continuous Release)</li>
<li>SA (Sustained Action)</li>
<li>Contin (Continuous)</li>
<li>LA (Long Acting)</li>
<li>Trade names that imply sustained release such as spansules, extentabs, extencaps</li>
<li>Trade names with the b.i.d. (twice a day) abbreviation in the name, such as Theobid, Cardabid</li>
<li>Liquid-containing capsules, although occasionally it may be acceptable to puncture the capsule and squeeze out the contents; consult the pharmacist or manufacturer</li>
</ul>
<p>The name alone may not provide enough information. Consult the pharmacist if in doubt. Some forms that look like sustained forms are not and vice versa. Some capsules containing small, slow-release pellets may be opened, and the pellets sprinkled on applesauce, or gently mixed into liquid or food, but they should not be crushed or dissolved.</p>
<p>Scored tablets may be broken along the scored line but should not be chewed or crushed.</p>
<p>Clark J, Queener S, and Karb, V: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.</p>
<p>c. Lozenges or troches: dissolve in the mouth
d. Powders: must be dissolved in liquid prior to use</p>
<ol start="2">
<li>
<p>Oral: liquids
a. Elixirs, spirits, and extracts: contain alcohol
b. Syrups: contain much sugar
c. Suspensions such as emulsions, gels, and magmas are mixtures that are not dissolved. These must be shaken well before use.
d. Tinctures: portions of drugs mixed in solutions with alcohol
e. Sprays</p>
</li>
<li>
<p>Topical
a. Creams, lotions, and ointments
b. Sprays</p>
</li>
</ol>
<p>26 ▼ CHAPTER 2 FUNDAMENTALS OF PHARMACOLOGY</p>
<p>c. Transdermal disks: medicated; allow for slow absorption of the medication through the skin, usually over a period of 3 to 7 days</p>
<ol start="4">
<li>
<p>Injectable
a. Powders: must be mixed with a diluent
b. Single-dose and multi-dose vials
c. Intravenous fluids</p>
</li>
<li>
<p>Vaginal and rectal
a. Creams and tablets: both
b. Suppositories: both
c. Douches: usually vaginal
d. Enemas: usually rectal</p>
</li>
<li>
<p>Eye and ear
a. Drops
b. Ointments</p>
</li>
<li>
<p>Other
a. Nose drops
b. Inhalation drugs
c. Implanted capsules
d. Insulin pumps</p>
</li>
</ol>
<p>B. Routes of administration</p>
<ol>
<li>
<p>Enteral: by way of the gastrointestinal (GI) tract
a. Oral preparations (PO)
b. Nasogastric tubes
c. Gastrostomy tubes
d. Intestinal tubes</p>
</li>
<li>
<p>Parenteral: by injection
a. Intradermal (ID)
b. Subcutaneous (SC or SQ)
c. Intramuscular (IM)
d. Intravenous (IV)</p>
</li>
<li>
<p>Topical: through the skin
a. Transdermal drug delivery system (TDDS)
b. Skin ointments, creams, gels</p>
</li>
<li>
<p>Inhalation: absorbed through the lungs
a. Oxygen by nasal cannula (NC) or mask in liters/min (L/m) or %
b. Aerosols</p>
</li>
<li>
<p>Mucous membranes: absorbed through the mucous membranes of various parts of the body
a. Eye and ear ointments and drops (gtt)</p>
</li>
</ol>
<p>ROUTES OF ADMINISTRATION ▼ 27</p>
<p>b. Vaginal applications: creams and tablets
c. Rectal suppositories
d. Buccal (BC): in the cheek or mouth
e. Inhalants: nasal drops (gtt)
f. Sublingual (SL): under the tongue</p>
<p>A client with abdominal pain reports to the emergency department. A brief history reveals an allergy to the analgesic morphine sulfate (morphine HP). The nurse should follow through by first asking which of the following questions? a. What other analgesics are you allergic to? b. Have you had this allergy long? c. Exactly what does the morphine do to you? d. Does the morphine make you nauseated?</p>
<p>A client reports to a cardiac rehabilitation session complaining of not feeling well. The nurse questions what is wrong and is told, “I've been having angina for several days.” During further assessment, the client reports that she has not been taking her nitrate because she gets a terrible headache. Which of the following nursing diagnoses is most appropriate? a. Knowledge deficit related to the side effects of nitroglycerin b. Knowledge deficit related to the need for nitrates c. Alteration in comfort: headache related to the side effects of the analgesic d. Noncompliance related to the side effects of nitroglycerin</p>
<p>A nurse's neighbor calls, concerned that the medicine prescribed for her daughter is too big to swallow. After a brief discussion, the nurse discovers that the capsule the child is having trouble swallowing is a sustained-release capsule. The nurse should a. Encourage her to open the capsule and mix it with ice cream b. Explain to her how to crush the medicine and then give it with plenty of liquid c. Explain that sustained-release capsules cannot be crushed; she should call her physician to report that the pills are too difficult to swallow d. Explain that sustained-release capsules cannot be crushed; she should stop the medication and inform her physician at the follow-up visit</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 29</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>Determining the exact nature of the allergic reaction will best help the nurse distinguish an allergy from a common side effect. A listing of all medications the client is allergic to would be more appropriate. The length of time of the allergy is irrelevant. Nausea is a common side effect, not an allergic reaction.</td><td>One strategy is to eliminate responses that are false or not the best. Responses <em>b</em> and <em>d</em> offer little information, since they are yes/no-phrased questions. The question in response <em>a</em> ignores the issue of the morphine allergy. It is a good question but is not the best for the “first” next question, given the situation in the stem. Thus, select response <em>c</em>.</td></tr><tr><td><strong>2. Correct answer: d</strong></td><td></td></tr><tr><td>Headache is a common side effect of NTG and can lead to noncompliance. There is not enough information to determine if responses <em>a</em> and <em>b</em> are true. Nitroglycerin is not an analgesic.</td><td>Responses <em>a</em> and <em>b</em> can be eliminated, since there is no data in the stem to support a knowledge problem. If you read response <em>c</em> too quickly and give the first part of the answer too much emphasis, you may overlook the word “analgesics”; the headache is related to the nitrates, which are not analgesics. Thus, response <em>d</em> is correct. This error of reading too quickly is common for this type of question, especially if you are tired or tense.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>A different medication or a liquid form of the drug needs to be ordered by the physician. Opening the capsule can alter absorption and cause toxicity. Crushing alters the absorption and</td><td>A medication should never be discontinued without notification of the physician. Key words in the stem are “sustained-release capsule.” Responses <em>a</em> and <em>b</em> can be immediately eliminated because of the word clues “open</td></tr></tbody></table>
<p>CHAPTER 2 FUNDAMENTALS OF PHARMACOLOGY</p>
<p>destroys the sustained-released action of the medication.</p>
<p>the capsule" and "crush the medicine." These are never used on time-released or enteric-coated medications. If you have difficulty deciding between responses  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>  and  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> , a clue exists in response  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> — "inform . . . physician at the follow-up visit"; notifying the physician about the medication should be done the day the client decides to stop and no later.</p>
<p>31</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principles-of-drug-therapy">Principles of Drug Therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-drug-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Define the three essential phases of drug action.</li>
<li>Define absorption, distribution, metabolism, and elimination.</li>
<li>Identify factors affecting absorption, distribution, metabolism, and elimination.</li>
<li>Identify factors affecting absorption with each route of medication administration.</li>
<li>Identify factors affecting a client’s response to drug therapy.</li>
<li>Describe the various effects and interactions of drugs.</li>
<li>Describe ways to monitor drug therapy.</li>
</ul>
<p>CHAPTER 3</p>
<p>32 ▼ CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Agonist</strong>
Drug with a certain affinity for a receptor to produce a predictable response. Example: morphine sulfate (Astramorph).</p>
<p><strong>Antagonists</strong>
Drugs that exert opposite actions to others or compete for the same receptor sites. Example: naloxone hydrochloride (Narcan).</p>
<p><strong>Extrapyramidal effect</strong>
Exhibiting movement disorders, especially postural, supporting, static, and locomotor mechanisms similar to those of Parkinson’s disease. Examples: dystonia: impaired muscle tone; akathisia: restlessness, agitation, inability to sit still; akinesia: hypoactivity or nonmovement as in muscular paralysis.</p>
<p><strong>Half-life</strong>
Amount of time required to reduce the plasma drug value to one half of its initial value.</p>
<p><strong>Iatrogenic effect</strong>
Caused by treatment or diagnostic procedures.</p>
<p><strong>Idiosyncracy</strong>
An individual sensitivity to effects of a drug caused by inherited or other bodily constitution factors.</p>
<p><strong>Loading dose</strong>
Dose that may be required to obtain a therapeutic blood level.</p>
<p><strong>Maintenance dose</strong>
Daily dose to maintain a therapeutic blood level.</p>
<p><strong>Side effect</strong>
Also called <strong>adverse effect</strong>—an undesirable or unintended effect of a drug.</p>
<p><strong>Therapeutic dose</strong>
Dose that may be required to produce a desired effect.</p>
<p><strong>Toxic effect</strong>
Undesirable or unintended effect of a drug when the drug’s blood levels are above the therapeutic range. Examples: lanoxin toxicity: serum levels &gt;2.0 ng/ml; lithium toxicity: serum levels &gt;1.5 or 2.0 mEq/L; theophylline toxicity: serum levels &gt;20 µg/ml.</p>
<p><strong>Toxicity</strong>
Blood level above the therapeutic range.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-three-reasons-for-medication-administration">I. Three reasons for medication administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-three-reasons-for-medication-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Treatment: acetylsalicylic acid (aspirin) for fever, digoxin (Lanoxin) for heart failure
B. Cure: antibiotic for infection</p>
<p>PHARMACOKINETICS ▼ 33</p>
<p>C. Maintenance: insulin for diabetes
D. Support: IV fluids, potassium supplements</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-the-study-of-pharmacology-includes-three-areas">II. The study of pharmacology includes three areas<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-the-study-of-pharmacology-includes-three-areas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Pharmacokinetics: the study of how drugs are absorbed, distributed, metabolized, and excreted within the body; think about transport
B. Pharmacodynamics: the study of how the medicine exerts an effect once it reaches the target cell; think about action
C. Pharmacotherapeutics: the study of the use of drugs to treat various illnesses, and the clients’ responses; think about barriers for specific drugs to meet specific needs</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-pharmacokinetics-transport-of-drug">III. Pharmacokinetics: transport of drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-pharmacokinetics-transport-of-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Four Steps</p>
<ol>
<li>Absorption</li>
<li>Distribution</li>
<li>Metabolism</li>
<li>Excretion</li>
</ol>
<p>B. Absorption: what happens to a drug from the time it enters the body until it enters the circulating fluid</p>
<ol>
<li>Mechanisms of absorption
a. Active transport: carriers + energy source
b. Passive transport: without an energy source
c. Pinocytosis: engulfing of the molecule to move it across the cell wall</li>
<li>Variables affecting absorption
a. Absorption surface: irritation to the lining of the stomach, abrasion to the skin
b. Drug formulation: enteric-coated, time-release, liquid versus solid
c. Route of administration: linked to blood flow; IV usually absorbed quicker than IM
d. Circulation: more blood flow increases absorption; less blood flow decreases absorption
e. Pain and stress: can decrease absorption; may be linked to blood flow
f. Hepatic first-pass effect: inactivation of drug by enzymes in the liver before the drug reaches the systemic circulation for distribution
g. Enterohepatic recycling: absorption of drug from the bile into the small bowel and then into the circulating system</li>
</ol>
<p>CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<p>h. Effects of pH in the stomach and small intestines: may increase or decrease absorption rate
i. Drug solubility: drugs must become liquid to be absorbed
j. Motility of the GI tract: may increase or decrease absorption rate
k. Drug interactions: drug to drug and drug to food</p>
<ol start="3">
<li>The different routes of medicine administration affect absorption in various ways (Table 3-1)</li>
</ol>
<p>C. Distribution: ways in which drugs are transported by body fluids to their sites of action</p>
<ol>
<li>
<p>Factors affecting distribution
a. Drug's affinity for
(1) Fatty tissue
(2) Bone
(3) Certain body tissue
b. Amount of blood flow to specific organs</p>
</li>
<li>
<p>Factors related to plasma protein binding
a. Drugs bound to protein albumin are transported and cannot be used until unbound or free
b. Situations that alter protein binding
(1) Hypoalbuminemia: decreased albumin level; in this situation more of a drug may be available with a result of toxic effects, i.e., digoxin
(2) Competition for protein</p>
</li>
<li>
<p>Blood-brain barrier: protects brain by preventing many medications from penetrating. Agents that can penetrate
a. Anesthetics
b. Barbiturates
c. Penicillin G
d. Atropine sulfate (Atropair)
e. Scopolamine hydrobromide (Hyoscine Hydrobromide)</p>
</li>
</ol>
<p>D. Metabolism: the breaking down or detoxification of medications</p>
<ol>
<li>Occurs primarily in the liver</li>
<li>Other sites of metabolism: kidneys, lungs, blood, and intestinal mucosa</li>
<li>Results of metabolism on a drug
a. Converted into a harmless substance
b. Converted into metabolites capable of exerting a therapeutic effect
c. Unchanged
d. Competition resulting in toxicity</li>
</ol>
<p>E. Excretion: process of elimination from the body</p>
<ol>
<li>Occurs primarily in the kidneys</li>
</ol>
<p>DRUG ROUTES AND EFFECTS ON ABSORPTION ▼ 35</p>
<p>Table 3-1. Comparison of Drug Administration Routes and their Effects on Absorption</p>
<table><thead><tr><th>Route</th><th>Effects on Absorption</th></tr></thead><tbody><tr><td>Enteral</td><td>Rapid absorption in small intestine</td></tr><tr><td>Presence of food diminishes absorption</td><td></td></tr><tr><td>Absence of food increases absorption</td><td></td></tr><tr><td>Liquids absorb more rapidly than solids</td><td></td></tr><tr><td>Absorption occurs within 3 to 5 minutes with SL or buccal</td><td></td></tr><tr><td>Increased intestinal motility decreases available time for absorption</td><td></td></tr><tr><td>Absorption through the GI tract may be undependable</td><td></td></tr><tr><td>Parenteral</td><td>IM injection has effects within 10 to 15 minutes</td></tr><tr><td>SQ injection can have effects within 10 to 15 minutes</td><td></td></tr><tr><td>IV requires no absorption and has immediate effects</td><td></td></tr><tr><td>Poor circulation may hinder IM or SQ absorption</td><td></td></tr><tr><td>Shock, edema, trauma, and coolness to tissue slow absorption</td><td></td></tr><tr><td>Massage and heat to tissue increase absorption</td><td></td></tr><tr><td>Topical</td><td>Local application of drugs can have a systemic effect: lidocaine (Xylocaine) + epinephrine (Adrenalin)</td></tr><tr><td>Some medications may be applied locally for a systemic effect: nitrol paste or patch (Nitroglycerin)</td><td></td></tr><tr><td>Scarred or burned skin can hinder absorption</td><td></td></tr><tr><td>Damaged or irritated skin can enhance absorption systemically</td><td></td></tr><tr><td>Inhalation</td><td>May be absorbed systemically: anesthetic agents.</td></tr><tr><td>May be absorbed locally: corticosteroids</td><td></td></tr><tr><td>Absorption is enhanced because of the large surface area</td><td></td></tr><tr><td>Mucous Membranes</td><td>May produce either local or systemic effect</td></tr><tr><td>Rectal route may result in incomplete absorption if feces is present in sigmoid or there are numerous internal hemorrhoids</td><td></td></tr><tr><td>Absorption is rapid through the rectal route because of the large vascularity—acetylsalicylic acid (aspirin)</td><td></td></tr><tr><td>Absorption by the vaginal route is usually enhanced because of the high vascularity</td><td></td></tr></tbody></table>
<ol start="2">
<li>Other excretory sites: sweat glands, feces, saliva, bile, maternal milk, lungs</li>
<li>"Steady State": obtained when absorption equals elimination</li>
</ol>
<p>36 ▼ CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<ol start="4">
<li>
<p>"Half-Life": the amount of time to reduce the plasma concentration by half. Usually takes five half-lives to completely eliminate a drug.</p>
</li>
<li>
<p>Factors affecting elimination
a. Urine pH can enhance or delay excretion
b. Kidney diseases may interfere with drug clearance from the body</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-pharmacodynamics-therapeutic-effect-or-action">IV. Pharmacodynamics: therapeutic effect or action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-pharmacodynamics-therapeutic-effect-or-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Alteration in the cell environment by drugs occurs as follows</p>
<ol>
<li>Physical modification of the cell environment by alteration of the surface tension (stool softeners) or by osmosis (osmotic diuretics)</li>
<li>Chemical modification of the cell environment such as changing the pH of stomach contents (antacids)</li>
</ol>
<p>B. Alteration in the cell function may occur when drugs interact to alter the cellular process. For example, insulin facilitates glucose into the cell.</p>
<p>C. Drug-Receptor Theory is the most commonly accepted mechanism for the action of drugs. Receptors attract drug molecules that attach and fit into the receptor (Lock and Key).</p>
<ol>
<li>Agonist: a drug with a certain affinity for a receptor. Example: morphine sulfate (Astramorph).</li>
<li>Antagonists: drugs that form a complex with the receptor, prohibiting a pharmacologic action or counteracting the effect of other drugs. Example: naloxone hydrochloride (Narcan).</li>
</ol>
<p>D. Effects of drugs</p>
<ol>
<li>Local: usually affecting one body part; effect occurs at the site of application. Example: acyclovir (Zovirax) cream for herpes simplex.</li>
<li>Systemic: may affect more than one body part; effect may not occur at the site of administration. Example: promethazine hydrochloride (Phenergan).</li>
<li>Local and systemic: an agent may be given for its local effect but produce a systemic effect also. Example: lidocaine hydrochloride (Xylocaine) with adrenalin chloride (Epinephrine) SQ.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-pharmacotherapeutic-phase-target-of-medications-and-response-by-clients">V. Pharmacotherapeutic phase: target of medications and response by clients<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-pharmacotherapeutic-phase-target-of-medications-and-response-by-clients" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Factors influencing therapeutic response</p>
<ol>
<li>Decreased muscle mass, total body weight, and fat (20% below or above ideal weight) can affect the dosage. The average adult dose is calculated on half the population weighing 150 pounds between the ages of 16 and 65.</li>
</ol>
<p>PHARMACODYNAMICS, PHARMACOTHERAPEUTICS ▼ 37</p>
<ol start="2">
<li>
<p>Age: clients more prone to drug effects (Table 3-2)
a. Neonates and infants because of immature organs
b. Older adults because of a decrease in the function of organs</p>
</li>
<li>
<p>Disease states or dysfunction of the following systems
a. Circulatory. Example: congestive heart failure.
b. Hepatic. Example: cirrhosis.
c. Renal. Example: renal failure.
d. Gastrointestinal (GI). Example: bowel inflammation or resection.</p>
</li>
<li>
<p>Immunological state: body's ability to form antibodies against medications can result in adverse effects</p>
</li>
<li>
<p>Psychological factors: a client's belief in the effects of the drug (such as a placebo)</p>
</li>
<li>
<p>Environmental factors: temperature and climate can affect dosage</p>
</li>
<li>
<p>Sex of client: females have proportionately less water owing to greater body fat. This is due to the low water content of fat cells; while most body cells are 70% to 80% water, fat cells are primarily composed of triglycerides.</p>
</li>
<li>
<p>Genetics: enzymes and acetylation rates are determined genetically, and alterations can cause toxicity</p>
</li>
</ol>
<p><strong>B. Drug effects and interactions</strong></p>
<ol>
<li>Primary effect: that which is intended</li>
<li>Secondary effect: any effect other than those intended
a. Drug allergy
(1) Unique tissue response. Example: dermatitis.
(2) Anaphylaxis: reaction within minutes that requires immediate attention
(3) Serum sickness: reaction one week after administration of a drug
b. Idiosyncracy: an individual sensitivity to effects of a drug caused by inherited or other bodily constitution factors. Example: malignant hyperthermia after receiving general anesthetics.
c. Side effect (also called adverse effect): an undesirable or unintended effect of a drug. Examples: nausea or insomnia.
d. Blood dyscrasias: anemias, leukopenia, thrombocytopenia
e. Photosensitivity: an abnormal reaction to light, particularly sunlight. Example: sunburn or puritus after a short time in the sun.
f. Extrapyramidal effect: exhibiting movement disorders similar to Parkinson's disease. Example: dystonia, akathisia, and akinesia.
g. Toxicity: blood level above the therapeutic range. Example: digitalis (Lanoxin) toxicity.</li>
</ol>
<p>38</p>
<table><thead><tr><th>Obstetrician</th><th>Obstetrician</th><th>Other Adult</th><th>Pediatric</th><th>Pregnant</th></tr></thead><tbody><tr><td>Absorption</td><td>Delayed, but more complete</td><td>Disposition</td><td>Exaggerated as a result of lack of gastric acidity and to shorter intestines</td><td></td></tr><tr><td>Impeded somewhat from a larger body surface</td><td></td><td></td><td></td><td></td></tr><tr><td>IM delayed</td><td></td><td></td><td></td><td></td></tr><tr><td>Enteral route unpredictable</td><td>Delayed because of decreased motility and prolonged gastric emptying</td><td></td><td></td><td></td></tr><tr><td>Distribution</td><td>Low albumin could create problem with plasma protein binding</td><td></td><td></td><td></td></tr><tr><td>Could cause toxicity</td><td></td><td></td><td></td><td></td></tr><tr><td>Altered because of less lean mass, less body water, greater body fat</td><td>Distribution</td><td>Protein binding may be a problem—greater chance of toxicity because of low albumin levels</td><td>Decreased protein binding because of decreased protein level</td><td></td></tr><tr><td>Metabolism</td><td>Decreased because of diseases and changes due to age, higher blood concentration and less excretion causes greater chances of toxicity</td><td>Metabolism</td><td>Immature liver and metabolism may be altered—best to give drugs based on body weight to avoid toxicity</td><td>Lower because of decreased blood flow to liver</td></tr><tr><td>Excretion</td><td>Less excretion from decreased glomerular filtration rate</td><td>Excretion</td><td>Delayed as a result of immature kidneys</td><td>Greater excretion from greater renal perfusion</td></tr></tbody></table>
<p>39</p>
<p>Considerations</p>
<ul>
<li>Polypharmacy: the use of a number of different drugs by a patient who may have one or several health problems</li>
<li>Multiple medications can cause many problems in absorption, distribution, metabolism and/or excretion</li>
<li>Higher chance of drug-to-drug interactions</li>
<li>Compliance may be a problem due to forgetfulness, cost, ability to manipulate lids of medication bottles or equipment such as syringes, aerosols, and inability to see clearly</li>
</ul>
<p>Calculate dosage by body surface area (BSA) or mg/kg
Nursing implications</p>
<ol>
<li>Be honest about pain</li>
<li>Allow choice of bandage</li>
<li>Assure that crying is all right</li>
<li>Tell how long procedure should last or if it will hurt</li>
<li>Offer comfort (pacifier, bottle, favorite toy)</li>
<li>Use age-appropriate words and a brief explanation</li>
<li>Prepare all medication in advance</li>
<li>Keep needle out of sight</li>
<li>Solicit parents' help</li>
<li>Act quickly—do not be nervous</li>
<li>Position child correctly</li>
</ol>
<p>FDA rating of drugs for effects on pregnancy
A—No risk
B—No risk evident in human studies or animal studies
C—Risk cannot be ruled out
D—Positive evidence of risk exists
X—Contraindicated in pregnancy</p>
<p>Many drugs pass to infants through maternal milk
Teratogenes is the major concern
1st trimester
Placental barrier is not a protective mechanism
Common ingestants such as alcohol, caffeine, and illegal drugs can cause serious complications.
Fetal Alcohol Syndrome (FAS) can be a side effect of alcohol consumption: a set of congenital psychological, behavioral, cognitive, and physical abnormalities; typical are limb, cardiovascular defects, and retarded development and craniofacial defects</p>
<p>CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<p>h. Teratogenic: causing harm to the fetus. Example: fetal alcohol syndrome (FAS).</p>
<ol start="3">
<li>
<p>Drug and food interactions occur. Example: penicillin G potassium (Pentids) is destroyed by food in the stomach.</p>
</li>
<li>
<p>Drugs may interact with other drugs</p>
</li>
</ol>
<p>a. Synergistic effect: a substance that augments or adds to the activity of another substance or agent. Example: ethanol (alcohol) and diazepam (Valium).</p>
<p>b. Additive effect: the combined effect of drugs that produces an enhanced effect greater than the sum of their separately measured individual effects. Example: acetaminophen (Tylenol) + codeine (Tylenol no. 3).</p>
<ol start="5">
<li>
<p>Placebo effect: a physical or emotional change occurring after a substance is taken or administered that is not the result of any special property of the substance. Example: sodium chloride (normal saline) in place of a narcotic.</p>
</li>
<li>
<p>Dependency</p>
</li>
</ol>
<p>a. Physical: the need for continued use of a substance to avoid abstinence symptoms. Example: ethanol (alcohol) used to avoid delirium tremors (DTs).</p>
<p>b. Psychological: the craving or desire to continue use of a substance in order to meet the demands of everyday life. Example: diazepam (Valium).</p>
<ol start="7">
<li>Tolerance: the need for increasing amounts of a substance to produce the same effect. Example: caffeine.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-monitoring-drug-therapy">VI. Monitoring drug therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-monitoring-drug-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Drug therapy goal is to maintain a therapeutic drug level. Examples:</p>
<ol>
<li>Digoxin (Lanoxin) level of 0.8 to 2.0 ug/ml</li>
<li>Theophylline ethylenediamide (Aminophylline) level of 10 to 20 ug/ml</li>
</ol>
<p>B. Loading dose may be required to obtain a therapeutic blood level. Most common with the following</p>
<ol>
<li>Initial digitalization</li>
<li>Urinary antiseptics</li>
<li>Anticonvulsants</li>
<li>Antidysrhythmics</li>
<li>Antibiotics</li>
<li>Bronchodilators—especially aminophylline</li>
</ol>
<p>C. Maintenance dose is the daily dose to maintain a therapeutic blood level</p>
<p>LEVELS: THERAPEUTIC, LOADING, TOXIC, PEAK, TROUGH ▼ 41</p>
<p>D. Toxicity occurs when the drug dose is greater than what is needed for a therapeutic level. Low plasma protein levels and hepatic and renal dysfunction may contribute to drug toxicities. Clients usually exhibit specific findings.</p>
<ol>
<li>For theophylline, first nausea then tremors</li>
<li>For digoxin, anorexia, nausea, and vomiting as initial findings</li>
</ol>
<p>E. The smallest drug dose needed to produce an effect is measured as the Minimal Concentration Level (MCL)</p>
<p>F. A blood test may be ordered to measure the following</p>
<ol>
<li>
<p>Plasma concentration level
a. Digoxin (Lanoxin)
b. Theophylline (Aminophylline)
c. Lithium carbonate (Lithium)
d. Gentamicin sulfate (Garamycin) or any aminoglycoside</p>
</li>
<li>
<p>Peak level: when drug exerts its greatest concentration; usually obtained for IV antibiotics one hour after dose is completely infused; insulin depends on specific type: fast acting is 2 to 4 hours, intermediate acting is 6 to 12 hours</p>
</li>
<li>
<p>Trough level: when drug is at its lowest concentration before next dose; usually antibiotics</p>
</li>
</ol>
<p>G. The relationship of various concentration levels is demonstrated in Figure 3-1</p>
<p><img src="assets/images/image-20251221-7ce36d62.jpeg" alt="img-1.jpeg"></p>
<p>Figure 3-1. Onset, peak, and trough levels in relation to minimal, therapeutic, and toxic blood levels. (Adapted from Baer C., and Williams B: Clinical pharmacology and nursing, ed 2, St Louis, 1992, Mosby.)</p>
<p>CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A nurse applies a medication in the form of an ointment to a client's rash. Shortly after applying the ointment, the nurse begins to feel a burning sensation on the hand and notices that it has a reddened area. The nurse then sees some ointment next to the reddened area and realizes that this drug reaction is a (an)</li>
</ol>
<p>a. Systemic effect
b. Local effect
c. Idiosyncrasy
d. Synergistic effect</p>
<ol start="2">
<li>The nurse must monitor factors affecting drug action. Which of the following clients has physiologic factors that most significantly determine and modify drug activity?</li>
</ol>
<p>a. Mr. Carver, age 45, an alcoholic with an ulcer
b. John, age 18, a large boy who fractured his leg and wrist in an accident
c. Mr. Cannon, age 89, who is a frail, underweight man with high blood pressure and heart disease
d. Susie, age 12, who has just been diagnosed with leukemia</p>
<ol start="3">
<li>A client who has received an initial dose of an antibiotic shows signs of acute respiratory distress within minutes. Which is the most appropriate documentation to describe the situation?</li>
</ol>
<p>a. Idiosyncratic reaction
b. Anaphylactic reaction
c. Serum sickness
d. Cumulative effect</p>
<ol start="4">
<li>The normal therapeutic range for the drug theophylline is 10 to 20 mcg/dl. A client has a serum level of 24. This level would be considered</li>
</ol>
<p>a. Tolerance
b. A high trough level
c. Exaggerated peak
d. Toxic</p>
<ol start="5">
<li>The nurse is caring for a client who has hypoalbuminemia. The nurse is concerned for which of the following reasons?</li>
</ol>
<p>a. There may be difficulty with elimination of a drug
b. Excess free drug may result in toxicity
c. A reduction in a drug effect may occur
d. Excess bound drug may result in toxicity</p>
<p>REVIEW QUESTIONS ▼ 43</p>
<ol start="6">
<li>
<p>A client has had most of the small intestine removed. The nurse would be most concerned about drug
a. Excretion
b. Absorption
c. Metabolism
d. Distribution</p>
</li>
<li>
<p>A client is currently maintained on a medication that is protein bound. A second drug that is more highly protein bound has been prescribed. What is likely to be the effect if these medications are administered?
a. The second drug will produce a greater effect than the first
b. The first medication will be inactivated
c. Toxic effects may occur from the first drug
d. The second drug will have a synergistic effect on the first</p>
</li>
<li>
<p>Which variable will decrease the absorption of an oral drug?
a. Increased surface area of the small intestine
b. Reduced surface area of the small intestine
c. Reduced stress
d. Increased splanchnic blood flow</p>
</li>
</ol>
<p>44 ▼ CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>The burning indicates a reaction from contact with the skin and a local reaction. A systemic effect would require absorption through the circulatory system and may be exhibited by a headache or nausea. An idiosyncracy is an unusual response, usually more on an individual basis. A synergistic effect involves the combination of two drugs.</td><td>Use a common sense approach—“ointment next to the reddened site” is a local effect. Don’t select terms that you can’t recall such as options c or d. Go with what you know!</td></tr><tr><td><strong>2. Correct answer: c</strong></td><td></td></tr><tr><td>His hypertension, heart disease, and weight greatly influence drug activity. In option a, the alcohol and ulcer can affect absorption, but more information is needed. In option b, the client has no significant factors that will modify drug activity. Leukemia could lower the resistance, but more information is needed in option d.</td><td>A common sense approach would also work here; the very young and the very old are more at risk for complications. The youngest given age is 12 and the oldest is 89. Look at the number of variables given for each; the young person has one and the older client has four, so c is the best choice.</td></tr><tr><td><strong>3. Correct answer: b</strong></td><td></td></tr><tr><td>The description of “acute” and “within minutes” signals this answer as anaphylactic. Respiratory distress as an anaphylactic response is not unusual to antibiotics,</td><td>Refer to rationale under response b. Be cautious to avoid an emotional response that may block your thinking process since you might not document the situation with terms of this type.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 45</p>
<p>especially penicillins. The response may occur with an initial dose or with later doses. Idiosyncratic means unusual and specific to an individual. Serum sickness usually manifests within a week after a medication administration. The “initial” dose indicates that the medication is being administered for the first time. A cumulative effect needs multiple doses.</p>
<ol start="4">
<li>Correct answer: d</li>
</ol>
<p>Toxicity occurs when the level is greater than the highest number indicated. (See Figure 3-1.) An increased dose is not indicated from the information in the stem. The trough level is the amount in the circulatory system before the next dose; it may be below the minimal dose. No peak time is indicated from the information to determine if it is exaggerated.</p>
<p>Remember that Toxic levels are above the Therapeutic’s maximum number. With theophylline the clinical findings would first be nausea, and later, Tremors. Another approach, if you have no idea of the correct response, is to cluster the first three responses under “normal.” In response d “toxic” indicates abnormal, so select it.</p>
<ol start="5">
<li>Correct answer: b</li>
</ol>
<p>A low albumin level allows more unbound drug to circulate in the body and leads to toxicity. A low albumin level does not indicate elimination problems. An increase in the drug effect would be seen. Excess bound drug would result in a reduction in the drug effect.</p>
<p>Eliminate responses a and c because of the key words “elimination” and “effect”; note that the remaining responses have the similar words, “excess . . . result in toxicity.” To decide between responses b and d, use common sense: if free drug is available, there will be more action than with the bound drug. Thus response b is best.</p>
<p>46 ▼ CHAPTER 3 PRINCIPLES OF DRUG THERAPY</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-b">6. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Many drugs are absorbed through the small intestine. The kidney is the main organ involved in elimination. The liver is the main organ involved in metabolism. Plasma protein and the circulatory system are the main elements of concern for drug distribution.</p>
<p>Recall the normal sequence of medication delivery from external and internal: 1. absorption, 2. distribution, 3. metabolism, 4. excretion. The first three steps can be remembered in alphabetical order. Common sense dictates that excretion occurs last. Refer to the rationale.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-c">7. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>More of the first drug will remain free, or unbound, and therefore can produce toxic effects. The second drug will compete to bind more with the protein and produce a lesser effect if it is more highly bound since less of the second drug will be free or unbound. Competition does not necessarily cause inactivation. Response <em>d</em> does not provide enough information.</p>
<p>If you have no idea of the correct answer, select the severest or most detrimental situation. The situations are, in option <em>a</em>—a greater effect, in option <em>b</em>—inactivated, in option <em>c</em>—toxic effects and in option <em>d</em>—synergistic effect. Select option <em>c</em>, toxic effects are the worst in the given choices.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-b">8. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Less intestinal surface area or time in the small intestine will decrease absorption. Example: diarrhea. Increased surface area will increase absorption. Increased stress will most likely decrease absorption. Increased blood flow will increase absorption.</p>
<p>Use common sense; decreased surface area results in decreased absorption. If you had no idea of a correct response, try matching the theme in the stem “decreased absorption” with the same in the responses—responses <em>b</em> and <em>c</em>. Then make an educated guess that reduced stress means the body is relaxed and more absorption would occur; thus, select response <em>b</em>.</p>
<p>CHAPTER 4</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="administration-of-medications">Administration of Medications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#administration-of-medications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify general principles in the administration of medications.</li>
<li>Describe nursing practices that help the nurse achieve the “five rights” of administration of medications.</li>
<li>Identify key principles for giving medications by oral, injectable, nasogastric, intravenous, and topical routes.</li>
<li>Identify the size of needle or cannula and type of syringe for injections.</li>
<li>Locate different sites for giving intramuscular injections.</li>
<li>Calculate medication dosages using various formulas.</li>
</ul>
<p>47</p>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Airlock</strong>
Small amount of air, 0.2 to 0.5 cc, added to the syringe after the medication is accurately measured; it enables the clearing of all of the drug from the needle after the medication is injected.</p>
<p><strong>Extravasation or infiltration</strong>
The process whereby a fluid or drug passes into the tissues with findings of pain, swelling, coolness, and a pale color at the infiltration site.</p>
<p><strong>Phlebitis or thrombophlebitis</strong>
Inflammation of a vein, often accompanied by a clot, with findings of pain, swelling, redness, and warmth along the inflamed vein.</p>
<p><strong>Tissue necrosis</strong>
Localized tissue death that occurs in groups of cells in response to disease or injury, for example, from an infiltrated, highly caustic, or vasoconstrictive drug such as norepinephrine (Levophed).</p>
<p><strong>Z-track</strong>
Technique for injecting preparations into the muscle without tracking residual medication through sensitive tissue (Figure 4-6).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-general-principles-for-medication-administration">I. General principles for medication administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-principles-for-medication-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Remember the five rights of medication administration</strong></p>
<ol>
<li>Right drug</li>
<li>Right dose</li>
<li>Right route</li>
<li>Right time</li>
<li>Right client</li>
</ol>
<p><strong>B. Always check for client allergies</strong></p>
<p><strong>C. Check all medications three times</strong></p>
<ol>
<li>When locating in the cart or on the shelf</li>
<li>When pouring or preparing</li>
<li>Before returning to cart or shelf (or before giving a unit dose)</li>
</ol>
<p><strong>D. Check all medications listed on the Medication Administration Record (MAR) against the chart orders at least once per shift</strong></p>
<p><strong>E. Never give medication another staff member has prepared</strong></p>
<p><strong>F. Sign controlled substance wastage that has been witnessed</strong></p>
<p><strong>G. Give medications within 30 minutes before or after the time scheduled if unable to give at the scheduled time</strong></p>
<p>GENERAL PRINCIPLES; DRUG ADMINISTRATION BY INJECTION ▼ 49</p>
<p>H. Identify clients by checking their identification bands and, if possible, ask them to speak their names. Ask parents to state children’s names.</p>
<p>I. Always double-check medications questioned by clients. (They are often right!)</p>
<p>J. Wash your hands prior to medication preparation and between clients</p>
<p>K. Use gloves when necessary to protect self from contamination or to avoid absorbing the medication through the skin</p>
<p>L. Assess the client according to the medication administered</p>
<p>M. Never give an unfamiliar medication. Question any unusual route, dosage, or combination of medications.</p>
<p>N. Sign out all controlled substances</p>
<p>O. In the narrative, document all prn drugs, any necessary assessments, unusual findings, the evaluation of the drug’s effectiveness, and the degree of the desired effect</p>
<p>P. Discard needles, gloves, and alcohol preps in containers clearly marked hazardous waste</p>
<p>Q. Check expiration dates of medications and IV fluids</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-administration-by-injection">II. Administration by injection<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-administration-by-injection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Three sites include the following</p>
<ol>
<li>Intramuscular (IM): into a muscle</li>
<li>Subcutaneous (SC or SQ): into the subcutaneous or fatty tissue</li>
<li>Intradermal (ID): into the dermis</li>
</ol>
<p>B. Locating sites (Figures 4-1 to 4-5)</p>
<p><img src="assets/images/image-20251221-507e6bf9.jpeg" alt="img-2.jpeg"></p>
<p>Figure 4-1. To define vastus lateralis and rectus femoris muscle sites, place one hand below patient’s greater trochanter and one hand above knee. Space between two hands declines middle third of underlying muscle. Rectus femoris is on anterior thigh; vastus lateralis is on lateral thigh. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<p><img src="assets/images/image-20251221-829f865d.jpeg" alt="img-3.jpeg">
Figure 4-2. To locate ventrogluteal muscle injection site, place palm of hand on greater trochanter of femur. Make V with fingers, with one side running from greater trochanter to anterosuperior iliac spine and other side running from greater trochanter to iliac crest. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p><img src="assets/images/image-20251221-42432798.jpeg" alt="img-4.jpeg">
Figure 4-3. Deltoid muscle injection site roughly forms inverted triangle, with acromion process as base. Muscle may be visible in muscular patients. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p>KEY PRINCIPLES—INJECTIONS ▼ 51</p>
<p><img src="assets/images/image-20251221-6f75aaf7.jpeg" alt="img-5.jpeg"></p>
<p><img src="assets/images/image-20251221-f0a9d495.jpeg" alt="img-6.jpeg">
Figure 4-4. Two accepted methods for defining dorsogluteal injection site. A, Client's buttocks can be divided on one side into imaginary quadrants. Center of upper outer quadrant should be used as injection site. B, Nurse locates by palpation posterior superior iliac spine and greater trochanter, then draws imaginary line between them. Injection site up and out from that line should be used. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p><img src="assets/images/image-20251221-b5c9d659.jpeg" alt="img-7.jpeg">
Figure 4-5. Commonly used subcutaneous injection sites. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p><img src="assets/images/image-20251221-f989bc7a.jpeg" alt="img-8.jpeg"></p>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-angles-of-injections">C. Angles of injections<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-angles-of-injections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Intradermal: 15 degrees</li>
<li>Subcutaneous: 45 or 90 degrees</li>
<li>Intramuscular: 90 degrees</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-key-principles">III. Key principles<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-key-principles" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-oral-route">A. Oral route<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-oral-route" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Avoid touching tablets when transferring into a cup</li>
<li>Do not crush sustained-release or enteric-coated tablets</li>
<li>Assess the client’s ability to swallow and the presence of a gag reflex</li>
<li>Assess whether client has swallowed the tablet</li>
<li>Elevate the head of the bed at least 60 degrees to administer</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-injections">B. Injections<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-injections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Know which medications should be given Z-track, usually oil-based, irritating, or large amounts of medications. This is a technique to prevent medication from leaking into the subcutaneous tissue (Figure 4-6).</li>
</ol>
<ul>
<li>a. Use 0.5 cc airlock: small amount of air added to the syringe after the medication is accurately measured to clear all of the drug from the injecting needle</li>
<li>b. Change the needle after drawing up the medication</li>
</ul>
<ol start="2">
<li>Recommended for children not yet walking is the vastus lateralis site</li>
<li>Always aspirate before injecting medications. If blood returns, remove the needle and discard the medication. For SQ</li>
</ol>
<p><img src="assets/images/image-20251221-ef254477.jpeg" alt="img-9.jpeg">
Figure 4-6. A, In Z-track intramuscular injection, skin is pulled laterally, then injection is administered. B, After needle is withdrawn, skin is released. Technique helps prevent medication from leaking. Clark J, Queener S, &amp; Karb V: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.</p>
<p>KEY PRINCIPLES—ALL ROUTES ▼ 53</p>
<p>medications such as heparin sodium (Heparin), aspiration is not recommended.</p>
<ol start="4">
<li>
<p>Use an airlock 0.2 cc for injections that are not Z-track. No airlock is needed for intradermal. The use of an airlock 0.2 cc for SQ is the decision of the nurse. However, consistency should be maintained in the use of the airlock so that the dosage given to the client is not altered. Examples: insulin, heparin sodium (Heparin).</p>
</li>
<li>
<p>Must produce a bleb for intradermal</p>
</li>
<li>
<p>Use the deltoid for 1 cc or less. The dorsal gluteal can tolerate a maximum of 5 cc per one site of injection.</p>
</li>
<li>
<p>Massage increases the absorption of medication. Heparin sodium (Heparin) SQ should not be massaged to prevent bruising.</p>
</li>
<li>
<p>Know which medications (usually oil-based) cannot be mixed IM. Example: diazepam (Valium).</p>
</li>
<li>
<p>Change the needle for irritating medications. Example: iron dextran (Imferon).</p>
</li>
<li>
<p>Penicillin IM is given Z-track, measured in “million units,” and given with no. 16 or no. 18 gauge, 2- to 3-inch needle</p>
</li>
</ol>
<p>C. Nasogastric (NG): a tube passed through the nose into the stomach; gastrostomy (G-tube): tube inserted into the stomach</p>
<ol>
<li>
<p>Wear gloves</p>
</li>
<li>
<p>Be sure medication can be crushed to mix with water for instilling in an NG tube. Liquid forms are available for some medications.</p>
</li>
<li>
<p>Check placement of the tube before instillation of any medications</p>
</li>
<li>
<p>Follow the medication with 30 to 60 cc of tap water to flush tube</p>
</li>
</ol>
<p>D. Other routes</p>
<ol>
<li>Vaginal</li>
</ol>
<p>a. Wear gloves</p>
<p>b. Offer the client a sanitary pad for comfort after application</p>
<p>c. Wash the applicator with warm water and soap. Applicators can be reused.</p>
<ol start="2">
<li>Rectal</li>
</ol>
<p>a. Wear gloves</p>
<p>b. Use a water-soluable lubricant such as K-Y Jelly</p>
<p>c. Instruct the client not to expel the suppository immediately after application and to try to retain for at least 30 minutes</p>
<ol start="3">
<li>Ear drops</li>
</ol>
<p>a. Pull pinna back and down for children under age 5, pull pinna back and up for adults—remember, “grow-up” and “pull-up”</p>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<p>b. Keep the dropper aseptic; avoid touching the ear
c. Allow the drop to slide down the wall of the ear canal to decrease sudden discomfort of medication falling on eardrum
d. Instruct clients to lie on their sides or keep their heads tilted to the side for 5 to-10 minutes
e. Cotton may or may not be recommended after instillation of the drops</p>
<ol start="4">
<li>Eye drops and ointments</li>
</ol>
<p>a. Instill in the lower lid with lower lid everted while patient looks up and slightly tilts head backwards with hyperextension of the neck (Figure 4-7)
b. Avoid touching the dropper on the eyelid
c. Hold pressure on the lacrimal sac for 1 to 3 minutes after instillation to decrease risk of sinus and systemic absorption
d. Wait 2 to 3 minutes before instilling another drop</p>
<ol start="5">
<li>Topical</li>
</ol>
<p>a. Use gloves for application of creams
b. Date the outside of transdermal patches
c. Apply a clear plastic wrap over nitroglycerin (NTG) ointment paper, which will increase the absorption
d. Rotate sites to prevent irritation to the skin; cleanse old site after patch removal</p>
<p><img src="assets/images/image-20251221-c7aba6cd.jpeg" alt="img-10.jpeg">
Figure 4-7. Administering ophthalmic ointment. To instill ointment, gently pull lower lid down as patient looks upward. Squeeze ophthalmic ointment into lower sac. Avoid touching tube to eyelid. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p>KEY PRINCIPLES—IV ROUTE ▼ 55</p>
<p>e. Do not shave hairy areas because shaving may inflame the skin, which then increases absorption</p>
<p>E. Intravenous (IV): into a vein</p>
<ol>
<li>
<p>Know how fast an intravenous push (IVP) should be given or an intravenous piggyback (IVPB) should be run. The literature identifies certain limits for some IVP medications. Most IVP medications should be given over at least 1 to 3 minutes, IVPB over 30 minutes.</p>
</li>
<li>
<p>Use sterile technique for all forms of IV administration</p>
</li>
<li>
<p>Wear gloves during administration to protect self from blood-borne diseases</p>
</li>
<li>
<p>Monitor for signs and symptoms of</p>
</li>
</ol>
<p>a. Phlebitis: inflammation of a vein: redness, warmth, pain
b. Infiltration: when the fluid passes into the tissue: pallor, edema, coolness, decreased IV flow</p>
<ol start="5">
<li>
<p>Do not rely on an IV pump alone; check the accuracy of the flow rate</p>
</li>
<li>
<p>Cleanse the ports on the IV tubing with a disinfectant before using the port for an IVP or IVPB; if needleless system, discard used caps and apply sterile ones</p>
</li>
<li>
<p>Never push medicines through a difficult or clogged IV line</p>
</li>
<li>
<p>Know which medications can and cannot be mixed together. If medications do not mix, flush with sterile water or normal saline (NS) before administering, or use another site. Example: diazepam (Valium) cannot be mixed with any other medications or diluted with NS.</p>
</li>
<li>
<p>Know the hospital protocol for rotating IV peripheral sites; usual recommendation is every 72 hours</p>
</li>
<li>
<p>Prime the IV line before beginning infusion and include all ports</p>
</li>
<li>
<p>Know which medications need filters. IV substances usually not filtered.</p>
</li>
</ol>
<p>a. Lipids
b. Amphotericin B
c. tPA Activase
d. Insulin
e. Nitroglycerine</p>
<ol start="12">
<li>Monitor for common complications of IV therapy</li>
</ol>
<p>a. Infiltration or extravasation: the process whereby a fluid or drug passes into the tissues
b. Thrombophlebitis: inflammation of a vein, often accompanied by a clot</p>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<p>c. Pain
d. Fluid overload: excess accumulation of intravascular fluid; may be manifested by pulmonary edema
e. Infusion-related infection: contamination of the IV system, site, or solution; manifested by purulent drainage, cellulitis, erythema, pain, thrombophlebitis
f. Tissue necrosis: localized tissue death that occurs in groups of cells in response to disease or injury</p>
<ol start="13">
<li>Avoid taping over the needle; insertion site needs to be easily viewed at all times</li>
<li>Know care differences for IV central lines—major action is to prevent air embolism with tubing change by closing clamp near insertion site, have client bear down or hold breath, (Valsalva maneuver) and then change tubing</li>
</ol>
<p>F. Venous Access Device (Venous Access Port—VAP): Internal surgically implanted catheter placed in the chest wall, abdomen, or antecubital area of the arm designed for continuous access to the venous system. Examples: Port-a-Cath, Infuse-a-Port, Mediport, Chemo-Port.</p>
<ol>
<li>Secure the implanted device with two fingers before injecting (Figure 4-8)</li>
<li>Cleanse site with povidone iodine (Betadine) before puncture</li>
<li>Aspirate for a blood return</li>
<li>Irrigate with sterile water or saline prior to and after administering the medication</li>
</ol>
<p><img src="assets/images/image-20251221-27beb1f6.jpeg" alt="img-11.jpeg">
Figure 4-8. Implanted infusion device. A, Side view illustrating needle inserted through skin and top of infusion device. Distal end of device is in vein. B, Use one hand to secure device before inserting needle. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p><img src="assets/images/image-20251221-c4174fdf.jpeg" alt="img-12.jpeg"></p>
<p>GUIDELINES FOR NEEDLE SELECTION; CALCULATION OF DOSAGES—THREE FORMULAS ▼ 57</p>
<ol start="5">
<li>Recommended needle size is no. 20 to 22 gauge, commonly Hubor point straight or 90 degree angled needle with a no. 22 gauge used</li>
</ol>
<p>G. Venous Access Device: External central VAD—most common are Hickman, Broviac, and Groshong. Care is similar to care of an IV central line.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-needles">IV. Needles<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-needles" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Intradermal (ID)
26 gauge (g): ¼ or ⅜ inches</p>
<p>B. Intramuscular (IM)
22 g: 1 to 1½ inches
16 to 18 g: 2 to 3 inches for penicillin injections</p>
<p>C. Subcutaneous (SQ)
25 or 26 g: ½ to ⅝ inches</p>
<p>D. Intravenous (IV)
18 to 22 g: general IV
14 to 20 g: blood transfusion</p>
<p>E. Huber needle—especially designed needle with a sharp-angle bevel used only for implanted VAD: can be either no. 22 straight or 90 degree angled (right angled) needle</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-calculation-of-dosages-can-be-accomplished-by-three-formulas">V. Calculation of dosages can be accomplished by three formulas<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-calculation-of-dosages-can-be-accomplished-by-three-formulas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Desired/Have: 50 mg ordered, have on hand 100 mg/2 cc</p>
<ol>
<li>
<p>Formula: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mtext>Desired&nbsp;dose</mtext><mtext>Have&nbsp;on&nbsp;hand</mtext></mfrac><mo>×</mo><mtext>Quantity</mtext><mo>=</mo><mtext>Dosage&nbsp;to&nbsp;give</mtext></mrow><annotation encoding="application/x-tex">\frac{\text{Desired dose}}{\text{Have on hand}} \times \text{Quantity} = \text{Dosage to give}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.2251em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8801em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Have&nbsp;on&nbsp;hand</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Desired&nbsp;dose</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Quantity</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Dosage&nbsp;to&nbsp;give</span></span></span></span></span></span></p>
</li>
<li>
<p>Example: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>50</mn><mtext>&nbsp;mg</mtext></mrow><mrow><mn>100</mn><mtext>&nbsp;mg</mtext></mrow></mfrac><mo>×</mo><mn>2</mn><mtext>&nbsp;cc</mtext><mo>=</mo><mn>1</mn><mtext>&nbsp;cc</mtext></mrow><annotation encoding="application/x-tex">\frac{50\ \text{mg}}{100\ \text{mg}} \times 2\ \text{cc} = 1\ \text{cc}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3783em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">100</span><span class="mspace mtight"><span class="mtight">&nbsp;</span></span><span class="mord text mtight"><span class="mord mtight">mg</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span><span class="mspace mtight"><span class="mtight">&nbsp;</span></span><span class="mord text mtight"><span class="mord mtight">mg</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">2</span><span class="mspace">&nbsp;</span><span class="mord text"><span class="mord">cc</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1</span><span class="mspace">&nbsp;</span><span class="mord text"><span class="mord">cc</span></span></span></span></span></span></p>
</li>
</ol>
<p>B. Ratio-Proportion (RP): 50 mg ordered, have on hand 100 mg/2 cc</p>
<ol>
<li>
<p>Formula: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mtext>Dosage&nbsp;on&nbsp;hand&nbsp;(units)</mtext><mtext>Dosage&nbsp;on&nbsp;hand&nbsp;(cc)</mtext></mfrac><mo>:</mo><mfrac><mtext>Desired&nbsp;dose&nbsp;(units)</mtext><mtext>Unknown&nbsp;X&nbsp;(cc)</mtext></mfrac><mo>=</mo><mtext>Dose&nbsp;to&nbsp;give</mtext></mrow><annotation encoding="application/x-tex">\frac{\text{Dosage on hand (units)}}{\text{Dosage on hand (cc)}} : \frac{\text{Desired dose (units)}}{\text{Unknown X (cc)}} = \text{Dose to give}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.53em; vertical-align: -0.52em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.01em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Dosage&nbsp;on&nbsp;hand&nbsp;(cc)</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.485em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Dosage&nbsp;on&nbsp;hand&nbsp;(units)</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.52em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">:</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.53em; vertical-align: -0.52em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.01em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Unknown&nbsp;X&nbsp;(cc)</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.485em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Desired&nbsp;dose&nbsp;(units)</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.52em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Dose&nbsp;to&nbsp;give</span></span></span></span></span></span></p>
</li>
<li>
<p>Example: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>100</mn><mtext>&nbsp;mg</mtext></mrow><mrow><mn>2</mn><mtext>&nbsp;cc</mtext></mrow></mfrac><mo>:</mo><mfrac><mrow><mn>50</mn><mtext>&nbsp;mg</mtext></mrow><mtext>X</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{100\ \text{mg}}{2\ \text{cc}} : \frac{50\ \text{mg}}{\text{X}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.2422em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mspace mtight"><span class="mtight">&nbsp;</span></span><span class="mord text mtight"><span class="mord mtight">cc</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">100</span><span class="mspace mtight"><span class="mtight">&nbsp;</span></span><span class="mord text mtight"><span class="mord mtight">mg</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">:</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.2422em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">X</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span><span class="mspace mtight"><span class="mtight">&nbsp;</span></span><span class="mord text mtight"><span class="mord mtight">mg</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
</li>
</ol>
<p>CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<p>(Note: Cross multiply 50 mg with 2 cc and 100 mg with X)</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mtable rowspacing="0.16em" columnalign="left" columnspacing="1em"><mtr><mtd><mstyle scriptlevel="0" displaystyle="false"><mrow><mn>100</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">X</mi><mo>=</mo><mn>100</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mrow><mi mathvariant="normal">c</mi><mi mathvariant="normal">c</mi></mrow></mrow></mstyle></mtd></mtr><mtr><mtd><mstyle scriptlevel="0" displaystyle="false"><mrow><mi mathvariant="normal">X</mi><mo>=</mo><mfrac><mrow><mn>100</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mrow><mi mathvariant="normal">c</mi><mi mathvariant="normal">c</mi></mrow></mrow><mrow><mn>100</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow></mfrac></mrow></mstyle></mtd></mtr><mtr><mtd><mstyle scriptlevel="0" displaystyle="false"><mrow><mi mathvariant="normal">X</mi><mo>=</mo><mn>1</mn><mrow><mi mathvariant="normal">c</mi><mi mathvariant="normal">c</mi></mrow></mrow></mstyle></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{array}{l}
100 \mathrm{mg} \mathrm{X} = 100 \mathrm{mg} \mathrm{cc} \\
\mathrm{X} = \frac{100 \mathrm{mg} \mathrm{cc}}{100 \mathrm{mg}} \\
\mathrm{X} = 1 \mathrm{cc} \\
\end{array}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 3.7783em; vertical-align: -1.6392em;"></span><span class="mord"><span class="mtable"><span class="arraycolsep" style="width: 0.5em;"></span><span class="col-align-l"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 2.1392em;"><span style="top: -4.2992em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">100</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord mathrm">X</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mord">100</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord"><span class="mord mathrm">cc</span></span></span></span><span style="top: -3.0419em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord mathrm">X</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">100</span><span class="mord mtight"><span class="mord mathrm mtight" style="margin-right: 0.01389em;">mg</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">100</span><span class="mord mtight"><span class="mord mathrm mtight" style="margin-right: 0.01389em;">mg</span></span><span class="mord mtight"><span class="mord mathrm mtight">cc</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span><span style="top: -1.7208em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord mathrm">X</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mord">1</span><span class="mord"><span class="mord mathrm">cc</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 1.6392em;"><span></span></span></span></span></span><span class="arraycolsep" style="width: 0.5em;"></span></span></span></span></span></span></span></div>
<p>(Note: "mg" cancel out)</p>
<p>C. Dimensional analysis (DA): 50 mg ordered, have on hand 1 gr/2 cc</p>
<ol>
<li>
<p>Formula: Dose ordered × Conversion × Dose on hand = Dose to give or dose needed (all units should cancel except the desired dose)</p>
</li>
<li>
<p>Example: 50 mg × <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>1</mn><mo>⋅</mo><mi>g</mi></mrow><mrow><mn>1000</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow></mfrac></mrow><annotation encoding="application/x-tex">\frac{1 \cdot g}{1000 \mathrm{mg}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3783em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1000</span><span class="mord mtight"><span class="mord mathrm mtight" style="margin-right: 0.01389em;">mg</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span><span class="mbin mtight">⋅</span><span class="mord mathnormal mtight" style="margin-right: 0.03588em;">g</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> × <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>15</mn><mo>⋅</mo><mi>g</mi><mi>r</mi></mrow><mrow><mn>1</mn><mo>⋅</mo><mi>g</mi></mrow></mfrac></mrow><annotation encoding="application/x-tex">\frac{15 \cdot gr}{1 \cdot g}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3783em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span><span class="mbin mtight">⋅</span><span class="mord mathnormal mtight" style="margin-right: 0.03588em;">g</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">15</span><span class="mbin mtight">⋅</span><span class="mord mathnormal mtight" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal mtight" style="margin-right: 0.02778em;">r</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> × <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>2</mn><mo>⋅</mo><mi>c</mi><mi>c</mi></mrow><mrow><mn>1</mn><mo>⋅</mo><mi>g</mi><mi>r</mi></mrow></mfrac></mrow><annotation encoding="application/x-tex">\frac{2 \cdot cc}{1 \cdot gr}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3262em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8451em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span><span class="mbin mtight">⋅</span><span class="mord mathnormal mtight" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal mtight" style="margin-right: 0.02778em;">r</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mbin mtight">⋅</span><span class="mord mathnormal mtight">cc</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> = 1.5 cc</p>
</li>
</ol>
<p>REVIEW QUESTIONS ▼ 59</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Which client response below should make a nurse double-check the tablets, dose, and timing of the medication that has been prepared by the nurse?
a. “I don’t know what these are for”
b. “I’ve never taken a yellow one before”
c. “Can you tell me what these do?”
d. “The blue tablet always makes me sleepy”</p>
</li>
<li>
<p>An injection of iron dextran (Imferon) should be given Z-track on an adult client in which location?
a. Dorsogluteal
b. Ventrogluteal
c. Deltoid
d. Vastus lateralis</p>
</li>
<li>
<p>Medications given by the nasogastric (NG) route require that
a. The medications are followed with formula
b. Heart sounds are assessed
c. 30 to 60 cc of water is instilled after medication instillation
d. All medications are crushed or liquid forms are used</p>
</li>
<li>
<p>Which of these IV complications would be manifested by pallor, coolness of the skin, and edema at the site?
a. Tissue necrosis
b. Thrombophlebitis
c. Infiltration
d. Infection</p>
</li>
<li>
<p>A client complains of nausea and has hydroxyzine HCL (Vistaril) 50 mg IM q 4 hours prn. The nurse knows the medication must be given Z-track with a 0.5 cc airlock. The purpose of an airlock is so that the medication
a. Will completely clear the hub
b. Cannot leak out
c. Is accurately measured
d. Will not irritate the muscle</p>
</li>
</ol>
<p>60 ▼ CHAPTER 4 ADMINISTRATION OF MEDICATIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>Clients frequently know the shape, color, and number of tablets they take every day. Unless a new medication has been added, the nurse could have made a drug error. Clients may not know what every medication is for, especially if new medications were ordered. Clients frequently want to know what actions drugs have. Drowsiness is a common side effect and does not require rechecking the medications.</td><td>If you have no idea of the correct response, cluster responses <em>a</em> and <em>c</em> under “knowledge deficit.” Eliminate these. Also eliminate <em>d</em> since it reflects client familiarity. Then select response <em>b</em>.</td></tr><tr><td><strong>2. Correct answer: a</strong></td><td></td></tr><tr><td>The dorsogluteal is a large muscle used for injection of irritating drugs. The ventrogluteal is used for IM injections but is not the preferred location for Z-track. The deltoid muscle is too small. The vastus lateralis is used for IM but is not the preferred site for injecting irritating medications.</td><td>Easily remember that the ventrogluteal and the vastus lateralis are both given on the lateral aspect of the body for IM, and only as a second choice for deep IM, Z-track. An easy way to remember the difference between deltoid and dorsogluteal is that deltoid comes first alphabetically and also is the first site at the top of the body on the upper arm. Dorsogluteal is next alphabetically and is positioned lower on the body.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>Water flushes the tube, clearing all the medication and preventing clogging of the tube. Clients often need water</td><td>Eliminate response <em>d</em> that has the absolute “all.”</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 61</p>
<p>separate from the formula and some of the medications may not mix with the ingredients of the formula. Heart sound assessment is not necessary for administration of NG medications. Time-released or enteric-coated tablets should never be crushed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-c">4. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Infiltration is manifested by pallor, edema, and coolness because the fluid escapes into the tissue around the site. Tissue necrosis is manifested by warm, irritated, and usually red or purplish-red skin. Thrombophlebitis is manifested by warmth and redness. Infection would exhibit findings of redness, warmth, pain, and possibly pus.</p>
<p>If you have no idea of the correct response, try to cluster a, b, and c under “inflammatory response,” which is characteristically red. Since the given data states “pallor,” eliminate these three answers.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-a">5. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>An airlock clears all medication from the hub and needle, since the air clears after the medication. The Z-track method prevents medication from leaking back into the subcutaneous tissue. Accurate measurement should occur before the drawing up of an airlock. The Z-track method is used to prevent irritation of oil-based, caustic, or large amounts of IM medications.</p>
<p>Use your knowledge and common sense to picture the air and its purpose—to clear medication from the hub.</p>
<p>^{}[]</p>
<p>63
CHAPTER 5</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-autonomic-nervous-system">Drugs Affecting the Autonomic Nervous System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-autonomic-nervous-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the names of agents used to treat the sympathetic and parasympathetic nervous system.</li>
<li>Discuss the action, use, side effects, and nursing implications of cholinergic agents and cholinergic blocking agents.</li>
<li>Discuss the action, use, side effects, and nursing implications of adrenergic agents and adrenergic blocking agents.</li>
</ul>
<p>64 ▼ CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Adrenergic or sympathetic</strong>
Pertaining to the sympathetic nerve fibers that use the neurotransmitters, epinephrine, or epinephrine-like substances.</p>
<p><strong>Adrenergic agonists</strong>
Also called <em>sympathomimetic</em>. Drugs that cause an adrenergic response from the body.</p>
<p><strong>Adrenergic receptor</strong>
Two types: Alpha receptor—stimulation of results in an excitatory response. Beta receptor—stimulation of results in an inhibitory response.</p>
<p><strong>Adrenergic response</strong>
A sympathetic-like response such as increased heart rate, peripheral vasoconstriction, and increased serum glucose.</p>
<p><strong>Antiadrenergic</strong>
Pertaining to the blocking effects of impulses transmitted by the adrenergic fibers of the sympathetic system. Examples: alpha adrenergic and beta adrenergic blocker agents.</p>
<p><strong>Cardiac terminology</strong>
Clinically discussed in terms of positive, meaning a faster or stronger response, and negative, meaning a slower or weaker response.</p>
<p><strong>Chronotropic</strong>
The act or process of affecting the rate of the heart.</p>
<p><strong>Dromotropic</strong>
The act or process of affecting the conduction through the heart.</p>
<p><strong>Inotropic</strong>
The act or process of affecting the contractility of the heart.</p>
<p><strong>Cholinergic</strong>
Pertaining to the nerve fibers that elaborate acetylcholine at the myoneural junctions; maintains normal, day-to-day functions of the body.</p>
<p><strong>Cholinergic blocking, anticholinergic agents</strong>
Pertaining to a substance that blocks the acetylcholine receptors or competes with acetylcholine for its receptor sites.</p>
<p><strong>Cholinergic response, parasympathomimetic, cholinergic agents</strong>
Pertaining to a substance that produces effects similar to those from the stimulation of the cholinergic system.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8538d533">ADRENERGIC AGENTS—SYMPATHOMIMETIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8538d533" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-adrenergic-agonists">I. Adrenergic agonists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-adrenergic-agonists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-division-table-5-1">A. Division (Table 5-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-division-table-5-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>ADRENERGICS, CLASSIFICATION OF AUTONOMIC NERVOUS SYSTEM DRUGS ▼ 65</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="table-5-1-classification-of-autonomic-nervous-system-drugs">Table 5-1. Classification of Autonomic Nervous System Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#table-5-1-classification-of-autonomic-nervous-system-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Sympathetic</th><th></th><th>Parasympathetic</th></tr></thead><tbody><tr><td><strong>Adrenergic Response</strong></td><td></td><td><strong>Cholinergic Response</strong></td></tr><tr><td>Catecholamines:</td><td></td><td></td></tr><tr><td>norepinephrine</td><td><strong>Neurotransmitters</strong></td><td>Acetylcholine ACh</td></tr><tr><td>epinephrine</td><td></td><td></td></tr><tr><td>dopamine</td><td></td><td></td></tr><tr><td>Beta 1</td><td><strong>Receptor Sites</strong></td><td>Nicotinic</td></tr><tr><td>Beta 2</td><td></td><td>Muscarinic</td></tr><tr><td>Alpha</td><td></td><td></td></tr><tr><td>Dopaminergic</td><td></td><td></td></tr><tr><td><strong>Agents</strong></td><td></td><td></td></tr><tr><td><strong>Adrenergic Drugs</strong></td><td></td><td><strong>Cholinergic Agents</strong></td></tr><tr><td>(Sympathomimetic)</td><td></td><td>(Parasympathomimetic)</td></tr><tr><td>▼ Catecholamines</td><td></td><td>▼ Direct-Acting</td></tr><tr><td>▼ Noncatecholamines</td><td></td><td>Cholinergic Agents</td></tr><tr><td><strong>Adrenergic Blocking</strong></td><td></td><td>▼ Anticholinesterase</td></tr><tr><td>Agents (Sympatholytic)</td><td></td><td>Agents</td></tr><tr><td>▼ Alpha Adrenergic Blockers</td><td></td><td><strong>Cholinergic Blocking</strong></td></tr><tr><td>▼ Beta Adrenergic Blockers</td><td></td><td>(Parasympatholytic)</td></tr><tr><td>▼ Ganglionic Blockers</td><td></td><td>Anticholinergic Agents</td></tr></tbody></table>
<ol>
<li>Includes Alpha₁, Alpha₂, Beta₁, Beta₂, and dopamine agonists</li>
<li>Divided into two groups
a. Catecholamines: a group of sympathomimetic compounds that cannot cross the blood-brain barrier, act directly, or be taken orally
(1) Those that are endogenous: norepinephrine, epinephrine and dopamine
(2) Those that are synthetic: dobutamine, isoproterenol
b. Noncatecholamines: compounds that can cross the blood-brain barrier, act directly or indirectly, and be taken orally: ephedrine, albuterol, phenylephrine
B. Catecholamines</li>
<li>Actions (Table 5-2)
a. +inotropic: increase force or contraction of heart
b. +chronotropic: increase rate of heartbeat</li>
</ol>
<p>66 ▼ CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<p>c. +dromotropic: increase conduction of impulse
d. adrenergic neurotransmission</p>
<ol start="2">
<li>
<p>Uses
a. Hypotension
b. Anaphylactic shock
c. Asthma
d. Hypoglycemia
e. Control bleeding—usually local
f. Local anesthetic
g. Congestive heart failure (CHF)
h. Mild renal failure</p>
</li>
<li>
<p>Major side effects
a. Tachycardia
b. Hypertension
c. Myocardial ischemia
d. Hyperglycemia</p>
</li>
<li>
<p>Nursing implications
a. Monitor vital signs (VS) and ECG
b. Assess respiratory effort and lung sounds</p>
</li>
</ol>
<p>Table 5-2. Autonomic Action of Cardiovascular Medications</p>
<table><thead><tr><th>Action</th><th>Refers To</th><th>To Increase</th><th>To Decrease</th></tr></thead><tbody><tr><td>Contractility</td><td>Stretch</td><td>+ Inotropic</td><td>– Inotropic</td></tr><tr><td>Heart Rate</td><td>Rate</td><td>+ Chronotropic</td><td>– Chronotropic</td></tr><tr><td>Conduction</td><td>Speed of electrical impulse transmission through the heart</td><td>+ Dromotropic</td><td>– Dromotropic</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td></tr><tr><td>Inotropic effects:</td><td>cardiac output</td><td>↑</td><td>↓</td></tr><tr><td></td><td>urinary output</td><td>↑</td><td>↓</td></tr><tr><td></td><td>cardiac workload</td><td>↑</td><td>↓</td></tr><tr><td>Chronotropic effects:</td><td>+ tachycardia or increase in heart rate</td><td></td><td></td></tr><tr><td>– bradycardia or decrease in heart rate</td><td></td><td></td><td></td></tr><tr><td>Dromotropic effects:</td><td>+ attribute to dysrhythmias</td><td></td><td></td></tr><tr><td>– decrease in dysrhythmias</td><td></td><td></td><td></td></tr><tr><td>+ = positive</td><td></td><td></td><td></td></tr><tr><td>– = negative</td><td></td><td></td><td></td></tr></tbody></table>
<p>AUTONOMIC ACTIONS OF CV DRUGS, ALPHA ADRENERGIC BLOCKERS ▼ 67</p>
<p>c. Monitor blood glucose levels
d. Monitor intake and output (I&amp;O)
e. Avoid extravasation</p>
<ol start="5">
<li>Common drugs
a. Epinephrine hydrochloride (Adrenalin Chloride)
b. Dobutamine hydrochloride (Dobutrex)
c. Dopamine hydrochloride (Inotropin)
d. Isoproterenol hydrochloride (Isuprel)
e. Norepinephrine bitartrate (Levophed)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-noncatecholamines">C. Noncatecholamines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-noncatecholamines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Action: selective catecholamine action because of their similarity</li>
<li>Uses
a. Asthma
b. Nasal decongestion
c. Premature labor
d. Hypotension</li>
<li>Major side effects
a. CNS reactions: nervousness, anxiety, headache, insomnia
b. ECG changes: palpitations, tachycardia, dysrhythmias
c. Musculoskeletal: weakness, mild tremors, and cramps</li>
<li>Nursing implications
a. Monitor vital signs, mental status
b. Teach client how to properly administer inhalants</li>
<li>Common drugs
a. Terbutaline sulfate (Brethine)
b. Albuterol (Proventil, Ventolin)
c. Metaproterenol sulfate (Alupent)
d. Phenylephrine hydrochloride (Neo-Synephrine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="adrenergic-blocking-agents">ADRENERGIC BLOCKING AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adrenergic-blocking-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-divided-into-three-groups-see-table-5-1">I. Divided into three groups (see Table 5-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-divided-into-three-groups-see-table-5-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Alpha adrenergic blockers
B. Beta adrenergic blockers
C. Ganglionic blockers</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-alpha-adrenergic-blockers">II. Alpha adrenergic blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-alpha-adrenergic-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-actions">A. Actions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Interrupt or antagonize the sympathomimetic agents</li>
<li>Vasodilate vascular smooth muscle</li>
<li>Lower peripheral vascular resistance</li>
</ol>
<p>68 ▼ CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Peripheral vascular disease</li>
<li>Raynaud’s disease</li>
<li>Pheochromocytoma</li>
<li>Hypertension</li>
<li>Vascular headaches (especially migraine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Nasal congestion</li>
<li>Gastrointestinal irritation, nausea, vomiting</li>
<li>Ergotism: an acute or chronic disease caused by excessive dosages of medications containing ergot; symptoms may include cerebrospinal findings such as spasms, cramps, or dry gangrene of the upper or lower extremities</li>
<li>Rebound tachycardia: sudden return of the heart rate to greater than 100 beats/min</li>
<li>Postural hypotension: drop in blood pressure greater than 20 mm Hg when client changes from a lying to a standing or a lying to a sitting position</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Monitor vital signs; take lying, sitting, and standing BPs</li>
<li>Instruct the client to change positions slowly</li>
<li>For headaches, instruct the client to take the medication at the first sign of the attack</li>
<li>Assess for signs of ergotism: numbness, weakness, tingling of fingers and toes</li>
<li>Instruct the client how to take ergotamine products; usually taken every hour until the headache is gone or a maximum of 5 pills is taken</li>
<li>Instruct client to limit caffeine intake, since caffeine causes vasoconstriction</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Ergotamine tartrate (Ergostat)</li>
<li>Ergotamine tartrate and caffeine (Cafergot)</li>
<li>Phentolamine mesylate (Regitine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-beta-adrenergic-blockers">III. Beta adrenergic blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-beta-adrenergic-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions-block-sympathetic-response-by-competing-for-beta-receptors-also-block-stimulation-of-the-heart-and-have-the-potential-to-block-bronchodilation">A. Actions: block sympathetic response by competing for beta receptors; also block stimulation of the heart and have the potential to block bronchodilation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-block-sympathetic-response-by-competing-for-beta-receptors-also-block-stimulation-of-the-heart-and-have-the-potential-to-block-bronchodilation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Hypertension</li>
<li>Angina</li>
</ol>
<p>BETA ADRENERGIC AND GANGLIONIC BLOCKERS ▼ 69</p>
<ol start="3">
<li>Tachyarrhythmias</li>
<li>Migraine headaches</li>
<li>Myocardial infarction</li>
<li>Anxiety</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Bradycardia</li>
<li>Hypoglycemia</li>
<li>Orthostatic hypotension</li>
<li>Impotence</li>
<li>Bronchospasm, especially with asthma and other COPD clients</li>
<li>Depression</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-these-drugs-interact-with-alcohol-and-central-nervous-system-depressants">D. These drugs interact with alcohol and central nervous system depressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-these-drugs-interact-with-alcohol-and-central-nervous-system-depressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Monitor vital signs for bradycardia and hypotension</li>
<li>Monitor blood glucose for hypoglycemia: blood sugar &lt;50</li>
<li>Instruct client to monitor pulse, BP, and to change positions slowly</li>
<li>Advise the client about the possibility of impotence</li>
<li>Assess lung sounds for inspiratory and expiratory wheezing</li>
<li>Avoid extreme heat, hot tubs, hot showers</li>
<li>Advise the client not to use OTC drugs such as decongestants unless directed by a physician</li>
<li>Monitor for a need to increase dosage since these drugs are affected by the hepatic first-pass effect</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Atenolol (Tenormin)</li>
<li>Timolol maleate (Inderal)</li>
<li>Metoprolol tartrate (Lopressor)</li>
<li>Nadolol (Corgard)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-ganglionic-blockers">IV. Ganglionic blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-ganglionic-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-action-compete-with-acetylcholine-and-affect-both-sympathetic-and-parasympathetic-systems">A. Action: compete with acetylcholine and affect both sympathetic and parasympathetic systems<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-compete-with-acetylcholine-and-affect-both-sympathetic-and-parasympathetic-systems" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Hypertension especially hypertensive crisis</li>
<li>Pulmonary edema resulting from pulmonary hypertension</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Hypotension</li>
<li>Bradycardia</li>
<li>Anticholinergic effects: dry mouth, dilated pupils, tachycardia, decreased GI and urinary motility</li>
</ol>
<p>70 ▼ CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Monitor BP and HR</li>
<li>Provide comfort measures for anticholinergic side effects</li>
</ol>
<p>E. <strong>Common drugs</strong></p>
<ol>
<li>Mecamylamine hydrochloride (Inversine)</li>
<li>Trimethaphan camsylate (Arfonad)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="9b622853">CHOLINERGIC AGENTS—PARASYMPATHOMIMETIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9b622853" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-divided-into-the-following-see-table-5-1">I. Divided into the following (see Table 5-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-divided-into-the-following-see-table-5-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Direct-acting cholinergic agonists
B. Anticholinesterase agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-direct-acting-cholinergic-agonists">II. Direct-acting cholinergic agonists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-direct-acting-cholinergic-agonists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. <strong>Action</strong>: mimics acetylcholine to produce parasympathetic stimulation
B. <strong>Uses</strong></p>
<ol>
<li>Glaucoma</li>
<li>Bladder atony
C. <strong>Major side effects</strong></li>
<li>Bronchoconstriction, wheezing, shortness of breath</li>
<li>Bradycardia, hypotension</li>
<li>Headache, flushing</li>
<li>Increased salivation, sweating</li>
<li>Nausea, vomiting, diarrhea, cramping
D. <strong>Interactions</strong>: decrease in action when given with adrenergic drugs
E. <strong>Nursing implications</strong></li>
<li>Assess respiratory and cardiac status</li>
<li>Instruct client to take before or after meals to limit gastrointestinal symptoms</li>
<li>Have atropine sulfate, an anticholinergic, available for emergency reactions</li>
<li>Instruct client how to instill eye drops if ordered. Eye drops for glaucoma have a miotic effect to constrict the pupil.
F. <strong>Common drugs</strong></li>
<li>Bethanechol chloride (Urecholine)—for bladder atony</li>
<li>Pilocarpine hydrochloride (Pilocar)—for glaucoma</li>
<li>Carbachol intraocular (Miostat)—for glaucoma</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-anticholinesterase-agents">III. Anticholinesterase agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-anticholinesterase-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. <strong>Action</strong>: inhibit the enzyme acetylcholinesterase, which breaks down acetylcholine</p>
<p>CHOLINERGIC, ANTICHOLINESTERASE, AND ANTICHOLINERGIC AGENTS ▼ 71</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Myasthenia gravis</li>
<li>Glaucoma</li>
<li>Postoperative complications of bladder distention or paralytic ileus</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>GI distress: nausea, vomiting, diarrhea</li>
<li>Bradycardia, hypotension</li>
<li>Diaphoresis, increased salivation</li>
<li>Muscle cramps, fatigue, weakness, paralysis</li>
<li>Respiratory depression</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Assess neuromuscular status with provision of safety measures if side effects occur</li>
<li>Keep atropine sulfate handy for an emergency to counteract drug effects</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Edrophonium chloride (Tensilon)</li>
<li>Neostigmine methylsulfate (Prostigmin)</li>
<li>Pyridostigmine bromide (Regonol)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cholinergic-blocking-agents">CHOLINERGIC BLOCKING AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cholinergic-blocking-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-anticholinergic-agents">I. Anticholinergic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-anticholinergic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-compete-with-acetylcholine-at-muscarinic-receptors">A. Action: compete with acetylcholine at muscarinic receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-compete-with-acetylcholine-at-muscarinic-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Preoperatively to reduce salivation and gastric secretions</li>
<li>Parkinson’s disease symptoms</li>
<li>Motion sickness</li>
<li>Gastrointestinal spasms, urinary spasms</li>
<li>Reverse heart blocks</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Dry mouth</li>
<li>Blurred vision, dilated pupils</li>
<li>Flushed skin color, decreased sweating, intolerance to heat</li>
<li>Constipation, urinary retention</li>
<li>Confusion, delusional status</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-interact-with-cns-depressants-antidysrhythmics-antihistamines">D. Interact with CNS depressants, antidysrhythmics, antihistamines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interact-with-cns-depressants-antidysrhythmics-antihistamines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Provide comfort measures for side effects</li>
<li>Encourage the use of ice chips and good oral care to relieve dry mouth</li>
</ol>
<p>CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<ol start="3">
<li>Encourage fluids to decrease risk of constipation</li>
<li>Carefully monitor older-adult clients to prevent severe complications from the side effects</li>
<li>Use the agent 30 minutes to 1 hour prior to traveling in order to relieve motion sickness</li>
<li>Monitor vital signs routinely and if side effects occur</li>
</ol>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Atropine sulfate (Isopto Atropine)</li>
<li>Scopolamine hydrobromide (Hyoscine)</li>
<li>Hyoscyamine sulfate (Levsin)</li>
<li>Propantheline bromide (Pro-Banthine)</li>
<li>Benztropine mesylate (Cogentin)—for Parkinson’s disease symptoms; extra-pyramidal symptoms associated with neuroleptic drugs</li>
</ol>
<p>REVIEW QUESTIONS ▼ 73</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>While being admitted through the emergency department for signs of congestive heart failure, a client experiences extreme hypotension, BP 78/50. The client is placed on a dopamine hydrochloride (Intropin) drip. The nurse would assess which of the following?</li>
</ol>
<p>a. Glucose level
b. Heart sounds
c. Neuromuscular status
d. Mental status</p>
<ol start="2">
<li>Which one of these drugs is indicated for a client who is experiencing respiratory distress as an anaphylactic reaction to a first dose of cephalexin (Keflex)?</li>
</ol>
<p>a. Atropine sulfate
b. Albuterol (Ventolin)
c. Ergotamine tartrate and caffeine (Cafergot)
d. Epinephrine hydrochloride (Adrenalin)</p>
<ol start="3">
<li>A client, age 5, enters the clinic with wheezing, shortness of breath, and a history of severe asthma. The physician orders epinephrine hydrochloride (Adrenalin) SC stat. After the epinephrine is given, the client should be monitored for which of the following?</li>
</ol>
<p>a. Heart rate of 140, BP 90/50
b. Severe tremors, heart rate of 99
c. Heart rate of 160, BP 130/80
d. Glucose level of 32 mg/dL, severe tremors</p>
<ol start="4">
<li>A client, age 3, was sent home on albuterol (Ventolin) treatments BID for bronchitis due to severe allergies. His mother phones complaining of her child's inability to sleep at night. The mother should be instructed to do what?</li>
</ol>
<p>a. Skip the evening treatment unless absolutely necessary
b. Give the second treatment at noon instead of in the afternoon
c. Give the second treatment around 4 P.M. instead of 8 P.M.
d. Divide the evening dose and give half at 4 P.M. and the other half at 8 P.M.</p>
<ol start="5">
<li>A client, age 22, diagnosed with migraine headaches, should be given which of these instructions while taking ergotamine tartrate (Cafergot)?</li>
</ol>
<p>a. Take 1 tablet when the headache is just beginning and every 4 hours until the headache is gone
b. Take 1 tablet at the first sign of the headache, then every hour until relieved, not to exceed 5 tablets</p>
<p>74 ▼ CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<p>c. Take 1 tablet at the first sign of the headache, then every hour until relieved, not to exceed 10 tablets
d. Take 1 tablet once the headache occurs, then every hour thereafter</p>
<ol start="6">
<li>
<p>Important information from a nursing history for the client taking metoprolol tartrate (Lopressor) would be a history of which of the following?
a. Hypertension
b. Asthma
c. Myasthenia gravis
d. Myocardial infarction</p>
</li>
<li>
<p>Atropine sulfate is more commonly used for which of the following?
a. Cardiovascular complications
b. Glaucoma
c. Hypertension
d. Reduction of salivation</p>
</li>
<li>
<p>Hyoscyamine sulfate (Levsin) is ordered for a 4-month-old client who is experiencing extreme episodes of colic during the early morning hours. The client's parent should be instructed to monitor the infant for which of the following?
a. Diarrhea
b. Constipation
c. Polyuria
d. Hypothermia</p>
</li>
</ol>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 75</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: a</strong></td><td></td></tr><tr><td>Adrenergic agonists can cause hyperglycemia. These agents cause tachycardia; therefore the vital signs, not the heart sounds, should be monitored. These agents do not affect neuromuscular status. These agents do not directly affect mental status.</td><td>If you have no idea of the correct answer, cluster responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> under “bedside assessment.” Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is correct.</td></tr><tr><td><strong>2. Correct answer: d</strong></td><td></td></tr><tr><td>Epinephrine is used in anaphylactic reactions and shock; it results in overall clinical improvement during an emergency because of the positive inotropic, chronotropic, and dromotropic effects. It is given IV or SQ in anaphalactic situations. Atropine increases the heart rate. Ventolin is used to treat asthma and hypotension. Cafergot is used for hypertension, peripheral vascular disease, and headaches; it is usually given PO or by suppository.</td><td>Remember Epinephrine for Emergencies.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>Side effects of epinephrine include both hypertension and tachycardia. Epinephrine causes hyperglycemia; 32 mg/dL is hypoglycemia, which is defined as a serum glucose of &lt;50 mg/dL.</td><td>Read the responses with a vertical technique; it clarifies and helps to eliminate responses without your reading all the information. Read down: HR 140—yes; tremors—not typical, so eliminate this answer; HR 160—yes; glucose 32—no, so</td></tr></tbody></table>
<p>CHAPTER 5 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM</p>
<p>eliminate this answer. Then read the second series down for the responses left: BP 90/50—no and BP 130/80—yes. The correct response is c.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-c">4. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Taking the drug earlier may decrease the irritability and insomnia and still allow the child to sleep. Skipping the dose could cause increased symptoms from the bronchitis. A dose at noon would be too soon after a morning dose and too long before the next morning dose. Giving half the dose could lower the agents therapeutic effects.</p>
<p>The key words in the stem are the BID frequency and his “severe” allergies—he “needs” the medication; so eliminate responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>. Use common sense to choose option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> since 4 P.M. is later in the day for a second dose.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-b">5. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Taking the drug every hour until the headache is relieved should prevent it from developing to maximum severity. The recommended dose should not exceed five tablets with one headache episode. Cafergot is to be taken to prevent a full-blown, severe headache; every 4 hours would have a minimal effect. Ten tablets would exceed the recommended dose for an attack. Cafergot is to be taken “before” the full attack of a migraine headache. Benefits of the drug cannot be experienced if the client waits until the headache has reached a maximum pain.</p>
<p>The major action with migraine headaches is “preventive,” not to treat after the fact. Usually, the responses are narrowed to either <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>. Be conservative and make an educated selection: choose response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> with the lesser number for a maximum.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 77</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-b">6. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Lopressor can cause bronchospasm and could cause respiratory problems for a client with asthma. Lopressor would decrease hypertension. This agent should not interfere with mysthenia gravis. These agents, beta blockers, may be recommended for clients with myocardial infarctions.</p>
<p>If you have no idea of the correct response, use what you know and go with the ABCs—airway, breathing, circulation—and select response b. Also, remember that with beta blockers—bb—the major complications are bb—bronchospasm and bradycardia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-d">7. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It has an antisecretory action that decreases salivation, mucosal secretions, and peristalsis of the GI and GU tracts. This action helps prevent intraoperative complications. Atropine is used preoperatively to limit potential side effects of aspiration during surgery. Atropine is contraindicated in glaucoma because of the effects of the agent: the mydriasis, pupillary dilation, and cycloplegia—paralysis of the ciliary muscle. Atropine affects heart rate, not the blood pressure.</p>
<p>Recall that atropine is an anticholinergic and therefore acts against the normal, day-to-day processes of the body (moist mucous membranes, peristalsis, pupillary response to light and visual gaze, and a heart rate within normal limits of 60 to 100). Thus, these findings will change after administration of a dose of atropine for a period of time.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-b">8. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Constipation is common with Levsin because of the anticholinergic effect, so fluids should be encouraged. Urinary retention, not polyuria, is a side effect of the drug. A last side effect of this drug is intolerance to heat, but not hypothermia.</p>
<p>Approach the responses to the situation in the stem in mind: colic = spasms of the GI tract, so treatment would be guided to decrease the motility of the GI tract. The only answer that suggests the end result or problem of slowing down the bowel is b, constipation.</p>
<p>^{}[]</p>
<p>79
CHAPTER 6</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-neuromuscular-system">Drugs Affecting the Neuromuscular System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-neuromuscular-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Describe the classifications and actions of drugs used as anticonvulsants.</li>
<li>Describe the difference between dopaminergic and cholinergic blocking agents used for Parkinson's disease.</li>
<li>Describe the mechanism of action of anticholinesterase inhibitors for treatment of myasthenia gravis.</li>
<li>Describe the action of neuromuscular blocking agents.</li>
<li>List common side effects of anticonvulsants, antiparkinsonism drugs, antimyastthenic agents, and neuromuscular blocking agents.</li>
<li>Identify nursing implications for anticonvulsants, antiparkinsonism drugs, antimyastthenic agents, and neuromuscular blocking agents.</li>
</ul>
<p>CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Anticonvulsant</strong>
A substance that prevents, reduces, or stops the severity of epileptic or other convulsive seizures.</p>
<p><strong>End-of-dose deterioration</strong>
Return of symptoms before the next dose.</p>
<p><strong>Extrapyramidal effect</strong>
Exhibiting movement disorders, especially postural, supporting, static, and locomotor mechanisms similar to those of Parkinson’s disease. Examples: dystonia: impaired muscle tone; akathisia: restlessness, agitation, inability to sit still; and akinesia: hypoactivity or nonmovement as in muscular paralysis.</p>
<p><strong>Gamma-amino-butyric acid (GABA)</strong>
An amino acid with neurotransmitter activity found in the brain, heart, lungs, and kidneys.</p>
<p><strong>On-off phenomenon</strong>
Alteration in the control of symptoms from day to day or within each day.</p>
<p><strong>Status epilepticus</strong>
A medical emergency characterized by continual, uninterrupted seizures; commonly treated with IV Valium.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="anticonvulsants">ANTICONVULSANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anticonvulsants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>I. Agents used to prevent or treat the severity of epilepsy or other convulsive seizures</strong></p>
<p><strong>II. General information</strong></p>
<p>A. There is no ideal drug to control seizures; therefore a trial period of evaluating the effects of a drug is needed
B. Abrupt withdrawal of these agents may precipitate seizures
C. Close supervision is needed to monitor the effects and serum levels of the drug
D. Safety measures should be taken by the nurse and taught to the client due to the sedative effect of these agents
E. Dosage is highly individualized and may require titrating the dose with several dosage adjustments
F. Many drug interactions may occur while a client is on anticonvulsants and other medications
G. Compliance is a major factor in the control of this disease</p>
<p>GENERAL INFORMATION, DILANTIN, PHENOBARBITOL ▼ 81</p>
<p>H. The therapeutic goal is to control the seizure activity without hindering the client's ability to perform normal daily activities
I. All use of alcohol should be eliminated while the client is on these agents because alcohol may cause an additive effect and increase sedation
J. A baseline neurologic assessment should be made by the nurse before beginning the anticonvulsant therapy, then made every shift thereafter</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-hydantoin-derivatives">III. Hydantoin derivatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-hydantoin-derivatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: decrease the focal activity in the CNS, decrease the spread of the seizure process, and decrease abnormal hyperactivity
B. Use: first line drug therapy for all types of seizures except absence (petit mal) seizures
C. Major side effects: minimal at therapeutic levels. Common effects related to the dose prescribed include the following</p>
<ol>
<li>Gingival hyperplasia: overgrowth of the gingival tissue</li>
<li>Gastrointestinal effects: nausea, vomiting, anorexia</li>
<li>Hypersensitivity</li>
<li>Hematologic reactions</li>
<li>Dysrhythmias and hypotension
D. Interactions: may occur with enzyme inhibitors, folic acid, oral contraceptives, and other agents that are highly protein bound
E. Nursing implications</li>
<li>Require careful monitoring of the therapeutic level</li>
<li>Require careful monitoring in a pregnant/lactating client; teratogenicity is possible</li>
<li>Should be given intravenous (IV) slowly because hypotension and dysrhythmias may occur; given only through a saline line, at the most proximal port to the insertion site</li>
<li>Should not be mixed with other agents when given IV; validate a good blood return; extravasation causes tissue death
F. Common drug: phenytoin (Dilantin) is the primary drug within this group</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-barbiturates">IV. Barbiturates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-barbiturates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: limit the spread of seizures by increasing the seizure threshold</p>
<p>82 ▼ CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<p>B. Uses</p>
<ol>
<li>All types of seizures except absence seizures</li>
<li>Status epilepticus</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Sedation (most common)</li>
<li>Agitation, confusion (especially in older adults)</li>
<li>Physical dependence</li>
<li>Congenital abnormalities to the fetus</li>
<li>Toxicity</li>
</ol>
<p>D. Interactions: may occur with oral contraceptives, oral anticoagulants (decreased effect), and other CNS depressants (additive effect)</p>
<p>E. Nursing implications</p>
<ol>
<li>Slow withdrawal may occur</li>
<li>A loading dose may be required</li>
<li>Tolerance may develop, so symptoms should be monitored; dosage may need to be increased</li>
</ol>
<p>F. Common drug: phenobarbital sodium (Luminal Sodium)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-iminostilbenes">V. Iminostilbenes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-iminostilbenes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: similar to phenytoin (Dilantin); used in cases refractory to first line drugs because of side effects</p>
<p>B. Uses: effective in tonic-clonic, simple partial, and complex partial seizures</p>
<p>C. Major side effects</p>
<ol>
<li>Vertigo, dizziness</li>
<li>Drowsiness</li>
<li>Nausea or vomiting</li>
</ol>
<p>D. Interactions: decreased effects with phenobarbital, phenytoin; toxicity potential with cimetidine, isoniazid, lithium, erythromycin</p>
<p>E. Nursing implications</p>
<ol>
<li>Monitor blood studies: CBB, hepatic and renal</li>
<li>Know that urine may turn pink or brown</li>
</ol>
<p>F. Common drug: carbamazepine (Tegretol)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-oxazolidinediones">VI. Oxazolidinediones<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-oxazolidinediones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: decrease seizures in cortex, basal, ganglia; decrease synaptic stimulation to low-frequency impulses</p>
<p>B. Use: most effective against absence seizures</p>
<p>C. Major side effects</p>
<ol>
<li>Extremely toxic</li>
</ol>
<p>TEGRETOL, ZARONTIN, VALPORIC ACID ▼ 83</p>
<ol start="2">
<li>Limited use because of toxicity</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Monitor blood studies, CBC, hepatic and renal</li>
<li>Teach that drug may take 1 to 4 weeks to work</li>
<li>Teach that if rash develops, to notify physician promptly</li>
</ol>
<p>E. Common drugs: trimethadione (Tridione), paramethadione (Paradione)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vii-succinimides">VII. Succinimides<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-succinimides" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit spike, wave formation in absence seizures; decrease amplitude, frequency, duration, spread of discharge in minor motor seizures
B. Use: primarily in absence seizures
C. Major side effects: mostly gastrointestinal including epigastric pain and hiccups
D. Interactions: decrease effects of estrogens, oral contraceptives; antagonist effect with tricyclic antidepressants
E. Nursing implications</p>
<ol>
<li>Teach clients to avoid alcohol ingestion and CNS depressants; may result in increased sedation</li>
<li>Monitor blood studies: CBC, hepatic and renal</li>
</ol>
<p>F. Common drug: ethosuximide (Zarontin)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="viii-valporic-acid">VIII. Valporic acid<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#viii-valporic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: similar to succinimides
B. Use: primarily in absence seizures
C. Major side effects</p>
<ol>
<li>Tremors</li>
<li>Gastric distress, diarrhea</li>
<li>Weight gain</li>
<li>Irregular menses</li>
</ol>
<p>D. Interactions: increase effects with CNS depressants; increase toxicity with salicylates, warfarin, phenytoin</p>
<p>E. Nursing implications</p>
<ol>
<li>Give elixir alone; do not dilute</li>
<li>Teach client that physical dependency may result if used long term</li>
<li>Monitor blood studies: CBC, hepatic, and renal</li>
</ol>
<p>F. Common drug: valporic acid (Depakene syrup or Depakene)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ix-benzodiazepines">IX. Benzodiazepines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ix-benzodiazepines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: facilitate GABA and inhibit nerve impulses</p>
<p>84 ▼ CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<p>B. Use: primarily for status epilepticus (a medical emergency characterized by uninterrupted seizures)
C. Major side effects: CNS—drowsiness, fatigue, lethargy
D. Nursing implications</p>
<ol>
<li>Administer IV slowly and in titrated dosages to most proximal IV site</li>
<li>Drugs may precipitate if mixed with any other agents
E. Common drug: diazepam (Valium)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antiparkinsonism-drugs">ANTIPARKINSONISM DRUGS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiparkinsonism-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I. Parkinson’s disease: a slowly progressive, degenerative, neurologic disorder characterized by nonintentional tremors, shuffling gait, masklike facial expression, muscle rigidity, and weakness</p>
<p>II. Goals of these agents: to relieve the symptoms of the disease and to aid the client in carrying out normal daily activities. These agents do not cure; they only treat the symptoms.</p>
<p>III. Actions
A. Increase the dopaminergic system in three ways</p>
<ol>
<li>By increasing the release of dopamine in the brain</li>
<li>By stimulating the dopamine receptor sites</li>
<li>By enhancing conversion of levodopa to dopamine in the brain
B. Anticholinergic drugs: used to decrease the cholinergic system by blocking the acetylcholine receptors in the brain. This action lessens the symptoms of the disease.</li>
</ol>
<p>IV. Uses: decrease the rigidity, spasms, and tremors associated with Parkinson’s disease. These agents also control extrapyramidal effects caused by antipsychotic agents.</p>
<p>V. Major side effects: drug effects are dose-dependent
A. Gastrointestinal effects: nausea, vomiting, anorexia, aversion to certain foods
B. Dysrhythmias, orthostatic hypotension
C. Extrapyramidal effects: tremors, tardive dyskinesia (rhythmic movements of the face manifested by active tongue movement, rocking, chewing, grimacing), dystonia (impaired</p>
<p>VALIUM, DRUGS TO TREAT PARKINSONISM ▼ 85</p>
<p>muscle tone), and akathisia (pathologic condition: restlessness, agitation, inability to sit still)</p>
<p>D. Behavioral symptoms: nervousness, agitation, anxiety</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-interactions-pyroidoxine-hydrochloride-hexa-betalin-can-reverse-the-effectiveness-of-levodopa">VI. Interactions: pyroidoxine hydrochloride (Hexa-Betalin) can reverse the effectiveness of levodopa<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-interactions-pyroidoxine-hydrochloride-hexa-betalin-can-reverse-the-effectiveness-of-levodopa" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vii-nursing-implications">VII. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Instruct the client to rise slowly if orthostatic hypotension occurs
B. Administer the medicine with food if GI symptoms occur
C. Monitor for the following</p>
<ol>
<li>On-off phenomenon: alteration in the control of symptoms from day to day or within each day</li>
<li>End-of-dose deterioration: return of symptoms prior to the next dose</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="viii-common-drugs">VIII. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#viii-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Dopaminergic agents: levodopa (L-dopa is the precursor of dopamine, which enters the brain). The problem with levodopa is that a majority of it is converted to dopamine in the periphery, so it cannot cross the blood-brain barrier. Carbidopa blocks the peripheral conversion of levodopa to dopamine and allows for more of the drug to enter the brain before it is converted to dopamine.</p>
<ol>
<li>Levodopa or L-dopa (Larodopa)</li>
<li>Carbidopa-levodopa (Sinemet)</li>
</ol>
<p>B. Dopamine receptor agonists</p>
<ol>
<li>Amantadine hydrochloride (Symmetrel)</li>
<li>Bromocriptine mesylate (Parlodel)</li>
</ol>
<p>C. Anticholinergic drugs</p>
<ol>
<li>Benztropine (Cogentin)</li>
<li>Diphenhydramine (Benadryl)</li>
<li>Trihexyphenidyl (Artane)</li>
</ol>
<p>D. Selegiline hydrochloride (L-Deprenyl)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antimyasthenic-agents">ANTIMYASTHENIC AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antimyasthenic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I. Myasthenia gravis: an abnormal condition characterized by the chronic fatigue and weakness of voluntary muscles. The goal of therapy for clients</p>
<p>CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<p>with myasthenia gravis is to maintain a normal lifestyle. These drugs do not cure the disease.</p>
<p>II. Action: these agents prevent the breaking down of acetylcholine at the neuromuscular junction so that receptors are activated and the effects of the acetylcholine are prolonged; this improves the symptoms of the disease (Figure 6-1)
III. Uses: to treat myasthenia gravis and to reverse the effects of neuromuscular blocking agents</p>
<p><img src="assets/images/image-20251221-465efd18.jpeg" alt="img-13.jpeg">
Figure 6-1. Acetylcholine is the neurotransmitter released by the nerve to occupy nicotinic receptors on the muscle and thereby initiates biochemical events causing the muscle to contract. Acetylcholine is rapidly degraded by acetylcholinesterase, present throughout the synapse. In myasthenia gravis, the number of receptors is greatly decreased. Acetylcholinesterase inhibitors prevent rapid breakdown of acetylcholine. With more acetylcholine present, fewer receptors are needed, and loss of receptors is partially compensated. (From Clark J et al: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p>DRUGS TO TREAT MYASTHENIA GRAVIS ▼ 87</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-major-side-effects">IV. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Muscle weakness, cramping, contractions
B. Parasympathetic stimulation: excessive salivation, nausea, vomiting, sweating, bronchospasm
C. Cholinergic crisis: a pronounced muscular weakness and respiratory paralysis caused by excessive acetylcholine or an overdose with anticholinesterase drugs, manifested by increased weakness, increased salivation, dyspnea, bradycardia, increased secretions, nausea, and vomiting</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-interactions-taken-concurrently-with-other-drugs-containing-anticholinergic-properties-may-cause-increased-side-effects">V. Interactions: taken concurrently with other drugs containing anticholinergic properties may cause increased side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-interactions-taken-concurrently-with-other-drugs-containing-anticholinergic-properties-may-cause-increased-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-nursing-implications">VI. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. A baseline neuromuscular assessment is necessary
B. Doses are highly individualized. Periods of stress and infection may require an increased dose.
C. Monitor signs of improved ptosis, ability to swallow, and muscle strength for evaluation of drug's effectiveness
D. Teach the patient the signs and symptoms of cholinergic crisis and to report them to physician immediately
E. Administer with food to decrease the GI side effects, and 30 to 60 minutes before a meal to increase strength for chewing and swallowing
F. Too small of a dose can result in myasthenic crisis (sudden return of original clinical findings), and too large of a dose can result in cholinergic crisis. The client should be taught to distinguish between the two and the importance of compliance.
G. The antidote for these drugs is atropine sulfate</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vii-common-drugs-acetylcholinesterase-inhibitors-are-the-drugs-of-choice-for-this-disease">VII. Common drugs: acetylcholinesterase inhibitors are the drugs of choice for this disease<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-common-drugs-acetylcholinesterase-inhibitors-are-the-drugs-of-choice-for-this-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Pyridostigmine bromide (Mestinon)
B. Neostigmine methylsulfate (Prostigmin)
C. Edrophonium chloride (Tensilon)—used more in the initial diagnostic process and to differentiate between myasthenic crisis and cholinergic crises; it has a short duration of action</p>
<p>CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="neuromuscular-blocking-agents">NEUROMUSCULAR BLOCKING AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neuromuscular-blocking-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-divided-into-two-groups">I. Divided into two groups<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-divided-into-two-groups" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Nondepolarizing agents
B. Depolarizing agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-general-information-about-the-classification">II. General information about the classification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-general-information-about-the-classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. These drugs act to relax the skeletal muscles by disrupting the transmission of nerve impulses
B. These drugs do not cross the blood-brain barrier; therefore the client remains conscious and aware of pain
C. Three clinical indications for these drugs</p>
<ol>
<li>Relax smooth muscles during surgery</li>
<li>Decrease the intensity of muscle spasms in drug-induced or electrically induced convulsions</li>
<li>Manage clients needing controlled mechanical ventilation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-nondepolarizing-agents">III. Nondepolarizing agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-nondepolarizing-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: compete with acetylcholine for the receptor sites on the motor end plate or by blocking depolarization
B. Uses</p>
<ol>
<li>Facilitate endotracheal intubation</li>
<li>Decrease amount of anesthetic during surgery</li>
<li>Relax skeletal muscles of intubated clients on mechanical assistance to allow for total control of breathing
C. Major side effects</li>
<li>Cardiac: hypotension, tachycardia, dysrhythmias</li>
<li>Respiratory: apnea, depression, bronchospasm, excess bronchial secretions
D. Interactions</li>
<li>Antibiotics intensify the effect of the neuromuscular blocking agents</li>
<li>Some antidysrhythmic agents may potentiate the effects of these drugs
E. Nursing implications</li>
<li>Implement safety measures and instruct the client on safety measures; eyes may need artificial tears and be patched during paralysis</li>
<li>Use suction and intubation equipment as needed</li>
<li>Offer pain medications if indicated</li>
<li>Keep the antidote (anticholinesterase drugs) available, edrophonium chloride (Tensilon)</li>
</ol>
<p>NEUROMUSCULAR BLOCKING AGENTS ▼ 89</p>
<ol start="5">
<li>Assess for signs of respiratory depression, if not ventilated</li>
<li>Maintain a calm environment</li>
<li>Monitor vital signs carefully</li>
<li>If client is on a ventilator, bring client out of paralysis once per shift to complete a neuro check</li>
</ol>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Pancuronium bromide (Pavulon)</li>
<li>Gallamine triethiodide (Flaxedil)</li>
<li>Pipecuronium bromide (Arduan)</li>
<li>Vecuronium bromide (Norcuron)</li>
</ol>
<p><strong>IV. Depolarizing agents</strong></p>
<p><strong>A. Action:</strong> these agents mimic the action of acetylcholine and cause depolarization of the muscle fiber, which makes the muscle incapable of becoming stimulated by another impulse. These agents are not destroyed by cholinesterase and therefore have a prolonged action.</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Short-term relaxation needed in orthopedic procedures</li>
<li>Intubation</li>
<li>Endoscopy</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Hypertension</li>
<li>Increased intraocular pressure</li>
<li>Muscle pain</li>
</ol>
<p><strong>D. Interactions:</strong> same as for nondepolarizing agents</p>
<p><strong>E. Nursing implications:</strong> same as for nondepolarizing agents</p>
<p><strong>F. Common drug:</strong> succinylcholine chloride (Anectine)</p>
<p>90 ▼ CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Nursing implications for the patient on an anticonvulsant include which of the following?</li>
</ol>
<p>a. A neurological assessment is essential after the drug regimen begins
b. Administering the medicine around the clock may decrease sedation
c. If toxicity occurs, the drug is abruptly discontinued
d. Compliance in taking the medicine should be stressed to the client</p>
<ol start="2">
<li>A client with status epilepticus might be given which of the following?</li>
</ol>
<p>a. Oxazolidones
b. Iminostilbenes
c. Valporic acid
d. Benzodiazepine</p>
<ol start="3">
<li>A client is admitted to the hospital for the control of seizures. The physician prescribes a hydantoin derivative—phenytoin (Dilantin). This class of agents helps to treat seizures by</li>
</ol>
<p>a. Limiting the spread of the seizure
b. Facilitating GABA to inhibit nerve impulses
c. Decreasing the focal activity in the CNS
d. Inhibiting nerve impulses</p>
<ol start="4">
<li>While taking the phenytoin (Dilantin), a female client should be advised to do which of the following?</li>
</ol>
<p>a. Use alcohol conservatively
b. Report for blood monitoring as ordered to avoid toxicity
c. Continue taking her oral contraceptives as ordered
d. Hold one dose if the drug is too sedating</p>
<ol start="5">
<li>Which possible adverse reaction to phenytoin (Dilantin) should be reported to the physician?</li>
</ol>
<p>a. Cavities
b. Hypertension
c. Agitation, confusion
d. Bleeding of gums</p>
<ol start="6">
<li>The drugs of choice in the treatment of Parkinson’s disease are those that</li>
</ol>
<p>a. Block acetylcholine receptors in the brain
b. Decrease the dopaminergic system
c. Increase the dopaminergic system
d. Increase cholinergic activity</p>
<p>REVIEW QUESTIONS ▼ 91</p>
<ol start="7">
<li>When a client on an antiparkinsonism drug, levodopa (L-dopa), is experiencing many side effects, the combination of levodopa/carbidopa (Sinemet) may work better because</li>
</ol>
<p>a. The latter blocks all side effects of levodopa
b. The levodopa is converted to dopamine more quickly after absorption
c. The carbidopa blocks the conversion of the levodopa to dopamine before its entry into the brain
d. The anticholinergic effects block the symptoms of the disease</p>
<ol start="8">
<li>A client is on an antiparkinsonism drug. He receives his dose as scheduled (9-1-5). The nurse notices that from 9 A.M. to 12 noon he seems calm, is without tremors, and walks normally. Between 12:30 P.M. and 4:30 P.M. his symptoms worsen. The nurse should suspect</li>
</ol>
<p>a. End-of-dose deterioration
b. On-off phenomenon
c. Extrapyramidal effects
d. Dawn phenomenon</p>
<ol start="9">
<li>Antimyasthenic agents exert their effects on improving the symptoms of myasthenia gravis by which action?</li>
</ol>
<p>a. Deactivating receptors at the neuromuscular junction
b. Decreasing the excitatory effects of the cholinergic system
c. Inhibiting the breakdown of acetylcholine at the neuromuscular junction
d. Increasing the destruction of acetylcholine</p>
<ol start="10">
<li>A client diagnosed with myasthenia gravis is placed on pyridostigmine bromide (Mestinon). She calls the office and complains of severe diarrhea, drooling, and intestinal cramping. What is the best advice for her?</li>
</ol>
<p>a. Avoid the next dose and see the doctor tomorrow
b. Report to the emergency room at once for treatment
c. Increase the next dose and report back to the physician
d. Come in to the office for an examination and perhaps an IV tension test</p>
<ol start="11">
<li>Which of the following would be appropriate nursing implications for a client on a nondepolarizing blocking agent?</li>
</ol>
<p>a. Monitor vital signs once per shift
b. Assess for the need to suction the client and for indications of pain
c. Instruct the client to ambulate at least twice per shift unless contraindicated by the physician
d. Allow frequent visitors in order to occupy the client during the therapy</p>
<p>CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: d</strong></td><td></td></tr><tr><td>Compliance is a major teaching effort for clients on these drugs in order to control the seizures. A baseline neurological assessment should be done before administering the agent, then used for comparison purposes later. Sedation is a major side effect. A bedtime (HS) dose is best for eliminating the sedating effect. Abrupt discontinuation could cause the seizures to return.</td><td>Key words in each response help to eliminate it as a choice. Refer to the rationale for further information. In response a the key word is “after;” in response b, “decrease”; and in response c, “abruptly.”</td></tr><tr><td><strong>2. Correct answer: d</strong></td><td></td></tr><tr><td>Diazepam (Valium), a benzodiazepine, is the drug of choice. Barbiturates can also be used. Ativan, an anticonvulsant agent, is also a drug of choice, since it has a longer duration with less respiratory depression for status epilepticus. Oxazolidones are not used for status epilepticus. Iminostilbenes are used for cases refractory to phenytoin (Dilantin). Valporic acid is used in absence seizures.</td><td>Go with what you know. If you cannot recall what the classifications of responses a, b, and c are and identified the classification in response d, then select that with which you are familiar.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>This action of hydantoin derivatives decreases the spread of the seizure by decreasing abnormal</td><td>Go with what you know plus use common sense to match the need to “control” the seizure by “decreasing” activity of the CNS.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 93</p>
<p>hyperactivity. This action in response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is the action of barbiturates. Responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> are the actions of benzodiazepines.</p>
<p>“Limiting the spread” in response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> would not control seizures. Avoid selecting option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> when you have no recall what it pertains to.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-b">4. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Maintaining a therapeutic level is absolutely necessary to control seizures. Alcohol should never be taken by a client while on an anticonvulsant because of the additive effect. Interactions can occur with this drug and oral contraceptives. The client should have the physician evaluate the dose of the oral contraceptive being taken. The excess sedation should be reported to the physician. A client should never avoid a dose without first notifying the physician.</p>
<p>Use a true-false approach to select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>. All the other answers are false. Refer to the rationale.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-d">5. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Gingival hyperplasia can cause softening and severe tenderness of the gums. If gums bleed the client probably has an additional problem. Cavities are not a side effect of this medication. Hypotension is a common side effect. Sedation, not agitation is a common side effect.</p>
<p>Use the ABCs if you have no idea of a correct answer. Select the response dealing with circulation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-c">6. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Increasing the dopaminergic system should decrease the symptoms of Parkinson’s. In response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> this is the action of anticholinergic agents, which</p>
<p>A way to remember Parkinson’s is to stutter . . . PDDD . . . Parkinson’s Disease is a Deficiency in Dopamine.</p>
<p>CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<p>can be used in Parkinson's but are not the drugs of choice. The dopaminergic system is already decreased in this disease. Increasing cholinergic activity will increase the symptoms of the disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-c">7. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Because the brain blocks the entry of dopamine, conversion of levodopa within the brain boosts the dopaminergic system. The combination increases the effectiveness of the agent but does not decrease all side effects. Dopamine does not cross the blood-brain barrier, since with L-dopa, dopamine is mostly converted in the periphery. Clients using Levodopa/ Carbidopa (Sinemet) do not exhibit anticholinergic effects.</p>
<p>A common sense approach here will help guide option selection. Reread the question with each option. The option that makes most sense is c; if conversion of levodopa to dopamine occurs in the brain, common sense tells you the effect will be better.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-b">8. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The control of the symptoms fluctuates with on-off phenomenon despite repeat dosing. End-of-dose deterioration would manifest a return of symptoms before each dose. Extrapyramidal effects may be manifested with a return of symptoms but would not occur for only a short time period. The dawn phenomenon occurs with antidiabetic agents. Dawn phenomena in Type I diabetics may require an increased insulin dose in the</p>
<p>The important item to clarify here is the time of the medication in relation to the abnormal clinical findings. If the client had end-of-dose deterioration the findings would occur mainly between the hours of 12 noon to 1 P.M. and 4 P.M. to 5 P.M., not between 12:30 P.M. and 4:30 P.M.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 95</p>
<p>early morning hours because of an increase in serum glucose; it is treated with extra insulin. In contrast, the Somogyi Phenomenon is a rebound effect where too much insulin induces hypoglycemia around 2 to 3 A.M. with resulting response of the body to break down glucose stores so that by 6 A.M. the fasting glucose is elevated.</p>
<ol start="9">
<li>Correct answer: c</li>
</ol>
<p>The action of these agents prolongs the effects of the acetylcholine, which improves the disease symptoms. The action of these agents involves activating receptors at the neuromuscular junction and slowing the destruction of acetylcholine. This action in response b is describing antiparkinson drugs.</p>
<ol start="10">
<li>Correct answer: d</li>
</ol>
<p>The side effects could be due to the dose being taken; a visit to her physician is necessary for an adjustment in the amount. Cholinergic crisis typically occurs when the dosage is being initiated or increased to determine the correct dose. The medication should not be held without prior notification of the physician. These symptoms do not warrant a cholinergic crisis but do need to be reported. Doses should</p>
<p>Associate acetylcholine is needed for action of voluntary muscles in myasthenic gravis. Cluster options a, b, and d with negative actions—deactivate, decrease and destruction increased. Option c is more neutral; select it.</p>
<p>Eliminate responses a and c, since they break the basic rules of medication administration. Since the findings do not include any threat to the ABCs there is no need for the client to go to the emergency room. The reasonable action is to advise as described in response d.</p>
<p>96 ▼ CHAPTER 6 DRUGS AFFECTING THE NEUROMUSCULAR SYSTEM</p>
<p>not be changed unless recommended by the physician.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="11-correct-answer-b">11. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#11-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>These agents do not control pain; therefore pain medication should be offered or routinely given along with these agents. A side effect is excess bronchial secretions for which suctioning may be needed. Vital signs should be monitored more frequently, at least every 30 minutes. Bed rest should be initiated, with side rails raised, while the client is under the influence of these agents. A calm environment would help the client relax and lessen any pain.</p>
<p>Recall that nondepolarizing blocking agents are neuromuscular paralyzers. Thus the client cannot move voluntary and involuntary muscles. Given this, the most reasonable answer is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>.</p>
<p>7
CHAPTER</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-central-nervous-system">Drugs Affecting the Central Nervous System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-central-nervous-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Describe the difference between preanesthetics, general anesthetics, and local anesthetics.</li>
<li>Describe the side effects and nursing implications for anesthetic agents.</li>
<li>Describe the therapeutic uses of stimulants.</li>
<li>Identify the difference between amphetamines, anorexiant agents, and analeptic agents.</li>
<li>Identify the major groups of drugs used as psychotropics and antianxiety agents.</li>
<li>List the major therapeutic uses and side effects of psychotropics and antianxiety agents.</li>
<li>Describe the differences among antidepressant agents.</li>
<li>Identify necessary client teaching of CNS depressants.</li>
<li>Discuss the action of skeletal muscle relaxants.</li>
<li>Identify common uses and side effects of skeletal muscle relaxants.</li>
<li>Identify nursing implications for skeletal muscle relaxants.</li>
</ul>
<p>98 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Amphetamines</strong>
A group of nervous system stimulants that are subject to abuse. Street names and routes: black beauties, lidpoppers, and pep pills, all taken by mouth; speed, an injectable form; and ice, a crystalline form of methamphetamine that is smoked.</p>
<p><strong>Analeptics</strong>
Also called <strong>CNS Stimulants</strong>. Substances that quicken the activity of the CNS by increasing the rate of neuronal discharge or by blocking an inhibitory neurotransmitter such as caffeine and amphetamines.</p>
<p><strong>Anorexiant</strong>
A drug or other agent that suppresses the appetite.</p>
<p><strong>Central nervous system (CNS)</strong>
One of the two main divisions of the nervous systems of the body, consisting of the brain and the spinal cord. The other main division is the peripheral nervous system.</p>
<p><strong>CNS depressant</strong>
Any drug or substance that decreases the function of the CNS, such as alcohol, barbiturates, and hypnotics. Such drugs can produce tolerance, physical dependence, and compulsive drug use. Street names: “reds,” for secobarbital and “yellows,” for pentobarbital.</p>
<p><strong>Monoamine oxidase enzyme (MAO)</strong>
An enzyme that catalyzes the oxidation of amines. The inhibition of this enzyme by MAO inhibitors is used in the treatment of depression. MAO inhibitors interact with foodstuffs and drugs such as ephedrine, a common ingredient in common cold remedies.</p>
<p><strong>Peripheral nervous system</strong>
The motor and sensory nerves and ganglia outside the brain and spinal cord.</p>
<p><strong>Photosensitivity</strong>
A skin reaction requiring the presence of a sensitizing agent, typically a medication such as tetracycline, and exposure to sunlight or its equivalent.</p>
<p><strong>Psychotropic agents</strong>
Substances that affect the mind or modify mental activity.</p>
<p><strong>Serotonin</strong>
Acts as a neurotransmitter in the CNS; found in platelets and the cells of the brain and the intestines. If released in the blood vessels, it is a potent vasoconstrictor; if in the intestines, it stimulates smooth muscles to contract.</p>
<p><strong>Tyramine</strong>
An amino acid synthesized in the body from the essential acid tyrosine. Tyramine stimulates the</p>
<p>PREANESTHETIC DRUGS ▼ 99</p>
<p>release of catecholamines: epinephrine, and norepinephrine. Clients on MAO inhibitors must avoid foods with tyramine, particularly aged cheeses and meats, bananas, yeast-containing products, and alcoholic beverages. If restrictions are not followed, severe hypertensive crisis may result.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-preanesthetics">I. Preanesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-preanesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: varies according to the classification</p>
<p>B. Uses</p>
<ol>
<li>Induce sedation and decrease anxiety</li>
<li>Decrease the risk of bradycardia</li>
<li>Allow for a smoother induction of anesthesia</li>
</ol>
<p>C. Nursing implications</p>
<ol>
<li>Often given IM or IV</li>
<li>May mix two or more drugs to produce the desired effect</li>
<li>May be ordered the night before or 30 to 60 minutes before the surgery</li>
<li>Use the Z-track method if medication is oil-based or more irritating, and chart this technique if applicable</li>
<li>Double-check the dosage, especially if given in a rushed situation</li>
<li>Know which drugs can be mixed together</li>
<li>Check the client’s drug allergies before preparation of medication</li>
<li>Verify the correct client, using the arm band, and ask client to state his/her name if able</li>
<li>Know the correct time to administer the injection, secure the medicine, and prepare the equipment, ahead of time if possible. Many of these drugs may be scheduled drugs and require signing out on a narcotic record.</li>
<li>Practice safety precautions after medication administration: put side rails up, place call light within reach, give instructions to the client not to get up without assistance, and encourage client to void prior to administration</li>
</ol>
<p>D. Common drugs within each classification</p>
<ol>
<li>Narcotics: morphine sulfate (MS)</li>
<li>Anticholinergics: atropine sulfate</li>
<li>Neuromuscular blocking agents: succinylcholine chloride (Anectine), pancuronium bromide (Pavulon)</li>
</ol>
<p>CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<ol start="4">
<li>Antiemetics: promethazine (Phenergan), droperidol (Inapsine)</li>
<li>Antianxiety agents: diazepam (Valium)</li>
<li>Barbiturates: pentobarbital (Nembutal), secobarbital (Seconal)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-anesthetics">II. Anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Anesthesia: the loss of sensation as a result of reversible central nervous system depression
B. Two basic categories</p>
<ol>
<li>
<p>General anesthesia: loss of consciousness and loss of sensation
a. Inhalation route
(1) Gases
(2) Volatile liquids
b. Intravenous route</p>
</li>
<li>
<p>Local anesthesia: loss of sensation, particularly the inability to detect pain in a selected area</p>
</li>
</ol>
<p>C. Balanced anesthesia: the selection of a combination of drugs to produce the desired effect for the type of surgery scheduled. This is required when there is no ideal anesthetic agent.
D. The role of the nurse is not to administer the agents but to know the nursing implications based on the effects of the agent used</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="general-anesthesia">GENERAL ANESTHESIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-anesthesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-three-phases-of-anesthesia">I. Three phases of anesthesia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-three-phases-of-anesthesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Induction: a large amount of anesthetic agent is administered
B. Maintenance: the desired level is maintained
C. Recovery: the anesthetic agent is no longer administered, and it may be reversed</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-anesthesia-requires-that-critical-concentration-levels-occur-in-the-brain-and-that-the-degree-of-effects-is-dose-dependent">II. Anesthesia requires that critical concentration levels occur in the brain and that the degree of effects is dose-dependent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-anesthesia-requires-that-critical-concentration-levels-occur-in-the-brain-and-that-the-degree-of-effects-is-dose-dependent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-anesthetic-agents-are-administered-until-the-client-reaches-the-stage-when-loss-of-consciousness-occurs-and-surgery-may-be-performed">III. Anesthetic agents are administered until the client reaches the stage when loss of consciousness occurs and surgery may be performed<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-anesthetic-agents-are-administered-until-the-client-reaches-the-stage-when-loss-of-consciousness-occurs-and-surgery-may-be-performed" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Clients are monitored by assessing respiration, pulse, blood pressure, pupil response, reflexes, and eye movement for maintenance levels during these stages</p>
<p>ANESTHETICS: GENERAL AND INHALATION ▼ 101</p>
<p>B. Diseases such as chronic airway limitation (obstructive pulmonary disease [COPD], emphysema), and congestive heart failure (CHF) can increase or decrease the absorption of these agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-inhalation-anesthetics">IV. Inhalation anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-inhalation-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: depression of the central nervous system, interference with nerve impulses, and relaxation of skeletal and smooth muscles. Their exact mechanism of action is unknown.</p>
<p>B. Uses: rapid control and depth of anesthesia</p>
<p>C. Administered by open drops, semiclosed method, or closed method</p>
<p>D. Major side effects</p>
<ol>
<li>Cardiovascular depression: bradycardia, hypotension, dysrhythmias</li>
<li>Respiratory depression and complications: bradypnea, apnea, decreased oxygen saturation</li>
<li>Nausea, vomiting</li>
<li>Hypothermia</li>
<li>Confusion</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>Monitor any turning, coughing, deep breathing, and client use of incentive spirometer to prevent pneumonia after surgery</li>
<li>Obtain a thorough nursing history prior to the surgery; note in particular any client allergies or previous problems with anesthesia</li>
<li>Assess the client's neurological status postoperative and cautiously administer analgesics</li>
<li>Practice and stress safety measures with the client because psychomotor function is impaired. Raise side rails; set bed in low position; assist with ambulation; and place the call light within reach.</li>
<li>Monitor vital signs; administer oxygen if indicated</li>
<li>Assess for problems with elimination; client may have urinary retention as a result of preoperative or intraoperative medication</li>
</ol>
<p>F. Common anesthetic gases</p>
<ol>
<li>Nitrous oxide</li>
<li>Halothane (Fluothane)—prototype</li>
<li>Enflurane (Enthrane)</li>
<li>Methoxyflurane (Penthrane)</li>
<li>Isoflurane (Forane)</li>
</ol>
<p>102 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-intravenous-iv-anesthetics">V. Intravenous (IV) anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-intravenous-iv-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-based-on-the-individual-agent-group-used">A. Action: based on the individual agent group used<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-based-on-the-individual-agent-group-used" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Before administration of inhalation agents</li>
<li>Diagnostic procedures</li>
<li>Outpatient surgeries</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>“Hangover” effect</li>
<li>Apnea, laryngospasm, bronchospasm, coughing</li>
<li>Depression of the cardiovascular system (however, less with IV anesthetics than with inhalation agents)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Have emergency equipment ready, IV fluids handy</li>
<li>Know each individual drug, since the classification varies</li>
<li>Practice and stress safety measures</li>
<li>Monitor vital signs especially for respiratory depression</li>
<li>Monitor elimination status; first 24 hours, focus on urinary; afterwards, monitor bowel movements</li>
<li>Cautiously administer analgesics for pain in the recovery period while client is in the postanesthetic care unit</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs-within-each-classification">E. Common drugs within each classification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs-within-each-classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Neuroleptics: droperidol (Inapsine), fentanyl and droperidol (Innovar)</li>
<li>Opoid narcotics: fentanyl citrate (Sublimaze)</li>
<li>Barbiturates: thiopental sodium (Pentothal)</li>
<li>Benzodiazepines and related drugs: diazepam (Valium), midazolam hydrochloride (Versed)—used more in outpatient surgery units</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="local-anesthesia">LOCAL ANESTHESIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-anesthesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-general-information">I. General information<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-these-drugs-are-given-to-affect-either-a-small-area-of-the-body-such-as-a-digit-or-a-larger-area-such-as-an-entire-extremity-they-may-be-applied-topically">A. These drugs are given to affect either a small area of the body such as a digit, or a larger area such as an entire extremity; they may be applied topically<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-these-drugs-are-given-to-affect-either-a-small-area-of-the-body-such-as-a-digit-or-a-larger-area-such-as-an-entire-extremity-they-may-be-applied-topically" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-methods-of-administration">B. Methods of administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-methods-of-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Topical: application of a topical anesthetic in the form of a solution, gel, or ointment to the skin, mucous membrane, or cornea</li>
<li>Infiltration: the process whereby a local anesthetic is administered through the tissue; field block: producing</li>
</ol>
<p>ANESTHETICS: IV AND LOCAL ▼ 103</p>
<p>anesthesia around the entire lesion or incision—used in emergency rooms to repair lacerations</p>
<ol start="3">
<li>Regional: anesthesia of an area of the body by injection of a local anesthetic to block a group of sensory nerve fibers
a. Spinal: injection of an analgesic or anesthetic drug into the subarachnoid space of the spinal column to achieve insensitivity to pain in the lower part of the body
b. Epidural: injection into the epidural space of the spinal cord
C. May be combined with epinephrine hydrochloride (Adrenalin) to slow drug absorption, prolong the effect of the anesthetic, and reduce bleeding at site. Caution should be taken in patients with cardiovascular compromise.</li>
</ol>
<p>II. Action: these agents block nerve impulses and decrease the ability of the cell to depolarize, which is necessary for impulse transmission</p>
<p>III. Uses
A. Minor surgery
B. Diagnostic procedures
C. Minor treatments
D. Toothaches</p>
<p>IV. Side effects
A. Toxicity
B. Interference with the organ involved
C. Reversal of the block
D. Cardiovascular effects: bradycardia, hypotension, respiratory failure
E. Frostbite with the topicals
F. Skin irritation</p>
<p>V. Nursing implications
A. Monitor vital signs
B. Use safety measures
C. Properly position the extremity (regional) or body (spinal)
D. Monitor the area anesthetized for return of motor function and sensation
E. Protect the anesthetized area from trauma, since motor function returns before sensory function
F. Caution client to avoid eating if the throat is involved</p>
<p>CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-common-drugs">VI. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-esters">A. Esters<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-esters" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Procaine (Novocain)</li>
<li>Tetracaine (Pontocaine)</li>
<li>Cocaine hydrochloride (Procaine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-amides">B. Amides<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-amides" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Lidocaine (Xylocaine)</li>
<li>Prilocaine (Citanest)</li>
<li>Mepivacaine (Polocaine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="central-nervous-system-stimulants">CENTRAL NERVOUS SYSTEM STIMULANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#central-nervous-system-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-general-information">I. General information<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-central-nervous-system-cns-stimulant-a-substance-that-quickens-the-activity-of-the-cns-by-increasing-the-rate-of-neuronal-discharge-or-by-blocking-an-inhibitory-neurotransmitter">A. Central nervous system (CNS) stimulant: a substance that quickens the activity of the CNS by increasing the rate of neuronal discharge or by blocking an inhibitory neurotransmitter<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-central-nervous-system-cns-stimulant-a-substance-that-quickens-the-activity-of-the-cns-by-increasing-the-rate-of-neuronal-discharge-or-by-blocking-an-inhibitory-neurotransmitter" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-many-drugs-can-stimulate-although-few-do-so-therapeutically-therapeutic-cns-stimulation-involves">B. Many drugs can stimulate, although few do so therapeutically. Therapeutic CNS stimulation involves<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-many-drugs-can-stimulate-although-few-do-so-therapeutically-therapeutic-cns-stimulation-involves" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Restoring mental alertness or consciousness</li>
<li>Stimulating the respiratory center, or overcoming respiratory depression</li>
<li>Treating hyperkinetic children by acting as a depressant in a child</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-classification-of-agents-that-stimulate-therapeutically">C. Classification of agents that stimulate therapeutically<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-classification-of-agents-that-stimulate-therapeutically" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Amphetamines</li>
<li>Anorexiant agents</li>
<li>Analeptics</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="d-most-of-these-agents-are-controlled-and-highly-abused-substances">D. Most of these agents are controlled (and highly abused) substances<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-most-of-these-agents-are-controlled-and-highly-abused-substances" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-amphetamines-and-amphetamine-like-drugs">II. Amphetamines and amphetamine-like drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-amphetamines-and-amphetamine-like-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-action-stimulate-the-release-of-norepinephrine-which-causes-increased-alertness-less-fatigue-and-elevated-mood">A. Action: stimulate the release of norepinephrine, which causes increased alertness, less fatigue, and elevated mood<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-stimulate-the-release-of-norepinephrine-which-causes-increased-alertness-less-fatigue-and-elevated-mood" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Narcolepsy: syndrome characterized by sudden sleep attacks. Stimulation of the CNS can alleviate these attacks and produce alertness.</li>
<li>Endogenous obesity: obesity resulting from dysfunction of the endocrine or metabolic systems. Amphetamines suppress the appetite.</li>
<li>Attention deficit hyperactivity disorder (ADHD): childhood condition involving inattention, impulsivity, and hyperactivity.</li>
</ol>
<p>CNS STIMULANTS ▼ 105</p>
<p>Amphetamines increase attention span while decreasing the hyperactivity.</p>
<ol start="4">
<li>
<p>Mental depression: amphetamines elevate mood, increase motor activity, and promote self-confidence</p>
</li>
<li>
<p>Withdrawal syndromes: physical reactions after cessation or severe reduction in intake of a substance that has been used regularly to induce euphoria, intoxication, or relief from pain or distress. Amphetamines can enhance the effects of some narcotics and reduce the symptoms of withdrawing from abusive agents by their ability to increase alertness, decrease fatigue, and elevate mood.</p>
</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>
<p>Tolerance, dependence, abuse</p>
</li>
<li>
<p>Tachyphylaxis: repeated administration of some drugs results in a marked decrease in effectiveness</p>
</li>
<li>
<p>Nervousness, irritability, increased motor activity</p>
</li>
<li>
<p>Headaches, dizziness, insomnia</p>
</li>
<li>
<p>Cardiovascular reactions: hypertension, palpitations, dysrhythmias</p>
</li>
<li>
<p>Weight loss and fatigue from prolonged use</p>
</li>
</ol>
<p>D. Interactions may occur with antidepressants, which increase the effect of the amphetamine, and with urine alkalinizers, which increase the half-life</p>
<p>E. Nursing implications</p>
<ol>
<li>
<p>A weight-reduction diet and exercise program should accompany the use of these agents for obesity. Short-term use is recommended.</p>
</li>
<li>
<p>The client and parent should be taught about the use of drug for attention deficit disorder. Teaching concepts include</p>
</li>
</ol>
<p>a. Check with a pharmacist about all over-the-counter medications</p>
<p>b. Do not abruptly stop taking the drug</p>
<p>c. Do not try to make up doses if one is skipped</p>
<p>d. If diabetic, check whether insulin or oral hypoglycemic requirements may be reduced</p>
<ol start="3">
<li>
<p>Avoid other stimulants while on these drugs</p>
</li>
<li>
<p>Avoid taking the last dose after 4 to 6 P.M. to prevent insomnia</p>
</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>
<p>Methylphenidate (Ritalin)—for ADHD most commonly</p>
</li>
<li>
<p>Amphetamine complex (Biphetamine)</p>
</li>
<li>
<p>Amphetamine sulfate</p>
</li>
<li>
<p>Dextroamphetamine sulfate (Dexedrine)</p>
</li>
</ol>
<p>106 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-anorexiant-agents">III. Anorexiant agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-anorexiant-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Classification: sympathomimetic agents
B. Action: suppress appetite by acting on the hypothalamus
C. Use: weight reduction when accompanied by medical complications
D. Side effects and nursing implications: similar to those of amphetamines. Tolerance and abuse are possible.
E. Common drugs</p>
<ol>
<li>Benzphetamine (Didrex)</li>
<li>Diethylpropion (Tenuate)</li>
<li>Phenmetrazine (Preludin)</li>
<li>Phentermine HCl (Adipex-P)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-analeptics-and-methylxanthines">IV. Analeptics and methylxanthines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-analeptics-and-methylxanthines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: stimulate the CNS by acting on the cerebral cortex and medulla
B. Uses</p>
<ol>
<li>In over-the-counter (OTC) drugs such as caffeine (Vivarin, NoDoz) to produce wakefulness and increase alertness. Also used in OTC cold medications and analgesics such as acetylsalicylic acid (aspirin) with caffeine (Anacin), acetaminophen and caffeine (Excedrin), Triaminicin.</li>
<li>Overdose of CNS depressants</li>
<li>Migraine headaches</li>
<li>Respiratory stimulation
C. Major side effects</li>
<li>Teratogenesis: fetal abnormalities</li>
<li>Cardiovascular: dysrhythmias, heart attacks, tachycardia, hypertension, tachypnea</li>
<li>Caffeinism: restlessness, insomnia, nervousness, muscle twitching, headache</li>
<li>Seizures</li>
<li>Tolerance and abuse
D. Nursing implications</li>
<li>Monitor the dietary intake of caffeine</li>
<li>Assess respiratory and cardiovascular systems</li>
<li>Watch for withdrawal symptoms that can occur if drugs are abruptly discontinued; manifested as nausea, vomiting, headaches</li>
<li>Avoid other foods and drinks that contain stimulants
E. Common drugs</li>
<li>Methylxanthines
a. Caffeine</li>
</ol>
<p>CNS STIMULANTS, PSYCHOTROPICS ▼ 107</p>
<p>b. Theophylline (various trade names)
c. Theobromide</p>
<ol start="2">
<li>Analeptic: doxapram hydrochloride (Dopram)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="psychotropics">PSYCHOTROPICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#psychotropics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-classifications">I. Classifications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-classifications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Antipsychotic agents (Neuroleptics)
B. Antianxiety or anxiolytic agents
C. Antidepressants and mood stabilizers</p>
<ol>
<li>Tricyclic compounds</li>
<li>Monoamine oxidase (MAO) inhibitors</li>
<li>Selective serotonin reuptake inhibitors</li>
<li>Lithium</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-antipsychotic-agents">II. Antipsychotic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antipsychotic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: block the dopamine receptors in the brain, which inhibits the dopamine response. This action results in improved symptoms in the client with a psychiatric disorder. They also work as antiemetics by inhibiting the chemoreceptor trigger zones in the medulla.
B. Uses</p>
<ol>
<li>Psychiatric disorders
a. Schizophrenia: a psychiatric disorder characterized by gross distortion of reality, withdrawal, and disorganization of thought
b. Bipolar disorder: manic-depressive illness
c. Delusional disorders
d. Organic syndromes</li>
<li>Antiemetic: prevention of emesis
C. Major side effects</li>
<li>Serious movement disorders, extrapyramidal effects
a. Tardive dyskinesia: involuntary repetitious movements of the muscles of the face, limbs, and trunk
b. Dystonia: impairment of muscle tone
c. Parkinsonism (see Chapter 6 pp. 84-85)
d. Akathisia: restlessness, agitation, inability to sit still
e. Neuroleptic malignant syndrome: a complication of psychotherapy, with neuroleptic drugs given in therapeutic doses
f. Tremors</li>
<li>Addiction and tolerance</li>
</ol>
<p>108 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<ol start="3">
<li>Sedation</li>
<li>Hypotension and tachycardia</li>
<li>Anticholinergic effects: dry mouth, dilation of pupils, tachycardia, decrease in GI and GU motility</li>
<li>Photosensitivity</li>
</ol>
<p>D. Interactions include additive effect with other CNS depressants, especially alcohol, and delayed or blocked absorption with antacids</p>
<p>E. Nursing implications</p>
<ol>
<li>Psychological and physical assessments are necessary as a baseline, and while client is taking the medicine</li>
<li>Monitor any controlled substances</li>
<li>Use safety measures due to the sedation</li>
<li>Carefully document the effects of the drug</li>
<li>Teach the client about compliance and need for skin protection in the sun</li>
<li>Evaluate for effectiveness in treating nausea and vomiting</li>
<li>Teach the client about the side effects, especially how to monitor for extrapyramidal effects and anticholinergic effects</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Phenothiazines
a. Chlorpromazine (Thorazine)
b. Thioridazine hydrochloride (Mellaril)
c. Prochlorperazine (Compazine)</li>
<li>Thioxanthines
a. Chlorprothixene (Taractan)
b. Thiothixene hydrochloride (Navane)</li>
<li>Butyrophenones: haloperidol (Haldol)</li>
<li>Dihydroindolones: molindone hydrochloride (Moban)</li>
<li>Dibenzodiazepines: clozapine (Clozaril)</li>
</ol>
<p>III. Antianxiety or anxiolytic
A. Action: depression of the central nervous system, thereby increasing the effects of gamma-aminobutyric acid (GABA), which produces relaxation and may depress the limbic system
B. Uses</p>
<ol>
<li>Anxiety states</li>
<li>Depression</li>
<li>Insomnia</li>
<li>Preanesthesia</li>
<li>Withdrawal syndromes</li>
</ol>
<p>ANTIANXIETY AGENTS, TRICYCLIC ANTIDEPRESSANTS ▼ 109</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Abuse, dependence, tolerance</li>
<li>Sedation, which causes decreased motor skills</li>
<li>Hypotension</li>
<li>Respiratory depression</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-interactions-will-occur-with-other-cns-depressants-especially-alcohol">D. Interactions: will occur with other CNS depressants, especially alcohol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-will-occur-with-other-cns-depressants-especially-alcohol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>These agents do not cure, only treat the symptoms.
Counseling and therapy should accompany treatment.</li>
<li>The amount of the medication taken should be monitored</li>
<li>In higher doses, drugs may be used as sedatives or hypnotics</li>
<li>Most are not recommended in pregnancy (unless absolutely necessary) because of the risk to the fetus</li>
<li>Should be used cautiously with older-adult and debilitated clients, as well as those with pulmonary disorders</li>
<li>Clients should be taught how to avoid effects of orthostatic hypotension</li>
<li>Safety measures should be ensured due to the sedative properties</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-groups-many-groups-of-drugs-have-the-potential-to-lower-anxiety">F. Common groups: many groups of drugs have the potential to lower anxiety<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-groups-many-groups-of-drugs-have-the-potential-to-lower-anxiety" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Benzodiazepines
a. Diazepam (Valium)
b. Alprazolam (Xanax)
c. Clorazepate dipotassium (Tranxene)
d. Oxazepam (Serax)</li>
<li>Antihistamines: diphenhydramine hydrochloride (Benadryl)</li>
<li>Other agents
a. Hydroxyzine hydrochloride (Atarax)
b. Hydroxyzine hydrochloride (Vistaril)
c. Buspirone hydrochloride (BuSpar)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-tricyclic-antidepressants">IV. Tricyclic antidepressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-tricyclic-antidepressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-increase-neurotransmitter-concentration-levels-of-norepinephrine-and-serotonin">A. Action: increase neurotransmitter concentration levels of norepinephrine and serotonin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-increase-neurotransmitter-concentration-levels-of-norepinephrine-and-serotonin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Treat depression</li>
<li>Treat chronic headaches</li>
<li>Treat enuresis</li>
<li>Normalize sleep</li>
<li>Increase appetite</li>
<li>Elevate mood</li>
</ol>
<p>CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Sedation</li>
<li>Orthostatic hypotension</li>
<li>Anticholinergic effects: dry mouth, dilated pupils (results in blurred vision), tachycardia, decreased GI motility</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-interactions-may-occur-with-other-cns-depressants-alcohol-and-many-medications">D. Interactions may occur with other CNS depressants, alcohol, and many medications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-may-occur-with-other-cns-depressants-alcohol-and-many-medications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>These agents do not cure, only treat symptoms. Other forms of nondrug therapy should be instituted.</li>
<li>Instruct client that the drug will take 1 to 3 weeks before benefits may occur</li>
<li>These drugs can mask suicidal tendencies</li>
<li>Teach client the need for compliance</li>
<li>A single dose at bedtime may be beneficial if sedation is problematic</li>
<li>Institute safety measures</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Amitriptyline hydrochloride (Elavil)</li>
<li>Doxepin hydrochloride (Sinequan)</li>
<li>Imipramine hydrochloride (Tofranil)</li>
<li>Perphenazine and amitriptyline (Triavil)</li>
<li>Chlordiazepoxide and amitriptyline (Limbitrol)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-monoamine-oxidase-mao-inhibitors">V. Monoamine oxidase (MAO) inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-monoamine-oxidase-mao-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-inhibit-monoamine-oxidase-enzyme-present-in-the-brain-blood-platelets-liver-spleen-and-kidneys-which-metabolizes-amines-norepinephrine-and-serotonin-thus-the-concentration-of-these-amines-increases">A. Action: inhibit monoamine oxidase enzyme (present in the brain, blood platelets, liver, spleen, and kidneys), which metabolizes amines, norepinephrine, and serotonin. Thus, the concentration of these amines increases.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-inhibit-monoamine-oxidase-enzyme-present-in-the-brain-blood-platelets-liver-spleen-and-kidneys-which-metabolizes-amines-norepinephrine-and-serotonin-thus-the-concentration-of-these-amines-increases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>As a second-choice antidepressant if tricyclic compounds do not work</li>
<li>When depression is not responsive to tricyclic compounds</li>
<li>When the side effects of tricyclic compounds are intolerable</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Hypertensive crisis, especially if food with tyramine is eaten</li>
<li>Insomnia</li>
<li>CNS stimulation: anxiety, agitation, mania</li>
<li>Orthostatic hypotension</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-interactions-are-numerous-with-otc-drugs-as-well-as-prescription-drugs-all-medications-should-be-approved-by-the-physician-while-the-client-is-on-mao-inhibitors">D. Interactions are numerous with OTC drugs as well as prescription drugs. All medications should be approved by the physician while the client is on MAO inhibitors.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-are-numerous-with-otc-drugs-as-well-as-prescription-drugs-all-medications-should-be-approved-by-the-physician-while-the-client-is-on-mao-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>MAO INHIBITORS, SELECTIVE SEROTONIN REUPTAKE INHIBITORS ▼ 111</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Avoid foods with tyramine, which may cause hypertensive crisis (Box 7-1)</li>
<li>Limit foods and beverages high in caffeine</li>
<li>Teach about compliance and possible side effects</li>
<li>Inform the client that it may take weeks before benefits are experienced</li>
<li>Instruct that if insomnia occurs, the drug should be taken early in the morning</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Phenelzine sulfate (Nardil)</li>
<li>Tranylcypromine sulfate (Parnate)</li>
<li>Isocarboxazid (Marplan)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-selective-serotonin-reuptake-inhibitors-ssri">VI. Selective serotonin reuptake inhibitors (SSRI)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-selective-serotonin-reuptake-inhibitors-ssri" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-antidepressant-response-is-from-the-inhibition-of-serotonin-uptake">A. Action: antidepressant response is from the inhibition of serotonin uptake<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-antidepressant-response-is-from-the-inhibition-of-serotonin-uptake" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-7-1-dietary-consideration-mao-inhibitors-and-tyramine">Box 7-1. Dietary Consideration: Mao Inhibitors and Tyramine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-7-1-dietary-consideration-mao-inhibitors-and-tyramine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Clients taking MAO inhibitors may experience a hypertensive crisis if they ingest foods containing a large amount of tyramine. Foods high in tyramine include the following:</p>
<table><thead><tr><th>avocadoes</th><th>paté</th></tr></thead><tbody><tr><td>bananas</td><td>pickled and kippered herring</td></tr><tr><td>beer</td><td>pepperoni</td></tr><tr><td>bologna</td><td>pods or broad beans (fava beans)</td></tr><tr><td>canned figs</td><td>raisins</td></tr><tr><td>chocolate</td><td>raw yeast or yeast extracts</td></tr><tr><td>cheese (except cottage cheese)</td><td>salami</td></tr><tr><td>cheese-containing food (e.g., pizza or macaroni and cheese)</td><td>sausage</td></tr><tr><td>liver</td><td>sour cream</td></tr><tr><td>meat extracts (e.g., marmite and bovril)</td><td>soy sauce</td></tr><tr><td>offal</td><td>wine and chianti</td></tr><tr><td>papaya products, including meat tenderizers</td><td>yogurt</td></tr></tbody></table>
<p>Clark J, Queener S, &amp; Karb V: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.</p>
<p>112 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Depression</li>
<li>Investigational use in obsessive-compulsive disorders and appetite disorders</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Nausea, diarrhea</li>
<li>CNS stimulation: insomnia, headache, nervousness, dizziness</li>
<li>Skin rash</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Administer with meals to reduce the nausea</li>
<li>Teach the client to report the side effects. A rash, especially with fever, should be reported immediately. These together could signal serious complications.</li>
<li>Use cautiously in older adults or those with impaired renal function</li>
<li>Monitor weight, since the agent can cause weight loss</li>
<li>Monitor the suicidal client especially during improved mood and increased energy levels</li>
<li>Teach the client to take a single morning dose to avoid insomnia</li>
<li>Stress safety precautions if dizziness develops</li>
</ol>
<p><strong>E. Common drugs</strong></p>
<ol>
<li>Fluoxetine hydrochloric (Prozac)</li>
<li>Sertraline hydrochloride (Zoloft)</li>
<li>Paroxetine (Paxil)</li>
</ol>
<p><strong>VII. Mood stabilizers</strong></p>
<p><strong>A. Action:</strong> normalize the catecholamine response in clients with bipolar, manic-depressive, disorders
<strong>B. Use:</strong> manic-depression illness
<strong>C. Major side effects</strong></p>
<ol>
<li>Minor toxicity: nausea, vomiting, diarrhea, fine hand tremors, GI upset, convulsions</li>
<li>Major toxicity: coarse tremors, severe thirst, tinnitus, diluted urine</li>
<li>Renal toxicity</li>
<li>Teratogenesis: physical defects in the embryo</li>
<li>Goiter: pronounced swelling in the neck, usually related to a hypertrophic thyroid gland</li>
<li>Metallic taste in mouth</li>
</ol>
<p><strong>D. Interactions:</strong> include diuretics, sodium chloride, nonsteroidal antiinflammatory (NSAID) drugs</p>
<p>PROZAC, MOOD STABILIZERS: LITHIUM ▼ 113</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Teach the client the side effects and the need for close blood monitoring of lithium levels to prevent side effects and toxicity</li>
</ol>
<ul>
<li>serum level &gt;2 mEq/L; initially check serum levels weekly, then every two months. Many of the side effects can occur at doses within the therapeutic range, which is 0.6 to 1.2 mEq/L.</li>
</ul>
<ol start="2">
<li>Since the half-life is short, administer these agents in divided doses; doses should not be skipped</li>
<li>Instruct the client that benefits may not be seen for 1 to 2 weeks</li>
<li>Assess renal status and serum creatinine, and avoid drugs that alter urinary elimination in any way</li>
<li>Avoid in pregnant or lactating women</li>
<li>Prevent dehydration, which may precipitate toxicity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drug-lithium-carbonate-lithane">F. Common drug: lithium carbonate (Lithane)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drug-lithium-carbonate-lithane" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="skeletal-muscle-relaxants">SKELETAL MUSCLE RELAXANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#skeletal-muscle-relaxants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-classifications">I. Classifications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-classifications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Centrally acting
B. Peripherally acting</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-general-information">II. General information<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-general-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Limited in usefulness because of the side effects
B. Relief may be obtained primarily because of the sedative properties
C. These agents do not cause loss of consciousness
D. Objective is to relieve musculoskeletal pain or spasm and severe musculoskeletal spasticity without causing loss of function</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-centrally-acting">III. Centrally acting<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-centrally-acting" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: depression of the central nervous system, thereby altering the neurotransmitter function in the spinal cord and depressing selected areas of the brain that control skeletal muscle function
B. Use: relieve spasms associated with trauma, injury, inflammation, postsurgical procedures, anxiety, and pain
C. Major side effects</p>
<ol>
<li>Potential for dependency or addiction</li>
<li>Drowsiness, dizziness</li>
<li>Flaccid muscles</li>
<li>Bradypnea, hypotension</li>
</ol>
<p>CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p>D. Interactions: with all other CNS depressants and alcohol</p>
<p>E. Nursing implications</p>
<ol>
<li>Check allergies before administration</li>
<li>Use safety precautions after administration, including using side rails, instructing the client not to ambulate without assistance, and advising precaution about driving or working around machinery</li>
<li>Assess the amount (and effects) of medication being taken</li>
<li>Instruct the client in the use of heat, rest, and physical therapy as indicated to minimize/treat muscle spasms</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Cyclobenzaprine hydrochloride (Flexeril)</li>
<li>Chlorzoxazone (Parafon Forte)</li>
<li>Diazepam (Valium)</li>
<li>Carisoprodol (Soma)</li>
</ol>
<p>IV. Peripherally or direct-acting agents</p>
<p>A. Action: work directly on the skeletal muscle, decreasing the availability of calcium in the muscle, that thereby decreasing the contractility of the muscles</p>
<p>B. Uses</p>
<ol>
<li>Decrease spasticity in chronic conditions such as multiple sclerosis, cerebral palsy, spinal cord injuries, and strokes</li>
<li>Rehabilitation</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Muscle weakness in the nonspecific muscles, manifested by slurring of speech and drooling</li>
<li>Drowsiness, dizziness, fatigue, malaise</li>
<li>Severe hepatotoxicity</li>
</ol>
<p>D. Interactions: with other CNS drugs and alcohol to produce an additive effect</p>
<p>E. Nursing implications</p>
<ol>
<li>May be combined with diazepam (Valium) to produce an additive effect. For this reason and because of the sedative potential, safety measures should be taken and instructed to the client.</li>
<li>Liver studies should be monitored; ALT, AST</li>
</ol>
<p>F. Common drug</p>
<ol>
<li>Dantrolene sodium (Dantrium)</li>
</ol>
<p>REVIEW QUESTIONS ▼ 115</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A client, age 40, enters the emergency department with a laceration to his left shoulder. The fitting from an oxygen tank exploded and is embedded in his arm. The entry is at the elbow, and the fitting can be felt at the shoulder. The physician anticipates a long procedure and will probably desire lidocaine hydrochloride (Xylocaine) with epinephrine because</li>
</ol>
<p>a. Epinephrine stops the bleeding
b. Epinephrine shortens the effect of the analgesia and can be repeated more often
c. Epinephrine lengthens the effect of the analgesia
d. Epinephrine is safe because the client is 40 years old</p>
<ol start="2">
<li>Which of the following clients would benefit most from a preanesthetic?</li>
</ol>
<p>a. Sally, age 26, who is having her third female operation
b. Joe, age 39, who has never had surgery and is scheduled for open heart surgery
c. John, age 79, who is having his shunt declotted
d. Jimmy, age 2, who is having a tonsillectomy</p>
<ol start="3">
<li>Which of the following groups of drugs is more likely to be questioned as a preanesthetic?</li>
</ol>
<p>a. Narcotics
b. Anticholinergic agents
c. Long-acting barbiturates
d. Short-acting barbiturates</p>
<ol start="4">
<li>Which of the statements is true about amphetamines as a group?</li>
</ol>
<p>a. They have a low abuse potential
b. They cause weight gain if used on long-term basis
c. They are indicated in treatment of narcolepsy
d. They can promote a tired feeling</p>
<ol start="5">
<li>A nursing implication for a client on an MAO inhibitor would include which of the following?</li>
</ol>
<p>a. Teach client the side effects, especially of a hypertensive crisis
b. Caution client to stop eating foods high in sodium
c. Administer the drug throughout the day if it causes sedation
d. Advise client to call for an appointment if no effect is noticed within a week</p>
<p>116 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<ol start="6">
<li>
<p>Which of the following is true about lithium (Lithane)?
a. The lithium (Lithane) concentration level must be monitored
b. It is the drug of choice for depression
c. Toxicity rarely occurs
d. Clients need to call for an appointment if no effect is noticed within a week</p>
</li>
<li>
<p>A client, age 45, takes an antipsychotic agent. She asks the nurse if she can drink a glass of wine with dinner each night. The nurse should tell her that she
a. Can drink one or two glasses of wine daily
b. Should consult her physician before consuming any alcohol
c. Can drink in moderation because the wine will not interact with her medication
d. Should drink wine because it will increase the drug’s effectiveness</p>
</li>
<li>
<p>Amphetamines are potent stimulants that act by
a. Decreasing the release of norepinephrine
b. Increasing the release of norepinephrine
c. Depressing the higher centers of the brain
d. Stimulating the CNS by acting directly on the cerebral cortex</p>
</li>
<li>
<p>Why might the anesthetist add an injection anesthetic with an inhalation anesthetic?
a. Injection anesthetics prevent adverse reactions to inhaled anesthetics
b. Injection anesthetics will promote more rapid induction of anesthesia
c. Injection agents are used because of their long duration of action
d. Injection anesthetics offer more precise and control of the depth of anesthesia than inhalation anesthetics do</p>
</li>
<li>
<p>Which statement is true concerning inhalation and IV anesthetics?
a. Diseases such as emphysema/CHF may increase or decrease the absorption of gases
b. Nitrous oxide is always used alone and is long-acting
c. Barbiturates are seldom used
d. IV anesthetics would be ineffective in outpatient surgeries</p>
</li>
<li>
<p>A client, age 61, weighs 205 pounds and has a history of respiratory difficulties. The physician tells her to lose at least 50 pounds during the next year to prevent further problems. She tells the nurse that she wants her physician to prescribe an amphetamine to help her lose weight. What should the nurse tell her?</p>
</li>
</ol>
<p>REVIEW QUESTIONS ▼ 117</p>
<p>a. An amphetamine can be used along with a weight-reduction plan for several months
b. She can take the amphetamine as long as she wants
c. Amphetamines are beneficial for a few weeks only, and the client must be on a weight-reduction diet
d. Amphetamines are relatively safe drugs with few side effects</p>
<ol start="12">
<li>
<p>A client is prescribed an MAO inhibitor. Which of the following foods should the nurse advise the client to avoid completely?
a. Beer, aged cheese, sausage
b. Chocolate, soy sauce, oranges
c. White wine, chicken, apples
d. Cottage cheese, yogurt, ham</p>
</li>
<li>
<p>Side effects of the tricyclic antidepressants are related to the anticholinergic actions of the drug. A common side effect is
a. Increased salivation
b. Constipation
c. Bradycardia
d. Hypertension</p>
</li>
<li>
<p>A client, age 32, is suffering from severe anxiety because her young daughter was seriously injured in an automobile accident. Her physician prescribes diazepam (Valium) as an antianxiety agent. Why would the physician be more likely to order a benzodiazepine than a barbiturate?
a. Benzodiazepines are faster acting than barbiturates
b. Benzodiazepines cause mild central nervous system effects
c. Benzodiazepines are not controlled substances
d. Benzodiazepines do not accumulate in the body</p>
</li>
<li>
<p>Which of the following clients would benefit the most from a local (spinal) anesthetic instead of a general anesthetic?
a. Bobby, age 40, who is anxious about the outcome of his surgery
b. Annie, age 89, who has COPD, hypertension (HTN), and a fractured pelvis
c. Brian, age 4, who is scheduled for a tonsillectomy
d. Joseph, age 56, who is having an open reduction of his arm</p>
</li>
<li>
<p>A client enters the emergency department complaining of having injured his right ankle during a game of flag football. He is diagnosed as having a sprain and sent home on cyclobenzaprine hydrochloride (Flexeril). He</p>
</li>
</ol>
<p>118 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p>questions his ability to return to work at a chemical plant. The nurse would instruct him to</p>
<p>a. Return to work the next day and use his lunch break to elevate his foot
b. Abstain from work for a week
c. Assess his ability to drive while on the cyclobenzaprine hydrochloride (Flexeril) and report the use of the drug to his immediate supervisor
d. Return to work and speak to his immediate supervisor if questioned about his treatment</p>
<ol start="17">
<li>A 32-year-old cerebral palsy client is taking a direct-acting skeletal muscle relaxant–dantrolene sodium (Dantrium). Dantrolene (Dantrium) achieves an effect by</li>
</ol>
<p>a. Increasing the release of calcium from muscle cells
b. Decreasing the release of calcium from muscle cells
c. Depressing the CNS
d. Depressing the cerebral cortex</p>
<ol start="18">
<li>Centrally acting skeletal muscle relaxants are commonly used to treat</li>
</ol>
<p>a. Muscle spasm caused by cerebral palsy
b. Chronic musculoskeletal disorders
c. Lower extremity spasticity
d. Severe muscle spasms</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 119</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>The epinephrine also</td><td></td></tr><tr><td>lengthens the effect of the</td><td></td></tr><tr><td>lidocaine by slowing the</td><td></td></tr><tr><td>absorption. Epinephrine</td><td></td></tr><tr><td>slows the tendency to bleed</td><td></td></tr><tr><td>but does not stop the</td><td></td></tr><tr><td>bleeding. Epinephrine</td><td></td></tr><tr><td>lengthens the effect of the</td><td></td></tr><tr><td>analgesic. Age has no effect</td><td></td></tr><tr><td>on the drug’s action.</td><td>Note the clue “anticipates a long</td></tr><tr><td>procedure.” Then match the</td><td></td></tr><tr><td>similar theme, option c. Use this</td><td></td></tr><tr><td>common sense approach only if</td><td></td></tr><tr><td>you have no idea of the correct</td><td></td></tr><tr><td>answer.</td><td></td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>A young man facing a major</td><td></td></tr><tr><td>operation would probably</td><td></td></tr><tr><td>benefit from the calming</td><td></td></tr><tr><td>effect of a preanesthetic. In</td><td></td></tr><tr><td>option a, there may not be</td><td></td></tr><tr><td>anxiety after already having</td><td></td></tr><tr><td>two operations; also not</td><td></td></tr><tr><td>enough information is</td><td></td></tr><tr><td>provided in order to</td><td></td></tr><tr><td>determine anxiety levels.</td><td></td></tr><tr><td>Declotting a shunt usually</td><td></td></tr><tr><td>does not evoke serious</td><td></td></tr><tr><td>anxiety. Children typically</td><td></td></tr><tr><td>benefit from being awake</td><td></td></tr><tr><td>with their parent to</td><td></td></tr><tr><td>accompany them to the</td><td></td></tr><tr><td>surgery suite.</td><td>If you narrowed the response to</td></tr><tr><td>either b or d because the surgery</td><td></td></tr><tr><td>would be a new experience,</td><td></td></tr><tr><td>reread the question and the two</td><td></td></tr><tr><td>responses. It will be evident that</td><td></td></tr><tr><td>the 39-year-old would be more</td><td></td></tr><tr><td>aware of the gravity of the</td><td></td></tr><tr><td>procedure and would need the</td><td></td></tr><tr><td>preanesthetic.</td><td></td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>Short-acting agents are</td><td></td></tr><tr><td>preferred so that there are</td><td></td></tr><tr><td>no complications with the</td><td></td></tr><tr><td>general anesthetic given. An</td><td></td></tr><tr><td>agent like morphine sulfate</td><td></td></tr><tr><td>is often used to decrease</td><td>Use the approach “Go with what you</td></tr><tr><td>know”—preanesthetics are</td><td></td></tr><tr><td>commonly short-acting drugs.</td><td></td></tr><tr><td>Thus, select response c which is</td><td></td></tr><tr><td>the opposite.</td><td></td></tr></tbody></table>
<p>120 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p>pain and relax the client before surgery. Anticholinergic agents are given to prevent the complication of bradycardia and atelectasis or aspiration. Barbiturates relieve anxiety, sedate, and decrease the complications of anesthetic agents.</p>
<ol start="4">
<li>Correct answer: c</li>
</ol>
<p>Amphetamines stimulate the CNS and produce wakefulness. Narcolepsy is the clinical condition where the client has sudden sleep attacks. Amphetamines have a high potential for abuse, and tolerance develops quickly. Weight loss usually occurs if they are taken on a long-term basis. Amphetamines increase the energy level unless abused. If abused then stopped, clients feel tired.</p>
<p>If you narrowed the responses to either c or d, reread the question and the two options. The question is a “general question” so select the disease over the specific finding of tired feeling.</p>
<ol start="5">
<li>Correct answer: a</li>
</ol>
<p>Hypertension is a typical side effect and can be severe. Foods high in tyramine, which can cause hypertensive crisis, should be avoided. Insomnia is the typical side effect. Usually a response is not evident for 1 to 3 weeks.</p>
<p>If you have no idea of the correct answer, go with what you know in general about teaching clients with drugs: teach the side effects. Select response a.</p>
<ol start="6">
<li>Correct answer: a</li>
</ol>
<p>Toxicity is a common side effect, and a lithium level must be maintained at a</p>
<p>Levels of drug concentration are measured in the drugs: lithium, theophylline, digoxin, and</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 121</p>
<p>serum therapeutic level of 0.6 to 1.2 mEq/L. Lithium is recommended for use in manic-depressive illness. Toxicity frequently occurs with this drug. Minor toxicity findings are vomiting, diarrhea, poor coordination, fine motor tremors, weakness, and lassitude. Major toxicity findings are coarse tremors, severe thirst, tinnitus, and diluted urine. Adequate fluids are essential during initial therapy of 2 to 3 liters/day and 1 to 2 liters/day during maintenance. Decreased sodium intake with decreased fluid intake may lead to lithium retention and toxicity and visa versa. An effect is usually not seen until the medicine has been taken for 1 to 3 weeks.</p>
<p>antibiotics. Peaks and troughs are done for antibiotics. Recall tip—lithium requires levels.</p>
<ol start="7">
<li>Correct answer: b</li>
</ol>
<p>Alcohol and other CNS depressants cause an additive effect. Alcohol should never be mixed with an antipsychotic agent. Alcohol in moderation should definitely not be mixed with the drug. Wine will increase the drug's effectiveness but is not recommended for this reason.</p>
<p>If you have no idea of the correct answer, cluster the responses into the three that suggest drinking alcohol. Response b is correct, since it falls outside of the cluster.</p>
<ol start="8">
<li>Correct answer: b</li>
</ol>
<p>This action of amphetamines in response b increases</p>
<p>Eliminate responses a and c, since these contradict the key word in</p>
<p>122 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p>alertness and elevates mood. Response <em>a</em> is an incorrect action for amphetamines. Amphetamines are CNS stimulants, not depressants. CNS stimulation is a result of the increase in norepinephrine.</p>
<p>the stem, “stimulates.” Then make an educated guess if these drugs are potent, they would act more generally than just locally on the cerebral cortex. Select option <em>b</em>.</p>
<ol start="9">
<li><strong>Correct answer: b</strong></li>
</ol>
<p>Most of the injection agents inhibit the area of the brain that controls alertness and produce an additive effect with inhalation anesthetics. Some of the injection agents may decrease the severity of the side effects, but they cannot prevent adverse reactions. Most of the injection agents have a short duration, which is an advantage for outpatient surgery. Inhalation offers the most control and precision in producing anesthesia.</p>
<p>Make an educated guess. The injection of a drug into the vein will have rapid results and be an aid to a drug that has been inhaled and has to cross the aveoli to get into the circulation. Select response <em>b</em>, not <em>d</em>, since IV anesthesia would not aid in the control of the depth of anesthesia; this is because once the drug is injected, there is loss of control of the severity of the effects.</p>
<ol start="10">
<li><strong>Correct answer: a</strong></li>
</ol>
<p>The lungs absorb and excrete anesthetic agents; therefore any change in the lung will affect the pharmacokinetics of the agent administered. This agent in option <em>b</em> is not potent enough on its own to produce analgesia, and it is short acting. Short-acting barbiturates are used to lessen the amount of inhalation anesthetics required. Injection</p>
<p>Eliminate responses <em>b</em> and <em>c</em>, since they have the absolutes “always” and “seldom.” Use common sense to eliminate response <em>d</em>. Select response <em>a</em>, which supports your general knowledge of these disease processes.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 123</p>
<p>anesthetics are ideal for outpatient surgeries because of their short duration.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="11-correct-answer-c">11. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#11-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Amphetamines should only be used to help the client adjust to a new diet and lifestyle. Using amphetamines for weight control is secondary to using diet and lifestyle modification. Short-term treatment of 2 to 3 weeks may be recommended. Long-term treatment is contraindicated because of the side effects. Amphetamines have many side effects, including toxic effects with overdosage, of which findings are excitement, tremors, tachycardia, hallucinations, delirium, convulsions, and circulatory collapse.</p>
<p>If you narrowed the responses to either <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, reread them. Note that in response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> the statement "can" be used with a weight reduction plan; in response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> the statement "must" be on a weight reduction plan. The stronger term leads to the selection of the correct response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="12-correct-answer-a">12. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#12-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>These agents are all high in tyramine, which could cause hypertension. Oranges are not contraindicated. Chicken and apples are not contraindicated. Most cheeses, especially aged, are prohibited, but cottage cheese is allowed.</p>
<p>The two foods to remember NOT to eat with MAO inhibitors are beer and aged cheese. If this is all that you can remember, go with what you know and select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="13-correct-answer-b">13. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#13-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The anticholinergic effect slows the GI motility and results in constipation and</p>
<p>Think of the prototype anticholinergic, atropine, which slows the GI and GU peristatsis.</p>
<p>124 ▼ CHAPTER 7 DRUGS AFFECTING THE CENTRAL NERVOUS SYSYEM</p>
<p>urine retention from the relaxation of the urinary muscles. Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is not a side effect of these agents; a decrease in salivation is more likely. Tachycardia, not bradycardia, is a possibility because of the anticholinergic effect. Orthostatic hypotension is a more common side effect; never hypertension.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="14-correct-answer-b">14. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#14-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In this situation only mild sedation is needed. Barbiturates can act more as hypnotics. Barbiturates can be short-acting and work as quickly as benzodiazepines. Both of these agents are controlled substances. Tolerance can develop with both agents.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="15-correct-answer-b">15. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#15-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Annie’s serious disease processes can cause severe complications after a general anesthesia. Bobby’s anxiety will be controlled better with a general anesthesia. Brian’s separation anxiety, age, and type of surgery warrant a general anesthesia. A spinal will not anesthetize the arm; spinals are typically used for body surgery below the waist.</p>
<p>The only answer that suggests a result of such action is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>.</p>
<p>Use a true-false approach to select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>; if you are not sure that one drug is faster than the other, do not select that response. Besides, the stem gives no data to support that a rapid-acting drug is indicated. By general knowledge of drugs, identify that responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> are false.</p>
<p>Use an educated guess that the youngest and oldest clients listed are at the greatest risk for surgery. Then reread these choices and by common sense conclude that the older client has multisystem threats that the younger client does not; select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 125</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="16-correct-answer-c">16. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#16-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Safety precautions should be assessed due to the sedating and relaxing properties of the medication. The sedative properties of the drug warrant notifying his supervisor before returning. The client may tolerate the medication without sedation and may be able to work while taking the drug. An injury is highly possible because of the relaxing and sedating properties of this agent.</p>
<p>Response <em>c</em> is the most realistic and reasonable. Response <em>d</em> is incorrect in approach, since he is only to tell if asked. Use the nursing process—select to assess then intervene.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="17-correct-answer-b">17. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#17-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These agents decrease the release of calcium, thereby decreasing the muscle’s ability to contract. This action in response <em>a</em> is not the action of these agents. This action in response <em>c</em> describes the centrally acting skeletal muscle relaxants. These agents do not depress the CNS but work directly on the muscle.</p>
<p>Key words in the stem guide you to the correct response: “direct acting . . . muscle relaxant.” Note that only responses <em>a</em> and <em>b</em> suggest direct muscle action. Then, recall your basic knowledge that with less calcium in the muscle there is less contraction. For relaxing the muscle, it follows that response <em>b</em> is correct.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="18-correct-answer-d">18. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#18-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Muscle spasms respond very well to centrally acting agents. These agents are usually not used for chronic diseases such as cerebral palsy. Spasticity experienced by paraplegics responds therapeutically to direct-acting agents.</p>
<p>If you have no idea of the correct response, try to cluster responses <em>a</em>, <em>b</em>, and <em>c</em> under “findings of chronic conditions.” Response <em>d</em> is selected; “severe” muscle spasms suggest a more acute situation.</p>
<p>^{}[]</p>
<p>Drugs Affecting Sleep
CHAPTER 8</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the difference between a sedative and a hypnotic.</li>
<li>Identify the difference between barbiturate and nonbarbiturate agents used as sedatives and hypnotics.</li>
<li>Describe the safety measures necessary for a client taking a sedative or hypnotic.</li>
<li>Identify the side effects and nursing implications of client use of sedatives or hypnotics.</li>
</ul>
<p>127</p>
<p>128 ▼ CHAPTER 8 DRUGS AFFECTING SLEEP</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Antabuse</strong>
A trade name for the alcohol abuse deterrent, disulfiram.</p>
<p><strong>Dependence</strong>
A total psychophysical state of one addicted to drugs or alcohol who must receive an increasing amount of the substance to prevent the onset of abstinence symptoms.</p>
<p><strong>Hypnotics</strong>
A class of drugs often used as sedatives.</p>
<p><strong>Rapid eye movement (REM) sleep</strong>
REM sleep periods, lasting from a few minutes to 30 minutes alternate with nonrapid eye movement (NREM) periods. NREM sleep, with its four stages, represents three-fourths of a period of typical sleep; REM represents one-fourth of that total time. Dreaming occurs during REM time. Infants tend to begin a sleep period with REM sleep, whereas adults usually begin with the four stages of NREM sleep before entering REM sleep.</p>
<p><strong>Rebound insomnia</strong>
The inability to sleep worsens after treatment.</p>
<p><strong>Sedative</strong>
An agent that decreases functional activity, diminishes irritability, and allays excitement.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2d776422">I. Sedatives and hypnotics—general considerations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2d776422" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-differences-between-classifications">A. Differences between classifications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-differences-between-classifications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Sedative: an agent that produces a state of calmness when given in divided doses. In high doses a sedative becomes a hypnotic.</li>
<li>Hypnotic: an agent given at bedtime (h.s.) to induce sleep, usually in a larger dose than a sedative</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-these-agents-alleviate-symptoms-but-do-not-cure-the-cause">B. These agents alleviate symptoms but do not cure the cause<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-these-agents-alleviate-symptoms-but-do-not-cure-the-cause" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-all-have-the-potential-for-producing-dependency">C. All have the potential for producing dependency<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-all-have-the-potential-for-producing-dependency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-many-of-these-agents-induce-rest-by-increasing-the-amount-of-sleep-obtained-but-do-not-necessarily-produce-restful-rem-sleep-the-period-of-sleep-needed-for-physical-and-mental-restoration-some-of-these-agents-decrease-rem-sleep-while-others-do-not-affect-rem-at-all">D. Many of these agents induce rest by increasing the amount of sleep obtained, but do not necessarily produce restful REM sleep (the period of sleep needed for physical and mental restoration). Some of these agents decrease REM sleep, while others do not affect REM at all.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-many-of-these-agents-induce-rest-by-increasing-the-amount-of-sleep-obtained-but-do-not-necessarily-produce-restful-rem-sleep-the-period-of-sleep-needed-for-physical-and-mental-restoration-some-of-these-agents-decrease-rem-sleep-while-others-do-not-affect-rem-at-all" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-additional-agents-affecting-sleep-patterns">E. Additional agents affecting sleep patterns<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-additional-agents-affecting-sleep-patterns" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Antianxiety agents: see Chapter 7 pp. 108-109</li>
<li>Amphetamines: see Chapter 7 pp. 104-105</li>
</ol>
<p>GENERAL INFORMATION: SEDATIVES, HYPNOTICS; BARBITURATES ▼ 129</p>
<ol start="3">
<li>Antihistamines</li>
<li>Alcohol</li>
</ol>
<p>F. Clients should not be awakened to receive these drugs unless absolutely necessary. Uninterrupted sleep and rest should be provided as much as possible, preferably in blocks of 4 to 6 hours.</p>
<p>G. Safety measures should be taken and taught to clients receiving these agents</p>
<ol>
<li>Elevate rails, place bed in low position, and document these actions in the nurse's notes</li>
<li>Encourage assistance in ambulating</li>
<li>Caution against driving or operating machinery</li>
<li>Monitor for suicidal tendencies</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-barbiturates">II. Barbiturates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-barbiturates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: produce various levels of CNS depression by decreasing the excitability of synaptic membranes in the cerebral cortex</p>
<p>B. Uses: particularly effective when sleep is interrupted early in the morning. Should be used only if nonbarbiturate does not work.</p>
<ol>
<li>Sedative (low dose) and hypnotic (high dose)</li>
<li>Preoperatively and as an anesthetic</li>
<li>Anticonvulsant agent</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Excessive central nervous system depression: drowsiness, dizziness, hangover effect, confusion</li>
<li>CNS excitement: restlessness, delirium, disorientation</li>
<li>Rebound insomnia: the inability to sleep worsens after treatment</li>
<li>Anxiety</li>
<li>Hypersensitivity</li>
<li>Respiratory depression because of the effect on the CNS</li>
<li>Toxicity: pinpoint pupils, sluggish reflexes, irregular and slower pulse, slow respirations</li>
<li>Chronic poisoning: slow thought, incoherent speech, failing memory, weight loss</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Teach safety precautions to clients (see General Considerations p. 128)</li>
<li>Assess level of consciousness (LOC), respiratory status, and effectiveness of the agent</li>
</ol>
<p>130 ▼ CHAPTER 8 DRUGS AFFECTING SLEEP</p>
<ol start="3">
<li>Teach clients not to abuse medication, and to monitor their use of the medication</li>
<li>Note that chronic use is contraindicated because the agents lose their effectiveness in 2 to 3 weeks and suppress REM sleep</li>
<li>Hold if respirations &lt;10/min</li>
<li>Instruct clients not to abruptly stop taking the medication</li>
<li>Note that some are controlled substances</li>
</ol>
<p>E. Interactions: additive effect with other CNS depressants (alcohol), increased metabolism of antidepressants and warfarin sodium (Coumadin)</p>
<p>F. Common drugs</p>
<ol>
<li>Phenobarbital (Luminal)</li>
<li>Secobarbital (Seconal)</li>
<li>Aprobarbital (Alurate)</li>
<li>Butabarbital sodium (Butisol Sodium)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-benzodiazepines">III. Benzodiazepines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-benzodiazepines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: CNS depression by increasing the GABA neuronal inhibition</p>
<p>B. Uses</p>
<ol>
<li>Insomnia</li>
<li>Preoperatively</li>
<li>Anxiety</li>
<li>Sleep induction</li>
<li>Prolonged hypnotic therapy</li>
<li>Withdrawal syndromes</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Drowsiness</li>
<li>Hypotension</li>
<li>Slurred speech, memory impairment</li>
<li>Hangover effect</li>
<li>Dizziness, potential for falls</li>
<li>Respiratory depression: bradypnea, shallow respirations</li>
<li>CNS excitement: nervousness, restlessness, euphoria, excitement, confusion (particularly in older adults)</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Follow safety measures and teach these to client (see general considerations p. 128)</li>
<li>Monitor use, since these are controlled substances</li>
<li>Assess respiratory status</li>
<li>Withdraw drugs slowly after prolonged use</li>
</ol>
<p>BENZODIAZEPINES, NONBARBITURATES, ALCOHOL ▼ 131</p>
<p>E. Contraindicated with other CNS depressants (alcohol).
Interactions: additive effect with CNS depressants, and decreased effectiveness with antacids.</p>
<p>F. Common drugs</p>
<ol>
<li>Flurazepam hydrochloride (Dalmane)</li>
<li>Temazepam (Restoril)</li>
<li>Haloperidol (Halcion)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-nonbarbiturates">IV. Nonbarbiturates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-nonbarbiturates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Similar in all ways to barbiturates
B. Common drugs</p>
<ol>
<li>Prescription
a. Chloral hydrate (Noctec)
b. Ethchlorvynol (Placidyl)
c. Methyprylon (Noludar)
d. Paraldehyde (Paral)</li>
<li>Nonprescription
a. Unisom
b. Diphenhydramine hydrochloride (Benadryl)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-alcohol">V. Alcohol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-alcohol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: CNS depressant that can produce sedation (low doses) and hypnotic effect or unconsciousness (high doses).
Effects</p>
<ol>
<li>Euphoria</li>
<li>Depressed learned inhibitions</li>
<li>Temporary increase in activity</li>
<li>Decreased fine motor skills</li>
<li>Decreased libido (in high doses)</li>
<li>Diuresis</li>
<li>Appetite stimulation
B. Use: by older-adult patients as a sedative
C. Major side effects</li>
<li>Cardiovascular response: increased pulse and BP</li>
<li>Carcinogenic effects</li>
<li>Toxicity to liver</li>
<li>Hangover effect, blackouts—lapse of memory of current events</li>
<li>Nausea, vomiting</li>
<li>Fetal alcohol syndrome (FAS): a set of congenital psychological, behavioral, cognitive, and physical abnormalities that tends to</li>
</ol>
<p>132 ▼ CHAPTER 8 DRUGS AFFECTING SLEEP</p>
<p>appear in infants whose mothers consumed alcoholic beverages during pregnancy</p>
<ol start="7">
<li>Disorientation, slurred speech, decreased motor coordination</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Assess the amount and frequency of alcohol consumption</li>
<li>Emphasize safety precautions if used by older adults. Monitor liver function tests: ALT, AST.</li>
<li>Report any signs of abuse</li>
<li>Use disulfiram (Antabuse) for treatment. Antabuse can cause severe complications within 30 minutes if taken along with alcohol: flushing, diaphoresis, hypoventilation, copious vomiting, confusion, chest pain, difficult breathing. Its use in combination with alcohol can be fatal.</li>
</ol>
<p>REVIEW QUESTIONS ▼ 133</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A client was prescribed a barbiturate, pentobarbital (Nembutal) 100 mg p.o., h.s. to aid in sleeping after an auto accident. She comments that after a month she finds sleep is a problem again. The nurse should recommend which of the following?</li>
</ol>
<p>a. Stop taking them because they have lost their effectiveness
b. Take them prn and stop the routine every h.s.
c. See your physician, since the pills lose effectiveness after 2 weeks
d. Take the agents with a small glass of wine</p>
<ol start="2">
<li>A client, age 63, is scheduled for open heart surgery in the morning. The physician has ordered secobarbital (Seconal) 100 mg p.o., h.s. After giving the tablet, the nurse should do which of the following?</li>
</ol>
<p>a. Raise the side rails and instruct him to try to rest
b. Raise the side rails and instruct him not to get out of bed without assistance
c. Instruct him to use the bedside commode for safety
d. Allow the family member to assist him to the bathroom if necessary</p>
<ol start="3">
<li>Which side effect would caution a nurse to hold a client's aprobarbital (Alura) at h.s. instead of giving the medicine as ordered?</li>
</ol>
<p>a. BP 110/62
b. P 92/min and regular
c. R 8/min and shallow
d. P 135/min and regular</p>
<ol start="4">
<li>While making rounds, the nurse finds a client confused, scared of her daughter, and unable to remember her name. The nurse should suspect which side effect of triazolam (Halcion)?</li>
</ol>
<p>a. CNS stimulation
b. CNS depression
c. Rebound CNS depression
d. Respiratory excitement</p>
<ol start="5">
<li>Nursing implications while a client is taking a hypnotic or sedative would include which of the following?</li>
</ol>
<p>a. Assess for signs of suicidal intention
b. Assure the client that the hangover effect gets better over time
c. Awaken the client to take the medicine if he/she is asleep
d. Assure the family that sluggish reflexes and slow respirations are normal responses to the agents</p>
<p>CHAPTER 8 DRUGS AFFECTING SLEEP</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>Use of these agents longer than 2 to 3 weeks can cause suppression of REM sleep. Clients should never abruptly withdraw from a barbiturate. A daily routine is required to adjust to the level of sedation produced by the agents. Alcohol produces an additive effect and should not be combined with a barbiturate.</td><td>If you have no idea of the correct answer, use common sense. The physician prescribed the medication. If problems occur, refer clients back to the physician.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>Side rails should be up at all times, and assistance would be needed for any activity outside of bed. Although this answer a is correct, the safety measures needed for this agent should be strongly enforced. Ambulating without assistance could result in a fall. Assistance should be demanded and enforced, even for a bedside commode. A family member could assist the client to ambulate to the bathroom to prevent an accident. However, of the given responses this is not the best choice.</td><td>Select the most specific answer, which would be b. The others give incomplete information.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>Respiratory depression manifested by bradypnea is a concern with these agents.</td><td>Use the ABCs and select a respiratory threat if you have no idea of the correct response.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 135</p>
<p>This is a normal blood pressure and should not prevent the client from taking the agent. An irregular pulse is a sign of toxicity. Tachycardia is not a usual side effect, and other causes should be investigated.</p>
<ol start="4">
<li>Correct answer: a
Excitement and confusion are signs of CNS stimulation, a side effect often seen in older clients. The action of the drug is depression of the CNS. Rebound CNS depression is not a side effect of this agent. Respiratory depression, not excitement, is the typical side effect.</li>
</ol>
<p>The important factor to identify in the stem is that the client is stimulated, confused, and excited. Of the given responses, only <em>a</em> and <em>d</em> match with stimulation. It is obvious that the stimulation is not of the respiratory system but of the neurological system.</p>
<ol start="5">
<li>Correct answer: a
Insomnia is often a symptom of depression or serious mental disorders. Suicidal tendencies could trigger the misuse of these agents. Some clients never adjust to the hangover effect and have to try other interventions or medications. As much uninterrupted sleep as possible should be provided to facilitate REM sleep. In response <em>d</em> the two symptoms reported by family are abnormal effects of the agents and should be reported.</li>
</ol>
<p>Use the true-false approach to identify that responses <em>b</em>, <em>c</em>, and <em>d</em> are false.</p>
<p>^{}[]</p>
<p>137</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-that-relieve-pain-and-inflammation">Drugs That Relieve Pain and Inflammation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-that-relieve-pain-and-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify common groups of drugs used to provide pain relief.</li>
<li>Describe the difference between narcotics, nonnarcotics, and narcotic antagonists.</li>
<li>Identify agents used to decrease inflammation, gout, and manifestations of arthritis.</li>
<li>Describe the major side effects and nursing implications of client use of pain-relieving agents.</li>
</ul>
<p>CHAPTER 9</p>
<p>138 ▼ CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Analgesic</strong>
A drug that relieves pain.</p>
<p><strong>Antagonists</strong>
A drug that exerts the opposite action to that of another or competes for the same receptor site.</p>
<p><strong>Inflammation</strong>
A protective response of the tissues of the body to irritation or injury. It may be acute or chronic. Cardinal findings are redness (rubor), heat (calor), swelling (tumor), and pain (dolor), accompanied by loss of function.</p>
<p><strong>Narcotic analgesics</strong>
Acts on the CNS to alter the client’s perception of pain; used for severe pain.</p>
<p><strong>Nonnarcotic analgesics</strong>
Acts at the site of the pain; does not produce tolerance or dependence or alter the client’s perception; used for mild to moderate pain.</p>
<p><strong>NSAID</strong>
Nonsteroidal antiinflammatory drugs—a classification of drugs that decreases prostaglandin synthesis. They are used to treat mild to moderate pain, osteo- and rheumatoid arthritis, and dysmenorrhea (pain associated with menstruation).</p>
<p><strong>Ototoxicity</strong>
Having a harmful effect on the eighth cranial nerve or the organs of hearing or balance from such drugs as aminoglycide antibiotics, aspirin, furosemide, and quinine. Damage may reverse when the drug is stopped.</p>
<p><strong>Tinnitus</strong>
A subjective noise sensation heard in one or both ears. It may occur for no apparent reason; commonly described as “ringing in the ears”; classic finding with too much aspirin or severe lithium toxicity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="analgesics">ANALGESICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#analgesics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-narcotics">I. Narcotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-narcotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Action:</strong> combine with opiate receptors to produce an analgesic effect by altering one’s perception of pain</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Severe pain, chronic pain</li>
<li>Suppression of GI motility</li>
</ol>
<p>ANALGESICS: NARCOTICS ▼ 139</p>
<ol start="3">
<li>Dyspnea</li>
<li>Antitussive</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Toxicity: pinpoint pupils, coma</li>
<li>Sedation, confusion, drowsiness</li>
<li>Euphoria</li>
<li>Respiratory depression, hypotension</li>
<li>Nausea, vomiting</li>
<li>Constipation</li>
<li>Tolerance and dependency</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-interactions-additive-effect-with-other-cns-depressants-alcohol-decreased-effect-with-smoking">D. Interactions: additive effect with other CNS depressants (alcohol), decreased effect with smoking<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-additive-effect-with-other-cns-depressants-alcohol-decreased-effect-with-smoking" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Assess respiratory status: depth, rate, and rhythm. Hold the medication if the respiratory rate is &lt;10/min.</li>
<li>Assess for hypotension</li>
<li>Monitor bowel elimination, offer stool softener, and fluids, increase dietary fiber, or increase assisted ambulation</li>
<li>Instruct the client to ask for the pain medication before the pain is too severe</li>
<li>Evaluate pain response to the analgesic</li>
<li>Implement and teach the client about safety: put side rails up, and place bed in low position; assist in ambulation; and teach proper safety in operating machinery or driving</li>
<li>Do not administer in clients with head injuries or with increased intracranial pressure (ICP); use only with caution in clients with chronic airway limitations (CAL) or with asthma</li>
<li>Do not abruptly withdraw the medication</li>
<li>Monitor the use of the narcotics and maintain them in a locked area</li>
<li>Teach clients who use a patient-controlled analgesia (PCA) pump how to administer the medicine; in particular, how to push button when they are uncomfortable, without waiting until their pain is severe</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Morphine sulfate (MS)</li>
<li>Meperidine hydrochloride (Demerol)</li>
<li>Codeine sulfate: suppresses cough</li>
<li>Methadone hydrochloride (Dolophine)</li>
<li>Hydromorphone hydrochloride (Dilaudid): for severe pain</li>
<li>Oxycodone terephthalate (Percocet)</li>
</ol>
<p>140 ▼ CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<ol start="7">
<li>Propoxyphene hydrochloride (Darvon)</li>
<li>Mixed agents: Brompton’s cocktail (morphine, cocaine, dextroamphetamine, and alcohol)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-mixed-narcotic-agonist-antagonist-agents">II. Mixed narcotic agonist-antagonist agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-mixed-narcotic-agonist-antagonist-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Action:</strong> bind with specific receptors to prevent the opioid from remaining on opioid receptor sites. These agents have no antitussive effects and fewer gastrointestinal effects than agonists do.</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Mild to moderate pain</li>
<li>Respiratory depression</li>
<li>Reduction in the potential for narcotic abuse</li>
<li>Obstetrical analgesia</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Same as for narcotics</li>
<li>Withdrawal findings in clients who are dependent on narcotics</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Same as for narcotics</li>
<li>Should not be given to clients dependent on narcotics</li>
</ol>
<p><strong>E. Common drugs</strong></p>
<ol>
<li>Butorphanol tartrate (Stadol)</li>
<li>Nalbuphine hydrochloride (Nubain)</li>
<li>Pentazocine hydrochloride (Talwin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-narcotic-antagonists">III. Narcotic antagonists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-narcotic-antagonists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Action:</strong> compete with narcotics for receptor sites</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Respiratory depression (particularly drug-induced)</li>
<li>Opioid toxicity</li>
<li>Diagnosis of opioid overdose</li>
<li>Treatment of newborns from addicted mothers</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Withdrawal symptoms in clients dependent on opiates or in infants of mothers addicted to opiates: nervousness, hypertension, palpitations, headache, shortness of breath</li>
<li>Nausea, vomiting</li>
<li>Tachycardia, hypertension</li>
<li>Return of pain or discomfort for which narcotic agonist was given</li>
</ol>
<p>NARCOTICS: AGONIST-ANTAGONIST, ANTAGONISTS; NONNARCOTICS ▼ 141</p>
<ol start="5">
<li>Relapse of respiratory depression 15 to 20 minutes after administration of the antagonists, since antagonist is shorter-acting than the agonist</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Monitor the patient closely for return of respiratory depression</li>
<li>Assess and implement interventions for relieving pain</li>
<li>Assess vital signs every 5 minutes: respirations and blood pressure</li>
<li>For acute respiratory depression may repeat dose if needed; usually administered IV push</li>
</ol>
<p><strong>E. Common drugs</strong></p>
<ol>
<li>Naloxone hydrochloride (Narcan), usually IV</li>
<li>Naltrexone (Trexan), usually p.o.</li>
</ol>
<p><strong>IV. Nonnarcotic analgesics</strong></p>
<p><strong>A. Actions:</strong> inhibit the enzyme necessary for the synthesis of prostaglandin, treat pain, and act on the hypothalamus to regulate body temperature</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Mild to moderate pain</li>
<li>Fever reduction</li>
<li>In combination with narcotics for an additive effect</li>
</ol>
<p><strong>C. Major side effects (rare with therapeutic use)</strong></p>
<ol>
<li>Toxicity, which can cause liver and kidney damage</li>
<li>Hypersensitivity</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Assess temperature every 4 hours</li>
<li>Administer acetylcysteine (Mucomyst), by mouth, as the antidote for acetaminophen toxicity, which should be treated immediately; usually given for 3 to 4 days</li>
<li>Evaluate the degree of pain relief obtained</li>
<li>Same nursing implications as those listed under narcotics for those nonnarcotic analgesics that are combined with a narcotic*</li>
</ol>
<p><strong>E. Common drugs</strong></p>
<ol>
<li>Acetaminophen (Tylenol)</li>
<li>Acetylsalicylic acid (aspirin)</li>
<li>Oxycodone terephthalate (Percocet)*</li>
<li>Oxycodone hydrochloride and acetaminophen (Tylox)*</li>
<li>Hydrocodone bitartrate and acetaminophen (Vicodin)*</li>
</ol>
<ul>
<li>combination of narcotic and nonnarcotic analgesic</li>
</ul>
<p>142 ▼ CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-nonsteroidal-antiinflammatory-drugs-nsaids-are-nonnarcotic-analgesics-but-are-discussed-in-length-under-antiinflammatory-agents">V. Nonsteroidal antiinflammatory drugs (NSAIDs) are nonnarcotic analgesics but are discussed in length under antiinflammatory agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-nonsteroidal-antiinflammatory-drugs-nsaids-are-nonnarcotic-analgesics-but-are-discussed-in-length-under-antiinflammatory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="drugs-used-to-treat-inflammation">DRUGS USED TO TREAT INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-to-treat-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="i-antiinflammatory-antipyretic-agents">I. Antiinflammatory/Antipyretic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antiinflammatory-antipyretic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h5 level="5" id="a-actions-prevent-the-formation-of-prostaglandins-prevent-platelet-aggregation-and-lower-body-temperature">A. Actions: prevent the formation of prostaglandins, prevent platelet aggregation, and lower body temperature<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-prevent-the-formation-of-prostaglandins-prevent-platelet-aggregation-and-lower-body-temperature" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h5></div>
<ol>
<li>Some have combination effects: acetylsalicylic acid (aspirin) (ASA) is a nonnarcotic analgesic (reduces pain), antiinflammatory (reducing inflammation), antiplatelet (increases coagulation time), and antipyretic agent (reduces temperature)</li>
<li>Nonsteroidal antiinflammatory agents (NSAID) inhibit the formation of prostaglandins; these include ibuprofen products</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h5 level="5" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h5></div>
<ol>
<li>Mild to moderate pain</li>
<li>Arthritis</li>
<li>Dysmenorrhea</li>
<li>Fever reduction</li>
<li>Minor postoperative procedures</li>
<li>Decrease of inflammation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h5 level="5" id="c-interactions-an-increased-chance-of-bleeding-when-drugs-are-used-in-combination-with-diseases-in-which-bleeding-can-occur-ulcers-with-alcohol-consumption-or-with-other-medications-anticoagulants">C. Interactions: an increased chance of bleeding when drugs are used in combination with diseases in which bleeding can occur (ulcers), with alcohol consumption, or with other medications (anticoagulants)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-interactions-an-increased-chance-of-bleeding-when-drugs-are-used-in-combination-with-diseases-in-which-bleeding-can-occur-ulcers-with-alcohol-consumption-or-with-other-medications-anticoagulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h5></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="d-major-side-effects">D. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>GI irritation: heartburn, GI bleeding, nausea, vomiting</li>
<li>Hematologic: bone marrow depression, anemia, thrombocytopenia</li>
<li>Tinnitus, ototoxicity</li>
<li>Reye’s syndrome with acetylsalicylic acid (aspirin) only. Reye’s syndrome can occur in clients 18 years of age or younger.</li>
<li>Toxicity in nonnarcotic agents: respiratory alkalosis, increase in rate and depth of respirations, nausea, vomiting, diarrhea, tinnitus, confusion, dizziness</li>
<li>Hypersensitivity to NSAIDs: skin rashes, urticaria, hypotension, dyspnea, and angioedema (also called angioneurotic edema: acute painless swelling of short duration involving the face, neck, lips, larynx, hands, feet, genitalia, or viscera)</li>
</ol>
<p>ANTIINFLAMMATORIES, ANTIPYRETICS, ANTIRHEUMATICS ▼ 143</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Give with food or antacids if GI upset occurs</li>
<li>Monitor CBC and stress compliance with frequent visits for blood monitoring. Older-adult clients should be monitored monthly.</li>
<li>Discontinue these products 5 to 7 days before any major procedure or surgery</li>
<li>Instruct mothers not to use ASA in children with high fevers</li>
<li>NSAID products can be alternated with acetaminophen (Tylenol) for extremely high or difficult-to-control temperatures</li>
<li>Teach the clients to report if a temperature does not subside, bleeding occurs, or the swelling and redness do not decrease</li>
<li>Administer with a full glass of water</li>
<li>These agents are highly protein bound. Competition with other agents that are protein bound is possible. Example: digoxin.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Acetylsalicylic acid (Aspirin) (ASA)</li>
<li>Ibuprofen (Advil, Motrin, Medipren, Nuprin)</li>
<li>Naproxen (Naprosyn, Aleve)</li>
<li>Fenoprofen calcium (Nalfon)</li>
<li>Flurbiprofen sodium (Ansaid)</li>
<li>Indomethacin (Indocin)</li>
<li>Tolmetin sodium (Tolectin)</li>
<li>Sulindac (Clinoril)</li>
<li>Nabumetone (Relafen)</li>
<li>Ketorolac (Toradol)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drugs-used-to-treat-arthritis">DRUGS USED TO TREAT ARTHRITIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-to-treat-arthritis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-antirheumatic-agents">I. Antirheumatic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antirheumatic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-major-classifications">A. Major classifications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-major-classifications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>NSAID products</li>
<li>Gold compounds</li>
<li>Antimalarial compounds</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-actions-suppress-inflammation-of-synovial-membrane-in-joints-affected-by-arthritis-during-active-stage-of-the-disease-relieve-pain-swelling-and-stiffness-and-can-arrest-the-progression-of-the-disease">B. Actions: suppress inflammation of synovial membrane in joints affected by arthritis during active stage of the disease. Relieve pain, swelling, and stiffness, and can arrest the progression of the disease.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-actions-suppress-inflammation-of-synovial-membrane-in-joints-affected-by-arthritis-during-active-stage-of-the-disease-relieve-pain-swelling-and-stiffness-and-can-arrest-the-progression-of-the-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-uses-for-arthritis-and-for-arthritic-clients-who-are-not-responsive-to-nsaid-therapy-alone">C. Uses: for arthritis and for arthritic clients who are not responsive to NSAID therapy alone<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-uses-for-arthritis-and-for-arthritic-clients-who-are-not-responsive-to-nsaid-therapy-alone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>144 ▼ CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<p><strong>D. Major side effects</strong></p>
<ol>
<li>Toxicity: nephrotoxicity, hepatotoxicity</li>
<li>Metallic taste in mouth, stomatitis, mouth ulcers with gold compounds</li>
<li>Thrombocytopenia, bone marrow depression</li>
<li>Skin changes: rash, dermatitis, changes in pigmentation</li>
<li>Neuropathy, headache, dizziness</li>
</ol>
<p><strong>E. Nursing implications</strong></p>
<ol>
<li>Monitor complete blood count for decreases, BUN, creatinine for elevations</li>
<li>Protect skin from overexposure to sun</li>
<li>Stress compliance with follow-up visits to the physician</li>
</ol>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>NSAID (refer to p. 142)</li>
<li>Gold compounds
a. Gold sodium thiomalate (Myochrysine)
b. Aurothioglycose (Solganal)
c. Auranofin (Ridaura)</li>
<li>Antimalarial medications
a. Chloroquine hydrochloride (Aralen)
b. Hydroxychloroquine sulfate (Plaquenil)</li>
</ol>
<p><strong>II. Antigout agents</strong></p>
<p><strong>A. Actions</strong></p>
<ol>
<li>Control acute inflammation of the attack</li>
<li>Increase excretion of uric acid (uricosuric)</li>
<li>Decrease production of uric acid</li>
</ol>
<p><strong>B. Uses</strong></p>
<ol>
<li>Gouty arthritis, a disease associated with an increased production of, or interference with, the excretion of uric acid</li>
<li>Control uric acid production with antineoplastic drug therapy (*see next page)</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Kidney stones</li>
<li>Bone marrow depression, anemia</li>
<li>Nausea, vomiting, diarrhea</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Encourage fluid intake of at least 2 to 3 L/day to prevent kidney stone formation</li>
<li>Stress compliance with treatment, and diet of low-purine foods; limit beer, wine, shellfish, and legumes to prevent recurrence</li>
</ol>
<p>ANTIGOUT AGENTS, STEROIDAL AGENTS ▼ 145</p>
<ol start="3">
<li>Monitor complete blood count (CBC) for decrease in values, agranulocytosis</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Colchicine (Novocolchine)</li>
<li>Probenecid (Benemid)</li>
<li>Sulfinpyrazone (Anturan)</li>
<li>Allopurinol (Zyloprim)*</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-steroidal-antiinflammatory-agents">III. Steroidal antiinflammatory agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-steroidal-antiinflammatory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: suppress the intensity of the inflammatory response
B. Uses</p>
<ol>
<li>Myocarditis: inflammation of the myocardium</li>
<li>Pericarditis: inflammation of the pericardium</li>
<li>Arthritis: inflammation of joints manifested by pain and swelling</li>
<li>Tendinitis: inflammation of tendon</li>
<li>Bursitis: inflammation of bursa (tissue around joint)</li>
<li>Ulcerative colitis: chronic inflammation of the large intestine and rectum</li>
<li>Dermatitis: inflammation of skin, with erythremia, pain, and pruritus</li>
<li>Collagen diseases: extensive disruption of connective tissue (systemic lupus, rheumatoid arthritis)</li>
</ol>
<p>C. Major side effects: discussed in Chapter 14 p. 225
D. Nursing implications: discussed in Chapter 14 p. 226
E. Common drugs</p>
<ol>
<li>Cortisone acetate (Cortistan)</li>
<li>Hydrocortisone (Cortisol, Cortaid)</li>
<li>Prednisone (Apo-Prednisone, Deltasone)</li>
<li>Dexamethasone (Decadron)</li>
</ol>
<p>CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A client is postoperative day one from a total abdominal hysterectomy and complains of pain. The nurse should withhold the meperidine hydrochloride (Demerol) based on which of these observations?</li>
</ol>
<p>a. BP 100/72, R 14, P 65
b. BP 98/68, R 8, P 72
c. BP 120/84, R 16, P 90
d. BP 155/98, R 23, P 130</p>
<ol start="2">
<li>A client, age 16, is brought into the emergency room unconscious without any explanation of causation. Narcotic overdose is suspected, and naloxone hydrochloride (Narcan) is administered based on which of these observations?</li>
</ol>
<p>a. Dilated pupils, BP 200/98, R 8
b. P 42, R 18, BP 118/62
c. Pinpoint pupils, R 8
d. P 88, R 20, BP 100/65</p>
<ol start="3">
<li>A migraine headache sufferer is seen frequently in the emergency department requesting pain relief. Stadol might be administered instead of meperidine hydrochloride (Demerol) because it is</li>
</ol>
<p>a. An effective analgesic for moderate pain
b. A narcotic antagonist
c. Better and has few side effects
d. A narcotic agonist-antagonist</p>
<ol start="4">
<li>Acetylcysteine (Mucomyst) is used as an antidote for</li>
</ol>
<p>a. Aspirin overdose
b. Tylenol overdose
c. Demerol overdose
d. NSAID toxicity</p>
<ol start="5">
<li>Upon discharge with a diagnosis of rheumatoid arthritis, a client should be taught which of the following for the prevention of side effects with an NSAID product?</li>
</ol>
<p>a. Take the NSAID q 4 hours and prn
b. Avoid antacids if the medication causes heartburn
c. Cautiously operate machinery because of the sedative effect
d. Report as requested for a CBC and checkup</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 147</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>Respirations &lt;10 should caution the nurse to avoid another dose. Respiratory depression will worsen with subsequent doses. These vital signs in responses <em>a</em> and <em>c</em> are within normal limits. These vital signs in response <em>d</em> may indicate that the pain is still present or worsened and that the Demerol could help.</td><td>Use the “vertical approach” to read down each part of the series. Keep in mind the ABCs when vital signs are involved. Response <em>b</em> jumps out with a respiration of 8. Then compare the other answers to confirm that response <em>b</em> is correct.</td></tr><tr><td><strong>2. Correct answer: c</strong></td><td></td></tr><tr><td>Both of these findings in response <em>c</em> are indicative of an opioid narcotic overdose. Narcotics cause pinpoint pupils and hypotension. These vital signs in responses <em>d</em> and <em>b</em> are all within normal limits.</td><td>Read each part of the series vertically and eliminate the answers indicating a normal respiratory rate, <em>b</em> and <em>d</em>. Between the remaining two answers, the clue of hypertension makes option <em>a</em> incorrect; select response <em>c</em>.</td></tr><tr><td><strong>3. Correct answer: d</strong></td><td></td></tr><tr><td>The agent will relieve pain but prevent the major side effects of narcotics. These agents also have less potential for dependency. The answer in response <em>a</em> is true but not the best reason for substituting the two agents. The correct classification for Stadol is narcotic analgesic. Stadol is not necessarily better with fewer side effects than Demerol.</td><td>If you narrowed the options <em>c</em> and <em>d</em>, reread the question. Note the question is specific; select the more specific option, option <em>d</em>.</td></tr></tbody></table>
<p>148 ▼ CHAPTER 9 DRUGS THAT RELIEVE PAIN AND INFLAMMATION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-b">4. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Acetylcysteine (Mucomyst) works by decreasing the buildup of a metabolite that is hepatotoxic in acetaminophen (Tylenol) poisoning. In addition, modifying the pH in the urine with a urinary alkalizer, acetazolamide (Diamox)—acarbonic anhydrase inhibitor that decreases the reabsorption of sodium bicarbonate in the proximal tubule—can help eliminate acetylsalicylic acid (Aspirin) when the client is overdosed. Naloxone hydrochloride (Narcan) is the recommended agent for meperidine hydrochloride (Demerol) overdose. Eliminating the NSAID will usually relieve symptoms of NSAID toxicity.</p>
<p>Associate acetylcysteine with acetaminophen to recall the treatment for overdosage.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-d">5. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Anemias are common with these agents, and a regular CBC is needed to avoid or detect any major complications. Response <em>a</em> is the recommended dose and does not eliminate side effects. Heartburn is a common side effect and should be treated with antacids. An NSAID typically does not cause excess sedation.</p>
<p>Key words in the stem are "prevention of side effects." Responses <em>a</em>, <em>b</em>, and <em>c</em> focus on actions to minimize or to deal with side effects.</p>
<p>CHAPTER 10</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-cardiovascular-system">Drugs Affecting the Cardiovascular System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-cardiovascular-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the action and use of cardiac glycosides.</li>
<li>Describe nursing implications concerning side effects and prevention of toxicity with cardiac glycosides.</li>
<li>Identify the groups of drugs that relieve angina.</li>
<li>Discuss the nursing implications for the antianginals.</li>
<li>Identify the classifications of drugs used as antihypertensives.</li>
<li>Discuss the stepped-care regimen for treating hypertension.</li>
<li>Describe nursing implications concerning diet and drug therapy to lower blood pressure.</li>
<li>Identify the classifications of drugs used as antidysrhythmics.</li>
<li>Describe nursing implications concerning cardiovascular assessment related to dysrhythmic agents.</li>
</ul>
<p>150 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="afterload">Afterload<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#afterload" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The resistance against which the left ventricle must eject its volume of blood during contraction. The resistance is produced by the volume of blood already in the vascular system plus the diameter of the vessel walls. <strong>Left ventricular afterload</strong>: referred to as peripheral vascular resistance (PVR); <strong>Right ventricular afterload</strong>: referred to as pulmonary vascular resistance (PVR).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antidysrhythmics">Antidysrhythmics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antidysrhythmics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A classification of drugs that prevent, alleviate, or correct an abnormal cardiac rhythm.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antilipidemics">Antilipidemics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antilipidemics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Agents that reduce the amount of lipids in the serum: Lovastatin (Mevacor)—interferes with the synthesis of cholesterol. Colestipol (Colestid), Cholestyramine (Questran)—combine with bile acids in the intestine to form an insoluble complex that is excreted in the feces. Clofibrate (Atromid-S)—reduces low-density lipoproteins in the serum.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="automaticity">Automaticity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#automaticity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A property of a specialized excitable tissue that allows self-activation through spontaneous development of an action potential, as in most of the cells called pacemaker cells in the heart.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="digitalis-toxicity">Digitalis toxicity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#digitalis-toxicity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A result of the cumulative effect of digitalis preparations; earliest findings are typically nausea, vomiting, and anorexia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="preload">Preload<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#preload" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The stretch of the myocardial fiber at end diastole which is related to filling volume.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cardiac-glycosides-and-similar-drugs">CARDIAC GLYCOSIDES AND SIMILAR DRUGS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cardiac-glycosides-and-similar-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Actions: a positive inotropic, negative chronotropic, and negative dromotropic effect produced by inhibiting the adenosine triphosphatase (ATPase) enzyme and increasing calcium into the myocardial cytoplasm (Box 10-1)</li>
</ol>
<p>CARDIAC GLYCOSIDES AND SIMILAR AGENTS ▼ 151</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-10-1-effect-of-drugs-on-the-heart">Box 10-1. Effect of Drugs on the Heart<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-10-1-effect-of-drugs-on-the-heart" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Inotropic</th><th>affects the force of contraction</th></tr></thead><tbody><tr><td>Chronotropic</td><td>interferes with the rate of the heart beat</td></tr><tr><td>Dromotropic</td><td>pertains to conduction</td></tr></tbody></table>
<p>A. Positive inotropic effect: increases myocardial contraction, which may decrease heart size in clients with cardiomyopathy and CHF, and increases renal blood flow
B. Negative chronotropic effect: decreases heart rate
C. Negative dromotropic effect: slows conduction through the atrioventricular (AV) node
D. Overall effects</p>
<ol>
<li>Increased cardiac output without increased oxygen demand in non-myocardial infarction situations</li>
<li>Decreased workload from the effect of decreased heart rate</li>
<li>Mild diuretic effect</li>
<li>Decreased heart size in cardiomyopathy clients</li>
<li>Specific to amrinone lactate (Inocor) as a result of vasodilation
a. Decreased preload: decreased stretch of myocardial fiber at the end of diastole
b. Decreased afterload and end-diastolic volume</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-uses">II. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Congestive heart failure (CHF)
B. Atrial dysrhythmias, atrial flutter, supraventricular tachycardia</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-major-side-effects">III. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Digitalis toxicity</p>
<ol>
<li>GI disturbances: nausea, vomiting, anorexia, diarrhea (first signs of adult toxicity), upset stomach (first sign of toxicity in older children)</li>
<li>Neurological symptoms: vertigo, headache, drowsiness, irritability, weakness, convulsions</li>
<li>Ophthalmologic disorders: photophobia, disturbances in color vision (yellow vision), yellow-green halos around objects, flickering lights</li>
<li>Cardiovascular effects: ECG changes, extra beats, bradycardia (first sign of toxicity in older children), heart block, tachycardias (first sign of toxicity in young children)</li>
</ol>
<p>152 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<p>B. GI disturbances similar to those listed above may occur without toxicity. If not toxic, these disappear with continued therapy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-nursing-implications">IV. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Monitor blood levels and signs of toxicity. Digitalis has a low therapeutic index (0.5 to 2 ng/ml), and toxicity occurs quickly.</p>
<p>B. Because of the long half-life, monitor for associated factors of toxicity</p>
<ol>
<li>
<p>Hypokalemia (&lt;3.5 mEq/L), hypercalcemia (&gt;10.5 mg/dl), hypomagnesemia (&lt;1.8 mg/dl)</p>
</li>
<li>
<p>Hypothyroidism or hyperthyroidism</p>
</li>
<li>
<p>Recent myocardial infarction, ventricular tachycardia, or heart block</p>
</li>
<li>
<p>Impaired renal function, dehydration, low serum albumin</p>
</li>
<li>
<p>Rapid administration IV</p>
</li>
</ol>
<p>C. Carefully monitor the older adults because of the possible interactions with other drugs, diseases, and slower absorption, which may lead to toxicity</p>
<p>D. Assess heart rate by taking an apical pulse for 1 full minute. Hold the drug for heart rates &lt;60 beats/min (adult) and &lt;110 (children); and &gt;120 beats/min (adults) and &gt;140 (children), unless parameters have been set by the physician.</p>
<p>E. Assess use of concurrent medications</p>
<ol>
<li>
<p>Give separately from antacids (at least 1 to 2 hours apart)</p>
</li>
<li>
<p>Use cautiously with other calcium channel blockers or beta blockers to prevent severe bradycardia or heart block</p>
</li>
</ol>
<p>F. Assess renal status, monitor intake and output (I&amp;O)</p>
<p>G. Assess for findings of increasing CHF: weight gain, edema of feet and ankles, or lung congestion, S₃ or S₄ heart sound</p>
<p>H. Usually requires digitalizing dose before beginning a maintenance dose. The preferred routes are IV and PO. These drugs are extremely painful if given IM.</p>
<p>I. Monitor hospitalized clients for electrolytes, ECG changes, creatinine, and BUN</p>
<p>J. Use digoxin immune FAB (Digibind) to treat toxicity if dysrhythmias are life-threatening</p>
<p>K. Teach the client</p>
<ol>
<li>
<p>Proper dose, time of day to take the medication, and other medications to avoid</p>
</li>
<li>
<p>How to count a pulse rate and when to notify the physician of changes</p>
</li>
</ol>
<p>ANTIANGINAL AGENTS: NITRATES ▼ 153</p>
<ol start="3">
<li>When to report to the physician: extra beats, fast heart rates, signs of toxicity, excess coughing, weight gain—report gain of &gt;2 pounds/week or/day</li>
<li>Information about toxicity and the importance of knowing what dose to take if the physician changes the prescription</li>
</ol>
<p>V. Interactions can occur with prescription and over-the-counter (OTC) medications. Nurses should review the current medication record, and clients should be sure to tell all physicians that they are taking a digitalis preparation. A pharmacist should be consulted before clients take OTC preparations. Interactions have occurred with quinidine, beta blockers, calcium channel blockers, loop diuretics, and thyroid preparations.</p>
<p>VI. Contraindicated in idiopathic hypertrophic subaortic stenosis (hypertrophic cardiomyopathy), Wolf-Parkinson-White syndrome, and heart blocks</p>
<p>VII. Common individual drugs</p>
<p>A. Digitalis preparations</p>
<ol>
<li>Digoxin (Lanoxin, Lanoxicaps)</li>
<li>Deslanoxide (Cedilanid-D)—given IV only</li>
</ol>
<p>B. Amrinone lactate (Inocor) is similar to cardiac glycosides but differs in the following ways</p>
<ol>
<li>Does not cause dysrhythmias in large doses</li>
<li>Side effects also include thrombocytopenia and hypotension</li>
<li>Used in CHF when cardiac glycosides fail</li>
<li>Should not be diluted in dextrose products</li>
<li>Should not be given with furosemide (Lasix)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antianginals">ANTIANGINALS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antianginals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I. Classifications of drugs used to treat angina
A. Nitrates
B. Beta adrenergic blockers
C. Calcium channel blockers</p>
<p>II. Nitrates</p>
<p>A. Actions</p>
<ol>
<li>Decrease oxygen demand</li>
<li>Decrease preload by dilating veins</li>
</ol>
<p>154 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<ol start="3">
<li>In higher doses, dilate all major systemic arteries, which decreases afterload: the resistance against which the left ventricle must eject its volume of blood during contraction</li>
</ol>
<p>B. Uses: first line treatment for immediate and long-term prevention of angina: chest pain due to lack of oxygenated blood supply to the heart</p>
<p>C. Major side effects</p>
<ol>
<li>Headache (most common)</li>
<li>Hypotension</li>
<li>Postural hypotension</li>
<li>Syncope</li>
<li>Flushed feeling</li>
<li>Dizziness</li>
<li>Weakness</li>
</ol>
<p>D. Hypotension can be severe with consumption of alcohol or when taken with beta blockers or calcium channel blockers</p>
<p>E. Nursing implications</p>
<ol>
<li>Know how to administer in all available forms: PO, IV, ointment, patch, SL, spray, chewable, inhalation</li>
<li>Assess the frequency and nature of the angina before drug therapy and as relief is obtained</li>
<li>Monitor BP before any dose. BP should be taken before, during, and after therapy. Parameters for administration should be documented by the physician.</li>
<li>Instructions for patches and ointment application</li>
</ol>
<p>a. Use nonhairy area
b. Rotate sites
c. Remove the old patch or ointment immediately before applying a new dose
d. Use gloves to avoid getting ointment on hands
e. Squeeze the prescribed amount of ointment onto the paper and apply to the skin without rubbing. Tape the paper in place or apply a plastic wrap over the paper to increase absorption.
f. Date the patch on the outside</p>
<ol start="5">
<li>Instructions for SL and spray preparations</li>
</ol>
<p>a. May take up to 3 SL tablets, 3 to 5 minutes apart to obtain pain relief. If relief is not obtained, seek medical attention.
b. Tablets should be protected from light, heat, and moisture
c. Tablets should always be available. Teach the clients to carry them at all times on their person.</p>
<p>ANTIANGINAL AGENTS: BETA ADRENERGIC BLOCKERS ▼ 155</p>
<p>d. Tablets should be replaced 3 to 6 months after bottle is opened. A burning sensation should occur when taken SL.
e. Spray should be applied directly to the oral mucosa (avoid inhaling)
f. Cotton should be removed from all new bottles, and expiration dates on bottles should be checked</p>
<ol start="6">
<li>
<p>IV nitroglycerin (Tridil) should be mixed with D5W or normal saline in a glass bottle with the manufacturer-supplied tubing. A pump should be used and the dose titrated every 3 to 5 minutes according to pain assessment, blood pressure, and pulse measurements. Do not mix any other drug with IV nitroglycerin (Tridil). IV nitroglycerin (Tridil) interferes with the effects of IV heparin, so IV heparin rates usually need to be increased to obtain a therapeutic effect.</p>
</li>
<li>
<p>Avoid use in head trauma or cases of increased intracranial pressure, cerebral hemorrhage</p>
</li>
<li>
<p>Client teaching
a. Take nitroglycerin (Nitrostat) tablets at the first sign of an anginal attack
b. Nitrates are not habit forming, but tolerance can develop
c. Lie or sit down while taking NTG for an acute attack to prevent falls from potential dizziness from the decreased preload
d. To prevent angina, take agents before stressful physical activity known to cause angina such as exercise, sexual activity
e. Teach the specifics about the form of nitroglycerin prescribed
f. Monitor BP if equipment available at home</p>
</li>
</ol>
<p>F. Interactions can occur with alcohol and other vasodilators
G. Common individual drugs: {NTG} nitroglycerin (Nitro-bid, Nitrostat, Tridil, Transderm-Nitro, Nitrodisc, Nitro-dur, Deponit, Minitran)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-beta-adrenergic-blockers">III. Beta adrenergic blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-beta-adrenergic-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: block beta receptor sites in the heart, which decreases the force of the contraction and lowers oxygen demand. These actions result in the following</p>
<ol>
<li>Lowered heart rate</li>
<li>Decreased cardiac output</li>
<li>Decreased contractility</li>
<li>Prevention of exercise-induced tachycardia</li>
<li>Decreased dysrhythmias</li>
</ol>
<p>156 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<p>B. Uses: for long-term prevention of angina. These agents assist chronic angina patients to increase their exercise potential. These agents are not used for acute attacks. Beta blockers are also used after a myocardial infarction (MI) and to prevent a further infarct. (Table 10-1 for other uses)</p>
<p>C. Major side effects</p>
<ol>
<li>Cardiovascular: hypotension, bradycardia</li>
<li>Beta blocker blues: decreased libido, depression</li>
<li>Bronchospasm</li>
<li>Worsening of CHF, heart blocks</li>
<li>Fatigue</li>
<li>Constipation</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Monitor BP and pulse before, during, and after therapy. If the apical pulse is below 60 for a full minute, consult the physician unless other parameters have been given.</li>
<li>Assess other medications the client is taking. Avoid administering at the same time as antacids (wait 1 to 2 hours), calcium channel blockers, or cardiac glycosides.</li>
<li>Use cautiously in clients with chronic airway limitations (CAL), asthma, CHF, heart blocks, and peripheral vascular insufficiency</li>
<li>Monitor the ECG status of the client</li>
<li>Client teaching
a. Do not abruptly withdraw the medication without consulting the physician first; abrupt withdrawal may result in angina
b. Take the medication at the same time each day
c. If a dose is forgotten, do not double the dose; rearrange the schedule to make up the dose
d. Report any side effects to the physician
e. Do not take hot baths, sit in hot tubs, or be exposed to the hot sun for long periods of time
f. Monitor the pulse at the same time daily; count for 1 full minute</li>
<li>Triglyceride and cholesterol level (LDL) may be elevated</li>
<li>Clients exercising or attending cardiac rehabilitation may not experience a rise in HR in response to the activity. Signs and symptoms of the client should be considered in response to the exercise undertaken.</li>
</ol>
<p>E. Interactions: increased potential for bradycardia with concurrent use of cardiac glycosides and calcium channel blockers, and an increased hypotensive effect with diuretics</p>
<p>157</p>
<p>Table 10-1. Clinical Uses for Beta Blockers and Calcium Channel Blockers</p>
<table><thead><tr><th>Classification</th><th>Antianginal</th><th>Antihypertensive</th><th>Antidysrhythmic</th></tr></thead><tbody><tr><td>Beta Blockers</td><td>Relieve pain by</td><td></td><td></td></tr><tr><td>▼ decreasing HR</td><td></td><td></td><td></td></tr><tr><td>▼ decreasing contractility</td><td></td><td></td><td></td></tr><tr><td>▼ decreasing oxygen demand</td><td></td><td></td><td></td></tr><tr><td>▼ producing negative inotropic effect</td><td></td><td></td><td></td></tr><tr><td>▼ producing negative chronotropic effect</td><td>Lower BP by</td><td></td><td></td></tr><tr><td>▼ blocking sympathetic stimulation</td><td></td><td></td><td></td></tr><tr><td>▼ decreasing cardiac output</td><td>Stop dysrhythmias by</td><td></td><td></td></tr><tr><td>▼ decreasing ischemia by</td><td></td><td></td><td></td></tr><tr><td>▼ lowering oxygen demand</td><td></td><td></td><td></td></tr><tr><td>▼ due to decreasing HR (negative chronotropic effect)</td><td></td><td></td><td></td></tr><tr><td>Calcium Channel Blockers</td><td>Relieve pain by</td><td></td><td></td></tr><tr><td>▼ decreasing intracellular calcium, which decreases myocardial contractility, which then lowers oxygen demand</td><td>Lower BP by</td><td></td><td></td></tr><tr><td>▼ decreasing peripheral vascular resistance</td><td></td><td></td><td></td></tr><tr><td>▼ decreasing calcium transport across cells</td><td>Stop dysrhythmias by</td><td></td><td></td></tr><tr><td>▼ decreasing conduction rate (negative dromotropic effect)</td><td></td><td></td><td></td></tr><tr><td>▼ blocking calcium influx, which decreases irritability</td><td></td><td></td><td></td></tr></tbody></table>
<p>158 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<p><strong>F. Common drugs</strong>*</p>
<ol>
<li>Propranolol hydrochloride (Inderal)</li>
<li>Nadolol (Corgard)</li>
<li>Metoprolol tartrate (Lopressor)</li>
<li>Atenolol (Tenormin)</li>
<li>Pindolol (Viskin)</li>
<li>Timolol maleate (Blocadren)</li>
</ol>
<ul>
<li>Note: these drugs end in “lol”</li>
</ul>
<p><strong>IV. Calcium channel blockers</strong></p>
<p><strong>A. Actions</strong></p>
<ol>
<li>Decrease myocardial contractility by preventing the influx of calcium ions into the cells</li>
<li>Decrease oxygen demand</li>
<li>Dilate coronary and peripheral arteries</li>
</ol>
<p><strong>B. Uses: see Table 10-1</strong></p>
<ol>
<li>Prevention of complications post-MI</li>
<li>Acute and long-term prevention of angina attacks</li>
<li>Angina caused by vasospasm</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Hypotension</li>
<li>Bradycardia</li>
<li>Heart blocks</li>
<li>Dyspnea</li>
<li>Wheezing</li>
<li>Worsening CHF</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Monitor BP and pulse before, during, and after administration. Parameters (high and low) should be set for BP and pulse.</li>
<li>Monitor ECG pattern and avoid giving the medication when existing heart blocks are present</li>
<li>Administer these medications with meals or milk</li>
<li>Monitor renal status: serum creatinine and urine output</li>
</ol>
<p><strong>E. Interactions: increased effects if taken with a beta blocker and increased digoxin level if taken with digoxin products</strong></p>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Diltiazem hydrochloride (Cardizem)</li>
<li>Nicardipine hydrochloride (Cardene)</li>
<li>Nifedipine (Procardia)</li>
<li>Verapamil hydrochloride (Calan, Isoptin)</li>
</ol>
<p>ANTIDYSRHYTHMIC AND ANTIHYPERTENSIVE AGENTS ▼ 159</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antidysrhythmic-agents">ANTIDYSRHYTHMIC AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antidysrhythmic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. Actions: separated into classes I through IV based on the action and type of dysrhythmia the drug treats. A dysrhythmia is a deviation from the normal pattern of the heartbeat. These drugs work by one or more of the following ways</p>
<p>A. Decrease automaticity: decreases the ability of any cell in the myocardium to self-activate through spontaneous development of an action potential. The ability of cells to fire an impulse accounts for many of the dysrhythmias and extra (premature) beats.
B. Decrease reentry phenomena: decreases the reactivation of myocardial tissue for the second or subsequent time by the same impulse
C. Decrease conduction: slows heart rate</p>
<p>II. Specific actions, uses, side effects, and nursing implications for each class are identified in Table 10-2</p>
<p>III. Nursing implications</p>
<p>A. Monitor vital signs before, during, and after treatment
B. Make sure IV forms of dysrhythmic drugs are always on an IV controller
C. Monitor ECG patterns; withhold if heart block occurs
D. Administer around-the-clock, since most require that a therapeutic level be maintained
E. Monitor electrolytes, especially potassium (K) and magnesium values</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antihypertensives">ANTIHYPERTENSIVES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antihypertensives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. The stepped-care approach (Table 10-3) for the treatment of high blood pressure should begin with lifestyle modification (Step 1) consisting of</p>
<p>A. Exercise
B. Reduction of stress
C. Cessation of smoking
D. Loss of excess weight
E. Restriction of sodium
F. Decrease in alcohol</p>
<p>160
Table 10-2. Antidysrhythmics: Class, Action, Side Effects, and Nursing Implications</p>
<table><thead><tr><th>Class/Name</th><th>Action/Use</th><th>Side Effects</th><th>Nursing Implications</th></tr></thead><tbody><tr><td>Class I</td><td></td><td></td><td></td></tr><tr><td>moricizine hydrochloride</td><td></td><td></td><td></td></tr><tr><td>(Ethmozine)</td><td>▼ Classes I, IA, IB, and IC</td><td></td><td></td></tr><tr><td>decrease conduction by</td><td></td><td></td><td></td></tr><tr><td>blocking sodium channels</td><td></td><td></td><td></td></tr><tr><td>in cardiac cells</td><td></td><td></td><td></td></tr><tr><td>▼ Used for life threatening</td><td></td><td></td><td></td></tr><tr><td>ventricular dysrhythmias</td><td>Exacerbation of existing</td><td></td><td></td></tr><tr><td>dysrhythmias or additional</td><td></td><td></td><td></td></tr><tr><td>dysrhythmias, dizziness,</td><td></td><td></td><td></td></tr><tr><td>nausea, fatigue, palpitations,</td><td></td><td></td><td></td></tr><tr><td>dyspnea, angina, CHF</td><td>▼ Monitor for findings</td><td></td><td></td></tr><tr><td>of CHF</td><td></td><td></td><td></td></tr><tr><td>▼ Observe for additional</td><td></td><td></td><td></td></tr><tr><td>dysrhythmias</td><td></td><td></td><td></td></tr><tr><td>Class I-A</td><td></td><td></td><td></td></tr><tr><td>quinidine sulfate</td><td></td><td></td><td></td></tr><tr><td>(Quinidine)</td><td>▼ Depresses contractility</td><td></td><td></td></tr><tr><td>▼ Depresses myocardial</td><td></td><td></td><td></td></tr><tr><td>excitability</td><td>Cinchonism (tinnitus,</td><td></td><td></td></tr><tr><td>headache, vertigo, fever,</td><td></td><td></td><td></td></tr><tr><td>visual disturbances)</td><td>▼ Monitor for QRS &gt; 0.12</td><td></td><td></td></tr><tr><td>and lengthening of</td><td></td><td></td><td></td></tr><tr><td>Q-T interval</td><td></td><td></td><td></td></tr><tr><td>quinidine gluconate</td><td></td><td></td><td></td></tr><tr><td>(Quinaglute)</td><td>▼ Depresses the refractory</td><td></td><td></td></tr><tr><td>period</td><td>Hypotension</td><td>▼ If GI upset occurs,</td><td></td></tr><tr><td>especially diarrhea, give</td><td></td><td></td><td></td></tr><tr><td>immediate attention</td><td></td><td></td><td></td></tr><tr><td>polygalacturonate</td><td></td><td></td><td></td></tr><tr><td>(Cardioquin)</td><td>▼ Used for atrial</td><td></td><td></td></tr><tr><td>dysrhythmias (atrial</td><td></td><td></td><td></td></tr><tr><td>fibrillation) and</td><td></td><td></td><td></td></tr><tr><td>ventricular dysrhythmias</td><td>GI upset (anorexia, diarrhea,</td><td></td><td></td></tr><tr><td>cramping)</td><td>▼ Monitor BP</td><td></td><td></td></tr><tr><td>procainimide</td><td></td><td></td><td></td></tr><tr><td>hydrochloride (Pronestyl)</td><td></td><td></td><td></td></tr><tr><td>disopyramide phosphate</td><td></td><td></td><td></td></tr><tr><td>(Norpace)</td><td></td><td>Cardiotoxicity: widening</td><td></td></tr><tr><td>of the QRS complex</td><td></td><td></td><td></td></tr><tr><td>and Q-T interval</td><td></td><td></td><td></td></tr><tr><td>Class I-B (Local</td><td></td><td></td><td></td></tr><tr><td>Anesthetic Antidysrhythmics)</td><td></td><td></td><td></td></tr><tr><td>lidocaine hydrochloride</td><td></td><td></td><td></td></tr><tr><td>(Lidocaine)</td><td>▼ Accelerates repolarization,</td><td></td><td></td></tr><tr><td>stabilizes cell membranes</td><td>CNS disturbances:</td><td></td><td></td></tr><tr><td>drowsiness, * confusion,</td><td></td><td></td><td></td></tr><tr><td>light-headedness,</td><td></td><td></td><td></td></tr><tr><td>slurred speech</td><td>▼ Check allergies to local</td><td></td><td></td></tr><tr><td>anesthetics</td><td></td><td></td><td></td></tr><tr><td>mexiletine hydrochloride</td><td></td><td></td><td></td></tr><tr><td>(Mexitil)</td><td>▼ Used to suppress or</td><td></td><td></td></tr><tr><td>prevent ventricular</td><td></td><td></td><td></td></tr><tr><td>dysrhythmias, to suppress</td><td></td><td></td><td></td></tr><tr><td>ventricular ecotopic beats</td><td>GI distress</td><td>▼ Give Mexitil and</td><td></td></tr><tr><td>Tonocard with food</td><td></td><td></td><td></td></tr><tr><td>tocainide hydrochloride</td><td></td><td></td><td></td></tr><tr><td>(Tonocard)</td><td></td><td>Hypotension</td><td>▼ Administer Lidocaine IV</td></tr><tr><td></td><td></td><td>Bradycardia</td><td></td></tr><tr><td></td><td></td><td>Seizures **</td><td></td></tr><tr><td></td><td></td><td>Toxicity: *first sign</td><td></td></tr><tr><td></td><td></td><td>**severe</td><td></td></tr></tbody></table>
<p>Continued.</p>
<table><thead><tr><th></th><th></th><th>Lidocaine toxicity, especially if administered with Tagamet or Inderal Respiratory arrest</th><th>Read labels carefully to be sure of administering correct IV form of drug</th></tr></thead><tbody><tr><td>Class I-C</td><td>↓ Interrupts reentry, stabilizes cell membrane, decreases depolarization</td><td>CNS disturbances: dizziness, headache, visual disturbances</td><td>Monitor K levels</td></tr><tr><td>flecainide acetate (Tambocor)</td><td>↓ Used for ventricular dysrhythmias and to prevent sustained ventricular tachycardia</td><td>Dyspnea</td><td>↓ Assess BP</td></tr><tr><td>encainide hydrochloride (Enkaid)</td><td></td><td>Abdominal and leg pain</td><td>↓ Assess for signs of CHF</td></tr><tr><td></td><td></td><td>Worsen CHF</td><td>↓ Give with food if GI upset occurs</td></tr><tr><td></td><td></td><td>Exacerbate existing dysrhythmias and create new ones</td><td></td></tr><tr><td>Class II (Beta Blockers)</td><td>↓ Decreases ischemia by decreasing oxygen demand and decreasing heat rate (negative chronotropic effect)</td><td>Bradycardia, hypotension syncope, precipitate CHF decreased libido fatigue, lassitude (see beta blockers under antianginals)</td><td>↓ Use cautiously with heart blocks, CHF, COPD</td></tr><tr><td>propranolol hydrochloride (Inderal)</td><td>↓ These actions cause less irritability and less dysrhythmias</td><td></td><td>↓ Withhold if HR&lt;60/min</td></tr><tr><td>acebutolol hydrochloride (Sectral)</td><td></td><td></td><td>↓ Monitor for signs of CHF</td></tr><tr><td>esmolol hydrochloride (Brivibloc)</td><td></td><td></td><td>↓ Do not abruptly withdraw—angina may result</td></tr></tbody></table>
<p>162</p>
<p>Table 10-2. Antidysrhythmics: Class, Action, Side Effects, and Nursing Implications—cont'd</p>
<table><thead><tr><th>Class/Name</th><th>Action/Use</th><th>Side Effects</th><th>Nursing Implications</th></tr></thead><tbody><tr><td>Clue: Drugs ending in “lol” are typically beta blockers</td><td>▼ Used for controlling atrial and ventricular ectopy and sudden atrial or ventricular tachycardia</td><td></td><td></td></tr><tr><td>Class III</td><td></td><td></td><td></td></tr><tr><td>amiodarone hydrochloride (Cordarone)</td><td></td><td></td><td></td></tr><tr><td>bretylium tosylate (Bretylol)</td><td></td><td></td><td></td></tr><tr><td>sotalol (Betapace)</td><td>▼ Decreases automaticity, stops reentry, delays repolarization of fast potentials</td><td></td><td></td></tr><tr><td>▼ All three can affect the heart in different ways; therefore they are not interchangeable</td><td></td><td></td><td></td></tr><tr><td>▼ Used for life-threatening ventricular dysrhythmias</td><td>Orthostatic hypotension, dizziness, can aggravate existing dysrhythmias, fatigue, malaise</td><td></td><td></td></tr><tr><td>Sotalol can cause torsades de pointes</td><td></td><td></td><td></td></tr><tr><td>Toxicity and dysrhythmias are increased by hypokalemia: widens QRS, prolongs PR and QT interval</td><td></td><td></td><td></td></tr><tr><td>Photosensitivity</td><td>▼ Monitor BP and pulse</td><td></td><td></td></tr><tr><td>▼ Monitor EKG for changes</td><td></td><td></td><td></td></tr><tr><td>▼ Teach client to use sunscreens</td><td></td><td></td><td></td></tr><tr><td>Class IV (Calcium Channel Blockers)</td><td></td><td></td><td></td></tr><tr><td>verapamil hydrochloride (Calan, Isoptin)</td><td>▼ Blocks calcium influx across myocardial cell and decreases conduction rate (negative dromotropic effect)</td><td></td><td></td></tr><tr><td>▼ Used for controlling ventricular rate in clients with supraventricular dysrhythmias</td><td>Severe orthostatic hypotension, especially when administered IV</td><td></td><td></td></tr><tr><td>Sinus and AV blocks</td><td></td><td></td><td></td></tr><tr><td>Worsen CHF</td><td></td><td></td><td></td></tr><tr><td>Flushing, headache, leg and muscle cramps</td><td>▼ Use cautiously with bradycardia, CHF clients, and sick sinus syndrome</td><td></td><td></td></tr><tr><td>▼ Give IV slowly, over 2 to 3 minutes</td><td></td><td></td><td></td></tr><tr><td>▼ Assess BP</td><td></td><td></td><td></td></tr><tr><td>▼ Assess signs of CHF</td><td></td><td></td><td></td></tr><tr><td>▼ Monitor EKG during IV administration</td><td></td><td></td><td></td></tr></tbody></table>
<p>STEPPED-CARE APPROACH FOR HYPERTENSION, DIURETICS ▼ 163</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="table-10-3-stepped-care-approach">Table 10-3. Stepped-Care Approach<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#table-10-3-stepped-care-approach" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>|  <strong>Step I</strong>
Sodium restriction
Weight control
Alcohol restriction
Exercise
Cessation of smoking
Stress reduction | <strong>Step II</strong>
Continue Step I
Add one agent:
Diuretic
Calcium channel blocker
ACE inhibitor
Beta adrenergic blocker | <strong>Step III</strong>
Continue Step I
Change or add another agent:
Adrenergic blocking agent | <strong>Step IV</strong>
Continue Step I
Change or add another agent:
Direct Vasodilator  |
| --- | --- | --- | --- |</p>
<p>Summary of the Stepped-Care Approach recommended in the 1993 revised report by the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-classifications-of-drugs-used-beyond-step-1">II. Classifications of drugs used beyond Step 1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-classifications-of-drugs-used-beyond-step-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Step 2</p>
<ol>
<li>Diuretics</li>
<li>Calcium channel blockers</li>
<li>Beta adrenergic blockers</li>
<li>Angiotensin antagonists</li>
</ol>
<p>B. Step 3: adrenergic blocking agents
C. Step 4: direct vasodilators</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-diuretics-see-chapter-11-p-182-are-often-tried-first-especially-in-older-adults-as-a-step-2-approach">III. Diuretics (see Chapter 11 p. 182) are often tried first, especially in older adults as a Step 2 approach<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-diuretics-see-chapter-11-p-182-are-often-tried-first-especially-in-older-adults-as-a-step-2-approach" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions</p>
<p>164 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<ol>
<li>Increase sodium and water excretion</li>
<li>Decrease cardiac output</li>
<li>Directly vasodilate arterioles</li>
<li>Decrease peripheral vascular resistance (PVR): a resistance to the flow of blood determined by the tone of the systemic vascular musculature and the diameter of the blood vessels</li>
</ol>
<p>B. Uses</p>
<ol>
<li>Essential hypertension (HTN): thiazides and loop diuretics</li>
<li>Potassium sparing are often combined with other agents to lower BP</li>
</ol>
<p>C. Refer to Chapter 11, p. 182 for side effects, nursing implications and common drugs</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-beta-adrenergic-blockers">IV. Beta adrenergic blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-beta-adrenergic-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit sympathetic stimulation, which lowers HR and decreases cardiac output to lower BP (see Table 10-1)
B. Often used in combination with a diuretic
C. Side effects and nursing implications: see antianginals, p. 153
D. Common drugs</p>
<ol>
<li>Atenolol (Tenormin)</li>
<li>Labetalol (Normodyne)</li>
<li>Metoprolol tartrate (Lopressor)</li>
<li>Nadolol (Corgard)</li>
<li>Pindolol (Viskin)</li>
<li>Propranolol hydrochloride (Inderal)</li>
<li>Timolol maleate (Blocadren)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-calcium-channel-blockers">V. Calcium channel blockers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-calcium-channel-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit release of intracellular calcium, which decreases the force of contraction and prevents entry of calcium ions into smooth muscle; this lowers arteriolar constriction, thereby lowering PVR and decreasing BP (see Table 10-1)
B. Uses: mild to moderate HTN alone or in combination with diuretics
C. Side effects and nursing implications: see antianginals, p. 153
D. Common drugs</p>
<ol>
<li>Diltiazem hydrochloride (Cardizem)</li>
<li>Felodipine (Plendil)</li>
</ol>
<p>ANGIOTENSION CONVERTING ENZYME (ACE) INHIBITORS ▼ 165</p>
<ol start="3">
<li>Nicardipine hydrochloride (Cardene)</li>
<li>Nifedipine (Procardia)</li>
<li>Verapamil hydrochloride (Isoptin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-angiotensin-antagonists-angiotension-converting-enzyme-ace-inhibitors">VI. Angiotensin antagonists (angiotension converting enzyme, ACE) inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-angiotensin-antagonists-angiotension-converting-enzyme-ace-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: interrupt the renin-angiotensin-aldosterone system in one of three ways (Box 10-2)</p>
<ol>
<li>Inhibit conversion of angiotensin I to angiotensin II</li>
<li>Decrease aldosterone secretion</li>
<li>Compete with angiotensin II to block its effect</li>
</ol>
<p>B. Uses: mild to moderate hypertension (HTN)</p>
<p>C. Major side effects</p>
<ol>
<li>Chest pain</li>
<li>Palpitations</li>
<li>Hypotension</li>
<li>Tachycardia</li>
<li>Proteinuria: large quantities of protein in the urine, associated with renal disease, hypertension, heart failure</li>
<li>Rash</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-10-2-three-mechanisms-of-action-from-ace-inhibitors-in-relation-to-normal-physiology">Box 10-2. Three Mechanisms of Action from ACE Inhibitors in Relation to Normal Physiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-10-2-three-mechanisms-of-action-from-ace-inhibitors-in-relation-to-normal-physiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="long-term-regulation-of-blood-pressure">Long-Term Regulation of Blood Pressure<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#long-term-regulation-of-blood-pressure" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>With a decrease in BP, stimulation of the kidneys occurs to excrete renin, an
(1) inhibits
enzyme involved in the formation of angiotensin I. Angiotensin I is converted
(3) competes with
to Angiotensin II (potent vasoconstrictor). Angiotensin II produces two
(2) decreases
effects: elevation of BP by potency, or a release in aldosterone, which
decreases the excretion of Na and water and thereby elevates BP.</p>
<p>Key: Mechanism of action</p>
<p>CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<ol start="7">
<li>Neuroterapia: an abnormal decrease in the number of neutrophils in the blood, associated with leukemia, infection, rheumatoid arthritis</li>
<li>Agranulocytosis: reduction in the number of basophils, eosinophils and neutrophils</li>
<li>Hyperkalemia: potassium &gt;5.0 mEq/L</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Monitor CBC and potassium (K) levels</li>
<li>Assess for signs of infection</li>
<li>Check BP daily and keep a monthly log as needed</li>
<li>Instruct client to</li>
</ol>
<p>a. Inform any new physician about the medication taken
b. Avoid excess intake of foods rich in potassium and potassium supplements. (Box 10-3)
c. Do not abruptly stop taking the medication
d. Avoid OTC medications without approval of the physician</p>
<p>E. Common drugs</p>
<ol>
<li>Captopril (Capoten)</li>
<li>Enalapril maleate (Vasotec)</li>
<li>Ramipril (Altace)</li>
<li>Benazepril hydrochloride (Lotensin)</li>
</ol>
<p>*Note: drugs ending in "ril" are typically ACE inhibitor, antihypertensives</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vii-adrenergic-blocking-agents">VII. Adrenergic blocking agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-adrenergic-blocking-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Groups of drugs within this class</p>
<ol>
<li>Centrally acting adrenergic blocking agents</li>
<li>Ganglionic blockers</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-10-3-dietary-consideration-potassium-sources">Box 10-3. Dietary Consideration: Potassium Sources<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-10-3-dietary-consideration-potassium-sources" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Dietary sources of potassium that should be avoided or restricted with ACE inhibitors.</p>
<ul>
<li>Citrus fruits and juices: especially tomato juice</li>
<li>Bananas, watermelon</li>
<li>Other juices: grape, cranberry, apple, pear, apricot</li>
<li>Cereals</li>
<li>Meat, fish, foul</li>
<li>Leafy vegetables</li>
<li>Salt substitutes (read label)</li>
<li>Coffee, tea, cola beverages</li>
<li>Nuts, peanut butter</li>
</ul>
<p>ADRENERGIC BLOCKING AND DIRECT VASODILATING AGENTS ▼ 167</p>
<ol start="3">
<li>Alpha adrenergic blocking drugs</li>
<li>Peripherally acting antiadrenergic agents</li>
</ol>
<p>B. Actions: vary depending on the group (see Chapter 5 p. 67). Most inhibit stimulation of the sympathetic nervous system, which causes a drop in BP from peripheral vasodilation or decreased cardiac output.</p>
<p>C. Uses: mild to severe essential hypertension
D. Side effects and nursing implications (see Chapter 5 p. 68)
E. Common drugs</p>
<ol>
<li>Centrally acting adrenergic agents
a. Methyldopa (Aldomet)
b. Quanfacine (Tenex)
c. Guanabenz acetate (Wytensin)
d. Clonidine hydrochloride (Catapres)</li>
<li>Ganglionic blockers
a. Mecamylamine hydrochloride (Inversine)
b. Trimethaphan camsylate (Arfonad)</li>
<li>Alpha adrenergic blocking drugs
a. Prazosin hydrochloride (Minipress)
b. Phentolamine (Regitine)</li>
<li>Peripherally acting antiadrenergic agents
a. Reserpine (Serpalan)
b. Terazosin (Hytrin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="viii-direct-vasodilating-agents">VIII. Direct vasodilating agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#viii-direct-vasodilating-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: relax arteriolar smooth muscle, dilate arteries, and decrease PVR
B. Uses: moderate to severe hypertension (HTN) and hypertensive crisis
C. Major side effects</p>
<ol>
<li>Headache</li>
<li>Sodium retention</li>
<li>Rebound HTN</li>
<li>Increased workload of heart: tachycardia, palpitations, nausea</li>
<li>Vomiting, abdominal pain
D. Nursing implications</li>
<li>Monitor VS every 5 to 15 minutes, titrate dose to BP, and do not leave patient unmonitored</li>
<li>Monitor I&amp;O, preferably with a foley catheter in critical care setting</li>
<li>Use microdrip tubing and have IV on a controller pump</li>
</ol>
<p>CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<ol start="4">
<li>Do not mix these drugs with any other drugs</li>
<li>Since sodium nitroprusside (Nipride) must be protected from light, wrap IV bag and tubing with foil</li>
<li>Give hydralazine hydrochloride (Apresoline) slowly IV push</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Sodium nitroprusside (Nipride)</li>
<li>Hydralazine hydrochloride (Apresoline)</li>
<li>Diazoxide (Hyperstat)</li>
<li>Guanethidine sulfate (Ismelin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ix-general-nursing-implications-for-antihypertensives">IX. General nursing implications for antihypertensives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ix-general-nursing-implications-for-antihypertensives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Monitor baseline BP and pulse before, during, and after therapy
B. Monitor I and O, renal function by creatinine clearance or serum creatinine levels
C. Encourage lifestyle changes: see Step I
D. Teach the client how to check the BP at home; offer parameters from which to report abnormal values. Explain orthostatic BP and the need to rise slowly from lying or sitting position.
E. Teach the client to report edema, cough, and weight gain of &gt;2 pounds per week
F. Stress need to comply with taking the BP and medication
G. Stress need to avoid all OTC products unless physician has been consulted</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antihyperlipidemia-agents">ANTIHYPERLIPIDEMIA AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antihyperlipidemia-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I. Therapy for high cholesterol levels (&gt;200 mg/dl-adult) and triglyceride levels (&gt;160 mg/dl in males and &gt;135 mg/dl in females)</p>
<p>A. First line of therapy: nondrug treatment</p>
<ol>
<li>Diet management</li>
<li>Exercise program</li>
<li>Reduction of other risk factors</li>
</ol>
<p>B. Second line of therapy: treatment with medications</p>
<ol>
<li>Cholesterol-lowering agents</li>
<li>Triglyceride-lowering agents</li>
</ol>
<p>II. Cholesterol-lowering agents</p>
<p>A. Actions</p>
<ol>
<li>Bile-sequestering agents: form insoluble complexes with the bile acids in the GI tract, which causes cholesterol to replace the lost bile acids, thereby lowering the cholesterol level</li>
</ol>
<p>ANTIHYPERLIPIDEMICS: CHOLESTEROL &amp; TRIGLYCERIDE-LOWERING AGENTS ▼ 169</p>
<ol start="2">
<li>Cholesterol inhibitors: inhibit the synthesis of cholesterol and increase the excretion of cholesterol</li>
</ol>
<p>B. Uses: when dietary management does not lower cholesterol and the lower density level (LDL) cholesterol is high</p>
<p>C. Major side effects</p>
<ol>
<li>Gastrointestinal: constipation, abdominal pain, nausea, diarrhea</li>
<li>Headache</li>
<li>Hepatotoxicity</li>
<li>Alteration of prothrombin time</li>
</ol>
<p>D. Interactions: binds with other acid drugs in the GI tract and thereby reducing absorption of fat-soluble vitamins A, D, E, and K</p>
<p>E. Nursing implications</p>
<ol>
<li>Instruct the client how to mix the powder or granules in a liquid or food</li>
<li>Monitor prothrombin time (PT) monthly</li>
<li>Assess cholesterol levels frequently (at least monthly)</li>
<li>Monitor for GI distress, especially bowel elimination patterns</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Bile-sequestering agents
a. Cholestyramine (Questran)
b. Colestipol hydrochloride (Colestid)</li>
<li>Cholesterol synthesis inhibitors
a. Probucol (Lorelco)
b. Iovastatin (Mevacor)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-triglyceride-lowering-agents-fibric-acid-derivatives">III. Triglyceride-lowering agents: fibric acid derivatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-triglyceride-lowering-agents-fibric-acid-derivatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: inhibit the synthesis of cholesterol and increase the excretion of triglycerides</p>
<p>B. Uses: decrease high levels of triglycerides and lower cholesterol</p>
<p>C. Major side effects</p>
<ol>
<li>Gastrointestinal: nausea, vomiting, diarrhea</li>
<li>Cholelithiasis</li>
<li>Benign and malignant liver tumors</li>
<li>Bleeding tendencies</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Use short-term only</li>
<li>Monitor prothrombin time (PT)</li>
<li>Assess for a prior history of gallstones and liver disease</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Clofibrate (Atromid-S)</li>
<li>Gemfibrozil (Lopid)</li>
</ol>
<p>170 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Which side effect of the calcium channel blocker nicardipine hydrochloride (Cardene) would be of concern to the nurse?
a. “My mouth is so dry”
b. “I haven’t had a BM in 4 days”
c. BP 200/100
d. BP 80/50</p>
</li>
<li>
<p>What is the <em>initial</em> treatment for a client with essential hypertension?
a. A diuretic agent
b. A diuretic, low-fat diet, and exercise
c. Low-sodium diet, weight reduction, and an exercise program
d. Adrenergic blocking agent and weight reduction</p>
</li>
<li>
<p>How should the nurse respond when a client asks how a beta blocker lowers his/her BP?
a. “The drug decreases the amount of O₂ demanded by the heart”
b. “The drug dilates veins, which increases the workload of the heart”
c. “You’ll have to discuss this with your doctor”
d. “The drug slows the HR and decreases cardiac output, thereby lowering BP”</p>
</li>
<li>
<p>The drugs of choice in reducing triglycerides in clients who do not respond to dietary management are
a. Bile-sequestering agents
b. Febric acid derivatives
c. Cholesterol synthesis inhibitors
d. Bile-sequestering agents and cholesterol synthesis inhibitors</p>
</li>
<li>
<p>A loading dose of digoxin (Lanoxin) 0.5 mg PO is administered and followed by 0.25 mg PO daily. The positive inotropic and negative chronotropic effect is reflected in which of the following sets of data?
a. BP 150/70, P 92, R 24, decrease in urine output
b. BP 130/80, P 60, R 22, increase in urine output
c. BP 80/50, P 60, R 22, no effect on urine output
d. BP 80/50, P 92, R 24, decrease in urine output</p>
</li>
<li>
<p>The nurse should suspect digoxin (Lanoxin) toxicity if a client states
a. “I can’t have a BM”
b. “The lights seem very bright”</p>
</li>
</ol>
<p>REVIEW QUESTIONS ▼ 171</p>
<p>c. "I have no appetite"
d. "My BP has been elevated lately"</p>
<ol start="7">
<li>
<p>Which of the following should alert the nurse to consider digoxin (Lanoxin) toxicity?
a. K level 5.5 mEq/L
b. Na level 146 mEq/L
c. Magnesium level 1.5 mEq/L
d. K level 2.3 mEq/L</p>
</li>
<li>
<p>After administering a client his first nitroglycerin (Nitrostat) sublingual (SL), the nurse checks his blood pressure and gets 80/50. He still complains of chest pain. The nurse should
a. Give the SL nitroglycerin (Nitrostat) tablet anyway and notify the physician
b. Hold the SL nitroglycerin (Nitrostat) tablet and notify the physician
c. Apply a nitroglycerin (Transderm-Nitro) transdermal patch instead
d. Wait 5 minutes, recheck the BP, and if elevated give the NTG (Nitrostat)</p>
</li>
<li>
<p>After application of a nitroglycerin (Nitrodur) patch, which of the following would be considered a common side effect?
a. "My skin itches all over"
b. "I see halos around everything"
c. "My head is pounding"
d. "I feel tired"</p>
</li>
<li>
<p>A client is admitted with ventricular tachycardia in an emergency situation. The physician orders a bolus of lidocaine hydrochloride (Xylocaine) followed by an IV infusion of lidocaine hydrochloride (Xylocaine), Class I-B antidysrhythmic. Which of the following is true about this medication?
a. Lidocaine is the drug of choice for ventricular dysrhythmias
b. It seldom causes drowsiness and/or confusion
c. It is indicated in the above dysrhythmia and heart blocks
d. It can be mixed with epinephrine (Adrenalin) to slow the absorption</p>
</li>
<li>
<p>After several bolus doses of lidocaine hydrochloride (Xylocaine), a Class I-B drug, the ventricular tachycardia does not stop. The physician would probably try
a. Class I-C, encainide hydrochloride (Enkaid)
b. Class I-A, quinidine sulfate
c. Class II, esmolal hydrochloride (Brivibloc)
d. Class IV, verapamil hydrochloride (Isoptin)</p>
</li>
</ol>
<p>172 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<ol start="12">
<li>
<p>Which of the following is true of beta blockers?
a. They have adverse effects as orthostatic hypotension
b. They are the drugs of choice in angina
c. They increase the rate and contractility of the heart
d. They are Step 3 drugs in treating hypertension</p>
</li>
<li>
<p>If a client who experiences angina abruptly stops taking a beta blocker, which of the following might be experienced?
a. Hypertension
b. Nausea
c. Lethargy
d. Acute myocardial infarction</p>
</li>
<li>
<p>By interrupting the conversion of angiotensin I to angiotensin II, ACE inhibitors act in which of the following ways?
a. Inhibit the autonomic nervous system
b. Increase PVR
c. Increase the effect of angiotensin I
d. Decrease aldosterone release</p>
</li>
<li>
<p>A client on a routine office visit complains of chest pain every time he cuts the grass, yet he refuses to hire someone else to perform this task. The nurse should instruct the client to
a. Stop every 15 minutes while cutting the grass
b. Take a NTG (Nitrostat) if chest pain occurs
c. Take a NTG (Nitrostat) before cutting the grass and rest periodically
d. Take three NTG (Nitrostat) 5 minutes apart and then cut the grass</p>
</li>
</ol>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 173</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: d</strong></td><td></td></tr><tr><td>The dilation of coronary and peripheral arteries causes the hypotensive effect. Responses <em>a</em> and <em>c</em> are not known side effects of these agents. The side effect is hypotension.</td><td>Calcium channel blockers act on the vascular system to relax smooth muscle; thus, narrow the response to either <em>c</em> or <em>d</em>. Then reread the question about side effects. With these drugs, hypotension is more of a problem than hypertension.</td></tr><tr><td><strong>2. Correct answer: c</strong></td><td></td></tr><tr><td>Diet, weight reduction, and exercise are indicated before drug therapy. The drug in response <em>a</em> is a step II drug, which should be added to step I. Response <em>b</em> is the step II phase. Adrenergic blocking agents are step III agents.</td><td>The key words are “initial treatment.” As with most other therapies a noninvasive or more natural approach is used first. Be cautious not to read too quickly and read over the diuretic in option <em>b</em>, since the other 2 items are correct.</td></tr><tr><td><strong>3. Correct answer: d</strong></td><td></td></tr><tr><td>The decrease in cardiac output lowers the BP. In response <em>a</em> the described action is true; it explains the agent’s antianginal and antiarrhythmic effect but not the HTN effect. In response <em>b</em> the description is for the function of the nitrates. Response <em>c</em> is inappropriate.</td><td>If you have narrowed the responses to <em>a</em> or <em>d</em>, reread the question. Note that the client is taking it to decrease the BP; thus response <em>d</em> is the best.</td></tr><tr><td><strong>4. Correct answer: b</strong></td><td></td></tr><tr><td>These agents lower cholesterol and triglycerides. In responses <em>a</em>, <em>c</em>, and <em>d</em>, the agents only lower cholesterol.</td><td>If you have no idea of the correct answer cluster responses <em>a</em>, <em>c</em>, and <em>d</em> under “having an effect on cholesterol.” The only response left is <em>b</em>.</td></tr></tbody></table>
<p>174 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-b">5. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The pulse rate indicates the negative chronotropic effect, and the increase in urine indicates the positive inotropic effect. Information in option <em>a</em> indicates a negative inotropic and positive chronotropic effect. The positive inotropic effect influences the urine output. Response <em>d</em> represents an effect directly opposite of these agents.</p>
<p>A tip to recall the definitions of inotropic and chronotropic is to identify that the action is the opposite of the beginning letter of <em>Chronotropic</em>—it is not <em>Contraction</em> but rate. Then remember that the other word is the opposite—<em>Inotropic</em> = contraction. Thus response <em>b</em>, with the lower HR, will increase cardiac output, resulting in increased urine output.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-c">6. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Anorexia is a first indicator of toxicity. Diarrhea usually indicates toxicity. Halos around objects, disturbances in color vision, a yellow or a yellow-green tint to vision, and flickering lights are symptoms of toxicity. BP is usually not affected in digoxin toxicity.</p>
<p>If you have no idea of the correct answer, use the approach that most drugs cause problems with the GI tract. Narrow options to <em>a</em> and <em>c</em>. Reread each option and think that anorexia would be more of an earlier finding than constipation. Select option <em>c</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-d">7. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Potassium levels &lt;3.0 usually indicate a risk for toxicity. Hypokalemia is usually evident in digatilis toxicity. Sodium levels are usually not altered in digatilis toxicity. Hypomagnesemia is usually evident, along with a low serum potassium; normal magnesium is 1.5 to 2.5 mEq/L.</p>
<p>The first step to the correct answer is to recall that the electrolyte to associate with digoxin is potassium. Step two is to pick between a high or low potassium; it is the low potassium.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 175</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-b">8. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A form of medication other than NTG can be administered to relieve the pain; the NTG will continue to lower the BP. The second NTG will lower the BP even further. The patch has the same side effects as the SL tablet. Waiting 5 minutes with a cardiac patient with chest pain is contraindicated.</p>
<p>The critical data in the stem is that it was the “first” dose with a drastic physiologic effect, and he still has pain. The reasonable action is described in response b.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="9-correct-answer-c">9. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A headache is common because of the vasodilation properties of the drug. The patch could be irritating to the skin directly under the patch, but it is not a common finding. A yellow-green halo in the vision is a sign of digitalis toxicity. Fatigue is not a common side effect of the drug, but rather a first indication of possible heart failure.</p>
<p>The important word in the question is “common” side effect. Eliminate response a because of the words “all over.” Refer to the Rationale.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="10-correct-answer-a">10. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#10-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Lidocaine suppresses ventricular irritability and thereby stops ventricular tachycardia. Both of these findings in option b are side effects, particularly in the older adult. Lidocaine is contraindicated in heart block because of the suppressive nature of the</p>
<p>Use the true-false approach to identify the correct response.</p>
<p>176 ▼ CHAPTER 10 DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM</p>
<p>drug. Heart block could be worsened. IV lidocaine cannot be mixed with epinephrine (Adrenalin). The topical subcutaneous lidocaine injection may have epinephrine in it to cause local vasoconstriction and minimize bleeding during suturing of lacerations.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="11-correct-answer-a">11. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#11-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Class I-C drugs include flecainide and encainide, which interrupt reentry and stabilize irritable tissue. Class I-A are administered PO except for pronestyl, which can also be given by IV drip. Class II drugs are beta blockers, which are indicated for ventricular dysrhythmias once they are stabilized. Class IV are calcium channel blockers which are used for controlling ventricular “rates.”</p>
<p>This type of question may increase your anxiety. The best approach is to give it your best try and go on to the next question. Expect that you will not be familiar with all the questions on the exam. Do your favorite relaxation exercise after difficult questions like this one.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="12-correct-answer-a">12. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#12-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Hypotension can occur because of the decrease in cardiac output, which lowers BP. Nitrates are the drugs of choice in angina. Beta blockers lower the heart rate and are step 2 drugs in treating hypertension.</p>
<p>You may have narrowed the responses to either a or d. Use the approach to go with what you know and select response a rather than d.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="13-correct-answer-d">13. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#13-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>If abruptly stopped, the angina could return and cause a heart attack. Hypertension could occur, but this would</p>
<p>The approach here is to go with what you know: angina frequently precedes myocardial infarction. Select response d.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 177</p>
<p>not be the main concern unless the medication were taken for hypertension. In response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> these adverse effects are not common with beta blocker withdrawal. Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> is not a common withdrawal effect of these agents.</p>
<ol start="14">
<li>Correct answer: d</li>
</ol>
<p>A decrease in aldosterone release causes an increase in the excretion of Na and water and a decrease in preload. The autonomic nervous system is not involved with ACE inhibitors. ACE inhibitors do not directly affect preload. The ACE inhibitors inhibit the effect of angiotensin I.</p>
<p>A close reading reveals that responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> contradict this information and are thus incorrect. Next make an educated guess that response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> is correct, since this drug has specific target sites and does not involve an entire system. Refer to Box 12-2.</p>
<ol start="15">
<li>Correct answer: c</li>
</ol>
<p>Since NTG is not habit forming, taking the agent to prevent angina could help the client perform the task in combination with appropriately spaced rest periods. Short rest periods in option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> would be advisable but may not by themselves relieve the angina. This action in option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> treats the pain, but prevention of angina is the better action. Three NTG may not be indicated or needed for the prevention of angina. Clients have individual needs established over time.</p>
<p>Cluster options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>, and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> as single actions. Select option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> which combines choices from the other selections.</p>
<p>^{}[]</p>
<p>179</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-renal-system">Drugs Affecting the Renal System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-renal-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Differentiate between the various groups of diuretic agents.</li>
<li>Identify the action and major side effects of diuretic agents.</li>
<li>Discuss nursing implications concerning clients taking diuretic agents.</li>
</ul>
<p>CHAPTER
11</p>
<p>180 ▼ CHAPTER 11 DRUGS AFFECTING THE RENAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Diuretic</strong>
A drug that promotes diuresis, the formation and excretion of urine.</p>
<p><strong>Edema</strong>
The abnormal accumulation of fluid in interstitial spaces of tissues.</p>
<p><strong>Pitting edema</strong>—most common bilaterally in the feet and ankles from right-sided heart failure or unilaterally from venous congestion or blockage of lymphatic vessels from malignant diseases.</p>
<p><strong>Anasarca</strong>—a generalized, massive edema often observed with renal disease or low serum albumin levels when fluid retention continues for an extended period of time.</p>
<p><strong>Periorbital edema</strong>—edema located in the area surrounding the socket of the eye, and is most commonly an initial sign in children with nephrosis, also called nephrotic syndrome.</p>
<p><strong>Hyperkalemia</strong>
Serum potassium levels &gt;5.0 mEq/L; a major threat in renal failure or with the diuretic, aldactone, which inhibits the function of aldosterone to reabsorb sodium in the distal renal tubule. Consequently sodium is lost into the urine and potassium is reabsorbed into the blood stream.</p>
<p><strong>Hyperpyrexia</strong>
An extremely high temperature elevation, which can occur in acute infections, especially in the kidney infections of pediatric clients.</p>
<p><strong>Hypochloremic alkalosis</strong>
A metabolic disorder resulting from increased blood bicarbonate secondary to the loss of chloride from the body; not uncommon in diuretic therapy with lasix or bumex.</p>
<p><strong>Hypokalemia</strong>
A serum potassium level &lt;3.5 mEq/L.</p>
<p><strong>Hypomagnesemia</strong>
A serum magnesium level &lt;1.5 mEq/L; both low potassium and magnesium are major threats with thiazide diuretics, Hydrochlorothiazide (Hydrodiuril), or loop diuretics, furosimide (Lasix), bumetanide (Bumex); if client is hypomagnesemic and hypokalemic and on digoxin, an increased risk of digoxin toxicity occurs.</p>
<p><strong>Renal failure</strong>
Inability of the kidneys to excrete wastes, concentrate urine, and conserve electrolytes. The diagnostic test is an elevated serum creatinine level.</p>
<p>DIURETICS: THIAZIDE, THIAZIDE-LIKE AGENTS ▼ 181</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diuretics">DIURETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-major-classifications">I. Major classifications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-major-classifications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Thiazide and thiazide-like agents
B. Loop diuretics
C. Potassium sparing
D. Carbonic anhydrase inhibitors
E. Osmotic agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-thiazide-and-thiazide-like-agents">II. Thiazide and thiazide-like agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-thiazide-and-thiazide-like-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: inhibit sodium and chloride reabsorption in the distal tubule and lower peripheral vascular resistance (PVR)</p>
<p>B. Uses</p>
<ol>
<li>Hypertension</li>
<li>Edematous states associated with the following
a. Congestive heart failure (CHF)
b. Pregnancy
c. Kidney failure
d. Liver disease</li>
<li>Decreased urine output in diabetics</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Orthostatic hypotension</li>
<li>Electrolyte imbalance: hypokalemia</li>
<li>Anorexia, nausea, vomiting</li>
<li>Glucose intolerance: high glucose levels</li>
<li>Dry mouth, thirst</li>
</ol>
<p>D. Interactions</p>
<ol>
<li>Decreased excretion of lithium, which could cause toxicity</li>
<li>Increased dysrhythmias with digitalis in the presence of hypokalemia</li>
<li>Increased potassium loss with corticosteroids and some penicillins</li>
<li>Orthostatic hypotension if taken with alcohol or other antihypertensives</li>
<li>Hyponatremia and hyperglycemia, which may be caused by oral hypoglycemics and insulin</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>See general nursing implications at the end of this chapter</li>
<li>Check for allergies to sulfonamides</li>
</ol>
<p>182 ▼ CHAPTER 11 DRUGS AFFECTING THE RENAL SYSTEM</p>
<ol start="3">
<li>Monitor glucose and potassium levels</li>
<li>Monitor closely in the presence of renal or liver dysfunction</li>
</ol>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Chlorothiazide (Diuril)—clue: remember, <em>Diuril</em> acts in the <em>distal tubule</em></li>
<li>Hydrochlorothiazide (Esidrix, HydroDiuril)</li>
</ol>
<p><strong>II. Loop diuretics (potent diuretics)</strong></p>
<p><strong>A. Actions:</strong> block the reabsorption of Na in the loop of Henle, the ascending loop where the greatest Na reabsorption normally occurs; also reduce preload and afterload</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Edema: congestive heart failure, renal or hepatic dysfunction</li>
<li>Hypertension (HTN)</li>
<li>Whenever a more potent diuretic is needed</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Increased electrolyte depletion because of potency</li>
<li>Excessive diuresis (urination), which could lead to circulatory collapse</li>
<li>High doses: transient hearing loss, abdominal pain</li>
<li>Leukopenia: abnormal decrease in white blood cells to &lt;5000/cm³</li>
<li>Thrombocytopenia: reduction in platelets to &lt;150,000/mm³</li>
<li>Postural hypotension</li>
</ol>
<p><strong>D. Interactions</strong></p>
<ol>
<li>Hypotension with alcohol</li>
<li>Toxicity with lithium</li>
<li>Gastrointestinal (GI) bleeding with anticoagulants</li>
<li>Toxicity with digitalis</li>
<li>Hyponatremia with oral hypoglycemics</li>
<li>Hypotension with nonsteroidal antiinflammatory drugs</li>
</ol>
<p><strong>E. Nursing implications</strong></p>
<ol>
<li>See general nursing implications at the end of this chapter</li>
<li>Schedule the last dose early enough to prevent nocturia</li>
<li>Avoid if client becomes anuric</li>
<li>Assess for allergy to sulfonamides</li>
<li>Give IM route by Z-track method because of pain at injection site</li>
<li>Teach the client to do the following
a. Consume K⁺ rich foods (Box 11-1)
b. Report muscle cramps, which are usually in calves of legs (especially at night)
c. Take tablets that change color, since they are still effective</li>
</ol>
<p>DIURETICS: LOOP, POTASSIUM SPARING ▼ 183</p>
<ol start="7">
<li>Assess for signs of dehydration, especially in older adults</li>
<li>Caution client about switching brands without physician consent; this may change bioavailability and the clinical effects</li>
</ol>
<p>F. <strong>Common drugs</strong></p>
<ol>
<li>Furosemide (Lasix); clue: <em>Lasix—remember loop diuretic and the way it acts in ascending loop</em></li>
<li>Ethacrylate sodium (Edecrin)</li>
<li>Bumetanide (Bumex)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-potassium-sparing-agents">IV. Potassium sparing agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-potassium-sparing-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit the pump mechanism that normally exchanges potassium for sodium in the distal convoluted tubule. Spironolactone (Aldactone) antagonizes aldosterone, which mediates Na⁺ and K⁺ exchange. This mechanism reduces Na reabsorption while retaining K⁺. The other drugs within this class produce the same effects as spironolactone (Aldactone) but do not depend on aldosterone.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-11-1-dietary-consideration-potassium-sources">Box 11-1. Dietary Consideration: Potassium Sources<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-11-1-dietary-consideration-potassium-sources" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Some drugs, especially the loop and thiazide diuretics, steroids, amphotericin B, cause excessive loss of potassium, resulting in hypokalemia which may go unnoticed but in severe cases may contribute to toxicity from other drugs, as well as cardiac toxicity. Good dietary sources of Potassium include:</p>
<ul>
<li>Citrus fruits and juices</li>
<li>Bananas, watermelon</li>
<li>Grape, cranberry, apple, pear, and apricot juices</li>
<li>Cereals</li>
<li>Leafy vegetables</li>
<li>Meat, fish, and fowl</li>
<li>Salt substitutes (read label)</li>
<li>Coffee, tea, and cola beverages</li>
<li>Nuts and Peanut butter</li>
</ul>
<p>Some sources of potassium may be contraindicated in persons who must also limit sodium intake. Licorice can cause potassium excretion and should be avoided by patients experiencing hypokalemia.</p>
<p>Clark J, Queener, S, &amp; Karb V: <em>Pharmacologic basis of nursing practice</em>, ed 4, St Louis, 1993, Mosby.</p>
<p>184 ▼ CHAPTER 11 DRUGS AFFECTING THE RENAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Edema</li>
<li>Diuretic-induced hypokalemia</li>
<li>Hyperaldosteronism: hypersecretion of aldosterone</li>
<li>Steroid-induced edema</li>
<li>In combination with other potassium-losing diuretics</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hyperkalemia if used alone and with high-potassium diet or potassium supplements</li>
<li>Hypotension</li>
<li>GI upset: nausea, vomiting, diarrhea, abdominal cramps</li>
<li>Weakness, fatigue</li>
<li>Paresthesia of hands and feet; numbness or tingling</li>
<li>Megaloblastic anemia</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-interactions">D. Interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hyperkalemia with K⁺ supplements</li>
<li>Toxicity with lithium</li>
<li>Nephrotoxicity with indocin</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>See general nursing implications at the end of this chapter</li>
<li>Teach that high-potassium diet is contraindicated</li>
<li>Monitor other medications for potassium sources</li>
<li>Frequently monitor complete blood count (CBC)</li>
<li>Teach the client the symptoms of hyperkalemia and to report these as soon as noticed</li>
<li>Keep tablets stored in a dark container</li>
<li>Assess K⁺ levels closely if patient is receiving blood. Blood can contain &gt;30 mEq of K⁺/liter when stored.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Spironolactone (Aldactone)</li>
<li>Amiloride hydrochloride (Midamor)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-carbonic-anhydrase-inhibitors-weak-diuretics">V. Carbonic anhydrase inhibitors (weak diuretics)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-carbonic-anhydrase-inhibitors-weak-diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="13fed927">A. Actions: inhibit the enzyme carbonic anhydrase, which prevents the secretion of hydrogen ions and causes an alkaline urine. The Na⁺ is excreted along with the bicarbonate.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#13fed927" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Glaucoma: lower intraocular pressure (internal pressure of the eye)</li>
<li>Edema</li>
<li>Premenstrual control</li>
<li>To alkalinize the urine in overdose</li>
<li>As anticonvulsant</li>
</ol>
<p>DIURETICS: CARBONIC ANHYDRASE INHIBITORS, OSMOTICS ▼ 185</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Electrolyte imbalance</li>
<li>Hemolytic anemia</li>
<li>Frequent moderate headaches</li>
<li>Nervousness, depression, malaise</li>
<li>Nausea, vomiting, anorexia</li>
<li>Hyperglycemia</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-interactions-are-limited-but-include-increased-effect-of-amphetamines-and-toxicity-of-salicylates">D. Interactions are limited but include increased effect of amphetamines and toxicity of salicylates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-are-limited-but-include-increased-effect-of-amphetamines-and-toxicity-of-salicylates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>See general nursing implications at the end of this chapter</li>
<li>Assess for allergy to sulfonamides</li>
<li>Monitor glucose, electrolytes, and CBC levels</li>
<li>Do not mix with fruit juices; use honey or syrup to disguise the bitter taste</li>
<li>Avoid IM due to pain</li>
<li>Administer with antacids to lower GI distress</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="f-common-drug-acetazolamide-diamox">F. Common drug: acetazolamide (Diamox)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drug-acetazolamide-diamox" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-osmotics">VI. Osmotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-osmotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-increase-osmotic-pressure-which-decreases-water-reabsorption">A. Action: increase osmotic pressure, which decreases water reabsorption<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-increase-osmotic-pressure-which-decreases-water-reabsorption" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Prevent oliguria in acute renal failure</li>
<li>Lower intracranial pressure in Cerebral edema</li>
<li>Lower intraocular pressure</li>
<li>Lower pressure in cerebral spinal fluid</li>
<li>Treat certain drug intoxications</li>
<li>Emergency management of any of the above</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Transient expansion of plasma volume, which can lead to circulatory overload; increased blood volume, which can lead to heart failure or pulmonary edema</li>
<li>Rebound intracranial pressure 8 to 12 hours after initial diuresis</li>
<li>Irritation at IV site, including sloughing of tissue</li>
<li>Headache (cerebral dehydration)</li>
<li>Thrombophlebitis: inflammation of a vein</li>
<li>Electrolyte imbalance</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Contraindication with acute renal failure, CHF, intracranial hemorrhage, pregnancy, or severe dehydration</li>
<li>Monitor urinary output closely: should be &gt;50 ml/hr with therapy</li>
<li>Monitor electrolytes and blood urea nitrogen (BUN)</li>
</ol>
<p>186 ▼ CHAPTER 11 DRUGS AFFECTING THE RENAL SYSTEM</p>
<ol start="4">
<li>Assess IV site frequently during administration; avoid extravasation</li>
<li>Warm mannitol (Osmitrol) vial or bottle under hot water and shake vigorously if crystallized</li>
<li>Do not mix with blood products or other drugs</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Mannitol (Osmitrol)</li>
<li>Isosorbide (Ismotic)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="vii-general-nursing-implications-for-all-diuretics">VII. General nursing implications for all diuretics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-general-nursing-implications-for-all-diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Assess weight (gain or loss) at the same time each day in the same clothes
B. Monitor I&amp;O carefully
C. Monitor food consumption and offer instructions according to K⁺ rich or K⁺ sparing foods (see Box 11-1)
D. Avoid all alcohol products because of diuretic effect and lowering of BP
E. Assess for findings of hypokalemia and hyperkalemia. Monitor electrolyte levels.
F. Administer early in the day to avoid nocturia (9 A.M. and 5 P.M. if ordered BID)
G. Limit Na⁺ if used for hypertension
H. Monitor pulse and BP; caution client about rising too abruptly to avoid orthostatic hypotension
I. Instruct the client in the signs of decreasing effectiveness: weight gain, edema, coughing
J. Instruct client to take with or after meals if GI distress occurs. Caution the client that nausea and vomiting may be indicative of electrolyte disturbance.
K. Diuretics are sometimes abused by overweight clients
L. Older adults may need lower doses and dietary counseling, as well as accurate assessment of BP and electrolytes</p>
<p>REVIEW QUESTIONS ▼ 187</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Administering furosemide (Lasix), a loop diuretic, too fast IVP could result in which of the following?
a. Hypertension
b. Permanent hearing loss
c. Transient hearing loss
d. Hyperkalemia</p>
</li>
<li>
<p>While on a potassium sparing diuretic—spironolactone (Aldactone)—a client should be instructed to avoid which foods?
a. Bananas, meat, peanut butter
b. Fish, red beans, bread
c. Carrots, green beans, apple juice
d. Tomato juice, potatoes, beets</p>
</li>
<li>
<p>When a client received a daily Aldactone and 3 units of packed red blood cells (RBC), the nurse would be most concerned with which of the following?
a. Potassium level of 2.3 mEq/L
b. Magnesium level of 1.5 mEq/L
c. Sodium level of 145 mEq/L
d. Potassium level of 5.8 mEq/L</p>
</li>
<li>
<p>A client, age 39, is diagnosed with glaucoma and can no longer drive his eighteen wheeler. His physician would most likely place him on which of the following diuretics?
a. Thiazide: hydrochlorothiazide (Hydrodiuril)
b. Loop: bumetanide (Bumex)
c. Carbonic anhydrase inhibitor: acetazolamide (Diamox)
d. Potassium sparing: spironolactone (Aldactone)</p>
</li>
<li>
<p>When preparing to give mannitol (Osmotrol), the nurse notices crystals in the ampule. The nurse should
a. Return the ampule to the pharmacy
b. Hold the ampule under cold tap water
c. Hold the ampule under warm tap water
d. Shake vigorously</p>
</li>
</ol>
<p>188 ▼ CHAPTER 11 DRUGS AFFECTING THE RENAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>Temporary hearing loss may be experienced. Hearing loss is a temporary side effect and may be due to a high dose or if administered too fast. Postural hypotension is a side effect. Hypokalemia is a side effect.</td><td>An approach is to cluster responses <em>a</em> and <em>d</em> under “Hyper” and eliminate. Then decide between responses <em>b</em> and <em>c</em>. Select response <em>c</em> based on knowledge that effects of drugs are more commonly transient than permanent.</td></tr><tr><td><strong>2. Correct answer: a</strong></td><td></td></tr><tr><td>All these foods are high in potassium. In response <em>b</em> only fish is high in potassium. In response <em>c</em> only apple juice is high in potassium. Tomato juice is high in sodium and potassium.</td><td><em>Go with what you know.</em> If you only identified that bananas and peanut butter are high in potassium, select that response. It is not advisable to select a response you do not know much about.</td></tr><tr><td><strong>3. Correct answer: d</strong></td><td></td></tr><tr><td>Potassium is not lost while a client is on a potassium-sparing diuretic, and stored blood can be high in potassium. Both the drug and the blood would raise the potassium level; aldactone is the potassium-sparing diuretic. Magnesium level should not be affected. Sodium level should not be affected.</td><td><em>Go with what you know:</em> the more units of blood given, the higher the risk of increasing potassium. Add to that the type of medication, and there is double jeopardy for the client.</td></tr><tr><td><strong>4. Correct answer: c</strong></td><td></td></tr><tr><td>Carbonic anhydrase inhibitors are used primarily to lower intraocular pressure in</td><td>An approach is to cluster responses <em>a</em>, <em>b</em>, and <em>d</em> under “common diuretics for heart failure or fluid</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 189</p>
<p>glaucoma. Thiazides are not recommended for glaucoma. Loop diuretics are extremely potent and not recommended for glaucoma. Aldactone is not recommended for glaucoma.</p>
<p>overload”; the one left, option c, must be used for the eyes.</p>
<ol start="5">
<li>Correct answer: c</li>
</ol>
<p>Warm tap water will dissolve the crystals so the drug can be used. Crystals form in the syringe while the drug is stored. The nurse can easily prepare the medicine. Cold water will not dissolve the crystals. Shaking the syringe will not dissolve the crystals.</p>
<p>An approach is to use common sense as to what dissolves substances. If in an emergency situation, get another ampule without crystals from pharmacy. Returning the ampule to pharmacy is an incomplete answer. Avoid reading into the response that option a also means to obtain a new ampule.</p>
<p>^{}[]</p>
<p>191</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-hematologic-system">Drugs Affecting the Hematologic System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-hematologic-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the groups of drugs that affect coagulation and anemia.</li>
<li>Describe specific actions of anticoagulants and thrombolytics.</li>
<li>Describe nursing implications for safe administration of these agents.</li>
<li>Identify hematinic agents used to treat anemia.</li>
</ul>
<p>192 ▼ CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Activated Partial Thromboplastin Time (APTT)</strong>
A test for detecting coagulation defects of the intrinsic system; used to monitor <strong>heparin</strong> activity.</p>
<p><strong>Anticoagulant</strong>
A substance that prevents or delays coagulation of the blood, such as Heparin. Heparin interferes with: (1) the formation of thromboplastin, the conversion of prothrombin to thrombin and (2) the formation of fibrin from fibrinogen. Coumarin—a Vitamin K antagonist, inhibits the formation of vitamin K-dependent clotting factors.</p>
<p><strong>Hematuria</strong>
The abnormal presence of blood in the urine, which may occur with too high of doses of anticoagulants.</p>
<p><strong>Hemophilia</strong>
A group of hereditary bleeding disorders in which there is a deficiency in one of the factors necessary for coagulation of blood. Hemophilia A (classic) is a deficiency or absence of factor VIII; Hemophilia B (Christmas disease) is a deficiency of the thromboplastin component.</p>
<p><strong>Hemorrhage</strong>
Loss of a large amount of blood in a short period of time, either internal or external, and from arterial, venous, or capillary sites.</p>
<p><strong>Hemostatic</strong>
Pertaining to a procedure or substance that arrests the flow of blood.</p>
<p><strong>Prothrombin Time (PT)</strong>
A test for detecting plasma coagulation defects caused by a deficiency of factors V, VII, and X; used to monitor <strong>coumarin</strong> activity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anticoagulants">ANTICOAGULANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anticoagulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-oral-anticoagulants">I. Oral anticoagulants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-oral-anticoagulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit blood clotting by depressing synthesis of factors VII, IX, X, thereby preventing utilization of vitamin K by the liver</p>
<p>B. Uses</p>
<ol>
<li>Slow down or prevent the extension of a blood clot
a. Deep vein thrombosis (DVT)
b. Pulmonary embolism</li>
</ol>
<p>ANTICOAGULANTS: ORAL ▼ 193</p>
<p>c. Coronary artery disease (CAD)
d. Atrial fibrillation
e. Cardiovascular thrombosis</p>
<ol start="2">
<li>Rheumatic heart disease</li>
<li>Prophylactically
a. Major surgery
b. Periods of prolonged immobilization when coagulation complications are possible</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>
<p>Greater incidence of bleeding than with parenteral anticoagulants
a. Hematuria: blood in the urine
b. Epistaxis: nose bleed
c. Ecchymosis: bruising
d. Tarry stools: black, sticky
e. Bleeding gums</p>
</li>
<li>
<p>Leukopenia, agranulocytosis</p>
</li>
<li>
<p>Hypersensitivity</p>
</li>
<li>
<p>GI upset: diarrhea, nausea, vomiting</p>
</li>
</ol>
<p>D. Interactions</p>
<ol>
<li>Increased effect with glucocorticoids, acetylsalicylic acid (aspirin), alcohol, and antibiotics</li>
<li>Decreased effect with barbiturates, estrogens, and oral contraceptives</li>
<li>Contraindicated in pregnancy or conditions in which hemorrhage is possible</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>Assess for bleeding</li>
<li>Monitor the prothrombin time (PT), which is normally 11 to 12.5 seconds. The PT can be maintained at 1.5 to 2.0 times the control for a therapeutic effect; for example, a range from 18 to 26 seconds is therapeutic. A physician may adjust the dose to maintain the PT at 2.0 to 2.5 times the control to reach the desired results of the agent. Careful monitoring for bleeding is necessary when the PT values are greater than 2.0 times the control. Note that each laboratory has established controls.</li>
<li>Give by mouth only; may be started while parenteral form is infusing. Use extreme caution to monitor for bleeding. Takes 2 to 3 days to reach therapeutic levels.</li>
<li>Instruct the clients to do the following
a. Protect themselves from excessive bruising or cuts. Use an electric razor and a soft toothbrush.</li>
</ol>
<p>CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<p>b. Wear a medical alert bracelet
c. Consult a physician before taking any OTC drugs
d. Avoid foods high in vitamin K such as green leafy vegetables, tomatoes, fish, liver, cheese, egg yolks, and red meats. A food-to-drug interaction could occur and increase the coagulation due to a decrease in the drug's effectiveness.
e. Avoid acetylsalicylic acid (aspirin and aspirin products)
f. Report any excess bruising, red urine, tarry stools
g. Take bleeding precautions for 9 to 10 days after the last dose of the drug</p>
<ol start="5">
<li>Have vitamin K (AquaMephyton) available as an antidote. Vitamin K activates the precursors in the liver needed for clotting.</li>
<li>Monitor the client's medication record sheet for the following
a. Acetylsalicylic acid (aspirin) and aspirin products. Pay particular attention to pain relievers.
b. Avoid IM injections if possible. If used, hold pressure for several minutes after the injection.</li>
<li>Since anticoagulants are highly protein bound, if a therapeutic effect is not seen, closely observe the other medications prescribed or the client's protein level</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Warfarin sodium (Coumadin)</li>
<li>Dicumarol (Bishydroxycoumarin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-parenteral-anticoagulants">II. Parenteral anticoagulants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-parenteral-anticoagulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: combine with antithrombin III to retard thrombin activity
B. Uses</p>
<ol>
<li>Short-term or emergency treatment</li>
<li>All of the situations listed for oral anticoagulants</li>
<li>Myocardial infarction (MI)</li>
<li>Postcoronary artery bypass surgery</li>
<li>Hemodialysis</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Hemorrhage (same as with oral products)</li>
<li>Heparin-induced thrombosis: white clot syndrome</li>
<li>Thrombocytopenia: decreased platelets &lt;150,000/mm³</li>
</ol>
<p>D. Interactions</p>
<ol>
<li>Increased effect with acetylsalicylic acid (aspirin), alcohol, antibiotics</li>
<li>Decreased effect with nitroglycerin products, digoxin (Lanoxin), antihistamines</li>
</ol>
<p>ANTICOAGULANTS: PARENTERAL; THROMBOLYTICS ▼ 195</p>
<ol start="3">
<li>Contraindicated in ulcers or situations threatening hemorrhage, liver, and renal disease</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>Assess for bleeding</li>
<li>Know proper application for SC or IV route</li>
<li>Always keep continuous IV administration on a controller pump</li>
<li>Monitor the activated partial thromboplastin time (APTT), which is normally 30 to 40 seconds. Should be maintained at 1.5 to 2.0 times the control for a therapeutic effect; for example, a therapeutic range is from 60 to 80.</li>
<li>Rotate sites for SC; do not rub the injection site</li>
<li>Let other disciplines know that patient is taking heparin</li>
<li>Have protamine sulfate available as an antidote</li>
<li>Instruct the client to avoid falls or abrasions to the skin, and to use caution with sharp utensils while eating. The physician should be consulted concerning the use of razors. Usually electric or battery-operated razors are preferred.</li>
<li>Monitor the medication record (same as with oral products)</li>
<li>Monitor the complete blood count (CBC)</li>
<li>Instruct the patient to report any signs of bleeding</li>
</ol>
<p>F. Common drug: heparin sodium (Liquaemin)</p>
<p>THROMBOLYTIC AGENTS</p>
<p>I. Thrombolytic agents
A. Actions: dissolve the clot by converting plasminogen to plasmin, which lyses the thrombi and fibrinogen
B. Uses</p>
<ol>
<li>Acute thromboembolic disorders</li>
<li>Pulmonary embolus</li>
<li>Deep vein thrombosis (DVT)</li>
<li>Myocardial infarction (MI)</li>
<li>Arterial or coronary thrombosis</li>
<li>Thrombi in parenteral cannulas
C. Major side effects</li>
<li>Hemorrhage</li>
<li>Allergic reaction: usually with streptokinase only</li>
<li>Febrile reaction</li>
<li>Dysrhythmias and chest pain</li>
<li>Reocclusion: occlusion of a vessel that had been opened
D. Interactions: increased tendency to bleed with any drug that alters coagulation or platelets. Contraindicated in</li>
</ol>
<p>CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<p>hemophilia, intracranial disorders, recent gastrointestinal bleeds, uncontrolled hypertension, high-risk situations for hemorrhage, or clients who bruise easily.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Monitor bleeding closely, especially during the loading dose period</li>
<li>Know how to mix properly for IV administration. Many of these agents are expensive. IV bags that are mixed should be used within 24 hours. Carefully calculate the dosage.</li>
<li>Administer with a controller pump, minidrip, and filter</li>
<li>Alert all other disciplines that these agents were infused; post sign on client door, on chart, or over bed if possible</li>
<li>Check with physician about all acetylsalicylic acid (aspirin) and aspirin products</li>
<li>Monitor the PT, APTT, and CBC</li>
<li>Assess the client for reperfusion dysrhythmias; reoccurrence of angina may indicate reocclusion</li>
<li>Hold excess pressure for 5 to 10 minutes on all discontinued IV sites</li>
<li>Have the antifibrinoltic agent—aminocaproic acid (Amicar)—available as an antidote</li>
<li>Follow same safety measures for the client as with anticoagulants</li>
<li>Monitor the client carefully for hemorrhage for 24 to 48 hours. These agents have a short half-life, but bleeding risk may persist for 24 hours after infusion.</li>
<li>Know that Benadryl or Solu-Cortef may be given before streptokinase to prevent allergic reactions</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Streptokinase (Streptase)</li>
<li>Alteplase (Activase), known as t-PA</li>
<li>Urokinase (Abbokinase)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-agents">OTHER AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-antiplatelet-agents">I. Antiplatelet agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antiplatelet-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: interfere or inhibit the adherence of platelets to exposed collagen at sites of vascular injury; hinders platelet aggregation</p>
<p>B. Uses</p>
<ol>
<li>Cerebral vascular accidents (CVA)</li>
<li>Myocardial infarction</li>
</ol>
<p>C. Side effects differ and are specific to the drug</p>
<p>ANTIPLATELET, HEMOSTATIC, AND HEMATINIC (IRON PRODUCTS) AGENTS ▼ 197</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-common-drugs">D. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Acetylsalicylic acid (Aspirin)</li>
<li>Dipyridamole (Persantine)</li>
<li>Ticlopidine (Ticlid)</li>
<li>Sulfinpyrazone (Anturane)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-hemostatic-agents">II. Hemostatic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-hemostatic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions-hasten-clotting-of-blood-by-inhibiting-the-substances-that-activate-plasminogen-and-inhibit-plasmin">A. Actions: hasten clotting of blood by inhibiting the substances that activate plasminogen and inhibit plasmin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-hasten-clotting-of-blood-by-inhibiting-the-substances-that-activate-plasminogen-and-inhibit-plasmin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Stop bleeding during surgery</li>
<li>Stop bleeding in emergencies</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects-minimal-and-depend-on-whether-used-topically-or-systemically-hypotension-is-the-most-common">C. Major side effects: minimal and depend on whether used topically or systemically. Hypotension is the most common.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects-minimal-and-depend-on-whether-used-topically-or-systemically-hypotension-is-the-most-common" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications-depend-on-the-agent">D. Nursing implications: depend on the agent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications-depend-on-the-agent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Know how to administer or mix the drug</li>
<li>Assess for cessation of bleeding</li>
<li>Some agents may be left in the wound (Gelfoam) and are self-absorbing. Others will not absorb (oxidized cellulose).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Vitamin K (AquaMephyton)</li>
<li>Aminocaproic acid (Amicar)</li>
<li>Gelfoam, Gelfilm: absorbable gelatin sponge or film</li>
<li>Thrombin (Thrombostat)</li>
<li>Oxidized cellulose (Surgicel)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hematinic-agents">HEMATINIC AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hematinic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-iron-products">I. Iron products<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-iron-products" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions-replace-the-depleted-iron-stores-and-raise-the-iron-in-hemoglobin">A. Actions: replace the depleted iron stores and raise the iron in hemoglobin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-replace-the-depleted-iron-stores-and-raise-the-iron-in-hemoglobin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Iron deficiency anemia</li>
<li>Premature infants</li>
<li>Pregnant females</li>
<li>Lactating females</li>
<li>Bleeding disorders</li>
<li>Menses with heavy blood loss</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>GI upset (most common): anorexia, nausea, vomiting, diarrhea, constipation</li>
<li>Dark, tarry stools—black or dark-green</li>
</ol>
<p>CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<ol start="3">
<li>Potential for staining of the teeth and the skin with administration</li>
<li>Iron poisoning in children: vomiting, bloody diarrhea, cyanosis, gastric and intestinal pain</li>
<li>Pain and soreness if given IM</li>
</ol>
<p>D. Interactions</p>
<ol>
<li>Increased absorption with ascorbic acid (vitamin C)</li>
<li>Decreased absorption with antacids, tetracyclines, milk</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>If given IM, use Z-track method. Intramuscular injections can stain the skin and be extremely painful.</li>
<li>Take PO form before or after eating</li>
<li>Instruct client on foods high in iron. Refer to nursing implications under vitamin  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="bold">B</mi><mn>12</mn></msub></mrow><annotation encoding="application/x-tex">\mathbf{B}_{12}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8361em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathbf">B</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">12</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span></li>
<li>Sip iron liquids through a straw to prevent staining teeth</li>
<li>Instruct client about bloody stools, which are abnormal. Darker, tarry stools are normal.</li>
<li>Monitor a complete blood count (CBC)</li>
<li>Teach clients the symptoms of accidental poisoning: lethargy, nausea, vomiting, abdominal pain, diarrhea, convulsions, pallor, or cyanosis</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Ferrous sulfate (Feosol, Fer-Iron)</li>
<li>Ferrous gluconate (Fergon)</li>
<li>Iron dextran (Imferon)</li>
<li>Ferrous fumarate (Feostat)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3171e7c3">II. Hydroxocobalamin (vitamin  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="bold">B</mi><mn>12</mn></msub></mrow><annotation encoding="application/x-tex">\mathbf{B}_{12}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8361em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathbf">B</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">12</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> )<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3171e7c3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: replaces  <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="bold">B</mi><mn>12</mn></msub></mrow><annotation encoding="application/x-tex">\mathbf{B}_{12}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8361em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathbf">B</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">12</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span>  not found in diet. Essential for cell growth and the nervous system.
B. Uses: treats megaloblastic anemia—a hemolytic disorder characterized by the production and peripheral proliferation of immature, large, dysfunctional erythrocytes; these megaloblasts are usually associated with severe pernicious anemia or folic acid deficiency anemia
C. Major side effects</p>
<ol>
<li>Hypersensitivity</li>
<li>Hematologic reactions</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Available in injectable form only because gastrointestinal absorption depends on an intrinsic factor in the gastric mucosa</li>
<li>Monitor folate levels; large doses mask folate deficiency</li>
</ol>
<p>HEMATINICS: VITAMIN B₁₂ AND B₉ (FOLIC ACID) ▼ 199</p>
<ol start="3">
<li>Stress compliance: monthly injections are usually required for life</li>
<li>Dietary teaching
a. Consume foods high in iron if intrinsic factor available from parietal cells in stomach: egg yolks, wheat germ, fish, fowl, cereal grains, beans, and green leafy vegetables
b. Avoid foods low in iron: milk, vegetables that are not green and leafy</li>
<li>Should be used cautiously in pregnant and lactating females</li>
<li>Cimetidine (Tagamet) impairs absorption</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="52704e58">III. Folic acid (vitamin B₆)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#52704e58" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: required for normal erythrocyte production and growth
B. Uses</p>
<ol>
<li>Folic acid anemia (megaloblastic anemia)</li>
<li>Prophylactically
a. Pregnancy
b. Alcoholism
c. Renal disease
d. Liver disease
C. Major side effect: allergic responses
D. Interactions: decreased metabolism with anticonvulsants or contraceptives
E. Nursing implications</li>
<li>Dietary teaching</li>
<li>Monitoring for B₁₂ deficiency, which may be masked</li>
</ol>
<p>200 ♥ CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>A client is on warfarin sodium (Coumadin) every day at 9 A.M. Her laboratory work comes back with her PT four times the control. The nurse notices that the client's laboratory work was within normal limits the day before. The nurse's first action would be to
a. Call the physician
b. Call the physician and prepare vitamin K
c. Check when the laboratory work was drawn
d. Call the laboratory to draw another level</p>
</li>
<li>
<p>A client has heparin sodium (Liquaemin) infusing IV for a deep vein thrombosis. The physician orders the dose to be lowered and starts him on warfarin sodium (Coumadin) 5 mg PO q day. Why should the nurse be concerned about bleeding?
a. Heparin sodium (Liquaemin) is a potent anticoagulant, and bleeding potential is high
b. Warfarin sodium (Coumadin) has a greater risk of bleeding than heparin sodium (Liquaemin) does
c. The warfarin sodium (Coumadin) dose is too high
d. Heparin sodium (Liquaemin) has a short half-life, but the bleeding tendencies last beyond the half-life</p>
</li>
<li>
<p>At 4 A.M., a client, who is on a heparin drip and has the initial dose of Coumadin given at 5 P.M. the previous day, notices oozing of blood from the IV site and at the site where the lab drew blood at 7 A.M. the previous day. The nurse would expect the physician to order which of the following?
a. Aminocaproic acid (Amicar)
b. Protamine sulfate
c. Vitamin K (AquaMephyton)
d. Hydroxocobalamin (vitamin B₁₂)</p>
</li>
<li>
<p>A client is diagnosed with a coronary thrombosis after a heart catheterization. The physician plans to infuse alteplase (t-PA) to prevent a myocardial infarction. This medicine exerts its fibrinolytic action by
a. Preventing the utilization of vitamin K
b. Retarding the extension of the clot
c. Using hemostatic action
d. Retarding thrombin formation and lysing the clot</p>
</li>
</ol>
<p>REVIEW QUESTIONS ▼ 201</p>
<ol start="5">
<li>Discharge instructions for a client going home on warfarin sodium (Coumadin) 10 mg PO q day would be which of the following?</li>
</ol>
<p>a. Eat plenty of foods rich in vitamin K
b. If bruising is noted, stop taking the medicine and call the physician
c. Wear a medical alert bracelet and use caution with sharp instruments
d. Report to the physician as ordered for a CBC</p>
<p>CHAPTER 12 DRUGS AFFECTING THE HEMATOLOGIC SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>The lab work could have been drawn after the 9 A.M. dose, especially since the value for the previous day was normal. A registered nurse would be expected to investigate the time the lab work was drawn. The physician would need to be notified if this value was drawn at the proper time. Vitamin K would be needed if bleeding were to occur. The nurse would first need to check with the physician prior to any medication change.</td><td>An approach to the evaluation of serum levels after medication administration is to investigate when the blood sample was drawn in relation to when the medication was given. Select response c.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>Coumadin does have a greater potential for bleeding than heparin. Also, the coumadin dose will be increased while the heparin dose is decreased. Response a is correct; however, note that the heparin dose is being lowered. In response c the dose is correct. Response d's statement is correct for thrombolytic agents, not anticoagulants.</td><td>Key information in the stem is that the heparin dose has been lowered; eliminate response a. Response d is false for heparin. In deciding between responses b and c, if you are not certain about the dose of coumadin, go with response b, which seems reasonable.</td></tr><tr><td><strong>3. Correct answer: b</strong></td><td></td></tr><tr><td>This is the antidote for heparin therapy, which he has been</td><td>Make an educated guess. The heparin has been given the</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 203</p>
<p>on for a longer period of time. Both agents would probably be stopped for a period of time. Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is the antidote for thrombolytic agents. Only 1 dose has been given of the coumadin, which has peak action from <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mfrac><mn>1</mn><mn>2</mn></mfrac></mrow><annotation encoding="application/x-tex">1\frac{1}{2}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.1901em; vertical-align: -0.345em;"></span><span class="mord">1</span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8451em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> to 3 days. It's too early for Coumadin to have peaked. In response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> this agent does not correct bleeding tendencies.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-d">4. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Thrombolytics dissolve or lyse clots. Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is the action of oral anticoagulants. Response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> is the action of parenteral anticoagulants. Hemostatic agents hasten the clotting of blood.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-c">5. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A medic-alert bracelet is needed in case of an emergency. Cuts could cause bleeding problems and safety is needed. In option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>, a food-to-drug interaction could occur, as could increased clotting. The client should notify the physician before completely stopping the agent. A reduced dose may be all that is necessary. A visit to the physician would probably be for a PT or APTT.</p>
<p>longest, so select the antidote for it, response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>.</p>
<p>Refer to the Rationale. Also, use the approach go with what you know—for coronary thrombosis the lysing of the clot is most important; select option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>.</p>
<p>Narrow the options to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> by the true-false approach to eliminate options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>. Reread options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>. Note the key words “stop taking the medicine” in option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>; physicians should be notified prior to “stopping medicine.” Select option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>.</p>
<p>^{}[]</p>
<p>Drugs Affecting the Immune System
CHAPTER 13</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the difference between agents that offer passive and active immunity.</li>
<li>Describe the clinical application of various immunity agents.</li>
<li>Identify assessments needed in administering immunizations.</li>
<li>Identify immunosuppressive and immunomodulating agents.</li>
</ul>
<p>205</p>
<p>CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Antitoxins
A subgroup of antisera such as botulism, tetanus, and diphtheria antitoxins; injected they confer passive immunity.</p>
<p>Antivenin
A suspension of venom-neutralizing antibodies that confers passive immunity and is given as part of emergency first aid for various snake and insect bites.</p>
<p>Attenuated vaccine
A vaccine made from a strain of virus whose virulence has been lowered by a physical or chemical process. It is used to prevent tuberculosis, small pox, measles, mumps, rubella, polio, and yellow fever. DTP (Diphtheria, Tetanus, Pertussis); MMR (Measles, Mumps, Rubella) vaccine; OPV (Oral Polio Vaccine).</p>
<p>HBV (hepatitis B vaccine)
A genetically engineered vaccine produced in yeast cells by recombinant DNA technology.</p>
<p>Hib (haemophilus influenzae) vaccine
A vaccine given to children at 24 months. Hib is a gram-negative bacterium found in the throats of 30% of normal, healthy people, yet it can cause bacterial meningitis, pneumonia, joint or bone infections, and throat inflammations in children through age 5 and older adults.</p>
<p>Immune globulin
Also called immune gamma globulin—passive immunizing agents obtained from pooled human plasma.</p>
<p>Immunity
The quality of being insusceptible to or unaffected by a particular disease or condition.</p>
<p>Immunosuppressive
A substance or procedure that lessens or prevents an immune response.</p>
<p>Vaccines
A suspension of attenuated or killed microorganisms administered PO, IM, IV, or intradermal to induce active immunity to infectious diseases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="immunological-agents">IMMUNOLOGICAL AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunological-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="i-general-considerations">I. General considerations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-considerations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>A. Immunity can be innate or acquired; natural or artificial (Table 13-1)</p>
<p>207</p>
<p>Table 13-1. Sources of Immunity</p>
<p>|  Natural Resistance |   | One's innate abilities to resist antigens
Influenced by rest, nutrition, stress, exercise
Beyond our natural resistance, immunity must be acquired  |   |   |
| --- | --- | --- | --- | --- |
|  Natural Immunity |   | Artificial Immunity  |   |   |
|  Passively Acquired | Actively Acquired | Passively Acquired | Actively Acquired |   |
|  Antibodies obtained passively by transfer via placenta or from breast milk | Protection obtained by actually contracting the disease | Temporary prophylactic immunity acquired by direct injection of antibodies, serums; immune globulin | Immunization with a live or attenuated organism (vaccine) or toxins from organisms (toxoids) so that antibodies are produced by the body |   |</p>
<p>208 ▼ CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-scheduling-box-13-1">B. Scheduling (Box 13-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-scheduling-box-13-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Children must have a current schedule to attend school</li>
<li>Schedule should be followed as closely as possible. Schedules should be altered or exemptions granted for the following
a. An ill, febrile child
b. Immunosuppressed child
c. Use of certain medications or other recent immunizations</li>
<li>Instruct parents to keep the immunization schedule in a safe place</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-public-emphasis-provide-pamphlets-use-local-health-units-as-resources-critical-ages-are-between-2-and-5-years-of-age">C. Public emphasis: provide pamphlets; use local health units as resources. Critical ages are between 2 and 5 years of age.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-public-emphasis-provide-pamphlets-use-local-health-units-as-resources-critical-ages-are-between-2-and-5-years-of-age" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-high-risk-groups">D. High risk groups<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-high-risk-groups" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Unimmunized parents</li>
<li>Refugees/immigrants</li>
<li>Healthcare providers</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-side-effects">E. Side Effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Common, should be taught to child’s care provider
a. Low-grade fever
b. Soreness at site
c. Joint pain
d. Minor rash
e. Malaise: fatigue</li>
</ol>
<p>Box 13-1. Immunization Schedule for Birth to 16 Years</p>
<table><thead><tr><th></th><th>HBV</th><th>DTP</th><th>OPV</th><th>Hib</th><th>MMR</th><th>Other</th></tr></thead><tbody><tr><td>In Hospital</td><td>#1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2 months</td><td>#2</td><td>#1</td><td>#1</td><td>#1</td><td></td><td></td></tr><tr><td>4 months</td><td></td><td>#2</td><td>#2</td><td>#2</td><td></td><td></td></tr><tr><td>6 months</td><td>#3</td><td>#3</td><td></td><td>#3</td><td></td><td></td></tr><tr><td>12 months</td><td></td><td></td><td></td><td></td><td></td><td>Td</td></tr><tr><td>15 months</td><td></td><td></td><td></td><td>#4</td><td>#1</td><td></td></tr><tr><td>18 months</td><td></td><td>#4</td><td>#3</td><td></td><td></td><td></td></tr><tr><td>4-5 years</td><td></td><td>#5</td><td>#4</td><td></td><td>#2</td><td></td></tr><tr><td>13-16 years</td><td></td><td></td><td></td><td></td><td></td><td>Td</td></tr><tr><td>HBV</td><td>Hepatitis B Vaccine</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DTP</td><td>Diphtheria, Tetanus, Pertussis</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OPV</td><td>Oral Polio Virus</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hib</td><td>Hemophilus influenzae</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>MMR</td><td>Measles, Mumps, Rubella</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Td</td><td>Tetanus Diphtheria</td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table>
<p>IMMUNOLOGICS: GENERAL INFORMATION, ADMINISTRATION SCHEDULE ▼ 209</p>
<p>f. Raised red area at site
g. Symptoms of the disease</p>
<ol start="2">
<li>Uncommon but more severe; report immediately
a. Convulsions
b. Anaphylaxis: an exaggerated, life-threatening hypersensitivity reaction
c. Encephalitis: an inflammatory condition of the brain
d. Serum sickness: an immunological disorder that may occur 2 to 3 weeks after the administration of an antiserum
e. Allergic response
f. Guillain-Barré syndrome: an idiopathic, peripheral polyneuritis occurring between 1 and 3 weeks after a mild episode of fever associated with a viral infection or with immunization; characterized by an ascending paralysis from the feet up</li>
</ol>
<p>F. Role of the nurse</p>
<ol>
<li>Know proper administration dose, route, and site</li>
<li>Conduct a history interview, assessing for the following
a. Allergies to eggs or egg products
b. Current acute or febrile illness
c. Immunosuppressive therapy in progress
d. Recent injection of an immune globulin or a blood transfusion
e. History of malignancies, chemotherapy
f. Possibility of pregnancy</li>
<li>Check expiration date on all vials</li>
<li>Properly store immunization vials in the refrigerator or freezer, but not in the doors of the appliances</li>
<li>Change needles after drawing up the injection and always aspirate</li>
<li>Observe the child for 30 minutes after immunization is given</li>
<li>Properly restrain the child and be truthful about pain</li>
<li>Report abnormal or severe reactions with the lot number and the symptoms experienced to the Center for Disease Control (CDC)</li>
</ol>
<p>G. Parent teaching</p>
<ol>
<li>Expected and unexpected side effects, and when to call the physician</li>
<li>How to use antipyretics for side effects</li>
<li>Closely observing the child for the first 24 hours</li>
<li>Encouraging the child to rest for the first 24 hours</li>
<li>Answer any questions about the injections and relieve any fears about harmful side effects</li>
</ol>
<p>210 ▼ CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-passive-immunity-agents">II. Passive immunity agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-passive-immunity-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Source: serums obtained from humans or animals in which antibodies have been formed against a pathogenic organism
B. Action: provide temporary immunity
C. Uses: prevent infectious disease from occurring or relieve symptoms of the disease after suspected or actual exposure
D. Common agents with their use</p>
<ol>
<li>Immune globulin—exposure to hepatitis A, immunodeficiency syndromes</li>
<li>Agents with known antibodies
a. Hepatitis B immune globulin (HBIG)—exposure to hepatitis B
b. Tetanus immune globulin (Hyper-Tet)—treatment of tetanus, prophylaxis after exposure—may be given in emergency rooms for severe massive trauma or for burn clients
c. Varicella-Zoster immune globulin (VZIG)—prevention or treatment of varicella, chickenpox
d. RhoD immune globulin (RhoGAM)—for Rh negative pregnant women or women who deliver an Rh positive baby</li>
<li>Antitoxins and antivenins
a. Antitoxin: an agent prepared from the serum of horses immunized against a particular toxin-producing organism
(1) Diphtheria antitoxin—treatment of diphtheria
(2) Tetanus antitoxin—treatment of tetanus when immune globulin not available
b. Antivenin: a suspension of venom-neutralizing antibodies prepared from the serum of immunized horses
(1) Rabies immune globulin—exposure to rabies
(2) Antivenin for snake and spider bites</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-active-immunity-agents">III. Active immunity agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-active-immunity-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Vaccines: biologic agents that stimulate antibodies to be produced in the body. Clue: remember the <em>a</em> in vaccine refers to active immunity; the body acts to produce antibodies and it takes awhile: about 2 to 3 weeks.</p>
<ol>
<li>Live vaccine: live microorganisms that are altered but will still multiply in the body over time and cause a reaction
a. Measles, mumps, rubella (MMR)
b. Poliovirus (Sabin, OPV)
c. Yellow fever</li>
</ol>
<p>PASSIVE AND ACTIVE IMMUNITY; IMMUNOSUPPRESSIVE AGENTS ▼ 211</p>
<ol start="2">
<li>Attenuated: microorganisms that are killed, inactivated, or altered in such a way that their virulence is reduced
a. Hemophilus influenzae (Hib)
b. Hepatitis B (Heptavax)
c. Poliovirus (Salk)
d. Influenza vaccine
e. Rabies vaccine
f. Cholera vaccine
g. Typhoid vaccine
h. Rubella vaccine—instruct female to wait at least 3 months before attempting pregnancy
i. Havrix vaccine—for Hepatitis A</li>
</ol>
<p>B. Toxoids: toxins that have been treated to eliminate the toxic properties but retain the ability to stimulate antibodies</p>
<ol>
<li>Tetanus toxoid—administer every 10 years</li>
<li>Diphtheria toxoid</li>
<li>Diphtheria, tetanus, pertussis (DTP)</li>
<li>Diphtheria and tetanus (Td)—recommended for 7 year olds and adults</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="immunosuppressive-and-immunomodulating-agents">IMMUNOSUPPRESSIVE AND IMMUNOMODULATING AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunosuppressive-and-immunomodulating-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-immunosuppressive-agents">I. Immunosuppressive agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-immunosuppressive-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Groups of drugs</p>
<ol>
<li>Corticosteroids</li>
<li>Antimetabolites</li>
<li>Cytotoxic agents</li>
<li>Certain antibiotics</li>
</ol>
<p>B. Action: lessen or prevent an immune response</p>
<p>C. Uses: organ transplantation and autoimmune diseases</p>
<p>D. Major side effects</p>
<ol>
<li>Infections</li>
<li>Cancer</li>
<li>Lymphomas</li>
<li>Gastrointestinal (GI) upset</li>
<li>Anemias</li>
<li>Leukopenia</li>
<li>Thrombocytopenia</li>
<li>Serum sickness</li>
</ol>
<p>E. Contraindications: live vaccines, combination immunosuppressive therapy</p>
<p>CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-nursing-implications">F. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Monitor complete blood count and liver enzymes</li>
<li>Assess for transplant rejection and signs of infection</li>
<li>Give oral forms with food or milk to reduce GI upset</li>
<li>Monitor IV site carefully; avoid extravasation</li>
<li>Frequently assess major body systems including oral cavity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="g-common-drugs">G. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#g-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Azathioprine (Imuran)</li>
<li>Lymphocyte immune globulin (ATG, Atgam)</li>
<li>Muromonab-CD3 (Orthoclone OKT3)</li>
<li>Cyclosporine (Sandimmune)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-immunomodulating-agents">II. Immunomodulating agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-immunomodulating-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-action-bind-to-the-cells-infected-with-the-human-immunodeficiency-virus-hiv">A. Action: bind to the cells infected with the human immunodeficiency virus (HIV)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-bind-to-the-cells-infected-with-the-human-immunodeficiency-virus-hiv" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses-clients-seroconverted-to-hiv-or-exposed-to-occupational-hiv">B. Uses: clients seroconverted to HIV or exposed to occupational HIV<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses-clients-seroconverted-to-hiv-or-exposed-to-occupational-hiv" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Neurological symptoms: insomnia, confusion, seizures, peripheral neuropathies</li>
<li>Bone marrow depression, leukopenia, thrombocytopenia, anemia</li>
<li>Pancreatitis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Obtain a thorough history of previous bone marrow depression, blood dyscrasias, anemias</li>
<li>Encourage good hydration and oral care</li>
<li>Encourage antipruritics and sedatives as needed</li>
<li>Institute seizure precautions</li>
<li>Monitor complete blood count (CBC)</li>
<li>Reorient as needed</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Zidovudine (Azidothymidine, AZT, Retrovir)</li>
<li>Didanosine (ddl, Videx)</li>
<li>Zalcitabine (Hivid)</li>
</ol>
<p>REVIEW QUESTIONS ▼ 213</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A frantic mother calls the nurse at the physician’s office. She states that her child is very sleepy, has a temperature of 100.4° F, and has a raised red area on his leg where he recently received the MMR (measles, mumps, rubella) injection. What should the nurse tell her?</li>
</ol>
<p>a. That these side effects are serious, so the child needs to be brought in to see the physician
b. That these side effects are common, and she should call if the temperature is &gt;102° F or if she cannot arouse the child
c. That she is overreacting and should not panic
d. That these side effects are common, so she should not be concerned at all</p>
<ol start="2">
<li>A client, age 22, accidentally falls into a hay bailer while working on a farm. He has multiple deep wounds and requires surgery. A tetanus toxoid would be given based on which of these responses in reference to the last tetanous shot?</li>
</ol>
<p>a. “I can’t remember, but it was less than 5 years”
b. “I can’t remember, but it was less than 10 years”
c. “I know I am up-to-date; I had an injection in 1993”
d. “I think it was 3 years ago”</p>
<ol start="3">
<li>A client plans to become pregnant and wants to plan everything just right. She receives the rubella as a prevention and calls the public health nurse to ask when she should begin trying to get pregnant. The nurse should suggest trying</li>
</ol>
<p>a. No sooner than 3 months
b. Whenever you feel like it
c. No sooner than 2 months
d. No sooner than 6 months</p>
<ol start="4">
<li>Blood work on a 17-year-old client who has a stillbirth returns normal, and she is Rh negative. The autopsy reveals the baby was Rh positive. Which of the following should she receive?</li>
</ol>
<p>a. Hepatitis B immune globulin (HBIG)
b. Haemophilus influenzae vaccine (Hib)
c. Rh₀ (D) immune globulin (RhoGam)
d. Hepatitis B vaccine (Heptavax)</p>
<p>214 ▼ CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<ol start="5">
<li>A client is concerned about having her current immunization schedule for her 13-month-old daughter. She calls the nurse at the health unit and asks which “shots” her daughter should have received by this time. What is the nurse’s best answer?</li>
</ol>
<p>a. 3 DTP, 1 MMR, Tb, 3 HBV
b. 2 DTP, Tb, 2 OPV, 3 HBV
c. 3 DTP, 3 Hib, 2 OPV, 2 HBV
d. 3 DTP, 3 Hib, Td, 2 OPV, 3 HBV</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 215</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>These are common effects. Acetaminophen (Tylenol), rest, and normal movement of the leg are the best treatment. The items in option <em>a</em> are not serious enough to panic an already frantic mother. Simple instructions would work best. Never tell a worried mother that she is overreacting. Concern is always warranted, but panic is unnecessary at this time.</td><td>Refer to the Rationale. Note that responses <em>b</em> and <em>d</em> are similar. If trying to decide between the two responses, be alerted to the key words in response <em>d</em>: “not be concerned . . . at all.” This absolute leads you to response <em>b</em>.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>With a serious wound an interval of more than 5 years usually requires another injection for prophylactic reasons. Injections given within 5 years are usually sufficient for accidents. An unknown or questionable date usually requires an injection for prophylactic reasons.</td><td>Select the longest time, 10 years.</td></tr><tr><td><strong>3. Correct answer: a</strong></td><td></td></tr><tr><td>A 3-month wait is recommended in the literature to prevent any complications to the fetus. Pregnancy too soon after injection could cause abnormalities in the pregnancy or baby. A 2-month wait is not long enough. A 6-month wait is too long.</td><td>Use the number approach if you have no idea of a correct answer. Throw out the smallest and largest numbers, 2 and 6; select 3 in response <em>a</em>.</td></tr></tbody></table>
<p>216 ▼ CHAPTER 13 DRUGS AFFECTING THE IMMUNE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-c">4. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>RhoGam provides temporary immunity from antibodies received from the child, and it protects the mother and the next baby from the incompatibility of the blood; it is passive-acquired immunity. In option <em>a</em> HBIG is to provide temporary immunity if there is contact with hepatitis B; it is passive-acquired immunity—the direct injection of antibodies in the form of an “immune globulin.” Hib is to prevent infection from haemophilus influenzae, which is serious in children and older adults; it is active-acquired immunity—the body has to actively produce its own antibodies within 2 to 3 weeks. Heptavax provides active-acquired immunity against hepatitis B. It is a series of 3 injections: the initial, at 3 months, and at 6 months.</p>
<p>Use common sense after rereading the stem. There is no problem with hepatitis or the flu, so the only possible answer is <em>c</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-d">5. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This schedule in response <em>d</em> is correct according to age. The schedule in option <em>a</em> is incorrect for the child’s age; the MMR is scheduled too soon. In option <em>b</em> for the child’s age there should have been 3 DTP and 3 HIB injections. In option <em>c</em> for the child’s age the HBV should be complete to a total of 3; the Td is also needed.</p>
<p>The easiest way to remember this is to list the numbers 3, 3, 3, 2, 1, then place the tests alphabetically DTP, HBV, HIB, OPV, and Td. These shots total 12 in number (add them up for yourself) and relate that a 12 month old should have completed this group of injections.</p>
<p>217
CHAPTER 14</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-endocrine-system">Drugs Affecting the Endocrine System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-endocrine-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the anterior and posterior pituitary hormones and the names of the replacement agents.</li>
<li>Identify the parathyroid and thyroid hormones and the replacement agents.</li>
<li>Describe corticosteroids and mineralcorticoids and their uses.</li>
<li>Identify hypoglycemic and hyperglycemic agents.</li>
<li>Describe the difference between short-acting, intermediate-acting, and long-acting insulin.</li>
<li>Describe nursing implications for clients on insulin therapy.</li>
</ul>
<p>218 ▼ CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Corticotropin</strong>
Also called <strong>adrenocorticotropic (ACTH) hormone</strong>; secreted from the anterior pituitary gland which in turn stimulates the adrenal cortex to secrete other hormones such as cortisol in times of stress, fever, or acute hypoglycemia.</p>
<p><strong>Dawn phenomenon</strong>
Hyperglycemia only in the early morning, without a prior hypoglycemia, results from an increased plasma glucose concentration (and related to the growth hormone); treated with an extra dose of insulin.</p>
<p><strong>Hyperfunction of the endocrine system</strong>
Thyrotoxicosis, Hyperglycemia, Hyperthyroidism, also called <strong>Grave’s Disease</strong>, Hyperparathyroidism.</p>
<p><strong>Hypofunction of the endocrine system</strong>
Addison’s Disease, Cretinism, Hypoparathyroidism, Hypoglycemia, Hypothyroidism.</p>
<p><strong>Iodism</strong>
A condition produced from excessive amounts of iodine in the body, with findings of lacrimation, salivation, rhinitis, weakness, and a typical skin eruption.</p>
<p><strong>Myxedema</strong>
The severest form of hypothyroidism, characterized by swelling of the hands, face, feet, and the periorbital tissues, at which stage coma may result.</p>
<p><strong>Somogyi effect</strong>
Hypoglycemia in the evening results in a rebound hyperglycemia in the early morning. The low blood sugar drawn around 3 A.M. usually pinpoints the problem.</p>
<p><strong>T₃ (Thyroxine)</strong>
Thyroid hormone that influences metabolism.</p>
<p><strong>T₄ (Triiodothyronine)</strong>
Thyroid hormone produced mainly from the metabolism of thyroxine in the peripheral tissues, but also made by and stored in the thyroid gland. It helps regulate growth and development, control metabolism and body temperature, and by negative-feedback loop inhibit the secretion of thyrotropin, a thyroid-stimulating hormone (TSH) by the pituitary.</p>
<p><strong>Thyroid storm</strong>
Also called <strong>thyrotoxic crisis</strong>—a life-threatening situation in uncontrolled hyperthyroidism with characteristic findings: fever as high as 106°F, sweating, tachycardia, extreme nervous excitability, and acute respiratory distress.</p>
<p>PITUITARY HORMONES: ANTERIOR ▼ 219</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pituitary-hormones">PITUITARY HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pituitary-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-anterior-pituitary-hormones-box-14-1">I. Anterior pituitary hormones (Box 14-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-anterior-pituitary-hormones-box-14-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-growth-hormone">A. Growth hormone<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-growth-hormone" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Action: increases cellular size and rate of growth</li>
<li>Use: pituitary dwarfism</li>
<li>Major side effects
a. Development of antibodies
b. Gigantism, too rapid growth
c. Hyperglycemia (diabetogenic effect)
d. Soft-tissue hypertrophy</li>
<li>Nursing implications
a. Monitor effects of the drug
b. Give by injection only and mix with sterile water
c. Assess glucose level</li>
<li>Common drugs
a. Somatrem (Protropin)
b. Somatropin (Humatrope)
c. Octreotide acetate (Sandostatin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c6d0893b">B. Corticotropin—ACTH (Acthar)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c6d0893b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Actions: controls cortisol release and assists in dealing with stress</li>
<li>Uses
a. Diagnosis of adrenal insufficiency
b. Myasthenia gravis
c. Rheumatic disease
d. Multiple sclerosis</li>
<li>Major side effects
a. Allergic reactions
b. Acne</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="box-14-1-anterior-pituitary-hormones">Box 14-1. Anterior Pituitary Hormones<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-14-1-anterior-pituitary-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<table><thead><tr><th>Somatotropin or growth hormone (GH)</th></tr></thead><tbody><tr><td>Thyrotropin or thyroid-stimulating hormone (TSH)</td></tr><tr><td>Corticotropin or adrenocorticotropic hormone (ACTH)</td></tr><tr><td>Gonadotropins: Follicle-stimulating hormone (FSH)</td></tr><tr><td>Luteinizing hormone (LH)</td></tr><tr><td>also called interstitial-stimulating hormone (ICSH)</td></tr></tbody></table>
<p>220 ▼ CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<p>c. Mood swings
d. Sodium retention, potassium loss, glucose elevated
e. Cushing’s syndrome (from excess hormone)
f. Depression of immune system</p>
<ol start="4">
<li>Nursing implications
a. Monitor for allergic response
b. Promptly treat any signs of infection
c. Monitor electrolytes and glucose</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-thyroid-stimulating-hormone-tsh">C. Thyroid-stimulating hormone (TSH)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-thyroid-stimulating-hormone-tsh" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>
<p>Actions
a. Controls functional activity of the thyroid gland
b. Increases production and release of the thyroid hormone</p>
</li>
<li>
<p>Use: diagnosing hypothyroidism</p>
</li>
<li>
<p>Major side effects
a. Cardiac arrhythmias: particularly atrial fibrillation because thyroid hormones increase the cardiac contractility and heart rate
b. Anaphylactic reactions because of the cardiostimulant effect</p>
</li>
<li>
<p>Nursing implications
a. Monitor cardiac status
b. Assess for allergic reaction</p>
</li>
<li>
<p>Common drug: thyrotropin (Thytropar)</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-posterior-pituitary-hormone-box-14-2">II. Posterior pituitary hormone (Box 14-2)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-posterior-pituitary-hormone-box-14-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="56b7a8ed">A. Oxytocics—oxytocin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#56b7a8ed" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>
<p>Actions
a. Cause vasopressor activity
b. Decrease urine output
c. Increase water absorption</p>
</li>
<li>
<p>Uses
a. Diabetes insipidus
b. Gastrointestinal (GI) bleeds
c. Induction of labor for term babies
d. Promotion of milk letdown and uterine involution</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="box-14-2-posterior-pituitary-hormones">Box 14-2. Posterior Pituitary Hormones<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-14-2-posterior-pituitary-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Vasopressin or antidiuretic hormone (ADH)
Oxytocin</p>
<p>PITUITARY HORMONES: POSTERIOR ▼ 221</p>
<ol start="3">
<li>
<p>Major side effects
a. Hypertension
b. Water intoxication
c. Anaphylaxis
d. Nausea, vomiting</p>
</li>
<li>
<p>Nursing implications
a. Monitor fetal activity: fetal heart tones (FHT), contractions, vital signs (especially BP)
b. Monitor fluid status, I&amp;O</p>
</li>
<li>
<p>Common drugs
a. Oxytocin (Pitocin, Syntocinon)
b. Oxytocin citrate (Pitocin Citrate)</p>
</li>
</ol>
<p>B. Oxytocics—ergot alkaloids</p>
<ol>
<li>
<p>Actions
a. Contract smooth muscle, primarily on the uterus and blood vessels, with the greatest effect at term and postpartum
b. Peripheral vasoconstriction
c. Antihypertensive effect
d. Alpha-adrenergic blockade</p>
</li>
<li>
<p>Uses
a. Production of uterine contractions
b. Postpartal bleeding
c. Migraine headaches
d. Hypertension</p>
</li>
<li>
<p>Major side effects
a. Nausea, vomiting
b. Dry mouth due to increased urinary output
c. Increased BP
d. Ergotism: cerebrospinal findings of spasms, cramps, dry gangrene</p>
</li>
<li>
<p>Nursing implications: same as for oxytocins</p>
</li>
<li>
<p>Common drugs
a. Ergonovine maleate (Ergotrate Maleate)
b. Ergotamine tartraye (Ergostat)</p>
</li>
</ol>
<p>C. Vasopressin: (antidiuretic hormone [ADH])</p>
<ol>
<li>Action: maintains normal osmotic pressure and volume in the ECF by regulating the amount of water absorbed in the renal distal tubule</li>
<li>Uses
a. Hormone replacement in diabetics
b. Hemorrhage control
c. Increase BP</li>
</ol>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<p>d. Diagnosis to determine the ability of the kidneys to concentrate urine
e. Replacement therapy after head injury with diabetes insipidus</p>
<ol start="3">
<li>Major side effects</li>
</ol>
<p>a. Irritation to tissue
b. Nasal congestion and inflammation
c. Nausea, vomiting, headache
d. Flushing, pallor</p>
<ol start="4">
<li>Nursing implications</li>
</ol>
<p>a. Contraindicated in cardiac disease
b. Monitor vital signs, I&amp;O
c. Assess weight changes
d. Monitor ECG
e. Assess for signs of water intoxication—hyponatremia and decreased urine output</p>
<ol start="5">
<li>Common drugs</li>
</ol>
<p>a. Desmopressin acetate (DDAVP)—usually nasally
b. Vasopressin (Pitressin)—maybe IM or IV</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="thyroid-and-parathyroid-hormones">THYROID AND PARATHYROID HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thyroid-and-parathyroid-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-parathyroid-hormone-box-14-3">I. Parathyroid hormone (Box 14-3)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-parathyroid-hormone-box-14-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: maintains calcium (Ca) levels in the blood by affecting the absorption of Ca from the gut and bone. The serum phosphate level changes in the opposite direction of the Ca level.
B. Agents for hypoparathyroid</p>
<ol>
<li>Hypoparathyroidism: a deficiency of parathyroid hormone (PTH) that causes a low calcium level and high phosphate level (tetany, cardiac arrhythmias, neuromuscular irritability)</li>
<li>Uses: to treat hypocalcemia, raise the calcium level, and decrease the phosphate level</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="box-14-3-hormones-influencing-overall-function">Box 14-3. Hormones Influencing Overall Function<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#box-14-3-hormones-influencing-overall-function" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Gland</th><th>Hormones</th></tr></thead><tbody><tr><td>Thyroid</td><td>Thyroxine (T₃), Triiodothyronine (T₄), Calcitonin</td></tr><tr><td>Parathyroid</td><td>Parathormone (PTH)</td></tr><tr><td>Pancreas</td><td>Insulin, Glucagon</td></tr><tr><td>Adrenals</td><td>Mineralocorticoids, Glucocorticoids</td></tr></tbody></table>
<p>PARATHYROID AND THYROID HORMONES ▼ 223</p>
<ol start="3">
<li>
<p>Major side effects
a. Azotemia: excess nitrogenous waste in the blood with elevated serum BUN
b. Renal failure</p>
</li>
<li>
<p>Common drugs
a. Calcium chloride
b. Calcium gluconate (Kalcinate)
c. Ergocalciferol (vitamin D)</p>
</li>
</ol>
<p>C. Agents for hyperparathyroid</p>
<ol>
<li>Hyperparathyroidism: excess of parathyroid hormone, which causes a high calcium level and low phosphate level</li>
<li>Uses: to treat hypercalcemia, lower the calcium level, and raise the phosphate level</li>
<li>Major side effects
a. Flushing of the face
b. Inflammation if injected
c. Nausea, vomiting</li>
<li>Common drugs
a. Calcitonin (Cibacalcin)
b. Etidronate disodium (Didronel)</li>
</ol>
<p>D. Nursing implications for both groups</p>
<ol>
<li>Monitor for signs of hypocalcemia and hypercalcemia</li>
<li>Give PO form of medication 1 to 1½ hour after eating</li>
<li>Closely monitor IV forms to prevent extravasation</li>
<li>Monitor vital signs and ECG</li>
</ol>
<p>II. Thyroid hormones (see Box 14-3)</p>
<p>A. Thyroid agents</p>
<ol>
<li>Action: replace missing thyroid hormones, synthetic or natural preparations of T₃ or T₄. Thyroid hormone is necessary for all cell metabolism.</li>
<li>Uses: hypothyroidism or decreased activity of the thyroid gland
a. Myxedema (greater in adults over 50 years of age)
b. Cretinism (congenital hypothyroidism)</li>
<li>Major side effects
a. Cardiovascular: palpitations, tachycardia, angina
b. Central nervous system: nervousness, irritability
c. Weight loss
d. Insomnia
e. Thyrotoxicosis: extreme hyperthyroidism or the sudden secretion of thyroid hormone in greater-than-normal amounts</li>
</ol>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<ol start="4">
<li>Nursing implications</li>
</ol>
<p>a. Give dose carefully, usually small amounts in micrograms
b. Encourage compliance with a single morning dose at breakfast
c. Teach signs and symptoms of hypothyroidism and hyperthyroidism
d. Hold if HR &gt;100 taken for a full minute; take apical pulse</p>
<ol start="5">
<li>Interactions: a decrease in antidiabetic agents, increase in oral anticoagulants</li>
<li>Common drugs</li>
</ol>
<p>a. Levothyroxine sodium (Synthroid)
b. Thyroglobulin (Proloid)
c. Liotrix (Euthroid)</p>
<p>B. Antithyroid drugs</p>
<ol>
<li>Actions: lower the thyroid level by three mechanisms</li>
</ol>
<p>a. Interfere with the hormone production: iodine must be present in the body for thyroid hormone synthesis. A high dose of iodine has a suppressant effect and causes a decrease in the production of thyroid hormone.
b. Modify the response to the hormone by blocking the synthesis of thyroid hormone
c. Destroy the gland: radioactive preparations destroy the thyroid tissue, thereby decreasing the production of thyroid hormone</p>
<ol start="2">
<li>Use: hyperthyroidism (Grave's disease or thyrotoxicosis)</li>
<li>Major side effects</li>
</ol>
<p>a. Granulocytopenia: decrease in granulocytes in blood
b. Hypersensitivity
c. Iodism: excess iodine in the body manifested by increased thirst; burning, brassy taste in the mouth
d. Myxedema coma: severe hypothyroidism leading to coma or death
e. Hypothyroidism</p>
<ol start="4">
<li>Nursing implications</li>
</ol>
<p>a. Dilute liquid iodine preparations in water and encourage use of a straw to prevent staining teeth
b. Teach the client about hypothyroidism and hyperthyroidism. Thyroid storm exhibited by fever, tachycardia, CHF, and CNS changes.
c. Monitor vital signs and weight
d. Contraindicated if client is pregnant
e. Avoid over-the-counter medications because they may contain iodine</p>
<p>ADRENAL HORMONES: STEROIDS ▼ 225</p>
<p>f. Teach client follow-up is needed to evaluate for hypothyroidism</p>
<ol start="5">
<li>Common drugs
a. Antithyroid drugs: taken about 3 weeks for a desired response
(1) Methimazole (Tapazole)
(2) Propylthiouracil (PTU)
b. Iodides
(1) Strong iodine solution (Lugol’s solution)
(2) Potassium iodide solution (SSKI)
c. Radioactive iodine (Sodium Iodide-131)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="adrenal-hormones">ADRENAL HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adrenal-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-glucocorticoids-see-box-14-3">I. Glucocorticoids (see Box 14-3)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-glucocorticoids-see-box-14-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-actions">A. Actions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Increase carbohydrate, protein, and fat metabolism</li>
<li>Exhibit antiinflammatory properties</li>
<li>Suppress the normal immune response</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Topical and systemic inflammation</li>
<li>Allergic disorders</li>
<li>Collagen diseases</li>
<li>Fractures, impaired healing</li>
<li>Shock</li>
<li>Replacement in adrenal cortical insufficiency, Addison’s disease</li>
<li>Eye diseases</li>
<li>Rheumatic disorders</li>
<li>Asthma</li>
<li>Acute leukemia</li>
<li>Cerebral edema</li>
<li>Skin disorders</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Buffalo hump—accumulation of fat on the back of the neck due to prolonged use of steroids</li>
<li>Moon face—rounded, puffy face due to prolonged use of steroids</li>
<li>Immunosuppressant effect: inability of the immune system to respond to antigenic stimulation by inhibiting cellular and humoral immunity</li>
<li>Growth retardation, muscle wasting</li>
<li>Hyperglycemia: blood sugar &gt;100 mg/dl</li>
</ol>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<ol start="6">
<li>Hypertension: blood pressure &gt;140/90</li>
<li>Mood swings</li>
<li>Sterility</li>
<li>Cardiac dysrhythmias: tachycardia most common</li>
<li>Cushingoid signs and symptoms: having the habitus and facies characteristic of Cushing's disease, which involves excess cortisol</li>
<li>Hypokalemia</li>
<li>Inhibited protein synthesis</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Usually recommended for short-term use only; stress the severe side effects from long-term use</li>
<li>Know and teach that they should not be abruptly withdrawn; taper off slowly</li>
<li>Encourage a diet rich in protein and potassium</li>
<li>Draw steroid levels at 7 A.M. and/or 4 P.M. to determine hypofunction or hyperfunction of adrenal gland's production of steroids</li>
<li>Monitor daily weight and teach patient to weigh at home because of the action of the drug. Report weight gain &gt;5 pounds.</li>
<li>Advise client to wear a medical alert tag</li>
</ol>
<p>E. Interactions: increased need for insulin or oral hypoglycemics. Contraindicated in clients with TB or peptic ulcers (may worsen the disease).</p>
<p>F. Common drugs</p>
<ol>
<li>Hydrocortisone (Cortef, Hydrocortone)</li>
<li>Hydrocortisone sodium succinate (Solu-Cortef)</li>
<li>Cortisone acetate (Cortone)</li>
<li>Prednisone (Deltasone, Orasone)</li>
<li>Triamcinolone (Aristocort)</li>
<li>Betamethasone (Celestone)</li>
<li>Dexamethasone (Decadron)</li>
</ol>
<p>II. Mineralcorticoids
A. Actions: conserve sodium stores in the body and affect fluid and electrolyte balance, thereby causing reabsorption of sodium (Na) and excretion of potassium (K)
B. Uses</p>
<ol>
<li>Addison's disease: a life-threatening condition caused by partial or complete failure of adrenocortical function</li>
<li>Adrenocortical insufficiency</li>
</ol>
<p>MINERALCORTICOIDS, HYPOGLYCEMICS ▼ 227</p>
<p>C. Major side effects</p>
<ol>
<li>Hypokalemia</li>
<li>Hypernatremia</li>
<li>Edema</li>
<li>Hypertension</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Weigh client daily</li>
<li>Monitor BP</li>
<li>Encourage a diet rich in potassium</li>
</ol>
<p>E. Common drug: fludrocortisone acetate (Florinef Acetate)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drugs-used-in-diabetes">DRUGS USED IN DIABETES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-in-diabetes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-hypoglycemic-agents-see-box-14-3">I. Hypoglycemic agents (see Box 14-3)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-hypoglycemic-agents-see-box-14-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: control carbohydrate (CHO) metabolism and decrease glucose levels</p>
<ol>
<li>Oral agents stimulate the pancreas to secrete more insulin; not given in children, type I diabetics, since pancreatic β cells are not functioning</li>
<li>Insulin aids glucose across the cell</li>
</ol>
<p>B. Uses: diabetes mellitus (DM), ketoacidosis, and coma associated with DM</p>
<p>C. Major side effects</p>
<ol>
<li>Somogyi effect: hypoglycemia in the evening or night with rebound hyperglycemia in the early morning. The blood sugar provides a good evaluation of the problem when drawn around 3 A.M.; it is typically low.</li>
<li>Hypoglycemia: weakness, hunger, sweating, nausea, BS &lt;50</li>
<li>Local allergic reaction: itching, redness at the site</li>
<li>Dawn phenomenon: hyperglycemia only in the early morning without a prior hypoglycemia; increased plasma glucose concentration and related to the growth hormone; treated by giving an extra dose of insulin</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Insulin is available in various forms (Table 14-1) for SQ or IV administration. The GI tract digests insulin if given orally.</li>
<li>Schedule snacks around insulin’s peak action time: the greatest hypoglycemic time</li>
<li>Give insulin SQ on a rotating basis; various SQ sites have different absorption times</li>
<li>May need to teach the client or family member how to give an injection</li>
</ol>
<p>228</p>
<p>Table 14-1. Insulin Preparations</p>
<table><thead><tr><th>Generic Name</th><th>Classification</th><th>Description</th><th>Pharmacokinetics</th><th></th><th></th></tr></thead><tbody><tr><td></td><td></td><td></td><td>Onset</td><td>Peak</td><td>Duration</td></tr><tr><td>Insulin injection (Regular)</td><td>Rapid-acting</td><td>Clear solution containing no zinc or modifying agents; IV only or subcutaneous injection</td><td>SQ: ½ to 1 hr</td><td></td><td></td></tr><tr><td>IV: 10 to 30 min</td><td>2 to 4 hr</td><td></td><td></td><td></td><td></td></tr><tr><td>15 to 30 min</td><td>6 to 8 hr</td><td></td><td></td><td></td><td></td></tr><tr><td>30 to 60 min</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Prompt insulin zinc suspension (Semilente)</td><td>Rapid-acting</td><td>Cloudy suspension of amorphous insulin precipitated with zinc to slow absorption; subcutaneous only</td><td>1 to 2 hr</td><td>4 to 7 hr</td><td>12 to 16 hr</td></tr><tr><td>Isophane insulin suspension (NPH)</td><td>Intermediate-acting</td><td>Cloudy suspension of insulin complexed with protamine to slow absorption; subcutaneous only</td><td>2 to 4 hr</td><td>10 to 16 hr</td><td>18 to 30 hr</td></tr><tr><td>Insulin zinc suspension (Lente)</td><td>Intermediate-acting</td><td>Cloudy suspension containing 30% semilente insulin and 70% ultralente insulin; subcutaneous only</td><td>1 to 2 hr</td><td>10 to 16 hr</td><td>18 to 30 hr</td></tr></tbody></table>
<table><thead><tr><th>Protamine zinc insulin suspension (PZI)</th><th>Long-acting</th><th>Cloudy when well mixed; suspension of insulin complexed with more protamine than NPH insulin; subcutaneous only</th><th>6 to 8 hr</th><th>14 to 24 hr</th><th>24 to 36 hr or longer</th></tr></thead><tbody><tr><td>Extended insulin zinc suspension (Ultralente)</td><td>Long-acting</td><td>Cloudy when well mixed; large complexes of insulin with zinc to slow absorption; no protein modifiers; subcutaneous only</td><td>5 to 8 hr</td><td>16 to 24 hr</td><td>24 to 36 hr or longer</td></tr></tbody></table>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<ol start="5">
<li>Teach about foot care, exercise, and diet. Stress that exercise decreases the need for supplemental insulin, while most other factors increase the need for supplemental insulin.</li>
</ol>
<p>a. Hypoglycemia (BS &lt; 50): too much insulin, too little food, too much exercise
b. Hyperglycemia (BS &gt; 120): too little insulin, too much food, too little exercise</p>
<ol start="6">
<li>Assess for allergies to sulfa; oral agents contraindicated if sulfa allergies because they are chemically related</li>
<li>Encourage compliance</li>
<li>Teach how to self-monitor glucose level with the appropriate equipment</li>
<li>Know the onset and peak time for the type of insulin given</li>
<li>Insulin ordered to sliding scale is usually regular. Sliding scale is additional insulin given intermittently for high blood glucose levels.</li>
<li>Do not shake, but gently rotate insulin bottle in the hand</li>
<li>Draw up regular insulin first when mixing agents</li>
<li>Only regular insulin can be given IV</li>
<li>Double-check dose with another nurse since dosages are minute</li>
<li>Encourage the use of a medical alert tag</li>
<li>The open vial can be stored at room temperature. Once refrigerated, however, the vial should be placed in the refrigerator.</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>See Table 14-1 for insulins</li>
</ol>
<p>a. Short-acting: regular, Humulin-R
b. Intermediate-acting: NPH, Humulin-N
c. Long-acting: Protamine Zinc, Ultralente</p>
<ol start="2">
<li>Oral agents</li>
</ol>
<p>a. Chlorpropamide (Diabinese)
b. Tolazamide (Tolinase)
c. Tolbutamide (Orinase)
d. Glipizide (Glucotrol)
e. Glyburide (Micronase)</p>
<p>II. Hyperglycemic agents (see Box 14-3)</p>
<p>A. Action: stimulate glucose synthesis to raise the glucose level
B. Use: severe hypoglycemic states
C. Major side effects</p>
<ol>
<li>Hyperglycemia: polydipsia, polyuria, polyphagia</li>
<li>Nausea, vomiting</li>
<li>Coma</li>
</ol>
<p>HYPERGLYCEMICS ▼ 231</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Consciousness should return within 15 to 20 minutes; may repeat dose with dextrose-50% by IV route</li>
<li>Client and family, should be taught how to use at home and have available at all times</li>
<li>Glucagon should be used as soon as concentrated and given SQ, IM, or IV</li>
<li>Patients not losing complete consciousness can be offered 4 ounces of soda (not diet) instead of or in addition to glucagon. A syrup base is absorbed more rapidly than a juice base.</li>
<li>Dextrose-50% by IV slow push is the drug of choice for unconscious clients</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Glucagon</li>
<li>Dextrose-50%</li>
</ol>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>In preparing to administer regular and NPH insulin, why would the nurse draw up the regular first?
a. It is easier to see the correct dose
b. It avoids contamination of the solution in the regular insulin vial
c. It avoids contamination of the solution in the NPH vial
d. It is not as thick and therefore easier to draw up</p>
</li>
<li>
<p>A client is given her usual 7:30 A.M. dose of NPH insulin along with an added amount of regular insulin to scale because her glucose is 329. When would the first signs of insulin action be expected to occur?
a. 10:30 A.M.
b. 8:00 A.M.
c. 9:00 A.M.
d. 9:30 A.M.</p>
</li>
<li>
<p>A client self-monitors her glucose at home and reports that every morning the level is extremely high. The glucose is within normal limits the rest of the day. The nurse would explain that this is called the
a. Somogyi effect
b. Peak time
c. Dawn phenomenon
d. Onset time</p>
</li>
<li>
<p>A client, age 16, is having difficulty giving herself insulin injections. She wants to take the insulin in an oral form. How should the nurse respond?
a. Insulin is better than the oral agents
b. Oral agents are more expensive than insulin
c. Insulin is not available orally because the gastrointestinal tract would destroy it
d. Oral agents can be destroyed by the gastrointestinal tract</p>
</li>
<li>
<p>A patient diagnosed with hyperthyroidism would most likely be prescribed
a. Levothyroxine sodium (Synthroid)
b. Thyroglobulin (Proloid)
c. Calcitonin-human (Cibacalcin)
d. Strong iodine solution (Lugol's solution)</p>
</li>
<li>
<p>The danger for a client with hypothyroidism in suddenly stopping the thyroid medication would be</p>
</li>
</ol>
<p>REVIEW QUESTIONS ▼ 233</p>
<p>a. Thyrotoxicosis
b. Addison's disease
c. Thyroid storm
d. Myxedema coma</p>
<ol start="7">
<li>
<p>A client, age 15, has made the varsity football team and wants to gain weight. He asks the nurse about taking steroids to "pump up." How should the nurse reply?
a. Steroids do not really increase weight, and they carry many dangerous side effects
b. Steroids can "pump you up" but should only be taken in extreme cases
c. Steroids cannot "pump you up" and should never be used
d. Steroids are safe and effective but could make you lose weight</p>
</li>
<li>
<p>The drug of choice for a client with Grave's disease would be
a. Thyroid agent
b. Parathyroid hormone
c. Antithyroid agent
d. Anterior pituitary agent</p>
</li>
</ol>
<p>CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>The NPH insulin is modified with a protein that can alter the regular insulin, which is unmodified and thereby contaminates the regular insulin solution. The dose should be correct no matter which agent is drawn up first. The regular insulin would not harm the NPH vial. The thickness of the solution is basically the same for both types of insulin.</td><td>Identify that the sequence of drawing up the medication is to prevent contamination. Then, to select between responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, stop and think of how the sequence follows; your common sense will guide you to response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>The onset time is 30 minutes to 1 hour for regular insulin; therefore the regular insulin, which should onset first, could be between 8 and 8:30 A.M. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> would be too long of a time for the onset of regular insulin. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> would be the onset time for NPH, which is 2 to 4 hours, but the regular insulin would have an onset first.</td><td>Read carefully to note that the question is asking about “the first sign of insulin action,” not the peak, which has typically been asked throughout your educational process.</td></tr><tr><td><strong>3. Correct answer: c</strong></td><td></td></tr><tr><td>The dawn phenomenon exhibits normally controlled glucose throughout the day except in early morning when it is high. The Somogyi effect would exhibit findings of hypoglycemia in the evening or early morning, 2 to 3 A.M.</td><td>A helpful way to remember somogyi effect is a slump then elevation in glucose levels. Dawn phenomenon only does a peak.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 235</p>
<p>The client might report waking up sweating in the middle of the night. Rebound hyperglycemia would then occur in the morning. For this problem, therapy may be directed at a decrease in the NPH dosage. In option b, the peak time would cause hypoglycemia and would not likely be only in the early morning. In option d, the onset time could be early morning, depending on the time the insulin is given, but the client would exhibit findings of hypoglycemia.</p>
<ol start="4">
<li>Correct answer: c
Insulin is not available orally, as explained in the answer. Neither agent is necessarily better than the other. Not all diabetics need insulin. The point in option b is not necessarily true and is irrelevant. Oral agents such as Micronase are not destroyed by the GI tract.</li>
</ol>
<p>Careful reading is a must for questions like this. Note that the client asks about “insulin in an oral form.” The only response that directly answers THE question is option c. Options a, b, and d can be clustered with the terms “oral agents” and eliminated as the correct answer.</p>
<ol start="5">
<li>Correct answer: d
Response d is an antithyroid agent used to lower thyroid levels. Responses a and b are thyroid agents used for hypothyroidism. The agent in option c is used to treat hyperparathyroidism; it increases calcium deposited into the bone.</li>
</ol>
<p>Eliminate responses a and b, using common sense; each has a medication with “thyro” in it. This hints that these drugs may supplement the hormone. Eliminate option c when calcitonin is associated with calcium which is unrelated to thyroid therapy. Use the above approach if you have no idea of a correct answer.</p>
<p>236 ▼ CHAPTER 14 DRUGS AFFECTING THE ENDOCRINE SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-d">6. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Myxedema coma, severe hypothyroidism, may occur if the agent is suddenly stopped. Responses <em>a</em> and <em>c</em> could be side effects of the medication. Addison’s disease is treated with mineralocorticoids and steroids.</p>
<p>Use an educated approach to match up ideas: a client with hypothyroidism who stops the medicine will be severely hypothyroid, which results in very slow metabolism. Select the response that suggests a slow metabolism—<em>d</em>, coma.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-a">7. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The side effects of steroids offset the short-term weight gain sought by weight lifters. Steroids should never be used just to increase one’s weight. Steroids can cause weight gain, but chronic use can cause weight loss. These agents must be monitored by a physician.</p>
<p><em>Go with what you know.</em> These drugs have dangerous side effects, so select response <em>a</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-c">8. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The agents in response <em>c</em> are used in hyperthyroidism, called Graves’ disease. The agents in response <em>a</em> are effective for clients with hypothyroidism. The agents in response <em>c</em> affect the absorption of calcium. Anterior pituitary drugs, as in response <em>d</em>, are not used for thyroid conditions.</p>
<p>Associate in Graves disease that the body is gassed-up to go at a great metabolism. Or recall that alphabetically <em>h</em> follows <em>g</em>; remember Graves is a high metabolic rate.</p>
<p>237
CHAPTER 15</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-respiratory-system">Drugs Affecting the Respiratory System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-respiratory-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Describe the difference between mucolytics, bronchodilators, antitussives, and antihistamines.</li>
<li>Identify common side effects of agents used to treat respiratory conditions.</li>
<li>Explain the proper application of inhalers.</li>
<li>Identify the use of respiratory stimulants versus depressants.</li>
</ul>
<p>CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Antihistamine</strong>
Any substance capable of reducing the physiologic and pharmacologic effects of histamine.</p>
<p><strong>Antitussive</strong>
Any of a large group of narcotic and nonnarcotic drugs that act on the CNS and peripheral nervous system to suppress the cough reflex. Examples: codeine and hydrocodone, which are potent narcotic antitussives.</p>
<p><strong>Decongestant</strong>
A substance that eliminates or reduces congestion or swelling, especially in the mucous membranes.</p>
<p><strong>Expectorant</strong>
An agent that promotes expectoration by reducing the viscosity of pulmonary secretions or by decreasing the tenacity with which exudates adhere to the lower respiratory tract.</p>
<p><strong>Histamine</strong>
A compound found in cells and released in allergic, inflammatory reactions with resultant dilation of capillaries, decreased BP, increased gastric secretions and constriction of the smooth muscles of the bronchi and uterus. Anaphylactic shock may result when massive amounts are released.</p>
<p><strong>Mucolytic</strong>
Any agent such as Mucomyst that dissolves or destroys mucus.</p>
<p><strong>Xanthine derivative</strong>
Any of the closely related alkaloids, caffeine, theobromine, and theophylline. Their pharmacologic properties stimulate the CNS, produce diuresis, relax smooth muscle; most importantly they dilate the bronchials.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="bronchodilators">BRONCHODILATORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bronchodilators" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>I. Groups of drugs</strong>
A. Sympathomimetics
B. Xanthine derivatives</p>
<p><strong>II. Sympathomimetics</strong>
A. Action: stimulate the production of cyclic adenosine monophosphate (CAMP), which relaxes smooth muscle</p>
<p>BRONCHODILATORS, METERED-DOSE INHALER USE ▼ 239</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Bronchospasms</li>
<li>Chronic pulmonary diseases</li>
<li>Asthma</li>
<li>Airway obstruction</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Anxiety</li>
<li>Restlessness, insomnia</li>
<li>Tremors</li>
<li>Palpitations, dysrhythmias</li>
<li>Headache</li>
<li>Rebound bronchospasm</li>
<li>Urinary retention</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-contraindicated-in-patients-with-hypertension-dysrhythmias-increased-cardiac-effects-with-theophylline-preparations">D. Contraindicated in patients with hypertension, dysrhythmias; increased cardiac effects with theophylline preparations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-contraindicated-in-patients-with-hypertension-dysrhythmias-increased-cardiac-effects-with-theophylline-preparations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Assess respiratory status and arterial blood gases</li>
<li>Instruct patient on how to use an inhaler or respiratory apparatus at home (Figure 15-1)</li>
<li>Monitor ECG and cardiac status</li>
<li>Administer with meals if gastrointestinal (GI) upset occurs</li>
<li>Emphasize compliance with dosage and schedule</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Epinephrine (Adrenalin)</li>
<li>Isoproterenol hydrochloride (Isuprel)</li>
</ol>
<p><img src="assets/images/image-20251221-65d674d9.jpeg" alt="img-14.jpeg">
Figure 15-1. Metered-Dose Inhaler. A, Cannister without a spacer. B, Cannister with a spacer for clients with coordination difficulty. Spacer improves drug delivery deep into lungs. (From Clark J, Queener S, &amp; Karb V: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.)</p>
<p><img src="assets/images/image-20251221-369297dc.jpeg" alt="img-15.jpeg"></p>
<p>240 ▼ CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<ol start="3">
<li>Isoetharine hydrochloride (Bronkosol)</li>
<li>Albuterol (Ventolin)</li>
<li>Metaproterenol sulfate (Alupent)</li>
<li>Terbutaline sulfate (Brethine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-xanthine-derivatives-methylxanthines">III. Xanthine derivatives: methylxanthines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-xanthine-derivatives-methylxanthines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Actions:</strong> inhibit phosphodiesterase, an enzyme responsible for breaking down CAMP. Because this enzyme is inhibited, more CAMP is available for bronchodilation. These agents also stimulate cardiac muscle and the central nervous system (CNS), increase cardiac output, produce diuresis, and decrease peripheral vascular resistance (PVR).</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Bronchospasm</li>
<li>Asthma</li>
<li>Wheezing and dyspnea associated with pulmonary diseases</li>
<li>Chronic obstructive pulmonary disease (COPD) or chronic airway limitations (CAL)</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>CNS stimulation: “tremors” (later sign of toxicity), nervousness, insomnia, agitation, convulsions</li>
<li>Cardiac stimulation: tachydysrhythmias, tachycardia, angina, hypotension</li>
<li>GI distress: “nausea” (first sign of toxicity), vomiting, anorexia</li>
<li>Toxicity</li>
</ol>
<p><strong>D. Interactions</strong></p>
<ol>
<li>Increased side effects with high intake of caffeine</li>
<li>Altered cardiac status with most of the cardiac agents</li>
</ol>
<p><strong>E. Nursing implications</strong></p>
<ol>
<li>Give during the daytime to prevent insomnia</li>
<li>Monitor blood levels for toxicity: therapeutic blood level is 10 to 20 ug/ml; toxicity may occur with small increases &gt;20 ug/ml</li>
<li>Instruct client as follows
a. Be compliant with dosing, schedule, and blood work
b. Do not crush or alter the dosage form
c. Take with milk or food if GI distress occurs
d. Avoid smoking because it increases metabolism of these agents</li>
<li>Monitor for side effects and report the first sign of cardiac disturbances. The event of tachycardia does not warrant discontinuing the drug; instead, the dosage may be decreased.</li>
</ol>
<p>XANTHINE DERIVATIVES, DECONGESTANTS, ANTIHISTAMINES ▼ 241</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Aminophylline (Aminophyllin, Somophyllin)—IV only</li>
<li>Oxtriphylline (Choledyl)</li>
<li>Theophylline (Theolair)</li>
<li>Anhydrous theophylline (Theodur)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="upper-respiratory-drugs">UPPER RESPIRATORY DRUGS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#upper-respiratory-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-decongestants">I. Decongestants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-decongestants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: shrink nasal membranes by a vasoconstrictive mechanism
B. Uses: upper respiratory infections (URI), sinusitis
C. Major side effects</p>
<ol>
<li>CNS stimulation: nervousness, restlessness, insomnia</li>
<li>Nausea, vomiting</li>
<li>Palpitations, hypertension</li>
<li>Rebound engorgement: swelling and congestion of the nasal mucosa when the parasympathetic nervous system tries to equalize the effects of the sympathomimetic decongestant drugs</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Instruct the client not to overuse the agent because it may be habit forming. Limit the number of days used.</li>
<li>Limit caffeine intake</li>
<li>Maintain sitting position when taking these drugs</li>
<li>Consult pharmacist before taking these products with diet pills</li>
<li>Consult physician before use if hypertension is present</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Oxymetazoline (Afrin, Dristan)</li>
<li>Phenylephrine (NeoSynephrine)</li>
<li>Pseudoephedrine + chlorpheniramine + dextromethorphan + acetaminophen (Comtrex)</li>
<li>Pseudoephedrine hydrochloride (Sinutab, Sudafed)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-antihistamines">II. Antihistamines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antihistamines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: compete for H₁ receptor sites
B. Uses</p>
<ol>
<li>Rhinitis: inflammation of the mucous membranes of the nose accompanied by swelling of the mucosa and nasal discharge</li>
<li>Common cold</li>
<li>Allergic responses: itchy, watery eyes</li>
<li>Sinusitis</li>
</ol>
<p>CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Headache</li>
<li>Anticholinergic effects: dry mouth, urinary retention, dilated pupils, tachycardia, decreased GI motility</li>
<li>CNS: sedation, dizziness; antihistamines cross the blood-brain barrier</li>
<li>Hypotension, palpitations</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Take at bedtime if possible to avoid sedation during the day</li>
<li>If taken during the day, caution the client about safety measures with driving, operating machinery, and ambulating. Sedation usually decreases with repeated doses.</li>
<li>Caution older adults in particular about sedative effects</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Diphenhydramine hydrochloride (Benadryl)</li>
<li>Terfenadine (Seldane)</li>
<li>Brompheniramine maleate (Dimetane)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drugs-affecting-cough">DRUGS AFFECTING COUGH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-cough" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-diluents">I. Diluents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-diluents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-sterile-water">A. Sterile water<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-sterile-water" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Action: liquefies mucus, which facilitates removal of secretions</li>
<li>Uses
a. Helps remove secretions
b. Decreases mucus plug formation
c. Diluent given by ultrasonic nebulization</li>
<li>Nursing implications
a. Taken systemically, tap water acts as an expectorant
b. Consume 2 to 3 quarts of tap water per day to help eliminate secretions unless contraindicated by presence of congestive heart failure (CHF) or fluid restrictions</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-sterile-normal-saline-sodium-chloride">B. Sterile normal saline (sodium chloride)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-sterile-normal-saline-sodium-chloride" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Action: exerts osmotic pressure on plasma fluids, which results in hydration of respiratory secretions</li>
<li>Nursing implications: caution use by clients with cardiac problems or when edematous states exist</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-mucolytic-drugs">II. Mucolytic drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-mucolytic-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-actions-work-directly-on-mucus-to-reduce-thickness-and-make-secretions-less-tenacious-alters-metabolism-of-acetaminophen-to-decrease-injury-to-the-liver-in-overdose">A. Actions: work directly on mucus to reduce thickness and make secretions less tenacious. Alters metabolism of acetaminophen to decrease injury to the liver in overdose.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-work-directly-on-mucus-to-reduce-thickness-and-make-secretions-less-tenacious-alters-metabolism-of-acetaminophen-to-decrease-injury-to-the-liver-in-overdose" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>DILUENTS, MUCOLYTICS, EXPECTORANTS ▼ 243</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Inhalation
a. Respiratory conditions with thick mucus
b. Cystic fibrosis</li>
<li>Orally: acetaminophen overdose</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Nausea, vomiting (may be due to rotten egg odor)</li>
<li>Bronchospasm</li>
<li>Burning in back of throat</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>May be given by nebulization, IV, orally, or instilled in endotracheal tube</li>
<li>Dilute with sterile water to ensure that all of drug is given</li>
<li>Use cautiously in older adults or individuals with severe respiratory insufficiency (may cause bronchospasm)</li>
<li>Offer face cloth after inhalation (leaves sticky coating)</li>
<li>Suction and encourage coughing after administration</li>
<li>Assess lung sounds and respiratory status</li>
<li>Administer by mouth mixed with iced liquid, about 17 doses over a 4-day period in acetaminophen overdose</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drug-acetylcysteine-mucomyst">E. Common drug: acetylcysteine (Mucomyst)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drug-acetylcysteine-mucomyst" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-expectorants">III. Expectorants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-expectorants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions">A. Actions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>remove viscid secretions by reducing adhesiveness and surface tension. Iodide preparations act directly on bronchial tissue to increase the secretion of respiratory fluids and decrease the viscosity of mucus.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Respiratory difficulty in children</li>
<li>Bronchitis</li>
<li>Persistent coughs</li>
<li>Mucus plugs</li>
<li>Influenza</li>
<li>Common cold</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects-rare-may-include-gi-upset">C. Major side effects: rare, may include GI upset<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects-rare-may-include-gi-upset" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Assess lung sounds and secretions: color, consistency, amount</li>
<li>Offer 2 to 3 quarts of fluid per day unless contraindicated</li>
<li>Administer potassium iodide solution (SSKI) with juices to disguise taste; have client use a straw to decrease taste</li>
<li>Do not offer water before or after expectorant agents except for SSKI</li>
</ol>
<p>244 ▼ CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Potassium iodide solution (SSKI)</li>
<li>Guaifenesin (Robitussin, Glycotuss)</li>
<li>Dextromethorphan hydrobromide + benzocaine (Formula 44D, Vicks Cough Syrup)</li>
<li>Dextromethorphan hydrobromide + guaifenesin + phenylpropanolamine HCL (Naldecon)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-antitussives">IV. Antitussives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-antitussives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: suppress the cough reflex center in the medulla. Some are peripherally acting and some are centrally acting.
B. Uses: suppress nonproductive cough and/or assist in nighttime sleep in children with productive cough. Can be combined with a narcotic or nonnarcotic agents.
C. Major side effects</p>
<ol>
<li>Dry secretions</li>
<li>Drowsiness without respiratory depression</li>
<li>Constipation</li>
<li>Narcotic abuse</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Wait 15 to 20 minutes after taking the syrup before drinking any liquid</li>
<li>Monitor use because these are controlled substances</li>
<li>Take at bedtime</li>
<li>Monitor bowel elimination</li>
<li>Humidify air during sleep time to improve effectiveness</li>
</ol>
<p>E. Interactions: a synergistic effect with alcohol and CNS depressants</p>
<p>F. Common drugs</p>
<ol>
<li>Nonnarcotic</li>
</ol>
<p>a. Benzonatate (Tessalon)
b. Diphenhydramine hydrochloride (Benylin)</p>
<ol start="2">
<li>Narcotic</li>
</ol>
<p>a. Codeine sulfate
b. Hydrocodone bitartrate (Hycodan)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-respiratory-agents">OTHER RESPIRATORY AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-respiratory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-prophylactic-asthmatic-drugs">I. Prophylactic asthmatic drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-prophylactic-asthmatic-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: prevent the release of histamine
B. Use: prevent acute attacks in asthma</p>
<p>ANTITUSSIVES, PROPHYLACTIC ASTHMATIC DRUGS, CORTICOSTEROIDS ▼ 245</p>
<p>C. <strong>Major side effects</strong></p>
<ol>
<li>Headache</li>
<li>Bronchospasm</li>
<li>Dry throat</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Teach client how to use inhaler</li>
<li>Do not mix with bronchodilators given by inhalation</li>
<li>Assess breath sounds</li>
<li>Give by inhalation, since it is absorbed poorly from oral route</li>
</ol>
<p>E. <strong>Common drugs</strong></p>
<ol>
<li>Cromolyn sodium (Intal)</li>
<li>Pirbuterol (Maxair)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-antiinflammatory-agents-corticosteroids">II. Antiinflammatory agents: corticosteroids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antiinflammatory-agents-corticosteroids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. <strong>Actions</strong>: inhibit bronchodilation; decrease activity of inflammatory cells in the respiratory tract</p>
<p>B. <strong>Uses</strong></p>
<ol>
<li>Asthma</li>
<li>Withdrawal from systemic corticosteroids</li>
<li>Exacerbation of COPD or CAL</li>
</ol>
<p>C. <strong>Major side effects</strong></p>
<ol>
<li>Oral and nasal irritation</li>
<li>Fungal infections</li>
<li>Death due to adrenal insufficiency</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Carefully monitor client during stressful situations or when acute asthma attacks occur</li>
<li>Assess oral cavity, encourage drinking of water after each inhalation</li>
<li>Allow 1 to 2 minutes between inhalations</li>
</ol>
<p>E. <strong>Common drugs</strong></p>
<ol>
<li>Beclomethasone dipropionate (Vanceril)</li>
<li>Beclomethasone dipropionate (Beclovent)</li>
<li>Dexamethasone sodium phosphate (Decadron Phosphate)</li>
<li>Flunisolide (AerobBid)</li>
</ol>
<p>246 ▼ CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>A client, age 4, with bronchitis, is producing a thick, yellow sputum, is febrile, and is not sleeping well at night. He is prescribed dextromethorphan hydrobromide (Naldecon), 1 tsp tid during waking hours and dextromethorphan hydrobromide + guaifenesin + phenylpropanolamine + codeine (Naldecon CX), 1 tsp at night. What would the nurse explain to the client's mother?</li>
</ol>
<p>a. The Naldecon is better and therefore given more often
b. There is no difference between the two; they both help him bring up the secretions
c. The Naldecon helps him bring up the secretions during the day, and the other suppresses the cough at night
d. The Naldecon CX is more potent in bringing up secretions</p>
<ol start="2">
<li>The active ingredient in most antitussives that makes them controlled substances is</li>
</ol>
<p>a. Codeine sulfate
b. Phenobarbital sodium
c. Meperidine hydrochloride (Demerol)
d. Morphine sulfate</p>
<ol start="3">
<li>While making early morning rounds, the nurse notices a client's hands trembling. This client with CAL receiving aminophylline (Aminophyllin) through a continuous drip. The client says he feels fine, but could not sleep last night. The nurse would be concerned about</li>
</ol>
<p>a. CNS depression sometimes accompanying xanthine derivatives
b. CNS stimulation often accompanying xanthine derivatives
c. Anticholinergic effects of Theophylline
d. Cardiovascular depression accompanying aminophylline agents</p>
<ol start="4">
<li>During assessment for sinusitis and influenza, the client uses oxymetazoline (Afrin) nasal spray twice. When asked about the use of the Afrin, she replies, “I can’t seem to get my nose open no matter how much I use this stuff.” The nurse would suspect</li>
</ol>
<p>a. CNS stimulation
b. Improper administration
c. Rebound engorgement
d. Oxymetazoline toxicity</p>
<p>REVIEW QUESTIONS ▼ 247</p>
<ol start="5">
<li>Instructions for a client with asthma who is learning to use an inhaler would be as follows
a. Hold the inhaler between the lips, activate the inhaler, and take a deep breath
b. Shake the inhaler while holding it between two fingers, exhale completely, activate the inhaler for as many puffs as the physician ordered as you inhale slowly and deeply, and hold breath for approximately 5 to 10 seconds
c. Hold the inhaler between two fingers, take a deep breath as you activate the inhaler for as many puffs as the physician ordered, and continue inhaling for 5 seconds
d. Shake the inhaler, then take several deep breaths while activating the inhaler</li>
</ol>
<p>248 ▼ CHAPTER 15 DRUGS AFFECTING THE RESPIRATORY SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>The Naldecon helps to bring up the secretions during waking hours, and the codeine in the CX form helps to suppress the cough. The Naldecon is not better but serves a different purpose during the day. Option <em>b</em> is partially true, but the difference is that the CX (with codeine) helps to suppress the cough. There is no truth to the statement in option <em>d</em>.</td><td>Remember that <em>codiene</em> controls the cough to allow for rest. Note it doesn’t <em>eliminate</em> the cough reflex; It suppresses the cough reflex.</td></tr><tr><td><strong>2. Correct answer: a</strong></td><td></td></tr><tr><td>Codeine is used in many prescription cough agents to suppress the cough. The agent in option <em>b</em> is not used in respiratory agents because of the CNS depressant effect. Demerol would decrease respiration rate and depth, which could worsen most respiratory problems. Morphine is not used for respiratory problems; it is used, however, in acute pulmonary edema—not to impact the lung or decrease pain, but to decrease severe anxiety.</td><td>Make an educated guess and eliminate answers <em>b</em>, <em>c</em>, and <em>d</em>. That leaves <em>a</em>. If you had no idea of the correct response, cluster <em>c</em> and <em>d</em> since they are in the same classification and eliminate them. Then “go with what you know”—phenobarbital is more commonly used for seizure activity. Select option <em>a</em>.</td></tr><tr><td><strong>3. Correct answer: b</strong></td><td></td></tr><tr><td>Stimulation of the CNS creates nervousness and trembling</td><td>Match the clue in the stem, “could not sleep,” with “stimulation” in</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 249</p>
<p>and is common with xanthine derivatives. Theophylline products do not have anticholinergic effects.</p>
<p><strong>4. Correct answer: c</strong></p>
<p>Frequent administration of Afrin can cause rebound engorgement. The complaints by the client in option <em>a</em> are not explained by CNS stimulation. Administration, even if improper, would not cause these symptoms in option <em>b</em>. Toxicity is not a side effect of this medication.</p>
<p><strong>5. Correct answer: b</strong></p>
<p>This is the best explanation of the length of inhalation after activation of the inhaler; if a second dose is needed the client should wait 1 to 2 minutes. The explanation in option <em>a</em> is true but not clear enough. The client should exhale before activating the inhaler and taking a deep breath. Activation of the inhaler should be slightly after initial inhalation.</p>
<p>response <em>b</em>. The other responses in <em>a</em> and <em>d</em> suggest a slowing.</p>
<p>Match ideas: “can’t get my nose open” suggests “engorgement.”</p>
<p>If you have no idea of the correct response, select the one that gives the most detail or information, <em>b</em>.</p>
<p>^{}[]</p>
<p>251
CHAPTER 16</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-used-to-treat-cancer">Drugs Used to Treat Cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-to-treat-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the major groups of drugs used to treat cancer.</li>
<li>Identify the most common side effects of antineoplastic agents.</li>
<li>Describe nursing implications for these agents.</li>
</ul>
<p>252 ▼ CHAPTER 16 DRUGS USED TO TREAT CANCER</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Alopecia</strong>
Partial or complete lack or loss of hair.</p>
<p><strong>Bone marrow depression</strong>
A suppression of the manufacture and maturation of red blood cells.</p>
<p><strong>Cell-cycle nonspecific</strong>
The action of an agent without regard to the stage of cell division.</p>
<p><strong>Cell-cycle specific</strong>
The action of an agent at a specified stage of cell division.</p>
<p><strong>Chemotherapeutic agent</strong>
The treatment of infections and other diseases with chemical agents. In <em>modern usage</em>, it usually refers to the use of chemicals to <em>destroy cancer cells</em> on a selective basis; not to kill the cells but to impair their ability to replicate. Agents are termed cytotoxic.</p>
<p><strong>Non-vesicant</strong>
A drug incapable of causing tissue necrosis when extravasated.</p>
<p><strong>Stomatitis</strong>
Any inflammatory condition in the mouth.</p>
<p><strong>Vesicant</strong>
A drug capable of causing tissue necrosis when extravasated.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antineoplastics">ANTINEOPLASTICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antineoplastics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-general-considerations">I. General considerations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-considerations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Goals of treatment are to kill cancer cells and to conserve normal cells by interfering with cancer cell reproduction. These agents are used to do the following</strong></p>
<ol>
<li>Cure</li>
<li>Relieve symptoms</li>
<li>Prevent complications</li>
<li>Reduce tumor size before surgery</li>
</ol>
<p><strong>B. Two types of agents</strong></p>
<ol>
<li>Cell-cycle specific: respond during a specific cycle of the cell. Usually work best in multiple, repeated doses.</li>
<li>Cell-cycle nonspecific: respond during any phase, sometimes in more than one phase at a time. These agents are dose-dependent.</li>
</ol>
<p><strong>C. Growth fraction: the number of proliferating cells in the system. Because the bone marrow, hair follicles, and cells of the gastrointestinal (GI) tract have the highest growth fraction, these areas suffer the greatest toxicity.</strong></p>
<p>ANTINEOPLASTICS ▼ 253</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-principles-of-chemotherapy">D. Principles of chemotherapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-principles-of-chemotherapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Timing of dose around the cell cycle and in relation to other drugs is critical</li>
<li>Combination therapy is often more effective</li>
<li>Effectiveness of the drug relies on the number of cells in division</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-recovery-periods-are-needed-to-allow-normal-cells-to-regenerate-therefore-chemotherapy-may-be-given-for-several-months-and-then-stopped-for-a-period-of-time">E. Recovery periods are needed to allow normal cells to regenerate. Therefore chemotherapy may be given for several months and then stopped for a period of time.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-recovery-periods-are-needed-to-allow-normal-cells-to-regenerate-therefore-chemotherapy-may-be-given-for-several-months-and-then-stopped-for-a-period-of-time" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="f-agents-are-classified-according-to-tissue-response-if-infiltration-occurs">F. Agents are classified according to tissue response if infiltration occurs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-agents-are-classified-according-to-tissue-response-if-infiltration-occurs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Vesicant: causing blisters, tissue sloughing, necrosis</li>
<li>Nonvesicant: usually administered first, no severe tissue destruction</li>
<li>Irritant: causing cellulitis, thrombophlebitis, possible necrosis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-preparation-and-administration">II. Preparation and administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-preparation-and-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-handling-of-chemotherapeutic-agents">A. Handling of chemotherapeutic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-handling-of-chemotherapeutic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Use gloves, protective garment, mask</li>
<li>Use laminar flow hood for preparation</li>
<li>Prime the intravenous (IV) line with normal saline, then hang the chemotherapeutic agent. The IV line can also be primed under a laminar flow hood.</li>
<li>Dispose all materials used in preparation and administration in a container labeled “Hazardous Waste”</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-management-during-administration">B. Management during administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-management-during-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>After drawing up the medication, change the needle</li>
<li>Check that the client has been informed of benefits and risks</li>
<li>Choose appropriate site (start distal and move to proximal sites; avoid sites over joints)</li>
<li>Know drug compatibilities</li>
<li>Consider sequence, delivery, vesicant properties</li>
<li>Check for blood return in IV according to agency policy</li>
<li>Avoid extravasation of IV; stabilize with splint if necessary</li>
<li>Know the characteristics of the individual drug being administered</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-major-side-effects-and-nursing-implications">III. Major side effects and nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-major-side-effects-and-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-bone-marrow-depression">A. Bone marrow depression<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-bone-marrow-depression" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Leukopenia: a decrease in the number of white blood cells. Assess for infection. A temperature of 99° F in the leukopenic client is a concern.</li>
</ol>
<p>CHAPTER 16 DRUGS USED TO TREAT CANCER</p>
<ol start="2">
<li>
<p>Thrombocytopenia: a decrease in the number of platelets. Assess for bleeding such as petechiae (typically on the chest or upper arms).</p>
</li>
<li>
<p>Anemia: a decrease in hemoglobin; monitor hemoglobin and hematocrit (H&amp;H). Assess H&amp;H and for clinical findings—pallor of skin, increased fatigue, or shortness of breath especially with activity.</p>
</li>
</ol>
<p>B. Nausea and vomiting (N/V): give antiemetics before symptoms develop and before therapy begins</p>
<ol>
<li>Chemotherapy agents stimulate the chemoreceptor trigger zone</li>
<li>N/V may be psychogenic or anticipatory</li>
</ol>
<p>C. Stomatitis: inflammation of the mouth; offer good mouth care and topical antibiotics or analgesics
D. Alopecia: loss of hair; may be most distressing for clients</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-classification-of-agents-table-16-1">IV. Classification of agents (Table 16-1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-classification-of-agents-table-16-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Alkylating agents
B. Antimetabolites
C. Antibiotics
D. Hormonal agents
E. Radioactive agents
F. Miscellaneous individual agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-general-nursing-implications">V. General nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-general-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Recommend use of body surface area (BSA) to determine correct dosage
B. Avoid contact with skin or inhalation
C. Know hospital protocol for administering agents
D. Monitor blood counts
E. Assess condition of skin, IV site, bowel habits, signs of dehydration, bleeding, infection
F. Offer oral hygiene and assess oral cavity
G. Offer small, frequent meals
H. Do not handle or administer if you are pregnant or breast feeding</p>
<p>I. What to teach the client</p>
<ol>
<li>Signs of infection, bleeding, dehydration</li>
<li>To avoid over-the-counter medications</li>
<li>The need for compliance</li>
<li>That relief of nausea is maximized with antiemetics before the next chemotherapy visit</li>
</ol>
<p>255
Continued.</p>
<p>Table 16-1. Antineoplastic Agents: Classifications, Actions, Side Effects, Uses, and Considerations</p>
<table><thead><tr><th>Classification/Action</th><th>Side Effects</th><th></th><th></th><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr><td></td><td>S</td><td>NS</td><td>BD</td><td>N-V</td><td>Alo</td><td>Sto</td><td>Uses</td><td>Considerations</td></tr><tr><td>Alkylating Agents</td><td></td><td>*</td><td>++</td><td>+</td><td>+</td><td></td><td>Leukemia; Hodgkin's; lymphoma; cancers of the breast, ovaries, testes, prostate</td><td>Cause infertility problems</td></tr><tr><td>Busulfan (Myleran)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Mustard is a vesicant</td></tr><tr><td>Chlorambucil (Leukeran)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Cisplatin is an irritant</td></tr><tr><td>Cisplatin (Platinol)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mechlorethamine (Mustard)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>▼ Disrupt structure of DNA</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Antimetabolites</td><td>*</td><td></td><td>++</td><td></td><td></td><td>+</td><td>Leukemia; cancers of the breast, GI tract, neck, cervix</td><td>Can cause nephrotoxicity and liver dysfunction</td></tr><tr><td>Cytarabine (Cytosar-U)</td><td></td><td></td><td></td><td></td><td></td><td></td><td>Effective in rapidly proliferating cancers</td><td>Monitor BUN, creatinine</td></tr><tr><td>Floxuridine (FUDR)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Encourage fluids</td></tr><tr><td>Fluorouracil (5-FU)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Taking folic acid may increase protection of normal cells</td></tr><tr><td>Mercaptopurine (6-MP)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Some are irritants</td></tr><tr><td>Methotrexate (MTX)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>▼ Inhibit DNA and RNA synthesis</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hormonal Antineoplastic Agents</td><td></td><td></td><td></td><td>+</td><td>+</td><td></td><td>Cancers of prostate, breast, endometrium, renal system</td><td>Mostly palliative</td></tr><tr><td>Androgens, estrogens, progesterones, corticosteroids</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Teach about characteristics of opposite sex, decreased libido, and breast tenderness</td></tr><tr><td>▼ Cytostatic; alter hormonal environment of tumor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S = Cell-cycle specific</td><td>N-V = Nausea/vomiting</td><td></td><td></td><td></td><td></td><td>+ = Frequently occurs</td><td></td><td></td></tr><tr><td>NS = Cell-cycle nonspecific</td><td>Alo = Alopecia</td><td></td><td></td><td></td><td></td><td>++ = Severe side affect</td><td></td><td></td></tr><tr><td>BD = Bone marrow depression</td><td>Sto = Stomatitis</td><td></td><td></td><td></td><td></td><td>▼ = Action of agents in classification</td><td></td><td></td></tr></tbody></table>
<p>Table 16-1. Antineoplastic Agents: Classifications, Actions, Side Effects, Uses, and Considerations—cont'd</p>
<table><thead><tr><th>Classification/Action</th><th>Side Effects</th><th></th><th></th><th></th><th></th><th></th><th>Uses</th><th>Considerations</th></tr></thead><tbody><tr><td></td><td>S</td><td>NS</td><td>BD</td><td>N-V</td><td>Alo</td><td>Sto</td><td></td><td></td></tr><tr><td>Radioactive Drugs</td><td>*</td><td></td><td>++</td><td></td><td></td><td></td><td>Leukemia, thyroid cancer</td><td>Require protective isolation to prevent radiation contamination</td></tr><tr><td>Sodium radioiodine (Iodotope)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>May cause radiation sickness</td></tr><tr><td>Sodium radiophosphate (P 32) Radiogold (150Au)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Emit radiation to destroy specific tissue</td><td></td><td>*</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Antibiotics</td><td>*</td><td>*</td><td>++</td><td>+</td><td>+</td><td></td><td>Hodgkin's, testicular carcinoma, breast and bladder cancers</td><td>All are vesicants except bleomycin is an irritant</td></tr><tr><td>Doxorubicin (Adriamycin)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Severe tissue damage if extravasate</td></tr><tr><td>Bleomycin (Blenoxane)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Teach signs of infection</td></tr><tr><td>Plicamycin (Mithracin)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Bind with DNA; cytotoxic effect; antimicrobial activity</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S = Cell-cycle specific</td><td>N-V = Nausea/vomiting</td><td></td><td></td><td></td><td></td><td>+ = Frequently occurs</td><td></td><td></td></tr><tr><td>NS = Cell-cycle nonspecific</td><td>Alo = Alopecia</td><td></td><td></td><td></td><td></td><td>++ = Severe side affect</td><td></td><td></td></tr><tr><td>BD = Bone marrow depression</td><td>Sto = Stomatitis</td><td></td><td></td><td></td><td></td><td>▼ = Action of agents in classification</td><td></td><td></td></tr></tbody></table>
<p>REVIEW QUESTIONS ▼ 257</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>A client diagnosed with cancer of the testes is receiving an antibiotic antineoplastic agent. The nurse would teach him to
a. Eat six small meals instead of three large ones
b. Report a temperature of 101° F, chills, and any discomfort
c. Drink 2400 cc of fluids to prevent constipation
d. Report signs of nephrotoxicity</p>
</li>
<li>
<p>Which of the following might occur because of the high growth fraction in response to chemotherapeutic agents?
a. Headache
b. Hypernatremia
c. Diarrhea
d. Constipation</p>
</li>
<li>
<p>Antimetabolites cause which additional severe side effect?
a. Liver complications
b. Infertility
c. Differences in sex characteristics
d. Ototoxicity</p>
</li>
<li>
<p>Before giving parenteral a chemotherapeutic agent, the nurse would perform which nursing assessment?
a. Assess bowel sounds
b. Check the last complete blood count for a high white count
c. Assess for stomatitis
d. Check for adequate blood return from the IV</p>
</li>
<li>
<p>A client is experiencing the signs of bone marrow depression—thrombocytopenia. The nurse would teach him to observe daily for
a. Infection
b. Stomatitis
c. Petechiae
d. Diarrhea</p>
</li>
<li>
<p>Two chemotherapeutic agents are ordered to be given: one is a vesicant, the other a nonvesicant. In what order would the nurse give them?
a. Give the nonvesicant first because the vesicant may irritate the IV site
b. Give the vesicant to get the most difficult one infused first
c. It should not matter
d. Administer the agents together</p>
</li>
</ol>
<p>258 ▼ CHAPTER 16 DRUGS USED TO TREAT CANCER</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>Bone marrow depression is the prime side effect and could cause leukopenia. <em>If</em> nausea is a problem, six small meals could help. Constipation and nephrotoxicity are not common side effects.</td><td>Make an educated guess: most chemotherapy for cancer has side effects of bone marrow depression. This results in a decreased white count with increased risk of infection. Thus response <em>b</em> is best.</td></tr><tr><td><strong>2. Correct answer: c</strong></td><td></td></tr><tr><td>Diarrhea is common because the cells of the GI tract multiply rapidly. High-growth fraction does not affect the brain, causing headaches. A high-growth fraction does not cause an elevated sodium level. Constipation is not a common side effect.</td><td>Figure that “high-growth fraction” attracts the medication for a toxic effect and irritability. Of the given responses, only <em>c</em> suggests irritability.</td></tr><tr><td><strong>3. Correct answer: a</strong></td><td></td></tr><tr><td>Hepatotoxicity is a common side effect of these agents. Option <em>a</em> is not a side effect with these drugs. Option <em>c</em> is a major side effect of the hormonal antineoplastic agents. Complications in hearing are not common with chemotherapeutic agents.</td><td>The important word in the stem is “severe.” It leads to response <em>a</em>, since, of the given responses, this option would be the most severe side effect in any situation.</td></tr><tr><td><strong>4. Correct answer: d</strong></td><td></td></tr><tr><td>Many of the agents are irritating if extravasation occurs; a healthy IV line with adequate blood flow is necessary to prevent vascular complications.</td><td>Use common knowledge that before administration of an IV medication, the line needs to be patent, especially if the agent is caustic to the vein.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 259</p>
<p>Assessing bowel sounds may be advisable if nausea and diarrhea are present, but not before administering the agent. Response <em>b</em> is not a necessary nursing action before giving the agents; since many of the agents lower the white count, high counts are not as common. Stomatitis is usually a side effect of the agents.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="5-correct-answer-c">5. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Bleeding is possible with thrombocytopenia because of a decrease in platelets. Petechiae, especially on the anterior chest or upper arms, is an early sign of low platelets. Infection would be a concern if leukopenia were present. Stomatitis is not a complication arising from bone marrow depression. Response <em>d</em> is not a side effect of bone marrow depression.</p>
<p>Cluster responses <em>a</em>, <em>b</em>, and <em>d</em> under “involvement with inflammation.” The only response left is <em>c</em>. Use this if you have no clue to the correct answer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="6-correct-answer-a">6. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>If the vesicant were given first and caused irritation, the non-vesicant would not be administered unless a new line were started. The most irritating should be given last in case complications arise. Because of the possible complications, it does make a difference which is given first. Two agents should never be given at the same time because of the possible side effects and complications.</p>
<p>Use common sense to conclude that the nonirritating agent is to be given first.</p>
<p>^{}[]</p>
<p>261
CHAPTER 17</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-used-to-treat-infections">Drugs Used to Treat Infections<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-to-treat-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the difference between narrow-spectrum and broad-spectrum antimicrobial agents.</li>
<li>Describe the major classifications of agents used: penicillins, cephalosporins, tetracyclines, sulfonamides, aminoglycosides, macrolides, quinolones.</li>
<li>Describe the agents and uses of antifungal, antiviral, antitubercular, antihelmintic, and antimalarial agents.</li>
<li>Identify the major side effects and nursing implications for each of the classifications.</li>
</ul>
<p>262 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Peak and trough</strong>
Test obtained to establish the peak, the highest concentration of a drug, may be measured immediately after the drug has been administered; and the trough, the lowest concentration of a drug, may be measured immediately before the drug is administered.</p>
<p><strong>Resistance</strong>
A situation when an organism is not affected or only minimally affected by antimicrobial drugs.</p>
<p><strong>Sensitivity</strong>
A situation when an organism is affected by low concentrations of antimicrobial drugs.</p>
<p><strong>Superinfection</strong>
An infection occurring during antimicrobial treatment for another infection.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antibiotics">ANTIBIOTICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antibiotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-general-information">I. General information<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-general-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Agent classifications</strong></p>
<ol>
<li>Narrow-spectrum: treat relatively limited number of organisms; less likely to disrupt the normal flora; used when an organism has been identified by a culture</li>
<li>Extended-spectrum: treat multiple organisms; more likely to disrupt the normal flora; used often when a specific causative organism is unknown</li>
</ol>
<p><strong>B. General side effects</strong></p>
<ol>
<li>Hypersensitivity</li>
<li>Toxicity to various organs: kidney, liver, skin, bone marrow</li>
<li>Superinfection based on the disruption of the normal flora of the body: black, furry tongue; thrush; vaginal discharge</li>
</ol>
<p><strong>C. Many microorganisms have become resistant to antibiotics. A culture and sensitivity (C&amp;S) or gram stain is preferred to specify the exact organism.</strong></p>
<p><strong>D. General nursing implications</strong></p>
<ol>
<li>Assess for the results of the C&amp;S or ensure that the culture has been completed before starting a new antibiotic</li>
<li>What to instruct the client
a. Take all of the medication, even after symptoms subside, to prevent recurrence of the infection</li>
</ol>
<p>ANTIBIOTICS: GENERAL INFORMATION, PENICILLINS ▼ 263</p>
<p>b. Use another type of contraceptive if the client is taking birth control pills. Many of the antibiotics will decrease the effectiveness of birth control pills.
c. Immediately report any signs of allergic reaction</p>
<ol start="3">
<li>
<p>Monitor blood levels
a. Peak: time of maximum effect
b. Trough: level prior to the next dose; should be drawn 30 minutes before the next dose is given</p>
</li>
<li>
<p>Monitor the complete blood count (CBC), especially the white blood count (WBC) and the differential to evaluate the effectiveness of the antibiotic; expect WBC to decrease</p>
</li>
<li>
<p>If severe diarrhea occurs, instruct the client to take buttermilk or yogurt to replace the normal intestinal flora</p>
</li>
<li>
<p>Know the difference
a. Bacteriostatic: tending to restrain the development of the reproduction bacteria
b. Bactericidal: tending to kill bacteria</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-penicillins">II. Penicillins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-penicillins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: interfere with cell wall synthesis and division of bacteria</p>
<p>B. Uses</p>
<ol>
<li>Gram-positive cocci, rods, and anaerobic bacteria</li>
<li>Pharyngitis: inflammation of the pharynx</li>
<li>Endocarditis: an abnormal, infectious condition that affects the endocardium and heart valves</li>
<li>Pneumonia</li>
<li>Meningitis</li>
<li>Syphilis, gonorrhea</li>
<li>Shigella: gram-negative organism causing gastroenteritis and bacterial dysentery</li>
<li>Salmonella: gram-negative, rod-shaped bacteria; affects the GI tract</li>
<li>Upper respiratory infections (URI)</li>
<li>Urinary tract infections (UTI)</li>
<li>Otitis media</li>
<li>Sinusitis</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Rash on abdomen, scalp, or arms—usually the first finding of allergic reaction</li>
<li>Anaphylaxis</li>
<li>Serum sickness: an immunologic disorder that may occur 2 to 3 weeks after the administration of an antiserum</li>
</ol>
<p>264 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<ol start="4">
<li>Hematologic reactions: decreased hemoglobin, prolonged bleeding</li>
<li>Diarrhea</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Assess for known previous allergies</li>
<li>Discontinue immediately if signs of allergic reactions occur. Benadryl may be given for mild reactions.</li>
<li>Monitor for seizures in clients with renal disease</li>
<li>Penicillin G (Pentids) should be given with food</li>
</ol>
<p><strong>E. Categories</strong></p>
<ol>
<li>Natural penicillins
a. Penicillin G (Pentids)
b. Penicillin VK (V-Cilin K)</li>
<li>Penicillinase-resistant penicillins
a. Methicillin (Staphcillin)
b. Nafcillin (Unipen)</li>
<li>Aminopenicillins
a. Amoxicillin (Amoxil) ☑
b. Ampicillin (Polycillin)</li>
<li>Extended-spectrum penicillins
a. Piperacillin (Pipracil)
b. Carbenicillin (Geopen)
c. Ticarcillin (Ticar)</li>
<li>Combination products
a. Amoxicillin + clavulanic acid (Augmentin) ☑
b. Ampicillin + sulbactam (Unasyn) ☑
c. Ticarcillin + clavulanic acid (Timentin)</li>
</ol>
<p><strong>III. Cephalosporins</strong></p>
<p><strong>A. Actions:</strong> inhibit cell wall synthesis, thereby resembling penicillin action. Work especially well on rapidly growing organisms; they are bacteriostatic and bacteriocidal.</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Upper respiratory infection</li>
<li>Urinary tract infection</li>
<li>MRSA (methicillin-resistant staphylococci)</li>
<li>Beta-hemolytic streptococci</li>
<li>Klebsiella infections</li>
<li>Surgical prophylaxis</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Superinfections</li>
</ol>
<p>CEPHALOSPORINS, TETRACYCLINES ▼ 265</p>
<ol start="2">
<li>More resistance to gram-positive organisms as spectrum broadens (third generation)</li>
<li>False-positive glucose values</li>
<li>Nephrotoxicity: toxicity to the kidney</li>
<li>Pain at injection site</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Assess for allergies; if allergic to penicillin, client may not be able to take these agents either</li>
<li>Monitor renal status: I&amp;O, serum creatinine</li>
<li>Assess for superinfection with teaching clients about the use of buttermilk and yogurt</li>
<li>Monitor IV infusion closely for pain and irritation</li>
<li>Monitor glucose level if client is a diabetic</li>
</ol>
<p><strong>E. Generations according to spectrum</strong></p>
<ol>
<li>
<p>First generation: work best against gram-positive bacteria; ☐ often used in clients allergic to penicillin
a. Uses: E. coli, klebsiella, proteus, salmonella, shigella
b. Common drugs
(1) Cephalothin (Keflin)
(2) Cephalexin (Kefzol)
(3) Cephapirin (Cefadyl) ☑
(4) Cephradine (Anspor) ☑
(5) Cefadroxil (Duricef) ☑</p>
</li>
<li>
<p>Second generation: work best against gram-negative bacteria
a. Uses: proteus, E. cloacae, hemophilus influenza
b. Common drugs
(1) Cefamandole (Mandol) ☑
(2) Cefoxitin (Mefoxin)
(3) Cefaclor (Ceclor)
(4) Cefonocid (Monocid)
(5) Cefotetan (Cefotan)
(6) Ioracarbef (Lorabid)</p>
</li>
<li>
<p>Third generation: work best against gram-negative bacteria
a. Uses: serratia, pseudomonas aeruginosa
b. Common drugs
(1) Cefotaxime (Claforan)
(2) Cefoperazone (Cefobid)
(3) Ceftriaxone (Rocephin) ☑</p>
</li>
</ol>
<p><strong>IV. Tetracyclines (broad-spectrum)</strong></p>
<p><strong>A. Actions:</strong> inhibit protein synthesis in the bacterial cell; bacteriostatic</p>
<p>266 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<p><strong>AB. Uses</strong></p>
<ol>
<li>Gram-positive and gram-negative bacteria</li>
<li>Aerobic and anaerobic bacteria</li>
<li>Lyme’s disease</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Superinfection</li>
<li>Interfere with normal calcification and may cause gray teeth</li>
<li>Photosensitivity: sunscreens do not seem to decrease photosensitivity</li>
<li>GI disturbances: nausea, vomiting, diarrhea</li>
<li>Hepatotoxicity: toxicity to the liver</li>
</ol>
<p><strong>D. Contraindicated for use in children under 8 years of age due to staining of teeth. Decreased absorption if taken with iron, milk, and antacids.</strong></p>
<p><strong>E. Nursing implications</strong></p>
<ol>
<li>Take on an empty stomach (better absorption) unless GI disturbances occur. Can be taken with food but may decrease absorption.</li>
<li>Use protection in direct sunlight; clothing rather than sunscreen</li>
<li>Assess for signs of superinfection: oral cavity, vaginal discharge</li>
<li>Administer with full glass of water</li>
<li>Inform patient that stools may be yellow or green</li>
</ol>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Doxycycline (Vibramycin)</li>
<li>Minocycline (Minocin)</li>
<li>Oxytetracycline (Terramycin)</li>
</ol>
<p><strong>V. Aminoglycosides</strong>
<strong>A. Actions:</strong> inhibit protein synthesis; bacteriostatic (low doses) and bacteriocidal (high doses)
<strong>B. Use:</strong> primarily for gram-negative bacilli
<strong>C. Major side effects</strong></p>
<ol>
<li>Ototoxicity: toxic to nerves or organs of hearing; results in a hearing loss</li>
<li>Nephrotoxicity</li>
<li>Dizziness, vertigo, ataxia</li>
<li>Neuromuscular blockade: the inhibition of a muscular contraction activated by the nervous system, resulting in weakness or paralysis</li>
</ol>
<p><strong>D. Interactions:</strong> inactivation when mixed with extended-spectrum penicillins</p>
<p>AMINOGLYCOSIDES, MACROLIDES, SULFONAMIDES ▼ 267</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Do not give at the same time as extended-spectrum penicillin; separate by at least 2 hours</li>
<li>Use cautiously with anesthetics and muscle relaxants</li>
<li>Monitor renal function: creatinine, I&amp;O</li>
<li>Monitor peak and trough levels</li>
<li>Assess for hearing loss</li>
<li>Give with a large amount of fluids</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Gentamicin (Garamycin)</li>
<li>Amikacin (Amikin)</li>
<li>Tobramycin (Nebcin, Tobrex)</li>
<li>Streptomycin</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="vi-macrolides">VI. Macrolides<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-macrolides" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-actions-bind-to-ribosomes-to-inhibit-protein-synthesis-bacteriostatic-action">A. Actions: bind to ribosomes to inhibit protein synthesis; bacteriostatic action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-bind-to-ribosomes-to-inhibit-protein-synthesis-bacteriostatic-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Gram-negative and gram-positive organisms</li>
<li>Staph Aureus infections</li>
<li>Pneumonia</li>
<li>Patients allergic to penicillin</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>GI disturbances: diarrhea, nausea, vomiting</li>
<li>Hepatotoxicity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Assess for frequent diarrhea and monitor weight loss, especially in children</li>
<li>Monitor for signs of hepatotoxicity (increase in ALT, AST)</li>
<li>Give with a full glass of water</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Erythromycin ethylsuccinate (EES)</li>
<li>Clarithromycin (Biaxin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="vii-sulfonamides-broad-spectrum">VII. Sulfonamides (broad-spectrum)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-sulfonamides-broad-spectrum" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-action-interfere-with-paba-to-decrease-synthesis-of-folic-acid-which-is-needed-for-bacteria-survival">A. Action: interfere with PABA to decrease synthesis of folic acid, which is needed for bacteria survival<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-interfere-with-paba-to-decrease-synthesis-of-folic-acid-which-is-needed-for-bacteria-survival" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Gram-negative and gram-positive organisms</li>
<li>Urinary tract infection</li>
<li>Otitis media</li>
<li>Vaginal infections</li>
<li>Prostatitis: inflammation of the prostate gland</li>
</ol>
<p>268 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Renal calculi</li>
<li>Hypersensitivity</li>
<li>Nephrotoxicity</li>
<li>Hematologic: decrease in WBC</li>
<li>Photosensitivity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Encourage fluids up to 1500 cc/day</li>
<li>Monitor I&amp;O, creatinine</li>
<li>Monitor CBC, WBC</li>
<li>Protect against sunlight with clothing</li>
<li>Take on an empty stomach (better absorption) unless GI disturbance occurs; then take with small amount of food</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Trimethoprim + sulfamethoxazole (Bactrim, Septra)</li>
<li>Sulfadiazine</li>
<li>Sulfisoxazole (Gantrisin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="viii-quinolones">VIII. Quinolones<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#viii-quinolones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-action-interrupt-dna-synthesis">A. Action: interrupt DNA synthesis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-interrupt-dna-synthesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Infection from E. coli</li>
<li>Gram-negative organisms</li>
<li>Urinary tract infection</li>
<li>Bronchitis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-common-side-effects">C. Common side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-common-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Photosensitivity</li>
<li>GI irritation: nausea</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Protect against sunlight</li>
<li>Inform the client that urine may be brown or bright orange</li>
<li>Monitor renal status (offer 1 to 2 L/day of fluids), I&amp;O, serum creatinine for an increase</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Ciprofloxacin (Cipro)</li>
<li>Norfloxacin (Noroxin)</li>
<li>Ofloxacin (Floxin)</li>
<li>Enoxacin (Penetrex)</li>
<li>Nitrofurantoin (Furadantin)</li>
<li>Phenazopyridine hydrochloride (Pyridium)</li>
</ol>
<p>QUINOLONES, ANTITUBERCULAR, ANTIVIRALS ▼ 269</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antitubercular-agents">ANTITUBERCULAR AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antitubercular-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. Actions: exert either a tuberculostatic or tuberculocidal effect by inhibiting mycolic acid, a necessary metabolite of the organism</p>
<p>II. Uses</p>
<p>A. Prevent or treat tuberculosis
B. Treat Hansen’s disease: leprosy
C. Treat persons with positive TB tests or known exposure</p>
<p>III. Major side effects</p>
<p>A. Hepatotoxicity
B. Headache, vertigo
☑ C. Neuritis: inflammation of a nerve from B₆ deficiency
D. Jaundice</p>
<p>IV. Nursing implications</p>
<p>A. Administer on empty stomach
B. Recommended for extended periods (&gt;6 months) because the organism may lie dormant in an individual
C. Stress compliance in completing the prescription
D. Monitor liver status for elevated serum ALT, AST and jaundice
E. Stress avoidance of alcohol because of the hepatotoxic effect and possible further impairment of the liver</p>
<p>V. Common drugs</p>
<p>A. Tuberculosis
☑ 1. Isoniazid (INH)
2. Rifampin (Rifadin)
☑ 3. Streptomycin
B. Hansen’s disease—dapsone (DDS)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-agents">OTHER AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I. Antivirals</p>
<p>A. Action: interfere with DNA replication of virus. This interference also can occur in the host cell.
B. Uses</p>
<ol>
<li>Herpes simplex</li>
<li>Influenza A and B</li>
<li>AIDS</li>
</ol>
<p>270 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<p>C. <strong>Major side effects</strong></p>
<ol>
<li>Nausea, vomiting</li>
<li>Diarrhea</li>
<li>Renal toxicity</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Use gloves, as some of the lesions are contagious</li>
<li>Monitor IV use carefully; prevent phlebitis</li>
</ol>
<p>E. <strong>Common drugs</strong></p>
<ol>
<li>Herpes: acyclovir (Zovirax)</li>
<li>Respiratory syncytial virus: ribavirin (Virazole)</li>
<li>AIDS
a. Didanosine (Videx)
b. Zidovudine (AZT)</li>
<li>☑ Influenza A: amantadine hydrochloride (Symmetrel)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-antifungals">II. Antifungals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antifungals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. <strong>Action:</strong> alter the permeability of the cell membrane</p>
<p>B. <strong>Uses</strong></p>
<ol>
<li>☑ Systemic and topical fungal infections</li>
<li><strong>Histoplasmosis:</strong> an infection caused by inhalation of spores of the fungus histoplasma capsulatum</li>
<li>☑ Thrush: candidiasis of the tissue of the mouth</li>
</ol>
<p>C. <strong>Major side effects</strong></p>
<ol>
<li>Nephrotoxicity</li>
<li>Fever, chills</li>
<li>Thrombophlebitis</li>
<li>Nausea, vomiting</li>
<li>Hypokalemia: low potassium (&lt;3.5 mEq/L)</li>
<li>Hypomagnesemia: low magnesium (&lt;1.5 mEq/L)</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>☑ Monitor electrolytes, BUN, creatinine, CBC</li>
<li>Monitor I&amp;O due to the nephrotoxicity</li>
<li>Assess vital signs and treat fever with acetaminophen</li>
<li>Instruct client to report any abnormal symptoms</li>
<li>Instruct client to swish Mycostatin around the mouth and then swallow</li>
</ol>
<p>E. <strong>Common drugs</strong></p>
<ol>
<li>Amphotericin B (Fungizone)</li>
<li>Miconazole (Monistat)</li>
<li>Ketoconazole (Nizoral)</li>
<li>☑ Nystatin (Mycostatin)</li>
</ol>
<p>ANTIFUNGALS, ANTIHELMINTICS, ANTIMALARIALS ▼ 271</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-antihelmintic-agents">III. Antihelmintic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-antihelmintic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: destroy parasitic helminths (worms) by affecting the nervous system
B. Uses: treat roundworms, tapeworms, flatworms, and flukes
C. Major side effects</p>
<ol>
<li>Toxicity: medicine kills the helminth, which spills out its toxin</li>
<li>GI distress: nausea, anorexia</li>
<li>Dehydration, anemia
D. Nursing implications</li>
<li>Assess for proper identification of the type of worm</li>
<li>Stress good handwashing, gloving, and proper disposing of feces and urine</li>
<li>Suggest treating all members of the family to prevent recurrence</li>
<li>Encourage washing bed linen with hot water to destroy the parasites</li>
<li>Instruct patient to take the entire recommended dose
E. Common drugs
☑ 1. For amebiasis: metronidazole (Flagyl)
☑ 2. For roundworm/hookworm: mebendazole (Vermox)
☑ 3. For pinworm: pyrantel pamoate (Antiminth)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-antimalarial-agents">IV. Antimalarial agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-antimalarial-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: kill the parasite
B. Use: malaria
C. Major side effects</p>
<ol>
<li>GI distress: nausea</li>
<li>Agranulocytosis</li>
<li>Headache, agitation
D. Nursing implications</li>
<li>Complete the entire course of therapy</li>
<li>May begin taking 1 to 2 weeks before traveling to an endemic area</li>
<li>Give with food to minimize GI distress
E. Common drugs</li>
<li>Chloroquine (Aralen)</li>
<li>Hydroxychloroquine sulfate (Plaquenil)</li>
</ol>
<p>CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Nephrotoxicity and ototoxicity are <strong>major side effects</strong> with which of the following?
a. Penicillin
b. Sulfonamides
c. Erythromycin
d. Aminoglycosides</p>
</li>
<li>
<p>Nursing implications for clients on antibiotics for an <strong>extended period</strong> would include which of the following?
a. Take with a full glass of water or food
b. Take buttermilk or yogurt if diarrhea occurs
c. Watch for a decrease in urine production
d. Watch for an increase in urine production</p>
</li>
<li>
<p>A <strong>serious and dangerous side effect</strong> of penicillin is
a. Anaphylaxis
b. Nephrotoxicity
c. Hepatotoxicity
d. Neuromuscular blockade</p>
</li>
<li>
<p>The best antibiotic for a urinary tract infection is which of these groups?
a. Penicillin G (Pentids)
b. Tobramycin sulfate (Tobrex)
c. Trimethoprim + sulfamethoxazole (Bactrim)
d. Erythromycin ethylsuccinate (EES)</p>
</li>
<li>
<p>Since a client's annual tuberculosis test was reported as positive, the client should be placed on which agent prophylactically?
a. Cloroquine (Aralene)
b. Mebendazole (Vermox)
c. Isoniazid (INH)
d. No agent; obtain a chest x-ray</p>
</li>
<li>
<p>Which is the best agent for amebiasis?
a. Mebendazole (Vermox)
b. Metronidazole (Flagyl)
c. Pyrantel pamoate (Antiminth)
d. Chloroquine (Aralen)</p>
</li>
</ol>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 273</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: d</strong></td><td></td></tr><tr><td>Both of these are major side effects of the aminoglycosides and should be monitored carefully. The key word is “major” side effects. The aminoglycosides, garamycin, kanamycin, and streptomycin, can be thought of as the “mycin” family, which has affects on a few major body functions. A major side effect of penicillins is rash, initially found on the abdomen. Renal calculi from crystals is a major side effect of sulfonamides, especially if sufficient fluids are not taken during therapy. GI disturbance, especially diarrhea, is a major side effect of erythromycin.</td><td>Refer to the rationale.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>All antibiotics can destroy the normal flora in the intestines, and diarrhea can occur. Yeast, buttermilk, or yogurt can replace the bacteria. Some of the agents require hydration because of the effect on the kidneys. Not all antibiotic agents are nephrotoxic. None of the antibiotic agents result in an increase in urine output.</td><td>The key word in the stem is “extended” period. Think of superinfections or secondary infections as the result of the suppression of normal flora. In short-term therapy this may be less likely.</td></tr></tbody></table>
<p>274 ▼ CHAPTER 17 DRUGS USED TO TREAT INFECTIONS</p>
<ol start="3">
<li><strong>Correct answer: a</strong>
Severe allergic response such as anaphylaxis is more common with the penicillin group.
Aminoglycosides are particularly nephrotoxic.
Tetracyclines are hepatotoxic.
Aminoglycosides can produce neuromuscular blockade.</li>
</ol>
<p>The important words in the stem are “serious” and “dangerous.” These guide you to response <em>a</em>.</p>
<ol start="4">
<li><strong>Correct answer: c</strong>
Sulfonamides are broad spectrum and work well on urinary tract infections. Penicillins work best on gram-positive bacteria. Aminoglycosides work best on gram-negative bacilli. Macrolides work best on pneumonia or staph aureus infections.</li>
</ol>
<p>Remember <em>Bactrim</em> is used for bladder infections.</p>
<ol start="5">
<li><strong>Correct answer: c</strong>
INH is the recommended drug to treat positive TB skin test or the active disease. The agent in option <em>a</em> is recommended for malaria. The agent in option <em>b</em> is recommended for roundworms. The most current recommendation is to treat any positive TB test with 6 months of INH, whether the chest x-ray is positive or not.</li>
</ol>
<p>Eliminate option <em>d</em> since it does not answer THE question of which agent. Then approach your choice with a “go with what you know”; most likely INH is a more familiar drug than the drugs in options <em>a</em> and <em>b</em>. Select option <em>c</em>.</p>
<ol start="6">
<li><strong>Correct answer: b</strong>
Option <em>b</em> is the drug of choice for amebiasisa. Option <em>a</em> is the drug of choice for roundworms. Option <em>c</em> is the drug of choice for pinworms. Option <em>d</em> is the drug of choice for malaria.</li>
</ol>
<p>For this type of difficult question, select an answer and go on. Keep your emotional reaction to a minimum so you can think about the remaining questions. This would be a good time for a few deep breaths with your eyes closed.</p>
<p>275
CHAPTER 18</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dermatological-agents">Dermatological Agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dermatological-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify agents used to treat various skin disorders.</li>
<li>Describe side effects, nursing implications, and uses for the different groups of drugs.</li>
<li>Discuss the medications administered to burn patients.</li>
</ul>
<p>276 ▼ CHAPTER 18 DERMATOLOGICAL AGENTS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Antiparasitic</strong>
A substance that kills parasites or inhibits their growth or reproduction such as amebicides, anthelmintics, and antimalarials.</p>
<p><strong>Antiseptic</strong>
A substance that inhibits the growth and reproduction of microorganisms.</p>
<p><strong>Astringent</strong>
A substance that causes contraction of tissues upon application, usually locally or in a bath such as alum or tannic acid.</p>
<p><strong>Debriding agent</strong>
A substance that removes damaged tissue or cellular debris from a wound to prevent infection and promote healing.</p>
<p><strong>Disinfectant</strong>
A chemical that can be applied to objects to destroy microorganisms.</p>
<p><strong>Emollient</strong>
A substance that softens tissue particularly the skin and mucous membranes.</p>
<p><strong>Keratolytics</strong>
A substance that loosens or causes shedding of the outer layer of skin.</p>
<p><strong>Liniments</strong>
A preparation, usually containing an alcoholic, oily, or soapy vehicle, that is rubbed into the skin as a counterirritant.</p>
<p><strong>PABA</strong>
Paraaminobenzoic acid, a topical sunscreen.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-antiseptics-and-disinfectants">I. Antiseptics and disinfectants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antiseptics-and-disinfectants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions-denature-protein-reduce-surface-tension-or-interfere-with-the-metabolic-processes-of-cell-growth">A. Actions: denature protein, reduce surface tension, or interfere with the metabolic processes of cell growth<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-denature-protein-reduce-surface-tension-or-interfere-with-the-metabolic-processes-of-cell-growth" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Slowing microorganisms that cause infection</li>
<li>Cleaning wounds</li>
<li>Douches</li>
<li>Irrigants</li>
<li>Preparing skin for treatment</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Hypersensitivity</li>
<li>Teratogenic effects on fetus</li>
<li>Nephrotoxicity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Know the proper use of the agent; some can be used to pack wounds and some cannot</li>
</ol>
<p>ANTISEPTICS, DISINFECTANTS, BATHS, CLEANSERS ▼ 277</p>
<ol start="2">
<li>Watch for signs of hypersensitivity: rash, itching, redness, drying of skin</li>
<li>Use gloves to apply</li>
<li>Know the proper dilution if required</li>
<li>Know the organism on the skin and the agent sensitive to that organism. Some of these agents are not effective against spores.</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Chlorhexidine gluconate (Hibiclens)</li>
<li>Sodium hydrochloride</li>
<li>Hydrogen peroxide</li>
<li>Acetic acid</li>
<li>Alcohol</li>
<li>Hexachlorophene (PhisoHex)</li>
</ol>
<p>II. Baths
A. Uses</p>
<ol>
<li>Cleanse</li>
<li>Soothe puritis</li>
<li>Medicate</li>
<li>Reduce temperature</li>
<li>Lubricate skin
B. Nursing implications</li>
<li>Can cause drying of the skin</li>
<li>Use only tepid water, without alcohol, to lower temperature
C. Common drugs</li>
<li>Oatmeal (Aveeno)</li>
<li>Starch</li>
<li>Gelatin</li>
<li>Alpha-Keri lotion</li>
</ol>
<p>III. Soaps and cleansers
A. Soaps</p>
<ol>
<li>Uses: for cleaning the skin and for enemas; are antimicrobial</li>
<li>Nursing implications
a. Soaps may irritate mucous membranes
b. May have glycerin or medication added</li>
<li>Common soaps
a. Safeguard
b. Zest
c. Dial
d. Lifebuoy
e. Castile</li>
</ol>
<p>278 ▼ CHAPTER 18 DERMATOLOGICAL AGENTS</p>
<p>B. Cleansers: soap-free or modified soap products; may include an emollient</p>
<ol>
<li>Uses: persons with sensitive or irritated skin or those with previous reactions to soap products; are not antimicrobial</li>
<li>Common cleansers
a. Phisoderm
b. Oatmeal (Aveeno bar)
c. Dove
d. Acne Aide
e. Caress
f. Neutrogena</li>
</ol>
<p>IV. Emollients
A. Actions: fatty or oily substances that soften or soothe irritated skin and mucous membranes; often used as vehicles for other medications
B. Uses</p>
<ol>
<li>Treating diaper rash</li>
<li>Lubricating</li>
<li>Soothing</li>
<li>Inserting tubes and catheters
C. Common emollients</li>
<li>Petrolatum (Vaseline)</li>
<li>Vitamin A&amp;D ointment (Clocream, Desitin)</li>
<li>Lubriderm</li>
<li>Nivea skin</li>
<li>Lanolin products</li>
<li>Glycerin (Corn Husker’s Solution)</li>
<li>K-Y Jelly</li>
</ol>
<p>V. Solutions and lotions
A. Actions</p>
<ol>
<li>Treat inflammation</li>
<li>Protect and heal skin</li>
<li>Decrease itching
B. Uses</li>
<li>Insect bites</li>
<li>Diaper rash</li>
<li>Prickly heat</li>
<li>Poison ivy</li>
<li>Acne</li>
<li>Chicken pox</li>
</ol>
<p>EMOLLIENTS, SOLUTIONS, ASTRINGENTS, SKIN PROTECTANTS ▼ 279</p>
<ol start="7">
<li>Infections</li>
<li>Wet dressings</li>
</ol>
<p>C. Common drugs</p>
<ol>
<li>Calamine lotion: shake well before application; good to relieve itching</li>
<li>Diphenhydramine hydrochloride (Benadryl)</li>
<li>Boric acid solution</li>
<li>Aluminum acetate solution (Burrow’s Solution)</li>
<li>Aluminum sulfate (Domeboro)</li>
</ol>
<p>D. Calamine + diphenhydramine hydrochloride (Caladryl) is not recommended for children with chicken pox. It will slow the recovery. Use oatmeal baths to minimize itching.</p>
<p>VI. Astringents
A. Actions: provide comfort because of tightening properties and ability to decrease inflammation and exudate
B. Uses: acne, hemorrhoids
C. Common agents</p>
<ol>
<li>Aluminum sulfate (Domeborro)</li>
<li>Tucks</li>
</ol>
<p>VII. Skin protectants
A. Actions: protect or coat minor skin irritations
B. Uses: ulcers, wounds, protection of skin
C. Nursing implications</p>
<ol>
<li>Physical sunscreens are thick and offer the best protection. Must be applied heavily.</li>
<li>Chemical sunscreens are absorbing and the most appealing</li>
<li>Sun protection factor (SPF) ranges from 2 to 45 and should be chosen depending on the climate and type of skin. The higher the number, the greater the protection.
D. Common drugs</li>
<li>Benzoin</li>
<li>Kerodex</li>
<li>PABA (suntan products)</li>
<li>Liquid petrolatum (mineral oil)</li>
</ol>
<p>VIII. Rubs and liniments
A. Actions</p>
<ol>
<li>Analgesic</li>
<li>Antiinflammatory</li>
</ol>
<p>280 ▼ CHAPTER 18 DERMATOLOGICAL AGENTS</p>
<ol start="3">
<li>Local anesthetic</li>
<li>Antiseptic</li>
</ol>
<p><strong>B. Uses</strong></p>
<ol>
<li>Muscle aches</li>
<li>Neuralgia</li>
<li>Rheumatoid arthritis</li>
<li>Sprains</li>
</ol>
<p><strong>C. Common drugs</strong></p>
<ol>
<li>BenGay</li>
<li>Vaporub</li>
<li>Aspercreme</li>
</ol>
<p><strong>IX. Protectives</strong>
<strong>A.</strong> Actions: soothe, cool, and form film on skin. The film aids in healing and in decreasing odors.
<strong>B.</strong> Uses: wounds or minor abrasions
<strong>C.</strong> Nursing implication: may have to be peeled off because the powders stick to wet surfaces only
<strong>D. Common drugs</strong></p>
<ol>
<li>Collodion</li>
<li>Zinc oxide</li>
<li>Talcum powder</li>
</ol>
<p><strong>X. Topical antiinfectives</strong></p>
<p><strong>A. Antibacterials</strong></p>
<ol>
<li>Actions: inhibit or destroy microorganisms by interfering with metabolic activity; also retard growth of bacteria</li>
<li>Uses
a. Wounds, minor abrasions
b. Acne
c. Burns
d. <em>Streptococcus</em> and <em>staphylococcus</em></li>
<li>Special considerations for silver sulfadiazine (Silvadene)
a. Stains clothing or skin a gray color
b. Hypersensitivity: can cause burning, itching, blistering
c. Can be absorbed systemically; monitor for renal insufficiency
d. Use gloves to apply</li>
<li>Common drugs
a. Bacitracin (Baciguent)
b. Neomycin sulfate (Myciguent)
c. Silver sulfadiazine (Silvadene Cream)
d. Mupirocin (Bactroban)</li>
</ol>
<p>PROTECTIVES, TOPICAL ANTIINFECTIVES, ANTIINFLAMMATORIES ▼ 281</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-antivirals">B. Antivirals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-antivirals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Actions: inhibit viral replication, decrease pain, and increase healing of skin lesions</li>
<li>Uses: treat herpes simplex, varicella zoster</li>
<li>Common drugs
a. Acyclovir (Zovirax)
b. Amantadine (Symmetrel)
c. Zidovudine (Retrovir)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-antifungals">C. Antifungals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-antifungals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Actions: offer fungistatic and fungicidal properties</li>
<li>Uses
a. Superficial fungal infections
b. Athlete’s foot
c. Jock itch
d. Ringworm
e. Candida albicans
f. Candidiasis</li>
<li>Common drugs
a. Clotrimazole (Lotrimin)
b. Toinaftate (Tinactin)
c. Nystatin (Mycostatin)
d. Amphotericin B (Fungizone)
e. Ketoconazole (Nizoral)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="xi-antiinflammatory-agents">XI. Antiinflammatory agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#xi-antiinflammatory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions">A. Actions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Alleviate inflammation response</li>
<li>Antipruritic</li>
<li>Vasoconstrictive</li>
<li>Reduce itching, redness, and swelling associated with an allergic response</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Psoriasis</li>
<li>Dermatitis</li>
<li>Minor skin irritations</li>
<li>Allergic responses</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-nursing-implications">C. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Do not use with an antifungal</li>
<li>Do not use on broken skin (increased absorption results)</li>
<li>Applying a dressing will increase absorption on thick lesions</li>
</ol>
<p>D. Common drugs 1. Hydrocortisone (Cortaid) 2. Betamethasone valerate (Valisone) 3. Desoximetasone (Topicort) 4. Fluocinonide (Lidex) 5. Flurandrenolide (Cordran)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="xii-antiparasitic-agents">XII. Antiparasitic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#xii-antiparasitic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Groups 1. Scabicides: eradicate scabies 2. Pediculicides: eradicate lice</p>
<p>B. Actions: cause paralysis and death of parasites by blocking nerve impulse transmission</p>
<p>C. Major side effects 1. Systemic effect, which can cause toxicity to kidneys, heart, and CNS 2. Seizures 3. Renal complications 4. Drying out of hair and skin 5. Irritation to skin: itching, stinging</p>
<p>D. Nursing implications 1. Encourage client to read the instructions well on the medication 2. Instructions vary concerning application a. Some call for repeating the application in 7 to 10 days b. Shampoos are left on 4 to 10 minutes. Instructions depend on whether hair is shampooed wet or dry. c. Lotion may need to be applied again in 24 hours, followed by a shower d. Gloves should be used if medication is applied by the nurse e. Bedding and clothing should be washed with hot water and bleached if possible f. The whole family may need to be treated</p>
<p>E. Common drugs 1. Lindane (Kwell) 2. Pyrethrins with piperonyl butoxide (RID) 3. Lindane shampoo (Kwell) 4. Permethrin (NIX)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="xiii-keratolytics">XIII. Keratolytics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#xiii-keratolytics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: soften and loosen the outer, horny layer of thickened skin by removing excess keratin</p>
<p>ANTIPARASITICS, KERATOLYTICS, DEBRIDING AGENTS ▼ 283</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Acne</li>
<li>Warts</li>
<li>Psoriasis</li>
<li>Corns</li>
<li>Calluses</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-nursing-implications-repeat-application-and-apply-dressings">C. Nursing implications: repeat application and apply dressings<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-nursing-implications-repeat-application-and-apply-dressings" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-common-drugs">D. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Salicylic acid (Occlusal)</li>
<li>Sulfur (Sebulex)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="xiv-debriding-agents">XIV. Debriding agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#xiv-debriding-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-proteolytic-preps">A. Proteolytic preps<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-proteolytic-preps" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Actions: digest or liquefy necrotic tissue and purulent exudate</li>
<li>Uses: debride decubitus, burns, severe wounds</li>
<li>Major side effects
a. Allergic response
b. Pain at the site
c. Bleeding at the site</li>
<li>Nursing implications
a. Use a tongue depressor to apply
b. Avoid excess heat
c. Protect the healthy skin
d. Clean the area if needed before application</li>
<li>Common drugs
a. Fibrinolysin + desoxyribonuclease (Elase)
b. Trypsin + Peru balsam + castor oil (Granulex)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-nonenzyme-forms">B. Nonenzyme forms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-nonenzyme-forms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Absorptive beads: debrisan is poured into the wound and acts by physical absorption of wound</li>
<li>Duoderm or op site: dressings used for decubitus and stasis ulcers. Duoderm has moisture-reactive particles that create a soft gel over the wound. Liquefied material resembling pus will be evident when the duoderm is removed. Both should be changed every 7 days.</li>
</ol>
<p>284 ▼ CHAPTER 18 DERMATOLOGICAL AGENTS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>A common side effect of silver sulfadiazine (Silvadene) cream used on burns is
a. Hives
b. Drying of the skin
c. Graying of the skin
d. Burning on the skin</p>
</li>
<li>
<p>A client, age 32, is suffering from athlete's foot with itching and discomfort. The nurse would recommend which of these products?
a. Acyclovir (Zovirax)
b. Hydrocortisone
c. Clotrimazole (Lotrimin)
d. Ketoconazole (Nizoral)</p>
</li>
<li>
<p>A frantic mother calls because her infant has excessively dry skin that is beginning to look cracked. The mother states that she has been washing it with Irish Spring soap. The nurse might recommend
a. Safe Guard
b. Oatmeal (Aveeno) cleansing bar
c. Calamine lotion after the bath
d. Dove</p>
</li>
<li>
<p>The nurses' aid reports that a client has red, bleeding, irritated buttocks from frequent diarrhea stools. The nurse should begin to use which preparation for protection of the skin?
a. Lubriderm
b. Zinc oxide
c. Glycerine (Corn Husker's Solution)
d. Silver sulfadiazine (Silvadene)</p>
</li>
<li>
<p>Instructions for a mother for treating her child's chicken pox would be to use
a. Oatmeal (Aveeno) baths for soothing and calamine lotion
b. Oatmeal (Aveeno) baths for healing and diphenhydramine hydrochloride + calamine (Caladryl Lotion)
c. Oatmeal (Aveeno) cleansing bar and calamine lotion
d. Alpha-Keri lotion in her bath water</p>
</li>
</ol>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 285</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>The ingredients in the agent cause graying of clothing and skin. Silver sulfadiazine (Silvadene) does not commonly result in irritation and hives; it dries the wound but not the skin; it treats burns, and does not cause a burning or stinging sensation unless an allergic reaction has occured.</td><td>Use an educated guess to eliminate options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>, which tend to be findings of reactions to a substance. Reread the question; it asks for a “common side effect.” Select option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> since a desired effect would be to dry a wound.</td></tr><tr><td><strong>2. Correct answer: c</strong></td><td></td></tr><tr><td>This is an antifungal and used to treat athlete’s foot. Acyclovir (Zovirax) is used primarily for herpes virus such as fever blisters. Hydrocortisone is used primarily for inflammation. Ketoconazole (Nizoral) is used for seborrheic dermatitis.</td><td>On these types of questions when you may have no idea of the correct answer, make a selection. Go to the next question only after you have done a relaxation exercise such as a few slow, deep breaths. Keep your tiredness or tenseness to a minimum so you can better answer the remaining questions. Remember you will have a few questions that will be unfamiliar content.</td></tr><tr><td><strong>3. Correct answer: d</strong></td><td></td></tr><tr><td>Dove is gentle and does not dry the skin. Safegard, an antibacterial or antimicrobial soap, is harsh for an infant and will dry the skin. The oatmeal could sooth but the continued use of Irish Spring would continue to dry the skin. A deodorant soap is antimicrobial and therefore</td><td>The best approach is to use your common knowledge of soaps.</td></tr></tbody></table>
<p>286 ▼ CHAPTER 18 DERMATOLOGICAL AGENTS</p>
<p>dries the skin out. Calamine lotion would further dry the skin.</p>
<ol start="4">
<li><strong>Correct answer: b</strong></li>
</ol>
<p>Zinc protects the skin to assist in healing. Lubriderm would not heal broken, irritated skin. Glycerine would soften skin and may irritate open, broken skin. Silvadene does heal the skin, but in this case the priority is protection from the diarrhea.</p>
<p>The key idea in the stem is to “protect” the skin. Of the given substances, associate that zinc oxide is used in the summertime as a skin protectant from the sun—recall those white-nosed children on the beach. Thus, select response <em>b</em> in this situation.</p>
<ol start="5">
<li><strong>Correct answer: a</strong></li>
</ol>
<p>These agents in option <em>a</em> together offer the most relief from itching. Caladryl should not be used because it prolongs the healing time and dries the skin. The approach in option <em>c</em> is not inappropriate, but rubbing the skin with a washcloth in using the oatmeal bar soap may not be tolerated by the child. Alpha-Keri would not soothe the itching.</p>
<p>It is important to identify the difference between “calamine” and “Caladryl”; remember that Caladryl has a <em>d</em> in it and has a significant <em>d</em>rying effect.</p>
<p>287
CHAPTER 19</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-gastrointestinal-system">Drugs Affecting the Gastrointestinal System<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-gastrointestinal-system" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify those drugs commonly used to treat peptic ulcer disease and hyperacidity.</li>
<li>Describe the difference between emetics and antiemetics.</li>
<li>Identify the groups of drugs commonly used as digestants, antidiarrheals, and laxatives.</li>
<li>Describe the use and action of activated charcoal.</li>
<li>Describe the side effects and nursing implications of the drugs used to treat the gastrointestinal system.</li>
</ul>
<p>288 ▼ CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Antispasmodics</strong>
A drug or other agent such as belladonna and dicyclomine hydrochloride (Antispas) that prevents smooth muscle spasms, as in the uterus, digestive system, or urinary tract.</p>
<p><strong>Cathartic</strong>
Also called <em>laxative</em> or <em>coprogogue</em>, a substance that promotes bowel evacuation by stimulating peristalsis, increasing the fluidity or bulk of intestinal contents, softening the stool, or lubricating the intestinal wall.</p>
<p><strong>Emetics</strong>
A substance such as syrup of ipecac that causes vomiting used in the emergency treatment of overdosage or in certain cases poisoning; it can be cardiotoxic if absorbed and not vomited.</p>
<p><strong>Malabsorption syndrome</strong>
A complex of symptoms resulting from disorders in the intestinal absorption of nutrients, characterized by anorexia, weight loss, bloating of the abdomen, muscle cramps, bone pain, and steatorrhea. Anemia, weakness and fatigue occur because iron, folic acid, and vitamin B₁₂ are not absorbed in sufficient quantities. Examples: gastric or small bowel resection, celiac disease, cystic fibrosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drugs-used-to-treat-peptic-ulcer-disease-and-gastric-hyperacidity">DRUGS USED TO TREAT PEPTIC ULCER DISEASE AND GASTRIC HYPERACIDITY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-to-treat-peptic-ulcer-disease-and-gastric-hyperacidity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-antacids">I. Antacids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antacids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Actions:</strong> neutralize gastric acid and raise the pH of the stomach, thereby relieving heartburn and the pain associated with gastric disorders</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Indigestion</li>
<li>Reflux esophagitis: esophageal irritation and inflammation resulting from reflux of the stomach contents into the esophagus</li>
<li>Peptic ulcers</li>
<li>Ulcer prevention</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Rebound hyperacidity: an excessive amount of acidity in the stomach</li>
</ol>
<p>ANTACIDS, H₃ HISTAMINE RECEPTOR ANTAGONISTS ▼ 289</p>
<ol start="2">
<li>Sodium retention</li>
<li>Gastrointestinal (GI) disturbances
a. Constipation (aluminum and calcium)
b. Diarrhea (magnesium)</li>
<li>Electrolyte disturbances
a. Hypermagnesemia: hypotension, nausea, vomiting, ECG changes (magnesium-containing antacids)
b. Hypophosphatemia: anorexia, malaise, muscle weakness (aluminum-containing antacids)</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Assess the effectiveness of the medication</li>
<li>Avoid other medications that lower the stomach pH or increase hyperacidity, such as caffeine and acetylsalicylic acid (aspirin)</li>
<li>Take 1 hour after eating and do not take other medications within 1 to 2 hours of taking the antacid</li>
<li>Shake most liquids well and follow with a full glass of water</li>
<li>Instruct clients to inquire about interactions with any new medications and over-the-counter (OTC) preparations</li>
<li>Inform clients that they may experience better relief from liquids than tablets</li>
<li>Monitor for constipation and diarrhea. Medication or dose may need to be changed.</li>
</ol>
<p><strong>E. Interactions are too numerous to name within this text. Of special importance is the decrease in absorption of medications when these agents are given with digoxin and antibiotics.</strong></p>
<p><strong>F. Common drugs</strong></p>
<ol>
<li>Aluminum hydroxide (AlternaGel, Amphojel)</li>
<li>Magnesium hydroxide (Milk of Magnesia)</li>
<li>Calcium carbonate (Alka-Mints, Tums)</li>
<li>Sodium bicarbonate (NaHCO₃)</li>
<li>Aluminum-magnesium complex (Maalox, Riopan, Riopan Plus)</li>
<li>Magnesium-hydroxide + aluminum hydroxide with simethicone (Maalox TC, Mylanta II)</li>
</ol>
<p><strong>II. H₃ histamine receptor antagonists</strong></p>
<p><strong>A. Actions:</strong> inhibits the release of histamine at histamine H₂ receptor sites and decreases gastric acidity</p>
<p><strong>B. Uses</strong></p>
<ol>
<li>Treatment of ulcers</li>
<li>Prevention of stress ulcers</li>
</ol>
<p>CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<ol start="3">
<li>Hyperacidity</li>
<li>Gastrointestinal (GI) bleed</li>
<li>Prevention of allergic responses</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Confusion</li>
<li>Nausea, diarrhea, abdominal pain</li>
<li>Anemia, blood dyscrasias</li>
<li>Severe bradycardia after IV administration</li>
</ol>
<p>D. Interactions: increased action of many of the cardiac drugs and anticoagulants</p>
<p>E. Nursing implications</p>
<ol>
<li>Instruct client to limit caffeine intake</li>
<li>Should administer before meals (AC) and at bedtime (HS)</li>
<li>Do not administer at the same time as antacids</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Cimetidine (Tagamet)</li>
<li>Ranitidine (Zantac)</li>
<li>Famotidine (Pepcid)</li>
<li>Nizatidine (Axid)</li>
<li>Other agents—gastric mucosa protectants
a. Sucralfate (Carafate) forms a barrier at the ulcer site, prevents NSAID-induced gastric ulcers and absorbs pepsin. It must be taken on an empty stomach for the best effect.
b. Misoprostol (Cytotec) is used with peptic ulcers. Uterine contractions are common and can cause miscarriages.</li>
</ol>
<p>III. Anticholinergic agents (antispasmodics)</p>
<p>A. Actions</p>
<ol>
<li>Reduce gastric acid secretion</li>
<li>Decrease smooth muscle motility</li>
<li>Delay gastric emptying time</li>
</ol>
<p>B. Uses</p>
<ol>
<li>Adjuncts to peptic ulcer disease</li>
<li>Spasms and cramping associated with irritable bowel syndrome</li>
<li>Colic in children</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Tachycardia</li>
<li>Dry mouth</li>
<li>Constipation</li>
<li>Urinary retention</li>
<li>Sedation (may be preferred)</li>
</ol>
<p>ANTICHOLINERGICS, DIGESTANTS, ANTIFLATULENT AGENTS ▼ 291</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Many of these agents come from belladonna plants and are termed belladonna alkaloids. Many others contain atropine sulfate (prototype).</li>
<li>Monitor bowel elimination</li>
<li>Treat side effects per physician orders</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Atropine sulfate</li>
<li>Belladonna alkaloids</li>
<li>Hyoscyamine sulfate (Levsin, Anaspaz)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-gastrointestinal-agents">OTHER GASTROINTESTINAL AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-gastrointestinal-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-digestants">I. Digestants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-digestants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: work in various ways to aid in digestion by replacing missing substances that naturally digest food</p>
<p>B. Uses</p>
<ol>
<li>Malabsorptive syndromes: a complex of symptoms resulting from disorders in the intestinal absorption of nutrients</li>
<li>Achlorhydria: absence of hydrochloric acid in the gastric juice</li>
<li>Hypochlorhydria: a deficiency of hydrochloric acid in the stomach's gastric juice</li>
</ol>
<p>C. Major side effects: vary with each drug and are limited</p>
<p>D. Nursing implications</p>
<ol>
<li>Take with or immediately after meals</li>
<li>Drink a full glass of water with each dose</li>
</ol>
<p>E. Common drugs</p>
<ol>
<li>Hydrochloric acid</li>
<li>Pancreatin (Dizymes)</li>
<li>Famotidine (Pepsin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-antiflatulent-agents">II. Antiflatulent agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antiflatulent-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: aids in breaking up gas bubbles trapped in the intestines</p>
<p>B. Uses</p>
<ol>
<li>Postoperatively</li>
<li>Children with colic</li>
</ol>
<p>C. Major side effect: constipation</p>
<p>D. Nursing implications</p>
<ol>
<li>Drink plenty of water</li>
<li>Treat the constipation</li>
</ol>
<p>E. Common drug: simethicone (Mylicon)</p>
<p>CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-antiemetics">III. Antiemetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-antiemetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-drug-groups">A. Drug groups<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-drug-groups" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Phenothiazines</li>
<li>Antihistamines</li>
<li>Anticholinergics</li>
<li>Other individual drugs</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-actions-depends-on-the-group-used">B. Actions: depends on the group used<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-actions-depends-on-the-group-used" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Phenothiazines decrease the response of the chemoreceptor trigger zone by inhibiting the dopaminergic receptors</li>
<li>Antihistamines block the H₁ receptors</li>
<li>Anticholinergics prevent motion sickness by decreasing GI motility and secretions</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-uses">C. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Severe nausea</li>
<li>Vomiting</li>
<li>Before or after chemotherapy</li>
<li>Motion sickness</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-major-side-effects-are-group-related">D. Major side effects: are group related<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-major-side-effects-are-group-related" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Anticholinergic effects: dry mouth, constipation, urinary retention, tachycardia</li>
<li>Drowsiness</li>
<li>Extrapyramidal findings with phenothiazines: tardive dyskinesia, chorea, athetosis, Parkinson's disease symptoms</li>
<li>Hypersensitivity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Motion sickness: take 30 minutes to 1 hour before the activity that causes nausea</li>
<li>Caution the client about the sedative properties</li>
<li>Give Vistaril Z-track</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Chlorpromazine hydrochloride (Thorazine)</li>
<li>Promethazine (Phenergan)</li>
<li>Prochlorperazine maleate (Compazine)</li>
<li>Metoclopramide hydrochloride (Reglan)</li>
<li>Scopolamine (Triptone)</li>
<li>Dimenhydrinate (Dramamine)</li>
<li>Hydroxyzine pamoate (Vistaril)</li>
<li>Diphenhydramine hydrochloride (Benadryl)</li>
<li>Meclizine hydrochloride (Antivert)</li>
<li>Trimethobenzamide hydrochloride (Tigan)</li>
</ol>
<p>ANTIEMETICS, EMETICS, LAXATIVES ▼ 293</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-emetics">IV. Emetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-emetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: irritate the stomach and stimulate the vomiting center in the brain</p>
<p>B. Uses</p>
<ol>
<li>Overdose</li>
<li>Accidental poisoning</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Toxicity</li>
<li>Abuse by bulemic patients</li>
</ol>
<p>D. Interactions with alcohol and central nervous system depressants</p>
<p>E. Nursing implications</p>
<ol>
<li>Instruct clients to have a bottle of ipecac at home in case of accidental ingestion especially with children. Note expiration date.</li>
<li>Never administer to semicomatose or comatose patients</li>
<li>Can be very messy and difficult for a child to ingest</li>
<li>Administer dosage for ipecac of 10 ml followed by a glass of water in children &lt;1 year of age; 15 ml followed by water for children &gt;1 year; 15 to 30 ml followed by several glasses of water for adults</li>
<li>May repeat ipecac dose in 30 minutes if first dose does not produce emesis</li>
<li>Never give with or after activated charcoal. If needed, give before the activated charcoal.</li>
<li>Never give to clients who are unconscious or who accidentally ingest a caustic substance</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Ipecac syrup</li>
<li>Apomorphine hydrochloride</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-laxatives-cathartic">V. Laxatives (cathartic)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-laxatives-cathartic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: specific to the group (Table 19-1)</p>
<p>B. Major side effects: dehydration, straining</p>
<p>C. General nursing implications</p>
<ol>
<li>Monitor the client for misuse of these agents; can be habit forming</li>
<li>Monitor electrolytes</li>
<li>Assess bowel elimination pattern, GI discomforts</li>
<li>Discontinue if diarrhea persists; do not give if obstruction is suspected</li>
</ol>
<p>CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<p>Table 19-1. Laxative Types</p>
<table><thead><tr><th>Name</th><th>Mechanism of Action</th><th>Nursing Considerations</th></tr></thead><tbody><tr><td><strong>Stimulants</strong></td><td></td><td></td></tr><tr><td>Senna (Senokot)</td><td>Irritant to bowel; peristalsis is stimulated</td><td>Not recommended for children</td></tr><tr><td>Phenolphthalein (Ex-Lax)</td><td>Used in preparation for surgery, acute constipation</td><td>Avoid in pregnancy</td></tr><tr><td>Cascara sagrada (Cascara)</td><td></td><td>Should obtain results in 6 to 12 hours</td></tr><tr><td>Castor oil</td><td></td><td></td></tr><tr><td><strong>Salines/Osmotics</strong></td><td></td><td></td></tr><tr><td>Normal saline solution</td><td>Act by drawing water into the bowel and increasing peristalsis</td><td>Electrolyte imbalance and dehydration can occur</td></tr><tr><td>Magnesium citrate (Citrate of Magnesia)</td><td>Used for elimination of poisons; before procedures; removal of parasites</td><td>Fleets are given and rectally come in an oil-retention form that is good for older clients</td></tr><tr><td>Epsom salts</td><td></td><td></td></tr><tr><td>Magnesium salts (MOM)</td><td></td><td></td></tr><tr><td>Sodium biphosphate (Fleets)</td><td></td><td></td></tr><tr><td><strong>Bulk-Forming</strong></td><td></td><td></td></tr><tr><td>Psyllium hydrophilic muclloid (Metamucil)</td><td>Act by forming a soft, bulky mass from absorbing water</td><td>May take up to 72 hours to work</td></tr><tr><td>Methylcellulose (Maltsupex, Citrucel)</td><td>Used for chronic constipation, in infants suffering from continuous constipation, in pregnant females</td><td>Monitor elimination</td></tr><tr><td>Polycarbophil (Fibercon)</td><td></td><td>Take with a full glass of water</td></tr><tr><td><strong>Emollients/Fecal Softeners</strong></td><td></td><td></td></tr><tr><td>Mineral oil</td><td>Coat the fecal mass with oil to help lubricate for easier elimination; reduce surface tension of feces</td><td>Assess electrolytes</td></tr><tr><td>Haley’s M-O</td><td></td><td>Offer candy or juice to disguise the taste</td></tr><tr><td>Docusate sodium (Colace)</td><td></td><td>Monitor electrolytes</td></tr><tr><td>Docusate calcium (Surfak)</td><td>Used in older adults when straining is prohibited (MI, eye surgery)</td><td></td></tr><tr><td>Docusate potassium (Dialose)</td><td></td><td></td></tr></tbody></table>
<p>LAXATIVE TYPES, ANTIDIARRHEALS ▼ 295</p>
<ol start="5">
<li>Teach clients the proper diet and exercise to aid in elimination</li>
<li>Clients who should avoid straining may benefit from a lubricant laxative. Mineral oil enemas work well without causing severe strain in clients who had a recent heart attack, clients with increased intracranial pressure, or older clients with fecal impaction; they also work well when saline is contraindicated.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-antidiarrheals">VI. Antidiarrheals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-antidiarrheals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Groups</p>
<ol>
<li>Absorbents</li>
<li>Opiates</li>
<li>Anticholinergics</li>
</ol>
<p>B. Actions: relieve symptoms or work against the cause of the diarrhea. Absorbents bind with bacteria or toxins.</p>
<p>C. Uses</p>
<ol>
<li>Short-term diarrhea</li>
<li>Irritable bowel syndrome</li>
<li>Overdose</li>
</ol>
<p>D. Major side effects</p>
<ol>
<li>Constipation</li>
<li>Abuse potential</li>
</ol>
<p>E. Nursing implications</p>
<ol>
<li>Know how to administer properly. Some of the agents can be given after each diarrhea stool.</li>
<li>Instruct client that the agents relieve symptoms but do not cure; notify physician if diarrhea persists longer than 48 hours</li>
<li>Assess elimination, dehydration, and the results obtained</li>
<li>Activated charcoal is a powder that must be mixed with water to administer; it is also used for overdose of caustic chemicals</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Absorbents
a. Bismuth subsalicylate (Pepto-Bismol)
b. Activated charcoal (Charcocaps)</li>
<li>Opiates
a. Paregoric (camphorated opium tincture)
b. Synthetic opiates
(1) Diphenoxylate hydrochloride + atropine sulfate (Lomotil)
(2) Loperamide (Imodium)</li>
<li>Anticholinergics: alcohol + kaolin + atropine + hyoscyamine sulfate + scopolamine hydrobromide (Donnagel suspension)</li>
</ol>
<p>296 ▼ CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="vii-flora-modifiers">VII. Flora modifiers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vii-flora-modifiers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: replace normal flora
B. Use: excessive diarrhea, usually from antibiotic use
C. Major side effects: overgrowth, since preparation contains lactobacillus organisms
D. Common drug: Lactinex</p>
<p>REVIEW QUESTIONS ▼ 297</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>With an aluminum antacid, which of the following symptoms would be expected?
a. Hyperkalemia
b. Hyponatremia
c. Hypophosphatemia
d. Hypercalcemia</p>
</li>
<li>
<p>A client is taking an antacid 1 hr PC and HS and a tetracycline q 6 hours. The best times to schedule each is as follows
a. Antacid 9-1-5-9, tetracycline 8-2-8-2
b. Antacid 8-12-4-9, tetracycline 9-4-9-4
c. Schedule both together
d. Antacid 7:30-11-4-9, tetracycline 8-2-8-2</p>
</li>
<li>
<p>An over-the-counter medication that mothers can use for infants with excess flatus is
a. Hyoscyamine sulfate (Levsin)
b. Simethicone (Mylicon)
c. Famotidine (Pepcid)
d. Diphenoxylate hydrochloride + atropine sulfate (Lomotil)</p>
</li>
<li>
<p>In preparing for a jet flight to Hawaii, Susan plans to take a dimenhydrinate (Dramamine) to relieve her motion sickness. When should she take it?
a. Once the plane has taken off
b. At least 2 hours before departure
c. When she becomes nauseated
d. About 30 minutes before boarding</p>
</li>
<li>
<p>The best laxative for a client, age 63, diagnosed with a heart attack (MI) and severe constipation would be
a. 1000 cc normal saline with Castile soap
b. Psyllium hydrophilic muciloid (Metamucil), 1 tsp TID
c. Oil Retention Fleets, holding for 15 to 30 minutes if possible
d. Senna (Senokot), 2 tsp BID</p>
</li>
<li>
<p>The best absorbent for accidental poisoning with a caustic substance would be
a. Bismuth subsalicylate (Pepto-Bismol)
b. Syrup of ipecac
c. Activated charcoal
d. Dimercaprol (BAL)</p>
</li>
</ol>
<p>298 ▼ CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>Low phosphorous is common with the aluminum-containing antacids. Thus, these antacids are used in renal failure to decrease the high phosphate levels. Antacids usually do not affect the potassium level. Sodium level may be raised with antacids. High calcium levels may be evident in calcium-containing antacids.</td><td>Remember that the two major categories for antacids are magnesium and aluminum. The two electrolytes effected are magnesium and phosphorus. Match magnesium antacid with magnesium and the other, aluminum, binds phosphorus to lower its levels.</td></tr><tr><td><strong>2. Correct answer: a</strong></td><td></td></tr><tr><td>This schedule separates the antacid and tetracycline by one hour and follows the usual mealtimes for the antacid. The antacid is ordered 1 hour after meals. Medications should not be scheduled at the same time as antacids, since the absorption can be changed.</td><td>Remember that with most medications and antacids, the time apart for each administration is about 1 hour.</td></tr><tr><td><strong>3. Correct answer: b</strong></td><td></td></tr><tr><td>Mylicon, available without a prescription, relieves excess gas associated with colic. Levsin will decrease flatus but must be prescribed by the physician. The agent in option c are used to treat ulcers and hyperacidity. Option d is an antidiarrheal agent.</td><td>Associate that Simethicone takes away the smell of flatus, since it decreases the production of the flatus.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 299</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-d">4. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This allows for absorption of the agent and a peak effect during the flight. Recall the basic knowledge of drug administration by route and time of effect: PO = 30 minutes; IM = 15 minutes; IV = within 5 minutes; rectal suppository = 15 minutes; SL = within 5 to 10 minutes. The Dramamine may not be absorbed enough to relieve the motion sickness if the plane has already taken off. Two hours before would be too long, and the agent may not relieve the motion sickness. Option c would involve too long of a wait.</p>
<p>Recall the time medication taken by mouth would begin to work—in 30 to 45 minutes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-c">5. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>An oil retention enema would provide the relief needed without the strain on the cardiac system. Saline is not recommended for a cardiac client. Metamucil may not provide the immediate relief needed but would probably be a good preventive approach. Senna would not provide the immediate relief needed.</p>
<p>Recall that when the client is already this constipated, the need is to help the stool slip out without straining. Thus the oil retention enema is the best choice.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-c">6. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Activated charcoal binds with the caustic agent to decrease the effects on the body. Pepto-Bismol would not be effective enough for a caustic agent. Vomiting is</p>
<p>If you have no idea of the correct response, “go with what you know”—that activated charcoal is used to absorb.</p>
<p>300 ♥ CHAPTER 19 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM</p>
<p>not recommended for a caustic substance. BAL is an antidote for heavy metal poisoning. It is given deep IM, since it is an oil-based medication. It is also used in arsenic, gold, mercury, and lead poisoning; administration is frequent, with the initial series of doses usually given daily for up to 10 days.</p>
<p>CHAPTER 20</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-the-ear-and-eye">Drugs Affecting the Ear and Eye<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-the-ear-and-eye" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Describe the difference between mydriatics and cycloplegics.</li>
<li>Identify drugs that lower intraocular pressure.</li>
<li>Identify agents that decrease and increase aqueous humor.</li>
<li>Describe the role of antiinfective, antiinflammatory, and anesthetic agents used in the ear and eye.</li>
<li>Define ceruminolytics.</li>
<li>Describe major side effects and nursing implications for these agents.</li>
</ul>
<p>301</p>
<p>302 ▼ CHAPTER 20 DRUGS AFFECTING THE EAR AND EYE</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Ceruminolytic</strong>
Pertaining to a drug or other agent that loosens or dissolves cerumen (earwax) to allow for removal.</p>
<p><strong>Cycloplegic</strong>
An agent that causes paralysis with relaxation of the ciliary or ocular muscles of accommodation.</p>
<p><strong>Miotic</strong>
An agent such as pilocarpine that causes constriction of the pupil; used to treat glaucoma.</p>
<p><strong>Mydriatic</strong>
An agent that causes dilation of the pupil from the contraction dilator muscle of the iris. Such drugs as atropine, homatropine, and scopolamine are both mydriatics and cycloplegics.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="agents-used-in-the-eye">AGENTS USED IN THE EYE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#agents-used-in-the-eye" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-mydriatics-and-cycloplegics">I. Mydriatics and cycloplegics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-mydriatics-and-cycloplegics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Actions</strong></p>
<ol>
<li>Mydriatics exert a sympathetic nervous system response, causing dilation of the pupil by contraction of the pupil’s dilator muscle</li>
<li>Cycloplegics paralyze the fine-focusing muscle (accommodative muscle) by blocking cholinergic stimulation of the muscle of the iris</li>
</ol>
<p><strong>B. Groups of drugs</strong></p>
<ol>
<li>Sympathomimetic</li>
<li>Anticholinergic acting</li>
</ol>
<p><strong>C. Uses</strong></p>
<ol>
<li>Intraocular exams</li>
<li>Pre- and post-eye surgery</li>
<li>Iris refraction in children</li>
</ol>
<p><strong>D. Major side effects</strong></p>
<ol>
<li>Local irritation</li>
<li>Burning</li>
<li>Blurred near vision; photophobia</li>
<li>Systemic reactions: tachycardia and dry mucous membranes</li>
</ol>
<p><strong>E. Nursing implications</strong></p>
<ol>
<li>Instruct the client to wear dark sunglasses until clear vision resumes</li>
</ol>
<p>EYE: MYDRIATICS, CYCLOPLEGICS, MIOTICS ▼ 303</p>
<ol start="2">
<li>Teach the client proper instillation (Figure 20-1)</li>
<li>Hold pressure on lacrimal sac 1 to 2 minutes</li>
</ol>
<p>F. Contraindicated in closed-angle glaucoma if use is prolonged. Some of these agents can increase intraocular pressure with resulting ocular congestion.</p>
<p>G. Common drugs</p>
<ol>
<li>Sympathomimetic
a. Epinephrine hydrochloride (Epifrin)
b. Naphazoline hydrochloride (Naphcon)
c. OcuClear
d. Phenylephrine hydrochloride (Neo-synephrine)
e. Tetrahydrozoline hydrochloride (Murine Plus)</li>
<li>Anticholinergic acting
a. Atropine sulfate (Isopto Atropine)
b. Cyclopentolate hydrochloride (Cyclogyl)
c. Scopolamine hydrobromide (Isopto Hyoscine)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-miotics">II. Miotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-miotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: exert a parasympathetic response resulting in constriction of the pupil, contraction of the accommodative muscle, and decrease resistance to outflow of aqueous humor</p>
<ol>
<li>Decrease intraocular pressure: the internal pressure of the eye, regulated by resistance to the flow of aqueous humor</li>
<li>Increase outflow of aqueous humor</li>
</ol>
<p>B. Groups of drugs</p>
<ol>
<li>Direct-acting cholinergics</li>
<li>Anticholinesterase agents</li>
</ol>
<p>C. Uses: treatment of glaucoma and esotropia (cross-eyed)</p>
<p>D. Major side effects: blurred vision and local irritation</p>
<p>E. Nursing implications</p>
<ol>
<li>Administer at bedtime to decrease blurring of vision</li>
<li>Avoid if inflammation is present</li>
<li>Teach the client how to administer</li>
<li>Hold pressure at the lacrimal sac for 1 to 2 minutes to decrease systemic absorption</li>
</ol>
<p>F. Common drugs</p>
<ol>
<li>Direct-acting cholinergics
a. Pilocarpine hydrochloride (Pilocar)
b. Carbachol (Isopto Carbachol)</li>
<li>Anticholinesterase agents
a. Demecarium bromide (Humorsol)
b. Isoflurophate (Floropryl)
c. Physostigmine salicylate (Isopto Eserine)</li>
</ol>
<p><img src="assets/images/image-20251221-75e8f536.jpeg" alt="img-16.jpeg">
C</p>
<p><img src="assets/images/image-20251221-07a8b454.jpeg" alt="img-17.jpeg">
B</p>
<p><img src="assets/images/image-20251221-c2a4c6d6.jpeg" alt="img-18.jpeg">
A
Figure 20-1. Eye medication administration. Eye drops. A, With tissue or cotton resting below lower lid, gently press downward with thumb or forefinger against bony orbit. Ask client to look at ceiling. B, Instill eye drops while explaining steps to client. With dominant hand resting on client's forehead, hold filled medication eye dropper approximately 1 to 2 cm (½ to ¾ inch) above conjunctival sac. Drop prescribed number of medication drops into conjunctival sac. Instill eye ointment. C, Holding ointment applicator above lid margin, apply thin stream of ointment evenly along inside edge of lower eyelid on conjunctiva from the center outward. Ask client to look down. Apply thin stream of ointment along upper lid margin on inner conjunctiva. Have client close eye and rub lid lightly in circular motion with cotton ball, if rubbing is not contraindicated. (From Perry A, Potter P: Clinical Nursing Skills and Techniques, ed 3, St Louis, 1994, Mosby.)</p>
<p><img src="assets/images/image-20251221-d0ed52aa.jpeg" alt="img-19.jpeg"></p>
<p>EYE DRUG ADMINISTRATION, GLAUCOMA DRUGS ▼ 305</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-other-drugs-used-to-lower-intraocular-pressure-iop">III. Other drugs used to lower intraocular pressure (IOP)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-other-drugs-used-to-lower-intraocular-pressure-iop" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-actions">A. Actions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Carbonic anhydrase inhibitors (CAI) reduce the amount of aqueous humor produced and thereby lower intraocular pressure (IOP)</li>
<li>Beta-adrenergic blocking agents are not quite understood; similar to CAI</li>
<li>Osmotic agents increase plasma osmolarity and thereby lower IOP</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-use">B. Use<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-use" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Open- and closed-angle glaucoma</li>
<li>Pre- and post-eye surgery</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>Bradycardia</li>
<li>Headache</li>
<li>Fatigue</li>
<li>Stinging when administered</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="d-nursing-implications">D. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>CAI and osmotics are diuretics and will increase urine production. Monitor electrolytes and advise client to take early in the morning.</li>
<li>Beta blockers: monitor vital signs especially HR</li>
<li>Teach client how to administer</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="e-common-drugs">E. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>CAI
a. Acetazolamide (Diamox)
b. Dichlorphenamide (Daranide)
c. Methazolamide (Neptazane)</li>
<li>Osmotics
a. Glycerin, anhydrous (Opthalgan)
b. Isosorbide (Ismotic)
c. Mannitol (Osmitrol)</li>
<li>Beta blockers
a. Timolol maleate (Timoptic)
b. Levobunolol hydrochloride (Betagan)
c. Carteolol hydrochloride (Ocupress)
d. Betaxolol hydrochloride (Betoptic)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-anesthetic-agents">IV. Anesthetic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-anesthetic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="a-action-anesthetize-the-corneal-surface">A. Action: anesthetize the corneal surface<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-action-anesthetize-the-corneal-surface" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>An aid to instruments that measure intraocular pressure or remove foreign bodies</li>
</ol>
<p>306 ▼ CHAPTER 20 DRUGS AFFECTING THE EAR AND EYE</p>
<ol start="2">
<li>Suture removal</li>
<li>Conjunctival scraping</li>
<li>Manipulation of lacrimal canal</li>
</ol>
<p><strong>C. Major side effects</strong></p>
<ol>
<li>Stimulation of the central nervous system: syncope, nausea, seizures</li>
<li>Hypotension</li>
<li>Transient eye pain, blurred vision, redness</li>
</ol>
<p><strong>D. Nursing implications</strong></p>
<ol>
<li>Provide protective eye patch while eye is anesthetized</li>
<li>Instruct client not to rub the eye to prevent corneal abrasions</li>
<li>Apply pressure to the lacrimal sac for 1 to 2 minutes to prevent systemic absorption</li>
</ol>
<p><strong>E. Common drugs</strong></p>
<ol>
<li>Proparacaine hydrochloride (Alcaine)</li>
<li>Tetracaine hydrochloride (Pontocaine Hydrochloride)</li>
</ol>
<p><strong>V. Antiinflammatory agents</strong>
<strong>A. Actions:</strong> decrease edema, redness, scarring, and exudate
<strong>B. Groups of drugs</strong></p>
<ol>
<li>Corticosteroids</li>
<li>Nonsteroidal agents
<strong>C. Uses:</strong> inflammatory disorders, hypersensitivity conditions
<strong>D. Major side effects</strong></li>
<li>Increased intraocular pressure</li>
<li>Optic nerve damage</li>
<li>Decreased visual activity</li>
<li>Cataracts
<strong>E. Nursing implications</strong></li>
<li>Instruct in proper administration</li>
<li>Use on short-term basis only</li>
<li>Instruct client not to rub eye
<strong>F. Common drugs</strong></li>
<li>Dexamethasone (Maxidex)</li>
<li>Prednisolone sodium phosphate (Ak-Pred)</li>
<li>Diclofenac sodium (Voltaren)</li>
</ol>
<p><strong>VI. Antiinfectives</strong>
<strong>A. Actions:</strong> interfere or destroy microorganisms that cause these infections: staphylococcus, streptococcus, pseudomonas, klebsiella, escherichia coli, neisseria gonorrhea</p>
<p>EYE ANESTHETICS, ANTIINFLAMMATORIES; EYE &amp; EAR ANTIINFECTIVES ▼ 307</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-groups-of-drugs">B. Groups of drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-groups-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Antibiotics</li>
<li>Antifungals</li>
<li>Antivirals</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-uses">C. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Infections: bacterial, fungal, viral</li>
<li>Pinkeye</li>
<li>Herpes simplex I</li>
<li>Conjunctivitis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-major-side-effects">D. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Local irritation</li>
<li>Overgrowth of microorganism</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-nursing-implications">E. Nursing implications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-nursing-implications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Teach proper administration</li>
<li>Instruct client to notify physician if edema, redness, or pain do not decrease</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-common-drugs">F. Common drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-common-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Antibiotics
a. Bacitracin ophthalmia (AK-Tracin)
b. Gentamicin sulfate (Garamycin Ophthalmic)
c. Tobramycin (Tobrex)
d. Sulfacetamide sodium 15% (Sulfair-15 Ophthalmic)</li>
<li>Antifungal: natamycin (Natacyn)</li>
<li>Antiviral: trifluridine (Viroptic)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="agents-used-in-the-ear">AGENTS USED IN THE EAR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#agents-used-in-the-ear" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-antiinfective-agents">I. Antiinfective agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-antiinfective-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Actions: inhibit or destroy gram-negative or gram-positive microorganisms that cause infection in the ear
B. Uses: treat external auditory canal infections (otitis externa) and middle ear infections (otitis media)
C. Major side effects</p>
<ol>
<li>Superinfections</li>
<li>Hypersensitivity
D. Nursing implications</li>
<li>Assess for hypersensitivity</li>
<li>Assess for culture and sensitivity before administering</li>
<li>Teach the client how to instill the drops (Figure 20-2)</li>
<li>Teach the client to report ringing of the ear and any decrease in hearing</li>
<li>Instruct the client to take all the medication prescribed</li>
</ol>
<p><img src="assets/images/image-20251221-21ab19b3.jpeg" alt="img-20.jpeg">
C</p>
<p><img src="assets/images/image-20251221-9dea69ad.jpeg" alt="img-21.jpeg">
B</p>
<p><img src="assets/images/image-20251221-ac242449.jpeg" alt="img-22.jpeg">
A
Figure 20-2. Ear medication administration. Have client assume side-lying position with ear to be treated facing up, or client may sit in chair or at the bedside. Straighten ear canal by pulling auricle down and back (children) or upward and outward (adult). A, If cerumen or drainage occludes outermost portion of ear canal, wipe out gently with cotton-tipped applicator. Do not force wax inward to block or occlude canal. B, Instill prescribed drops holding dropper 1 cm (½ inch) above ear canal. C, Ask client to remain in side-lying position 2 to 3 minutes. Apply gentle massage or pressure to tragus of ear with finger. At times physician orders insertion of portion of cotton ball into outermost part of canal. Do not press cotton into canal. Remove cotton after 15 minutes. (From Perry A, Potter P: Clinical Nursing Skills and Techniques, ed 3, St Louis, 1994, Mosby.)</p>
<p>EAR MEDS: ADMINISTRATION, ANTIINFLAMMATORIES, CERUMINOLYTICS ▼ 309</p>
<p>E. Common drugs</p>
<ol>
<li>Topical
a. Chloramphenicol (Chloromycetin Otic)
b. Neosporin</li>
<li>Oral
a. Ampicillin (Polycillin)
b. Trimethoprim + sulfamethoxazole (Septra)
c. Penicillin VK (V-Cillin K)
d. Amoxicillin (Amoxil)
e. Cefaclor (Ceclor)
f. Amphotericin B (Fungizone)
g. Amoxicillin + clavulanic acid (Augmentin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-antiinflammatory-agents">II. Antiinflammatory agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-antiinflammatory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: inhibit edema and fibrin deposition to decrease inflammation of the ear
B. Use: decrease inflammation in the external ear canal
C. Major side effects: mask underlying otic infections
D. Nursing implications: do not administer if tympanic membrane is ruptured
E. Common drugs</p>
<ol>
<li>Dexamethasone sodium phosphate (Ak-dex)</li>
<li>Hydrocortisone acetate (Coly-Mycin S Otic)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-anesthetic-agents">III. Anesthetic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-anesthetic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Action: block nerve conduction
B. Use: relieve ear pain temporarily
C. Common drug: benzocaine (Auralgan Otic)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-ceruminolytic-agents">IV. Ceruminolytic agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-ceruminolytic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Actions: emulsify hardened or impacted cerumen or prevent accumulation of cerumen
B. Major side effects: local irritation
C. Nursing implications: instruct the client to irrigate the ear for 15 minutes after use and not to use cotton swabs
D. Common drugs</p>
<ol>
<li>Carbamide peroxide (Debrox)</li>
<li>Triethanolamine polypeptide oleate-condensate (Cerumenex)</li>
</ol>
<p>310 ▼ CHAPTER 20 DRUGS AFFECTING THE EAR AND EYE</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Instructions to a mother for instilling drops in a 2-year-old would be as follows
a. Pull the auricle downward and slightly backward
b. Pull the auricle upward and backward
c. Pull the auricle downward and slightly forward
d. Lay the child flat and do not pull the ear in any direction</p>
</li>
<li>
<p>After an eye examination, the nurse would instruct the client to
a. Expect burning and itching
b. Wear sunglasses and avoid driving
c. Expect blurred vision for several days
d. Avoid reading for several days</p>
</li>
<li>
<p>If given with Timoptic drops, which of the following medications would warrant careful monitoring of the cardiovascular system?
a. Dexamethasone
b. Neptazane
c. Diamox
d. Digoxin</p>
</li>
<li>
<p>To prevent systemic absorption of eye medications, the nurse should
a. Put pressure on the tragus
b. Hold slight pressure on the lacrimal sac for 5 minutes
c. Hold slight pressure on the lacrimal sac for 1 to 3 minutes
d. Gently rub the eye for 1 to 2 minutes</p>
</li>
<li>
<p>Medications such as carbonic anhydrase inhibitors work in glaucoma by
a. Increasing the formation of aqueous humor
b. Decreasing the formation of aqueous humor
c. Increasing the outflow of aqueous humor
d. Decreasing the outflow of aqueous humor</p>
</li>
</ol>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 311</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: a</strong></td><td></td></tr><tr><td>This action helps straighten the ear canal in children. The action in response <em>a</em> applies to adults. The action in response <em>c</em> does not assist with ear drops. A flat position may be helpful, but the auricle must be slightly down and back.</td><td>Remember that adults grow “up”; therefore the instillation of ear drops is pull back and “up.” The child is the opposite—pull back and down.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>The eyes are often dilated for an examination; also, the sunlight makes vision difficult, since the dilated pupil results in photophobia. Driving could be dangerous if the vision is blurred due to the dilation. Burning and itching may signal an allergic reaction to any agent used. The blurred vision should subside within a few hours after the examination and should be reported if still present 24 hours later. Reading may be difficult if the vision is blurred, but only for a few hours.</td><td>Cluster responses <em>c</em> and <em>d</em> with the time frame of “several days” and eliminate them as not reasonable. Between the remaining responses, use basic knowledge that instilling a substance into the eye to result in burning is inappropriate; select response <em>b</em>.</td></tr><tr><td><strong>3. Correct answer: d</strong></td><td></td></tr><tr><td>Both these agents have the potential for lowering the heart rate; therefore vital signs should be monitored closely. Timoptic has similar properties to the by-mouth</td><td>Go with what you know: the most familiar drug listed is digoxin, and the question is asking about cardiovascular effects. Select response <em>d</em>.</td></tr></tbody></table>
<p>312 ▼ CHAPTER 20 DRUGS AFFECTING THE EAR AND EYE</p>
<p>beta blockers. The agents in options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>, and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> do not interact with Timoptic.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="4-correct-answer-c">4. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This is to avoid pressure on the tear duct and to prevent the medication from entering the sinuses. Pressure on the ear, option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>, does not affect eye drops. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> is too long a time. Rubbing and excessive blinking should be avoided after application of drops or ointment.</p>
<p>“Go with what you know” if you have no clue of the correct answer. Eliminate option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>, which have nothing to do with systemic absorption. In deciding between options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, use common sense to select less time of 1 to 3 minutes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="5-correct-answer-b">5. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Decreasing the aqueous humor is necessary in glaucoma to decrease the intraocular pressure. Options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> would worsen the glaucoma. The formation, not the outflow, of aqueous humor is affected.</p>
<p>Miotic drops constrict the pupil and facilitate the outflow of the aqueous humor from the eye. In carbonic anhydrase inhibitors, the key word to remember is “inhibitors,” which can be associated with a decrease in humor production.</p>
<p>313
CHAPTER 21</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drugs-affecting-sexuality-and-reproduction">Drugs Affecting Sexuality and Reproduction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-affecting-sexuality-and-reproduction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="study-outcomes">STUDY OUTCOMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#study-outcomes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After completing this chapter, the reader will be able to do the following:</p>
<ul>
<li>Identify the uses of agents containing estrogen and progesterone.</li>
<li>Describe the differences between oral contraceptives.</li>
<li>Identify agents and the uses of ovulation stimulants, uterine stimulants, uterine relaxants, and lactation suppressants.</li>
<li>Describe side effects and nursing implications of these agents.</li>
</ul>
<p>314 ▼ CHAPTER 21 DRUGS AFFECTING SEXUALITY AND REPRODUCTION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-terms">KEY TERMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><strong>Follicle-stimulating hormone (FSH)</strong>
Also called <strong>menotropin</strong>—a gonadotropin that stimulates the growth and maturation of the graafian follicles in the ovaries in females, and promotes spermatogenesis in males.</p>
<p><strong>Infertility</strong>
Inability to produce offspring.</p>
<p><strong>Luteinizing hormone (LH)</strong>
A glycoprotein. In females LH works together with FSH to stimulate the ovaries to secrete estrogen in which high concentrations stimulate the release of a surge of LH, which stimulates ovulation. In men it induces the secretion of testosterone, which together with FSH stimulates the production of sperm.</p>
<p><strong>Premenstrual syndrome</strong>
A syndrome of nervous tension, irritability, weight gain, edema, headache, mastalgia, dysphoria, and lack of coordination that occurs during the last few days of the menstrual cycle before the onset of menstruation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="content-review">CONTENT REVIEW<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#content-review" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="female-and-male-sex-hormones">FEMALE AND MALE SEX HORMONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#female-and-male-sex-hormones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-estrogens">I. Estrogens<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-estrogens" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>A. Actions:</strong> bind with receptors to produce the same effect as naturally occurring estrogen. Estrogen is needed for the following</p>
<ol>
<li>Female reproductive organs</li>
<li>Secondary sex characteristics
a. Fullness of breasts
b. Appropriate distribution of body fat
c. Soft skin texture
d. Growth and distribution of body hair
e. Female voice</li>
<li>Maintenance of menstrual cycle</li>
<li>Growth of the ducts and nipples of the mammary glands</li>
</ol>
<p><strong>B. Uses</strong></p>
<ol>
<li>Menopausal symptoms: hot flashes, night sweats, somatic complaints, fatigue, nervousness, headache, memory loss</li>
<li>Osteoporosis</li>
<li>Menstrual disturbances: abnormal uterine bleeding, premenstrual symptoms, dysmenorrhea</li>
</ol>
<p>ESTROGENS, PROGESTINS ▼ 315</p>
<ol start="4">
<li>Prostate cancer and female breast cancer</li>
<li>Oral contraceptives</li>
<li>Postcoital contraception</li>
<li>Lactation suppressant</li>
<li>Acne in females</li>
<li>Prostate cancer treatment in men</li>
</ol>
<p>C. Major side effects</p>
<ol>
<li>Nausea, vomiting, loss of appetite</li>
<li>Salt and water retention, weight gain</li>
<li>Breast tenderness</li>
<li>Headache</li>
<li>Thromboembolic disorders</li>
<li>Hypertension</li>
</ol>
<p>D. Nursing implications</p>
<ol>
<li>Monitor BP because of hypertension potential</li>
<li>Instruct client to report any breakthrough bleeding—bleeding between cycles of regular menses</li>
<li>Inform male clients receiving estrogen therapy that the female characteristics usually disappear when the therapy is complete and the drug discontinued</li>
<li>Offer instruction on how to use the form ordered: oral, intravaginal, transdermal</li>
<li>Warn against cigarette smoking; side effects are increased in women over 35</li>
<li>Estrogens may alter certain laboratory tests</li>
<li>Monitor weight gain</li>
<li>Emphasize compliance</li>
</ol>
<p>E. Interactions: occur with antidiabetic and anticoagulant drugs (increased dose may be needed)</p>
<p>F. Common agents</p>
<ol>
<li>Chlorotrianisene (Tace)</li>
<li>Conjugated estrogenic substances (Premarin)</li>
<li>Diethylstilbestrol (DES)</li>
<li>Esterified estrogens (Estrace)</li>
<li>Estropipate (Ogen)</li>
</ol>
<p>II. Progestins</p>
<p>A. Actions: replace the missing progesterone by modifying the progesterone molecule from inactivation by the liver. Needed for the following</p>
<ol>
<li>Preparation of the uterus for pregnancy</li>
<li>Development of mammary gland duct during pregnancy</li>
<li>Reduction of spontaneous contractions</li>
</ol>
<p>CHAPTER 21 DRUGS AFFECTING SEXUALITY AND REPRODUCTION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-uses">B. Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Dysmenorrhea: pain associated with menstruation</li>
<li>Endometriosis: ectopic growth and function of endometrial tissue</li>
<li>Functional uterine bleeding</li>
<li>Prevention of abortion</li>
<li>Premenstrual syndrome (PMS)</li>
<li>Infertility: inability or difficulty in becoming pregnant</li>
<li>Contraception</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Nausea</li>
<li>Weight gain</li>
<li>Dizziness, headache</li>
<li>Decreased libido</li>
<li>Thrombolytic disease</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-contraindicated-in-patients-with-epilepsy-migraine-headaches-cardiac-disorders-and-asthma">D. Contraindicated in patients with epilepsy, migraine headaches, cardiac disorders, and asthma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-contraindicated-in-patients-with-epilepsy-migraine-headaches-cardiac-disorders-and-asthma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-common-agents">E. Common agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-common-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Medroxyprogesterone acetate (Provera)</li>
<li>Progesterone (Progestasert)</li>
<li>Norethindrone (Norlutin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-oral-contraceptives-birth-control-pills">III. Oral contraceptives: birth control pills<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-oral-contraceptives-birth-control-pills" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-actions-block-fsh-and-lh-which-decreases-the-release-of-the-ovum-and-alters-the-viscosity-of-the-mucus-of-the-cervix-thereby-hindering-the-fertilized-ovum-from-implanting-properly">A. Actions: block FSH and LH, which decreases the release of the ovum and alters the viscosity of the mucus of the cervix, thereby hindering the fertilized ovum from implanting properly<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-actions-block-fsh-and-lh-which-decreases-the-release-of-the-ovum-and-alters-the-viscosity-of-the-mucus-of-the-cervix-thereby-hindering-the-fertilized-ovum-from-implanting-properly" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-combinations">B. Combinations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-combinations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Fixed dose of estrogen and progestin</li>
<li>Fixed estrogen dose, varying progestin dose (low, then high level in cycle)</li>
<li>Varying amounts of progestin and estrogen</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-major-side-effects">C. Major side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-major-side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Early signs of pregnancy: nausea, breast fullness, weight gain, dizziness, fatigue, depression, irregular bleeding</li>
<li>Amenorrhea: the absence of menstruation</li>
<li>Thromboembolic disorders</li>
<li>Carcinogenesis and tumors</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-interactions-are-numerous-antibiotics-anticonvulsants-anticoagulants-antihypertensive-agents-caffeine-corticosteroids-analgesics">D. Interactions are numerous: antibiotics, anticonvulsants, anticoagulants, antihypertensive agents, caffeine, corticosteroids, analgesics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-interactions-are-numerous-antibiotics-anticonvulsants-anticoagulants-antihypertensive-agents-caffeine-corticosteroids-analgesics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>CONTRACEPTIVES: ORAL AND OTHER; ANDROGENS ▼ 317</p>
<p>E. Nursing implications</p>
<ol>
<li>Teach the client how to take the medications: begin on day 5 of the cycle and take 1 pill every day until day 21; then take the 7 pills containing no hormones during the menstrual cycle</li>
<li>Instruct the client that missing a dose could result in pregnancy</li>
<li>Instruct the client to do breasts exams monthly</li>
</ol>
<p>F. Common agents (Table 21-1)</p>
<p>IV. Contraceptives: other devices
A. Spermicides: creams, gels, and foams, which are applied vaginally before penetration and ejaculation. Instruct clients not to douche for 6 to 8 hours afterwards.
B. Contraceptive sponge: contains a spermicide that absorbs the semen
C. Intrauterine devices (IUD): contains a reservoir of progesterone, which must be replaced every year
D. Subdermal implant: the Norplant system, which slowly releases progestin over 5 years
E. Morning-after pill (the estrogen hormone DES): used in rape, incest, or pregnancy when it threatens the woman's mental well-being. Must be taken within 72 hours of intercourse.</p>
<p>V. Androgens
A. Action: replacement therapy of testosterone given orally, subcutaneously, or intramuscularly. Testosterone is needed for the following</p>
<ol>
<li>Male sex characteristics</li>
<li>Normal development of male sex organs and structures (penis, prostate, seminal vesicles)</li>
<li>Synthesis of sperm</li>
</ol>
<p>B. Uses</p>
<ol>
<li>Hypogonadism: a deficiency in the secretory activity of the ovary or testis</li>
<li>Delayed puberty</li>
<li>Palliative management of metastatic breast cancer in postmenopausal women</li>
<li>Endometriosis</li>
<li>Impotence: inability to achieve penile erection</li>
<li>Oligospermia: insufficient spermatozoa in the semen</li>
</ol>
<p>318</p>
<p>Table 21-1. Oral Contraceptives</p>
<table><thead><tr><th>Progestin</th><th>Estrogen</th><th>Progestin: Estrogen Ratio</th><th>Trade Name</th></tr></thead><tbody><tr><td>Ethynodiol diacetate</td><td>Ethinyl estradiol</td><td>1.0 mg:50 μg</td><td></td></tr><tr><td>1.0 mg:35 μg</td><td>Demulen 1/50*</td><td></td><td></td></tr><tr><td>Demulen 1/35</td><td></td><td></td><td></td></tr><tr><td>Levonorgestrel</td><td>Ethinyl estradiol</td><td>0.15 mg:30 μg</td><td></td></tr><tr><td>0.05 mg:30 μg (6 tablets), and</td><td></td><td></td><td></td></tr><tr><td>0.075 mg:40 μg (5 tablets), and</td><td></td><td></td><td></td></tr><tr><td>0.125 mg: 30 μg (10 tablets)</td><td>Nordette and Levien</td><td></td><td></td></tr><tr><td>Triphasil' and Tri-Levlen'</td><td></td><td></td><td></td></tr><tr><td>Norethindrone</td><td>None</td><td>0.35 mg</td><td>Micronor*, Norlutin, and Nor-QD</td></tr><tr><td>Norethindrone acetate</td><td>Ethinyl estradiol</td><td>2.5 mg:50 μg</td><td></td></tr><tr><td>1.5 mg:30 μg</td><td></td><td></td><td></td></tr><tr><td>1.0 mg:50 μg</td><td></td><td></td><td></td></tr><tr><td>1.0 mg:20 μg</td><td>Norlestrin 2.5/50*</td><td></td><td></td></tr><tr><td>Loestrin 1.5/30*</td><td></td><td></td><td></td></tr><tr><td>Norlestrin 1/50*</td><td></td><td></td><td></td></tr><tr><td>Loestrin 1/20</td><td></td><td></td><td></td></tr><tr><td>Norethindrone</td><td>Ethinyl estradiol</td><td>1.0 mg:50 μg</td><td></td></tr><tr><td>1.0 mg:35 μg</td><td>Ovcon-50</td><td></td><td></td></tr><tr><td>Genora 1/35, N.E.E. 1/35,</td><td></td><td></td><td></td></tr><tr><td>Nevola 1/35, Norcept-E,</td><td></td><td></td><td></td></tr><tr><td>Norethin 1/35, Norinyl 1+35, and</td><td></td><td></td><td></td></tr><tr><td>Ortho-Novum 1/35</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>0.5 mg:35 μg</td><td>Brevicon*, Modicon, and</td></tr><tr><td>Nelova 0.5/35E</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>0.4 mg:35 μg</td><td></td></tr><tr><td>0.5 mg:35 μg (10 tablets), and</td><td></td><td></td><td></td></tr><tr><td>1.0 mg:35 μg (11 tablets)</td><td>Ovcon-35</td><td></td><td></td></tr><tr><td>Nelova 10/11^{1} and</td><td></td><td></td><td></td></tr><tr><td>Ortho-Novum 10/11^{1}</td><td></td><td></td><td></td></tr></tbody></table>
<p>319</p>
<p>|  Norethindrone
—cont’d |  | 0.5 mg:35 μg (7 tablets), and
0.75 mg:35 μg (7 tablets) and,
1.0 mg:35 μg (7 tablets)
0.5 mg:35 μg (7 tablets), and
1.0 mg:35 μg (9 tablets), and
0.5 mg:35 μg (5 tablets) | Ortho-Novum 7/7/7^{§}
Tri-Norinyl^{§}  |
| --- | --- | --- | --- |
|  Norethindrone | Mestranol | 1.0 mg:50 μg | Norinyl 1+50, Genora 1/50,
Nelova 1/50, Norethin 1/50, and
Ortho-Novum 1/50  |
|  Norethynodrel | Mestranol | 9.85 mg:150 μg
5.0 mg:75 μg | Enovid 10 mg
Enovid 5 mg  |
|  Norgestrel | Ethinyl estradiol | 0.5 mg:50 μg
0.3 mg:30 μg | Ovral^{*}
Lo/Ovral  |
|  Norgestrel | None | 0.075 mg | Ovrette  |</p>
<p>All oral contraceptives are FDA Pregnancy Category X.</p>
<ul>
<li>Available in Canada and United States.
† Triphasic preparation—0.05 mg:30 μg pills are taken the first 6 days of the cycle, 0.075 mg:40 μg pills the next 5 days, and 0.125 mg:30 μg pills the next 10 days of the cycle, followed by a week of no medication or placebo.
‡ Biphasic preparation—0.5 mg:35 μg pills are taken the first 10 days of the cycle, and 1.0 mg:35 μg pills the next 11 days of the cycle, followed by a week of no medication or placebo.
§ Triphasic preparation—0.5 mg:35 μg pills are taken the first 7 days of the cycle, 0.75 mg:35 μg pills the next 7 days, and 1.0 mg:35 μg the next 7 days, followed by a week of no medication or placebo.
¶ Triphasic preparation—0.5 mg:35 μg pills are taken the first 7 days of the cycle, 1.0 mg:35 μg pills the next 9 days, and 0.5 mg:35 μg pills the next 3 days of the cycle, followed by a week of no medication or placebo.
From Clark J, Queener S, Karb V: Pharmacological basis of nursing practice, ed 4, St Louis, 1993, Mosby.</li>
</ul>
<p>320 ▼ CHAPTER 21 DRUGS AFFECTING SEXUALITY AND REPRODUCTION</p>
<ol start="7">
<li>Cryptorchidism: failure of one or both testicles to descend</li>
<li>Weight gain in debilitated patients: anabolic steroids, which are closely related to testosterone, increase weight. They are often misused by athletes and weight builders.</li>
</ol>
<p>C. <strong>Major side effects</strong></p>
<ol>
<li>Signs of masculinization in females: hirsutism, acne, deepening of the voice, clitoral enlargement, menstrual irregularities, regression of the breasts</li>
<li>Water and sodium retention, edema</li>
<li>Increased libido</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Monitor weight gain</li>
<li>Emphasize compliance</li>
<li>Teach the female client about potential side effects</li>
<li>Recommend use of nonhormonal contraception</li>
</ol>
<p>E. <strong>Common agents</strong></p>
<ol>
<li>Fluoxymesterone (Halotestin)</li>
<li>Testosterone (Testoject)</li>
<li>Testosterone cypionate (Depo-Testosterone)</li>
<li>Danazol (Danocrine)</li>
<li>Anabolic steroids
a. Nandrolone phenopropionate (Durabolin)
b. Nandrolone deconoate (Deca-Durabolin)
c. Oxymetholone (Anadrol)</li>
</ol>
<p>VI. <strong>Ovulation stimulants</strong>
A. <strong>Actions</strong>: stimulate the growth and maturation of ovum and increase the release of gonadotropins
B. <strong>Use</strong>: infertility
C. <strong>Major side effects</strong></p>
<ol>
<li>Multiple births</li>
<li>Cyst on ovaries</li>
<li>Breast tenderness</li>
<li>Hot flashes, sweating</li>
</ol>
<p>D. <strong>Nursing implications</strong></p>
<ol>
<li>Careful monitoring and compliance with follow-up visits to the physician are necessary</li>
<li>Instruct the client to report any symptoms</li>
<li>After three months, clients usually do not continue medication</li>
</ol>
<p>E. <strong>Common agents</strong></p>
<ol>
<li>Clomiphene citrate (Clomid): first choice</li>
<li>Menotropins (Pergonal)</li>
</ol>
<p>OVULATION AND UTERINE STIMULANTS, UTERINE DEPRESSANTS ▼ 321</p>
<ol start="3">
<li>Bromocriptine mesylate (Parlodel)</li>
<li>Danazol (Danocrine)</li>
<li>Progesterone (Progestaject)</li>
<li>Chorionic gonadotropin (HCG)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drugs-used-during-pregnancy">DRUGS USED DURING PREGNANCY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-used-during-pregnancy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-uterine-stimulants">I. Uterine stimulants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-uterine-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: stimulate the uterine smooth muscle
B. Groups</p>
<ol>
<li>Oxytocin</li>
<li>Ergot derivatives</li>
<li>Prostaglandins
C. Uses</li>
<li>Inducing more rapid deliveries</li>
<li>Hemorrhages</li>
<li>Post-cesarean section</li>
<li>Abortions
D. Major side effects</li>
<li>Nausea, vomiting, diarrhea</li>
<li>Postpartal hemorrhage</li>
<li>Hypertension
E. Nursing implications</li>
<li>Monitor vital signs</li>
<li>Assess uterine contractions, hemorrhage</li>
<li>Live birth from abortion is possible
F. Common agents</li>
<li>Oxytocin (Pitocin)</li>
<li>Ergot alkaloids
a. Ergonovine maleate (Ergotrate)
b. Methylergonovine maleate (Methergine)</li>
<li>Prostaglandins: dinoprostone (PGF₂)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-uterine-depressants">II. Uterine depressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-uterine-depressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A. Action: most act on the beta₂ adrenergic receptors to inhibit uterine contractions by relaxation of smooth muscles in the uterus
B. Uses: uncomplicated premature labor, threatened miscarriage
C. Major side effects</p>
<ol>
<li>Hypertension and tachycardia in the mother</li>
<li>Hyperglycemia</li>
<li>Pulmonary edema in the mother</li>
</ol>
<p>322 ▼ CHAPTER 21 DRUGS AFFECTING SEXUALITY AND REPRODUCTION</p>
<p>D. Nursing implications</p>
<ol>
<li>Monitor the VS in the mother and fetal heart tones in the neonate</li>
<li>Place client on her left side</li>
<li>Monitor IV closely on a pump</li>
<li>Stop if complications occur</li>
</ol>
<p>E. Common agents</p>
<ol>
<li>Ritodrine hydrochloride (Yutopar)</li>
<li>Magnesium sulfate</li>
<li>Terbutaline sulfate (Brethine)</li>
</ol>
<p>III. Lactation suppressants
A. Action: prohibit prolactin secretion
B. Use: suppress lactation postdelivery
C. Major side effects: rare
D. Nursing implications: give the agent 1 to 5 days postdelivery
E. Common agents: bromocriptine mesylate (Parlodel)</p>
<p>REVIEW QUESTIONS ▼ 323</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="review-questions">REVIEW QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#review-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>A client placed on tetracycline for her bronchitis asks the nurse about continuing with her birth control pills. She is in college and does not want to become pregnant. What should the nurse tell her?
a. Continue taking the birth control pills prescribed
b. Take a double dose for it to be effective
c. Use an additional form of protection such as a spermicide
d. Continue the birth control pills because they will remain effective</p>
</li>
<li>
<p>A client, age 57, is exhibiting hot flashes, irritability, and extreme fatigue. The doctor determines that she is having menopausal symptoms and would probably recommend a(an)
a. Androgen
b. Estrogen
c. Progesterone
d. Testosterone</p>
</li>
<li>
<p>When a client enters the hospital, why should the nurse ask about estrogen therapy during the nursing history?
a. It could be useful information
b. Estrogen therapy affects many lab tests
c. Clients on estrogen should be monitored for hypotension
d. Estrogen therapy should not be abruptly withdrawn</p>
</li>
<li>
<p>A client trying to get pregnant has had no success for the past year. If she is diagnosed with infertility, the first drug of choice would be
a. Clomid
b. Pergonal
c. Parlodel
d. Danocrine</p>
</li>
<li>
<p>A client's husband is transferred to the United States from France during her seventh month of pregnancy. During the stress of moving and a 10-hour flight, she begins to have severe labor pains. Upon arriving, she would most likely be placed on an IV of
a. Parlodel
b. Ergotrate
c. Yutopar
d. Clomid</p>
</li>
</ol>
<p>324 ▼ CHAPTER 21 DRUGS AFFECTING SEXUALITY AND REPRODUCTION</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: c</strong></td><td></td></tr><tr><td>An additional contraceptive such as a spermicide or condom is recommended. The antibiotic can cause the birth control pills to be less effective. There is no interaction between the two agents. There is a possibility, however, that the birth control pills will be less effective. Doubling the dose may not help and is not advisable. Extra protection by another form of contraception is recommended. There is no guarantee that the birth control pills will remain effective.</td><td>Eliminate responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> since they are similar. Reread options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>; select <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> since it makes the most sense. Doubling a dose of medication is rarely a correct action. Use the above approach if you have no idea of the correct answer.</td></tr><tr><td><strong>2. Correct answer: b</strong></td><td></td></tr><tr><td>Estrogens act by exerting the same effect as naturally occurring estrogen, which is decreased and responsible for the symptoms during menopause. Androgens are not recommended for menopausal symptoms. Progesterones are more commonly used for menstrual and pre-menstrual symptoms. Testosterone’s action is the same as androgen’s.</td><td>Think of menopause as Early older age and that Estrogen needs to be replaced.</td></tr><tr><td><strong>3. Correct answer: b</strong></td><td></td></tr><tr><td>Laboratory tests, as listed in the text, can be altered. All home</td><td>If you have no idea of the correct answer, try the cluster approach.</td></tr></tbody></table>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 325</p>
<p>medications should be documented upon the client’s entrance into the hospital, but this is not the <em>best</em> answer. Hypertension is a common side effect, partly from the water retention and weight gain. There is no severe complication of stopping the therapy.</p>
<p>Responses <em>a</em>, <em>c</em>, and <em>d</em> are more specific than response <em>b</em>, which talks in general about lab tests. Select response <em>b</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-a">4. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Clomid is usually tried first for infertility problems. Pergonal is used for infertility but only after successive tries with Clomid. Parlodel is an ovulation stimulant but is not the first line of choice. Danocrine is usually not the first-line drug.</p>
<p>Remember that Clomid is first alphabetically, so associate that it is a first drug of choice for infertility.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-c">5. Correct answer: c.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Yutopar inhibits uterine contractions and could decrease the chances of premature labor. Parlodel would not stop the possible premature labor. Ergotrate is a uterine stimulant and could induce premature labor. Clomid does not stop premature labor.</p>
<p>For these type of questions that you have no idea of the correct answer, select a response and go on to the next question. Keep your emotional reaction, your tiredness, to a minimum by taking three slow deep breaths. Do this before reading the next question so you will have your clearest perception and thinking ability. Remember that you will have some questions with unfamiliar content area.</p>
<p>^{}[]</p>
<p>Comprehensive Exam
327</p>
<p>328 ▼ COMPREHENSIVE EXAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="comprehensive-exam-questions">COMPREHENSIVE EXAM QUESTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#comprehensive-exam-questions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Mrs. Smith is brought into the emergency department after a motor vehicle accident. She is experiencing extreme pain in her right arm and an inability to bend her elbow. Stat blood work reveals hypoglycemia and an alcohol level of 250 mg/dl. She has been taking the antidepressant paroxetine hydrochloride (Paxil) once a day. The nurse should be concerned about which of the following effects if the pain medication meperidine (Demerol) is given as ordered?</li>
</ol>
<p>a. Extrapyramidal
b. Additive
c. Synergistic
d. Idiosyncracy</p>
<ol start="2">
<li>The nurse would be most concerned about metabolism of drugs in which of the following situations?</li>
</ol>
<p>a. Sally, 6 years old, going to surgery for a tonsillectomy
b. Bobby, 43 years old, experiencing a myocardial infarction
c. Fred, 65 years old, admitted with cirrhosis of the liver and diabetes
d. Morgan, 16 years old, recovering from hip surgery following a motor vehicle accident</p>
<ol start="3">
<li>Mrs. Moller, age 65, is receiving heparin sodium (Liquaemin Sodium) SQ BID. Which of the following is the correct method to administer the medication?</li>
</ol>
<p>a. 22 gauge, 1 inch needle; 90 degree angle, 0.2 cc airlock, using the vastus lateralis
b. 25 gauge, ½ inch needle; 45 degree angle, no airlock, using the abdomen
c. 25 gauge, 1 inch needle; 45 degree angle, no airlock, using the ventral gluteal
d. 22 gauge, 1 inch needle; 90 degree angle, 0.5 cc airlock, Z-track, using the abdomen</p>
<ol start="4">
<li>Mrs. Carter received hydroxyzine hydrochloride (Vistaril), 75 mg as ordered IM q 4 hr PRN for pain. The correct charting entry for administering this injection would be</li>
</ol>
<p>a. Vistaril, 75 mg IM in the deltoid muscle as needed for pain
b. Vistaril, 75 mg deep IM in the hip for complaint of pain
c. Vistaril, 75 mg, IM, Z-track, in the dorsal gluteal for complain of pain
d. Vistaril, 75 mg, IM, Z-track, in the dorsal gluteal for complaint of radiating, constant pain in the hip</p>
<p>COMPREHENSIVE EXAM ▼ 329</p>
<ol start="5">
<li>
<p>The physician orders the following nasogastric feeding for Mrs. James. Order: Ensure Plus 75 cc/hr with no more than 2 L of fluid for 24 hours. How many cc of water will Mrs. James be able to have if water is given every 4 hours and is part of the 2 liters?
a. 30 cc
b. 33 cc
c. 35 cc
d. 40 cc</p>
</li>
<li>
<p>Theophylline ethylenediamide (Aminophylline) is being administered per pump to Mr. Jacobs at 35 gtt/min with a minidrip tubing. The bag is mixed with 2 g/500 cc. How many mg is he receiving per hour?
a. 100 mg/hr
b. 140 mg/hr
c. 200 mg/hr
d. 240 mg/hr</p>
</li>
<li>
<p>The nurse in a senior care clinic is concerned about Mrs. Bessie, age 82, who does not seem to be responding to her new medication. If the nurse suspects an absorption difficulty, the nurse should
a. Change to a liquid form of the drug
b. Administer the medication before meals
c. Administer the drug in a suppository dosage form
d. Call the doctor and suggest a different frequency</p>
</li>
<li>
<p>An emergency room nurse would prepare which of the following preparations for a 32-year-old woman brought in because of an attempted suicide using meperidine (Demerol)?
a. Dimercaprol (BAL)
b. Naloxone (Narcan)
c. Acetylcysteine (Mucomyst)
d. Activated charcoal</p>
</li>
<li>
<p>Constipation, bradypnea, and cough suppression are common side effects of which of the following?
a. Beta blockers
b. Anticonvulsants
c. Narcotic analgesics
d. Cholinergic agents</p>
</li>
<li>
<p>Mr. Smiley is admitted to the telemetry unit with sudden onset of acute chest pain, shortness of breath, and vomiting. He is diagnosed with</p>
</li>
</ol>
<p>330 ▼ COMPREHENSIVE EXAM</p>
<p>probable myocardial infarction. His blood pressure dropped with nitroglycerin therapy. The best analgesic for relief of his pain would be</p>
<p>a. Hydromorphone HCL (Dilaudid)
b. Proposyphene (Darvon)
c. Codeine and acetaminophen (Tylenol no. 3)
d. Morphine sulfate (MS)</p>
<ol start="11">
<li>Susie, age 3, has a tympanic temperature of 102.6° F, productive, thick, yellow sputum, a constant cough, and irritability. She has been on an antibiotic for 4 days without improvement. Her mother should avoid which of the following?</li>
</ol>
<p>a. Ibuprofen for children
b. Acetaminophen (Tylenol)
c. Acetylsalicylic acid (aspirin)
d. Tepid bath for 20 minutes</p>
<ol start="12">
<li>Karen, age 40, suffers from migraine headaches associated with her menses. She seeks advice on medication that can be taken while at work and that will not make her sleepy. Preventive treatment could consist of which of the following?</li>
</ol>
<p>a. Ibuprofen (Advil)
b. Ergotamine tartrate (Ergostat)
c. Diphenhydramine hydrochloride (Benadryl)
d. Codeine and acetaminophen (Tylenol no. 2)</p>
<ol start="13">
<li>Mrs. Rose is placed on the medicine unit with a diagnosis of upper respiratory infection. She has had progressive difficulty breathing and is placed on aminophylline IV. Common side effects to monitor for are</li>
</ol>
<p>a. Hypertension, tachycardia
b. Nervousness, tachycardia
c. Tachycardia, tremors
d. Bradycardia, tremors</p>
<ol start="14">
<li>A client with flushed skin, dry mouth, constipation, and urinary retention is experiencing which of the following?</li>
</ol>
<p>a. Side effects to an anticholinergic agent
b. Normal reaction to an anticholinesterase agent
c. Toxicity to an adrenergic blocking agent
d. Side effect of a noncatecholamine</p>
<p>COMPREHENSIVE EXAM ▼ 331</p>
<ol start="15">
<li>
<p>A drug exerting a positive inotropic and negative chronotropic effect would have which of the following effects?
a. Bradypnea, oliguria, and tachycardia
b. Tachypnea, polyuria, and bradycardia
c. Polyuria, bradycardia, and an increased blood pressure
d. Oliguria, tachycardia, and a decreased blood pressure</p>
</li>
<li>
<p>Mr. Smith is given his antiparkinsonism agent at 9-1-5-9 q day. You notice at 12:00 and 4:00 that his tremors increase and he shuffles his feet more. The nurse would suspect
a. End-of-dose deterioration
b. On-off phenomenon
c. Both of the above
d. Toxicity</p>
</li>
<li>
<p>A newly diagnosed epileptic client should be encouraged to continue the phenytoin (Dilantin) therapy regardless of the sedation because this side effect
a. Suddenly disappears after several weeks
b. Improves after administration of the drug
c. Cannot be helped and the client must learn to live with it
d. May get worse but the drug still controls the seizure</p>
</li>
<li>
<p>The drug of choice for a client in status epilepticus is
a. Phenytoin (Dilantin)
b. Phenobarbital sodium (Luminal sodium)
c. Valporic acid
d. Diazepam (Valium)</p>
</li>
<li>
<p>A client who eats figs, smoked sausage, and cheese might experience which of the following if taking an MAO inhibitor?
a. BP 80/50
b. HR 210
c. BP 230/120
d. HR 42</p>
</li>
<li>
<p>While on his medication for three months, Eric experiences tardive dyskinesia and dystonia. These side effects are common in
a. Tricyclic antidepressants
b. Anticonvulsants
c. MAO inhibitors
d. Antipsychotic agents</p>
</li>
</ol>
<p>332 ▼ COMPREHENSIVE EXAM</p>
<ol start="21">
<li>Which of the following drugs should be avoided if the client is taking a centrally acting skeletal muscle relaxant such as cyclobenzaprine hydrochloride (Flexeril)?</li>
</ol>
<p>a. Benylin elixir
b. Acetylsalicylic acid (aspirin)
c. Nylidrin HCL (Arlidin)
d. Methyldopa (Aldomet)</p>
<ol start="22">
<li>Mr. Halton, age 22, is brought to the clinic, having received several deep lacerations in a knife fight. The nurse anticipates a long suturing time and should prepare which of the following preparations with the local anesthetic?</li>
</ol>
<p>a. Epinephrine
b. Diazepam (Valium)
c. Vitamin K
d. Tetanus toxoid</p>
<ol start="23">
<li>The action of general anesthetics that produce depression of the vasomotor center of the brain along with the action of narcotics could cause which of the following?</li>
</ol>
<p>a. Dilated pupils
b. Hypotension
c. Hypertension
d. Tachycardia</p>
<ol start="24">
<li>After an attempted suicide, John, age 21, is placed on the mood stabilizer lithium carbonate (Lithobid). He should avoid which of the following items?</li>
</ol>
<p>a. Furosemide (Lasix)
b. High-sodium diet
c. Antacids (Maalox)
d. Milk products</p>
<ol start="25">
<li>A neighbor calls a nurse at home for advice regarding the best time to take her newly prescribed antidepressant amitriptyline (Elavil). The best time would be</li>
</ol>
<p>a. 9 P.M. or bedtime
b. 5 P.M. or suppertime
c. 9 A.M. after breakfast
d. 12 noon after lunch</p>
<ol start="26">
<li>Mr. Rogers, age 47, is admitted for surgery in the morning. Because of his anxiety, the physician orders a sedative before bedtime. The nurse should institute which of the following?</li>
</ol>
<p>COMPREHENSIVE EXAM ▼ 333</p>
<p>a. Leave the side rails down if Mr. Rogers prefers
b. Place all four side rails up
c. Encourage the client to call if necessary and let him choose whether to put the side rails up or down
d. Place at least one side rail up</p>
<ol start="27">
<li>
<p>While taking a cardiac glycoside digoxin (Lanoxin), the client should withhold the medication and call the physician if he or she experiences which of the following findings?
a. HR 45, irregular
b. HR 110, irregular
c. HR 80, regular
d. HR 150, regular</p>
</li>
<li>
<p>Mr. Ben, a client with chronic cardiac problems, is taking a loop diuretic, a cardiac glycoside, an antihypertensive, an NSAID, and a baby aspirin q day. Which of the following drugs, taken along with the cardiac glycoside, increases the possibility of digitalis toxicity?
a. NSAID
b. Antihypertensive
c. Baby aspirin
d. Diuretic</p>
</li>
<li>
<p>While taking verapamil (Calan), client reports of which of the following would concern the nurse?
a. BP 155/82
b. BP 89/60
c. "I have diarrhea every other day"
d. "Sometimes my head spins around"</p>
</li>
<li>
<p>Mr. Tason complains of headaches after his sublingual dose of nitroglycerin. Which of the following responses by the nurse is correct?
a. "You must tolerate these headaches; nothing can really stop the pain"
b. "The headache means you are taking too many nitroglycerin tablets"
c. "Headaches are common with these medications and should decrease with continued use"
d. "A narcotic can be given before the nitroglycerin to relieve the headache"</p>
</li>
</ol>
<p>334 ▼ COMPREHENSIVE EXAM</p>
<ol start="31">
<li>Mrs. Bailey enters the emergency department complaining of acute chest pain for the first time. The least likely medication for the physician to prescribe would be</li>
</ol>
<p>a. Propranolol (Inderal)
b. Nitroglycerin (Tridil)
c. Isosorbide dinitrate (Isordil)
d. Nifedipine (Procardia)</p>
<ol start="32">
<li>Mrs. Marley, a chronic COPD client, complains of chest discomfort. Which one of the following medications, if ordered, should be questioned by the nurse?</li>
</ol>
<p>a. Nitroglycerin
b. Nifedipine (Procardia)
c. Propranolol (Inderal)
d. Verapamil (Calan)</p>
<ol start="33">
<li>Which laboratory result listed below would concern the nurse caring for a client taking a thiazide diuretic?</li>
</ol>
<p>a. K level of 2.5
b. K level of 4.0
c. Glucose of 140
d. Na level of 145</p>
<ol start="34">
<li>An over-the-counter (OTC) cough medicine for a hypertensive client could produce which of the following effects?</li>
</ol>
<p>a. BP 200/120
b. Sedation
c. HR 156
d. BP 90/50</p>
<ol start="35">
<li>The combination of an aminoglycoside antibiotic and a loop diuretic would likely cause which of the following effects?</li>
</ol>
<p>a. K of 4.5
b. Ototoxicity
c. Nephrotoxicity
d. Muscle cramps</p>
<ol start="36">
<li>An older adult client being treated for multiple injuries after a motor vehicle accident experiences a decrease in urinary output and edema to the feet. The most likely medication to administer would be</li>
</ol>
<p>a. Triamterene (Dyrenium)
b. Spironolactone (Aldactone)</p>
<p>COMPREHENSIVE EXAM ▼ 335</p>
<p>c. Furosemide (Lasix)
d. Prazosin (Minipress)</p>
<ol start="37">
<li>
<p>Which of the following responses by a client receiving anticoagulation therapy for several days should concern the nurse?
a. "I can't breathe and I feel anxious"
b. "I'm itching all over and I have whelps"
c. "My throat feels sore"
d. "My urine looked pink the last time I went to the bathroom"</p>
</li>
<li>
<p>While receiving heparin sodium (Liquaemin), the nurse notices on the medication record that the client is also receiving aspirin QID for arthritis. The aspirin could produce which effect?
a. Hemostatic
b. Antihemophilic
c. Antiplatelet
d. Thrombolytic</p>
</li>
<li>
<p>Friends call seeking advice concerning the administration of immunizations for their child. They voice concern about the side effects of the DTP and the oral polio vaccines. The nurse's best response would be
a. "The side effects can be severe; it is a chance you have to take"
b. "The physician will explain all this to you when the child goes to the clinic"
c. "Side effects can occur, but the illness is far worse than the possible side effects"
d. "Choose the killed version of the immunization instead of the live form"</p>
</li>
<li>
<p>The records of children entering kindergarten must be monitored through the school nurse. The nurse would expect to see documentation of which of the following immunizations before entering school?
a. 3-HBV, 5-DTP, 4-OPV, 4-HIB, 2-MMR
b. 3-HBV, 4-DTP, 3-OPV, 3-HIB, 1-MMR
c. 5-DTP, 4-OPV, 4-HIB, 2-MMR
d. 3-HBV, 5-DTP, 4-OPV, 4-HIB</p>
</li>
<li>
<p>When administering an iodine solution such as Lugol's solution, the nurse should
a. Give the dose at bedtime
b. Monitor the BP before administration
c. Monitor the pulse before administration
d. Dilute the medication in a small glass of liquid</p>
</li>
</ol>
<p>A pregnant client presents in labor to the OB floor. The baby is at term and the mother is placed on oxytocin (Pitocin). The nurse should monitor for which side effect? a. Increased uterine blood flow b. Dehydration c. Fetal heart tones of 160 d. Blood pressure of 189/98</p>
<ol start="43">
<li>
<p>A newly diagnosed 16-year-old diabetic asks the nurse what the insulin shots do for her diabetes. Which of the answers listed would be the least correct? a. Insulin transports glucose across the cell membrane b. Insulin promotes conversion of glycogen to glucose c. Insulin increases the absorption of dietary glucose d. Insulin enhances protein synthesis</p>
</li>
<li>
<p>The physician's order reads NPH insulin 25 u IV stat. The nurse should a. Prepare the medication as ordered b. Question the physician's order c. Consult another nurse about the order d. Give the insulin SQ instead of IV</p>
</li>
<li>
<p>Mrs. Hill, a 35-year-old insulin-dependent diabetic, is found unconscious on a nurse's rounds at 4:00 p.m. Because the cause is unknown, the best action would be treatment for a. Ketoacidosis b. Somogyi effect c. Insulin reaction d. Dawn phenomenon</p>
</li>
<li>
<p>Joey, an 8-year-old with chronic asthma, is experiencing severe dyspnea. The child is placed on aminophylline because it will a. Produce bronchoconstriction b. Produce bronchodilation c. Increase the oxygen consumption d. Decrease the respiratory rate</p>
</li>
<li>
<p>Excessive use of the nasal spray oxymetazoline hydrochloride (Afrin) would probably result in which of these side effects? a. Nasal bleed b. Rhinitis c. Nervousness d. Rebound congestion</p>
</li>
</ol>
<p>COMPREHENSIVE EXAM ▼ 337</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="answers-rationales-and-test-taking-tips">ANSWERS, RATIONALES, AND TEST-TAKING TIPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#answers-rationales-and-test-taking-tips" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Rationales</th><th>Test-Taking Tips</th></tr></thead><tbody><tr><td><strong>1. Correct answer: b</strong></td><td></td></tr><tr><td>The combination of the alcohol and the antidepressant could produce a greater sum effect. The term in option <em>a</em> means a client exhibits movement disorders similar to those of Parkinson’s disease. The term in option <em>c</em> means agents do not add to the activity of the other. This term in option <em>d</em> means an inherited sensitivity.</td><td></td></tr></tbody></table>
<p><strong>2. Correct answer: c</strong>
The liver is the primary organ for metabolizing drugs. Metabolism should be sufficient in a client age 6 for such a short surgery in option <em>a</em>. The condition in option <em>b</em> should not cause a metabolism problem. The age in option <em>d</em> should not present a metabolism problem.</p>
<p><strong>3. Correct answer: b</strong>
For SC medications no airlock is required, and the abdomen is the preferred site for the quickest absorption. In option <em>a</em> the needle length and gauge are too big, and the site is inappropriate. Note that the angle would be appropriate only if the client were obese. In option <em>c</em> the needle is too long, and the | The strategy here is to go with what you know—more drugs have additive effects than any of the other items given as choices. Avoid selection of unfamiliar terms or concepts.</p>
<p>The key words in the question are “the metabolism of drugs”; avoid focusing on the words “most concerned,” for you may then select the youngest person. Given the age of the clients, the oldest person has the greatest decrease in the metabolic rate. Recall that with aging most body functions decline.</p>
<p>Use the vertical technique to read the responses for the best clarity and quickest understanding. The vertical technique, step 1: read down the first series—the gauge. Immediately eliminate responses <em>a</em> and <em>d</em>, since this size is too large. Of the remaining responses, it seems that response <em>c</em> is incorrect, since 1 inch is typically too long; however, read through the other  |</p>
<p>338 ▼ COMPREHENSIVE EXAM</p>
<p>site is incorrect for SC injections. In option <em>d</em> the length and gauge of the needle are too big; Z-track and an airlock are not required for SC injections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-correct-answer-d">4. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Z-track is identified, and a complete description of the pain is given. Z-track is not identified, and the description of pain is incomplete in options <em>b</em> and <em>c</em>; these are incomplete descriptions. Option <em>c</em> has no description of the pain.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-correct-answer-c">5. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>75 cc × 24 hr = 1800 cc
2 L = 2000 cc
2000 cc – 1800 cc = 200 cc. If water is given every 4 hours: 24 hours divided by 4 = 6 times a day or every 6 hours for water.
200 cc divided by 6 times = 33 cc each time water is given. In responses <em>a</em>, <em>b</em>, and <em>d</em> the calculations are incorrect.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-correct-answer-b">6. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mfrac><mrow><mn>60</mn><mtext>&nbsp;min</mtext></mrow><mrow><mn>1</mn><mtext>&nbsp;hr</mtext></mrow></mfrac><mo>×</mo><mfrac><mrow><mn>35</mn><mtext>&nbsp;gtt</mtext></mrow><mtext>min</mtext></mfrac><mo>×</mo><mfrac><mrow><mn>1</mn><mtext>&nbsp;cc</mtext></mrow><mrow><mn>60</mn><mtext>&nbsp;gtt</mtext></mrow></mfrac><mo>×</mo><mfrac><mrow><mn>2</mn><mtext>&nbsp;g</mtext></mrow><mrow><mn>500</mn><mtext>&nbsp;cc</mtext></mrow></mfrac><mo>×</mo><mfrac><mrow><mn>1000</mn><mtext>&nbsp;mg</mtext></mrow><mrow><mn>16</mn><mtext>&nbsp;m</mtext></mrow></mfrac><mo>=</mo><mn>140</mn><mtext>&nbsp;mg/hr</mtext></mrow><annotation encoding="application/x-tex">\frac{60 \text{ min}}{1 \text{ hr}} \times \frac{35 \text{ gtt}}{\text{min}} \times \frac{1 \text{ cc}}{60 \text{ gtt}} \times \frac{2 \text{ g}}{500 \text{ cc}} \times \frac{1000 \text{ mg}}{16 \text{ m}} = 140 \text{ mg/hr}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 2.0309em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3449em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">1</span><span class="mord text"><span class="mord">&nbsp;hr</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">60</span><span class="mord text"><span class="mord">&nbsp;min</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 2.0074em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">min</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">35</span><span class="mord text"><span class="mord">&nbsp;gtt</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 2.2019em; vertical-align: -0.8804em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">60</span><span class="mord text"><span class="mord">&nbsp;gtt</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">1</span><span class="mord text"><span class="mord">&nbsp;cc</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.8804em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 2.0074em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">500</span><span class="mord text"><span class="mord">&nbsp;cc</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">2</span><span class="mord text"><span class="mord">&nbsp;g</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 2.0074em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">16</span><span class="mord text"><span class="mord">&nbsp;m</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">1000</span><span class="mord text"><span class="mord">&nbsp;mg</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">140</span><span class="mord text"><span class="mord">&nbsp;mg/hr</span></span></span></span></span></span></div>
<p>In options <em>a</em>, <em>c</em>, and <em>d</em> the calculations are incorrect.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-correct-answer-a">7. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Drugs are more readily absorbed in liquid form.</p>
<p>items in that line and note that the site is for an IM injection. Thus select response <em>b</em>.</p>
<p>Select the most comprehensive and specific response as an example of correct documentation.</p>
<p>If you have no idea how to calculate the correct answer, try the numbers strategy. First, eliminate the highest and lowest numbers, responses <em>a</em> and <em>d</em>. Then note that the choices left are 33 and 35 cc; take a conservative approach to select the smaller number—33 cc. Remember to use this approach ONLY when you have no idea how to calculate the answer.</p>
<p>If you have no idea how to calculate the answer try the numbers strategy—eliminate the highest and lowest numbers, responses <em>a</em> and <em>d</em>. With the remaining responses be conservative and select the smaller number, <em>b</em>.</p>
<p>The key words in the question are “an absorption difficulty.” The</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 339</p>
<p>Obtaining the liquid form needs no new order; simply notify the pharmacy to change the medication to a liquid form. There is not enough information to determine this as a need in option b. The rectal route is sometimes unreliable in the elderly. Frequency may not be the problem.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-correct-answer-b">8. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Narcan counteracts the effects of narcotics such as Demerol, but the duration of action is short and the findings of the overdose may return quickly. The usual dose of 1 mg IV push can be repeated without adverse effects. BAL is recommended for heavy metals like gold, lead, copper, mercury, and arsenic; it binds with these substances to form a water-soluble complex that is removed by the kidneys. It is given deep IM. Mucomyst is used for Tylenol overdose. It is typically mixed with iced juice or soda, given by mouth QID for 4 days. Activated charcoal, given by mouth or nasogastric tube, is used to bind with caustic agents.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="9-correct-answer-c">9. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>All three of these symptoms are common, depending on the type and frequency of the narcotic used. Beta blockers do not cause cough suppression but can cause common sense approach leads to response a (change the medication to a liquid form).</p>
<p>Cluster responses c and d under "given by mouth." BAL is given IM; eliminate it as a choice, since it takes 15 to 20 minutes for effectiveness. Select Narcan; it is given IV, and with a narcotic overdose the route with the most immediate effect is the best choice. Remember for Narcotics give Narcan to negate the action of this group of medications.</p>
<p>Remember that beta blockers (BB) have the most common side effects of BB—bronchospasm and bradycardia. Cholinergic agents such as reglan and urecholine may cause intestinal cramps or bladder</p>
<p>340 ▼ COMPREHENSIVE EXAM</p>
<p>constipation and bradypnea. Anticonvulsants do not typically cause these reactions. Cholinergic agents cause the opposite effects.</p>
<ol start="10">
<li><strong>Correct answer: d</strong></li>
</ol>
<p>MS is chosen because it is most effective and rapid acting to eliminate cardiac pain. It is typically given IV, with the dose titrated, until the client is pain free. Dilaudid can be used for MI because it is a morphine type of drug; a side effect however, is severe respiratory depression, which may not be desirable with cardiac clients. Dilaudid is the drug of choice for clients with severe pain from terminal diseases. Darvon is too weak for the rapid relief needed with an MI. Tylenol no. 3 is an effective pain medication but is not typically used for MI, since it is given by mouth and would take too long to have the desired and rapid effect.</p>
<ol start="11">
<li><strong>Correct answer: c</strong></li>
</ol>
<p>Aspirin should be avoided in children, especially those with viral infections, which are possible in this situation because the antibiotic has not produced any response. The complication from aspirin in children is Reye’s syndrome. Ibuprofen is effective in spasms. Anticonvulsants typically cause a side effect of drowsiness.</p>
<p>Remember that morphine is the drug of choice for cardiac pain, even if the blood pressure has dropped from other therapy. The nurse would probably adjust the nitroglycerine drip and medicate the client with morphine.</p>
<p>If you found this question to be easy, smile, take a deep breath, and relax. There will be similar easy questions on the exam. Use them to help you relax and think more clearly on the different questions.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 341</p>
<p>lowering temperature and can be alternated with Tylenol. Tylenol is preferred in children. Tepid baths will effectively relieve temperature in children.</p>
<ol start="12">
<li><strong>Correct answer: b</strong></li>
</ol>
<p>Ergostat constricts smooth muscle in peripheral and cranial blood vessels, yet relaxes uterine muscles. It is typically used by sublingual route for vascular headaches from migraines or histamine release. Ibuprofen is too weak for the vascular response of a migraine. Benadryl has been used at bedtime to provide some clients with relief from headaches. It is ineffective in acute attacks and typically causes sedation. Option <em>d</em> could produce sedation without relief of severe pain.</p>
<p>Migraine headaches are thought to be the result of cerebral vasodilation. The best drugs are those that have a vasoconstriction effect, such as ergotamine tartrate.</p>
<ol start="13">
<li><strong>Correct answer: b</strong></li>
</ol>
<p>Jitters, nervousness, and tachycardia are common with therapeutic doses of aminophylline. Tachycardia is expected and usually controlled by adjusting the aminophylline drip if the client exhibits other symptoms. Tremors are findings of toxicity, when serum theophylline levels &gt;20 mEq.</p>
<p>Remember that any of the bronchodilators may have findings similar to sympathetic effect—bronchodilation, tachycardia, and nervousness. In addition, the urine output of a client on aminophylline may increase, since it has a slight diuretic effect.</p>
<p>342 ▼ COMPREHENSIVE EXAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="14-correct-answer-a">14. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#14-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are typical reactions to anticholinergic agents such as atropine. The opposite effects of those in option <em>b</em> can be seen from anticholinesterase agents such as Mestinon, except for the dry mouth and flushed skin. These effects in option <em>c</em> are not seen with adrenergic blocking agents. These side effects in option <em>d</em> are not seen with noncatecholamines.</p>
<p>Remember that the Cholinergic or parasympathetic system is the Common system used daily for normal bodily functions—moist mouth, urine output, regular heart rate, and bowel movements. The Adrenergic or sympathetic system is used only for an Adventure of new experiences (the fight or flight response)—dilated pupils, dry mouth, increased heart rate, and dilated bronchials.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="15-correct-answer-c">15. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#15-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The positive inotropic effect increases blood to the kidneys and polyuria; the negative chronotropic effect decreases HR. No respiratory response such as bradypnea should be seen. Option <em>d</em> presents opposite effects.</p>
<p>Responses <em>a</em> and <em>b</em> can be eliminated; the heart and lungs work together, in that both will be tachy or brady. As in these responses, if tachycardia is with bradypnea or visa versa, the response is incorrect. In deciding between responses <em>c</em> and <em>d</em>, remember that “inotropic” starts with an “i,” yet it means contractility; “chronotropic” begins with a “c,” yet it means rate. Think in inverse terms for these two words. Positive Inotropic is increased Contractility. Negative Chronotropic is decreased heart rate.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="16-correct-answer-a">16. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#16-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>When the symptoms return before the next dose, it is called end-of-dose deterioration. With the on-off phenomenon, symptoms return at any time despite the continuous medication schedule. In option <em>c</em> it is unlikely to be</p>
<p>To make the correct selection, simply think of the description of when the medication is given in contrast to when the symptoms occur. The medication is given at 9 A.M. and 1 P.M. and 5 P.M., with the symptoms at 12 noon and 4 P.M.—both of these times are 1 hour before the next dose.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 343</p>
<p>both. Toxicity findings would be sustained and not decreased between doses.</p>
<ol start="17">
<li>Correct answer: b
A slow improvement should be noted with each administration of the agent. The sedation does not suddenly disappear. Severe sedation is not desirable for safety reasons, and a different medication should be tried. The sedation should not worsen unless the dose is increased.</li>
</ol>
<p>The key word in response a that makes it incorrect is “suddenly.” Eliminate response c, since it reflects a rote or slang type of answer. Eliminate response d, since it reads, “this side effect may get worse but still control the seizure.” The side effect does not control the seizure; the medication effects control the seizure.</p>
<ol start="18">
<li>Correct answer: d
Benzodiazepine (Valium) works most effectively in status epilepticus. Ativan can also be used and may be preferred, since it has less of a sedating effect than Valium. Dilantin can be used but is usually not the drug of choice. Phenobarbital can be used but is also not the drug of choice mainly because of the sedating properties. Option c is recommended for petit mal seizure activity.</li>
</ol>
<p>The key term in the stem is “status epilepticus,” not epilepsy.</p>
<ol start="19">
<li>Correct answer: c
Hypertension is the most common and serious side effect of combining foods containing tyramine with MAO inhibitors. In option a the opposite effect is noted. Heart rate is unaffected.</li>
</ol>
<p>Recall that a MAO inhibitor results in hypertension if foods with tyramine are eaten.</p>
<p>344 ▼ COMPREHENSIVE EXAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="20-correct-answer-d">20. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#20-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Antipsychotic agents are usually major tranquilizers that can cause extrapyramidal effects such as these. Cogentin and Artane are given to counteract these side effects. Sedation is the most common side effect with options <em>a</em> and <em>b</em>. Hypertension is the common side effect with option <em>c</em>.</p>
<p>Remember that Tranquilizers result in Tardive dyskinesia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="21-correct-answer-a">21. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#21-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>An additive effect can occur with alcohol (CNS depressant), which is in any elixir. Aspirin may improve the condition due to its antiinflammatory properties. No noticeable effect is documented with option <em>c</em>. Aldomet is used for hypertension and should not cause severe interactions.</p>
<p>Associate the factor of relaxants and match up the muscle relaxant with the benylin elixir that relaxes the cough reflex. Remember that alcohol commonly results in an additive effect when it is combined with medications that depress the nervous system.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="22-correct-answer-a">22. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#22-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Epinephrine prolongs the effect of the local agent and decreases bleeding as a result of the local vasoconstrictive effects. Option <em>b</em> would not help the suturing process or procedure. Option <em>c</em> would be used for bleeding disorders. The client should be assessed for the last tetanus to have been within the prior 10 years, but this will not aid the suturing time.</p>
<p>The key term in the stem is “local anesthetic,” which is typically given subcutaneously. A need during any laceration is to control bleeding by vasoconstriction, and the only drug in the responses that vasoconstricts is epinephrine.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 345</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="23-correct-answer-b">23. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#23-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Both agents decrease blood pressure. Narcotics cause pinpoint pupils. Both agents are CNS depressants and would not increase the BP. Effects on the heart rate should not necessarily be seen.</p>
<p>Recall that narcotics and anesthetics both depress the body functions. Use common sense to select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>, hypotension.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="24-correct-answer-a">24. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#24-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Drugs that alter urinary status should be avoided. Renal toxicity is a typical problem of clients on lithium. There is no interaction between a high-sodium diet and this drug. An antacid could be taken with this agent without any effects. Milk products should not interfere with this drug.</p>
<p>Think of the responses in more general terms: a renal drug, a special diet, a GI drug, and dairy products. Use an educated approach and determine which of these factors warrants the most concern. Of course the renal system would have the highest priority—select response <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="25-correct-answer-a">25. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#25-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Taking Elavil at bedtime is best for offering a good night's sleep and decreasing the sedative effect during waking hours. Elavil given as early as in option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> may cause drowsiness too early in the evening. The times in options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> would cause too much sedation for early morning and afternoon.</p>
<p>If the medication's effect is unknown and the data given are nonspecific, select bedtime to give medication.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="26-correct-answer-b">26. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#26-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Safety measures should be taken with any sedative. The nurse should document that</p>
<p>If in doubt put the rails up, no matter what the age or the condition, especially if the</p>
<p>346 ▼ COMPREHENSIVE EXAM</p>
<p>the rails were raised and that the client received and agreed with the instruction to keep the rails up. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> is an unsafe action from a legal view. If the client refuses, this should be noted in the nurse's notes. He should not have a choice for side rail position because he has received a sedative. All side rails are raised for safety.</p>
<ol start="27">
<li><strong>Correct answer: a</strong></li>
</ol>
<p>The negative chronotropic effect of Lanoxin decreases the HR. In options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> the fast rate and irregular rhythm would both warrant using Lanoxin. In option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, the Lanoxin is maintaining the rate within normal ranges and a regular rhythm.</p>
<ol start="28">
<li><strong>Correct answer: d</strong></li>
</ol>
<p>A low serum potassium from the loop diuretic, plus the cardiac glycoside, increase the possibility of toxicity. Options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span>, and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span> are incorrect; these drugs should not cause interactions.</p>
<ol start="29">
<li><strong>Correct answer: b</strong></li>
</ol>
<p>Hypotension is a common and possibly serious side effect requiring close monitoring during administration. The client has been given a sedative.</p>
<p>Remember that Lanoxin is to be held if the heart rate is <span class="math math-inline"><span class="katex-error" title="ParseError: KaTeX parse error: Expected 'EOF', got '&amp;' at position 1: &amp;̲lt;60" style="color: rgb(204, 0, 0);">&amp;lt;60</span></span> or <span class="math math-inline"><span class="katex-error" title="ParseError: KaTeX parse error: Expected 'EOF', got '&amp;' at position 1: &amp;̲gt;120" style="color: rgb(204, 0, 0);">&amp;gt;120</span></span> and the rhythm is irregular. Remember 60 and then double it to get the maximum rate. Also note that of the given heart rates, the nurse would be most concerned about either the 45 or the 150 heart rate. Then think—digoxin is given for fast rates, so the correct answer must be <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>.</p>
<p>Think of the responses in more general terms: antiinflammatories in responses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, antihypertensives, and a renal drug. If you have no idea of a correct response, select the renal drug, since the renal system is a priority system.</p>
<p>Of the given responses, the low blood pressure is a priority. Note that this is related to the cardiovascular system, which</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 347</p>
<p>opposite effect occurs in option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span>. GI effects are not common side effects. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> is not a common side effect. More information is needed to make an association of this finding with the drug: during what activity or what time of day? What was the frequency?</p>
<p>takes precedent over the GI system.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="30-correct-answer-c">30. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#30-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Clients learn to tolerate and to use medication before or right after the nitroglycerin dose for the relief of pain. Preventing the headache entirely may be impossible, but something can be taken to decrease the severity and to relieve the pain. Option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> is a common side effect with the normal dose. Usually a nonnarcotic drug such as Tylenol is effective.</p>
<p>Eliminate options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>b</mi></mrow><annotation encoding="application/x-tex">b</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">b</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span> since neither make sense and are a correct approach. Between options <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>c</mi></mrow><annotation encoding="application/x-tex">c</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">c</span></span></span></span></span>, eliminate option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>a</mi></mrow><annotation encoding="application/x-tex">a</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal">a</span></span></span></span></span> because of the words “must tolerate” and “nothing . . . stop . . . pain.” These absolutes give a clue this is an incorrect answer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="31-correct-answer-a">31. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#31-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Inderal is used for chronic, not acute, cardiac pain. It is used to prevent angina. If the drug is stopped suddenly, the client may experience rebound, severe angina. The IV form of NTG is often given after the SL nitroglycerin is tried. The SL form of Isordil is used effectively for angina. In option <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>d</mi></mrow><annotation encoding="application/x-tex">d</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span></span></span></span></span>, procardia is a capsule that contains liquid that can be squirted under the tongue, may provide for quick relief of acute pain or hypertensive episodes.</p>
<p>Be very cautious in reading this question. If you missed the word “least,” you probably answered it incorrectly. Cluster the responses by usual route: Inderal—PO, Tridil—IV drip, Isordil—SL, and Procardia—PO or SL. Note that the PO medication would take the longest to be effective, so it is the least likely to be administered.</p>
<p>348 ▼ COMPREHENSIVE EXAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="32-correct-answer-c">32. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#32-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Beta blockers can worsen COPD due to the side effects on the respiratory system. Nitroglycerin is safe with COPD clients. Calcium channel blockers are usually safe to administer. Calan is also a calcium channel blocker.</p>
<p>Remember that Inderal is a <em>Beta Blocker</em>. Major side effects: Bradycardia and Bronchospasm—<em>BB</em> = <em>BB</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="33-correct-answer-a">33. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#33-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Thiazides are potassium-loosing, and this potassium level is below normal. Option <em>b</em> is a normal level for potassium. The diuretic should not alter the glucose. Option <em>d</em> is a normal level for sodium.</p>
<p>An approach to this question is to identify the lab value that is the farthest from normal values and at a dangerous level. The glucose is elevated but not to a dangerous level. The potassium is low and at a dangerous level. With serum potassium levels, a small variation from the normal values, 3.5 to 5.0 mEq/L, is quite dangerous.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="34-correct-answer-a">34. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#34-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>OTC cold and cough preparations tend to increase the BP in hypertensive clients. The label warning clearly indicates not to use if taking medication for hypertension. Sedation could occur due to the type of product used, but this should not interfere with the BP. No effect should be seen on heart rate. The opposite effect from option <em>d</em> is seen.</p>
<p>If you have no idea of the correct answer, use a combination approach of education and common sense. The question is about a client with hypertension; select a response with BP in it, either <em>a</em> or <em>d</em>. Then select the high pressure, since this is the more common problem for hypertensives than low pressure is.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="35-correct-answer-b">35. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#35-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Both of these agents can cause ototoxicity. Usually with the loop diuretic it is from an IV</p>
<p>The most important approach is to read the question carefully. The question is asking about “both”</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 349</p>
<p>administration that was too rapidly injected, &gt;10 mg/minute. Option <em>a</em> is a normal potassium level. The diuretic could drop the level but not necessarily in combination with the antibiotic. Some of the antibiotics in this classification in option <em>c</em> carry this side effect, but the Lasix does not. The diuretic may have this side effect in option <em>d</em> due to potassium loss.</p>
<p><strong>36. Correct answer: c</strong></p>
<p>The loop diuretics are fast acting and extremely potent. Responses <em>a</em> and <em>b</em> would not be the diuretics of choice. Response <em>d</em> is used for hypertension.</p>
<p><strong>37. Correct answer: d</strong></p>
<p>The most common and severe complication from anticoagulation is hemorrhage. Not enough information is given to know if pulmonary embolus is a concern. Urticaria is common but would have occurred early, the first day after the initial medication was given. Option <em>c</em> is not a side effect of an anticoagulant.</p>
<p><strong>38. Correct answer: c</strong></p>
<p>Aspirin inhibits platelet aggregation. Hemostatic effects stop bleeding. Option <em>b</em> would correct free drugs—not just one. Note that response <em>d</em>, muscle cramps, is an effect of loop diuretics when the serum potassium levels drop. Response <em>c</em>, nephrotoxicity, is a side effect of the aminoglycosides. Since the K level is normal in response <em>a</em>, the only answer left is <em>b</em>.</p>
<p>Try the approach of going with what you know—Lasix is a potent diuretic, used most commonly in acute situations. Avoid selecting a drug with which you are not familiar.</p>
<p>Another approach is to cluster responses <em>a</em> and <em>b</em> under “allergic type of responses.” Since these would have occurred earlier, eliminate them. Between the remaining responses, the renal system problem takes precedent over a sore throat.</p>
<p>Note that ASA has many effects: antipyretic, antiinflammatory, antiplatelet or anticoagulant, and analgesic.</p>
<p>350 ▼ COMPREHENSIVE EXAM</p>
<p>bleeding for a client with hemophilia. Thrombolytic effects dissolve clots such as with streptokinase.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="39-correct-answer-c">39. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#39-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Parent education should emphasize that the illnesses are far worse than the side effects of the immunizations. This response in option <em>a</em> would only scare the mother further. Written information must be given to the parent from the office or physician, but option <em>b</em> is not the best response. The killed forms can be chosen at most offices, but these forms do not offer the best immunization.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="40-correct-answer-a">40. Correct answer: a<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#40-correct-answer-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This is the most complete schedule for a child entering school. The second MMR may not be required in some states. Option <em>b</em> is an incomplete series of DTP, OPV, and HIB. In option <em>c</em> the HBV series should be completed. Option <em>d</em> has an incomplete series of DTP.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="41-correct-answer-d">41. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#41-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The medication must be diluted. It is typically used as a temporary treatment for hyperthyroid conditions. SSKI is a similar medication. Both of these inhibit the release of the thyroid</p>
<p>Response <em>a</em> describes the effects as “severe,” which is unlikely. Response <em>b</em> has the absolute “all” in it; quite unlikely that the physician will tell “all” the information. Of the two responses left, response <em>c</em> is more complete.</p>
<p>Try to remember the series as a countdown, as well as somewhat alphabetical with a switch in the middle between HIB and HBV:
5 DPT
4 HIB, 4 OPV
3 HBV
2 MMR (think 2 Ms)</p>
<p>Try an educated guess and match the solution in the question with response <em>d</em>, which is the only one that presents information about a liquid.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 351</p>
<p>hormones. Bedtime dosing is not required. Vital signs are not necessary before administration.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="42-correct-answer-d">42. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#42-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Hypertension is a side effect and should be monitored during administration. The side effect is a decreased uterine blood flow. Water intoxication or overhydration, not dehydration, is a side effect. FHT should be monitored, but this value is within normal limits.</p>
<p>If you have no idea of the correct response, try to go with what you know—select response d, the high blood pressure, which is obviously too high.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="43-correct-answer-c">43. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#43-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is the least correct answer because it is not true. Options a, b, and d are normal actions of insulin.</p>
<p>Note the key word “least.” Response c is the least correct answer because of the key words “absorption” and “dietary glucose.” These words suggest that insulin has an effect in the GI tract. It does not, since it is destroyed if taken orally; besides, insulin is always given parenterally.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="44-correct-answer-b">44. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#44-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The physician should be called because of the route. Only rapid-acting, regular insulin is given IV. The nurse would be taking responsibility for her action if the medication were given as ordered. Option c could be an appropriate action, but the nurse should know that only regular insulin is given IV. A nurse cannot change the route without notifying the physician.</p>
<p>If you narrow the responses to b and c, select b, since there is not enough information in the stem for the action of consulting another nurse. It just states “about the order”—what about the order? the route? the dose? More specific information is needed in the stem or the response.</p>
<p>352 ▼ COMPREHENSIVE EXAM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="45-correct-answer-c">45. Correct answer: c<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#45-correct-answer-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is the most likely cause if A.M. NPH insulin were given; an insulin reaction is anticipated at this time of the day. A STAT glucose should be obtained. Option <em>a</em> is not the most likely response if the client received insulin in the A.M. Given the client’s history, NPH insulin was most likely given that morning. The somogyi effect is a rebound effect of hypoglycemia from 3 to 4 A.M. Not enough information is given for selection of this response. The dawn phenomenon usually manifests a high glucose early in the morning.</p>
<p>Note the clues in the stem—“insulin dependent” and “found unconscious”—think insulin reaction or acute hypoglycemia. If the glucose is low, 50% glucose would be given IV push. If the glucose is high, IV regular insulin would be given.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="46-correct-answer-b">46. Correct answer: b<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#46-correct-answer-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Bronchodilation is the main action that assists asthmatics. Option <em>a</em> is the opposite effect and would worsen the dyspnea. The drug itself does not increase the oxygen consumption; this will be caused by the bronchodilation then delivery of oxygen to the tissues. The relief obtained from the bronchodilation could lower the respiratory rate; however, the rate may not be fast, only labored.</p>
<p>The stem gives no information on the respiratory rate; response <em>d</em> is not appropriate. Eliminate response <em>c</em>, since medications are not routinely given to increase oxygen use, especially if the client is having difficulty breathing. Then, common sense guides the selection of response <em>b</em>, bronchodilation. Bronchoconstriction is inappropriate for any client in respiratory distress or otherwise.</p>
<p>ANSWERS, RATIONALES, AND TEST-TAKING TIPS ▼ 353</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="47-correct-answer-d">47. Correct answer: d<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#47-correct-answer-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Relief is obtained temporarily; the rebound congestion can increase the frequency of use. Option <em>a</em> is not a typical side effect of nasal sprays. A drying effect, not inflammation or nasal drip, should occur as an action of the agent. Option <em>c</em> is not a typical side effect of nasal sprays.</p>
<p>The clue in the stem is “excessive” use. Think of these sprays as having local effects of vasoconstriction and decreased congestion in the nasal membranes. Thus frequent use will result in rebound effects opposite of the therapeutic effect.</p>
<p>^{}[]</p>
<p>BIBLIOGRAPHY</p>
<p>Baer C and Williams B: Clinical pharmacology &amp; nursing, ed 2, Springhouse, Pa, 1992, Springhouse Corp.
Beare P and Myers J: Principles and practice of adult health nursing, ed 2, St Louis, 1994, Mosby.
Behrman RE and Kliegman R: Nelson essentials of pediatrics, Philadelphia, 1990, WB Saunders.
Bennett EG and Woolf D: Substance abuse, ed 2, Albany, NY, 1991, Delmar.
Clark J, Queener S, and Karb V: Pharmacologic basis of nursing practice, ed 4, St Louis, 1993, Mosby.
Deglin J and Vallerand A: Davis's drug guide for nurses, ed 4, Philadelphia, 1995, FA Davis Co.
Gray D: Calculate with care, St Louis, 1994, Mosby.
Kuhn M: Pharmacotherapeutics: A nursing process approach, ed 3, Philadelphia, 1994, FA Davis Co.
Lehne R, Moore A, Crosby L, and Hamilton D: Pharmacology for nursing care, ed 2, Philadelphia, 1994, Saunders.
Mosby's medical, nursing, &amp; allied health dictionary, ed 4, St Louis, 1994, Mosby.
Pagana K and Pagana T: Mosby's diagnostic and laboratory test reference, St Louis, 1992, Mosby.
Perry A and Potter P: Clinical nursing skills and techniques, ed 3, St Louis, 1994, Mosby.
Perry A and Potter P: Fundamentals of nursing, ed 3, St Louis, 1993, Mosby.
Reiss B and Evans M: Pharmacological aspects of nursing care, ed 4, Albany, NY, 1993, Delmar.
Richardson JK and Richardson L: The mathematics of drugs and solutions, ed 5, St Louis, 1994, Mosby.
Rollant P: Acing multiple choice tests, AJN Career Guide for 1994, pp. 18-21, 36, Jan 1994.
Skidmore-Roth L: Mosby's nursing drug reference, St Louis, 1995, Mosby.
Spratto G and Woods AL: RN Magazines's: Nurse's Drug Reference, Albany, NY, 1994, Delmar.
The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Arch Intern Med. 153 (2):154-183, 1993.
Vallerand A: Nursing pharmacology, ed 2, Springhouse, Pa, 1993, Springhouse Corp.
Wallace L and Wardel S: Nursing pharmacology, ed 2, Boston, 1992, Jones &amp; Bartlett Publishers.
Wilson B, Shannon M, and Stang C: Nurse's drug guide, Norwalk, Ct, 1995, Appleton &amp; Lange.</p>
<p>355</p>
<p>^{}[]</p>
<p>INDEX</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a">A<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Absorption, drug administration routes, comparison of, 35</p>
<p>Acetylcholine, 86
interactions, 87
side effects, 87</p>
<p>Acetylcholinesterase inhibitor, 87</p>
<p>Activated partial thromboplastin time, defined, 192</p>
<p>Adenosine triphosphatase, inhibition, with calcium, increase of, 150-151</p>
<p>Adenosine triphosphate
heart block, 153
hypertrophic cardiomyopathy, 153
nursing implications, 152-153
prescription/over-the-counter medications, interactions with, 153
side effects, 151-152
subaortic stenosis, idiopathic hypertrophic, 153
uses of, 151
Wolf-Parkinson-White syndrome, 153</p>
<p>Administration of medication, 47-61, 52-57
airlock, defined, 48
deltoid muscle, injection site, 50
dorsogluteal injection site, methods for defining, 51
extravasation, defined, 48
implanted infusion device, 56
infiltration, defined, 48
injection, 49-52
needles, 57
ophthalmic ointment, administration of, 54
phlebitis, defined, 48
principles of, 48-49
subcutaneous injection sites, 51
tissue necrosis, defined, 48
vastus lateralis, 49
ventrogluteal muscle, injection site, location of, 50</p>
<p>Administration of medication—cont'd
Z-track
defined, 48
intramuscular injection, 52</p>
<p>Adrenal hormones, 225-227
glucocorticoids, 225-226
mineralcorticoids, 226-227</p>
<p>Adrenergics
agonists, 64-67
defined, 64
blocking agents, 67-70, 166-167
defined, 64
receptor, defined, 64
response, defined, 64
sympathomimetic, 64-67</p>
<p>Afterload, defined, 150</p>
<p>Agonist, defined, 32</p>
<p>Airlock, defined, 48</p>
<p>Alcohol, 131-132</p>
<p>Alkalosis, hypochloremic, defined, 180</p>
<p>Alpha (α) adrenergic blockers, 67-68</p>
<p>Aminoglycosides, 266-267</p>
<p>Amphetamine-like drugs, 104-105</p>
<p>Amphetamines, 104-105
defined, 98</p>
<p>Analeptics, 106-107
defined, 98</p>
<p>Analgesics, 138-142
antagonists, narcotic, 140-141
defined, 138
narcotic agonist-antagonist agents, mixed, 140
narcotics, 138-140
nonnarcotic, 141</p>
<p>Androgens, 317-320</p>
<p>Anesthesia, 100-101
concentration levels, 100
general, 100-102
local, 102-104
action of, 103
drugs, 104</p>
<p>358  INDEX</p>
<p>Anesthesia—cont'd
local—cont'd
nursing implications of, 103
overview, 102-103
side effects of, 103
uses of, 103
phases of, 100</p>
<p>Anesthetics, 100
ear, 309
eye, 305-306
inhalation, 101
intravenous, 102</p>
<p>Angina, drugs used to treat, classification of, 153
Angiotensin antagonists, 165-166</p>
<p>Anorexiant
agents, 106
defined, 98</p>
<p>Antabuse, defined, 128
Antacids, 288-289
Antagonists, defined, 32, 138
Anterior pituitary hormones, 219-220
Antiadrenergic, defined, 64
Antianginals, 153-158
beta (β) adrenergic blockers, 155-158
calcium channel blockers, 158
classification, drugs used to treat angina, 153
nitrates, 153-155</p>
<p>Antianxiety psychotropics, 108-109
Antibiotics, 262-268
aminoglycosides, 266-267
cephalosporins, 264-265
macrolides, 267
overview, 262-263
penicillins, 263-264
quinolones, 268
sulfonamides, 267-268
tetracyclines, 265-266</p>
<p>Anticholinergic agents, 71-72, 290-291
defined, 64</p>
<p>Anticholinesterase agents, 70-71
Anticoagulant, 192-195
defined, 192
oral, 192-194
parenteral, 194-195</p>
<p>Anticonvulsants, 80
defined, 80</p>
<p>Antidiarrheals, 295
Antidysrhythmics, 158, 160-162
actions of, 159
defined, 150
nursing implications, 159
side effects, 159</p>
<p>Antiemetics, 292
Antiflatulent agents, 291</p>
<p>Antifungals, 270
Antigout agents, 144-145
Antihelmintic agents, 271
Antihistamine, 241-242
defined, 238</p>
<p>Antihyperlipidemia agents, 168-169
cholesterol levels, 168
cholesterol-lowering agents, 168-169
fibric acid derivatives, 169
triglyceride levels, 168
triglyceride-lowering agents, 169</p>
<p>Antihypertensives, 159-168
adrenergic blocking agents, 166-167
angiotensin antagonists, 165-166
beta (β) adrenergic blockers, 164
calcium channel blockers, 164-165
classification, 163
diuretics, 163-164
nursing implications, 168
stepped-care approach, 159-163
vasodilating agents, 167-168</p>
<p>Antiinfectives
ear, 307-309
eye, 306-307
topical, 280-281</p>
<p>Antiinflammatory agents, 142-143, 245, 281-282
ear, 309
eye, 306</p>
<p>Antilipidemics, defined, 150
Antimalarial agents, 271
Antimyasthenic agents, 85-87
Antineoplastics, 252-256
actions, 255-256
administration, 253
classification, 255-256
classification of agents, 254
nursing implications, 253-254
overview, 252-253
preparation, 253
side effects, 253-254, 255-256
uses of, 255-256</p>
<p>Antiparasitics, 282
defined, 276</p>
<p>Antiplatelet agents, 196-197
Antipsychotic agents, 107-108
Antirheumatic agents, 143-144
Antiseptics, 276-277
defined, 276</p>
<p>Antispasmodics, 290-291
defined, 288</p>
<p>Antitoxins, defined, 206
Antitubercular agents, 269
actions, 269
nursing implications, 269</p>
<p>INDEX ▼ 359</p>
<p>Antitubercular agents—cont’d
side effects, 269
uses of, 269</p>
<p>Antitussives, 244
defined, 238</p>
<p>Antivenin, defined, 206</p>
<p>Antivirals, 269-270</p>
<p>Anxiolytics, 108-109</p>
<p>Apothecary system
conversion, 57
dosage calculation, 57</p>
<p>APTT. see Activated partial thromboplastin time</p>
<p>Arthritis, 143-145
antigout agents, 144-145
antirheumatic agents, 143-144
steroidal antiinflammatory agents, 145</p>
<p>Asthmatic drugs, prophylactic, 244-245</p>
<p>Astringents, 279
defined, 276</p>
<p>Attenuated vaccine, defined, 206</p>
<p>Automaticity, defined, 159</p>
<p>Autonomic nervous system, 63-77, 64-72, 67, 70, 73-74
adrenergics
agonists, 64-67
defined, 64
blocking agents, 67-70
defined, 64
receptor, defined, 64
response, defined, 64
sympathomimetic, 64-67
alpha (α) adrenergic blockers, 67-68
antiadrenergics, defined, 64
anticholinergics, 71-77
anticholinesterase agents, 70-71
beta (β) adrenergic blockers, 68-69
cardiac terminology, defined, 64
cardiovascular medications, autonomic action of, 66
cholinergic
agonists, direct-acting, 70
anticholinergic agents, defined, 64
blocking, 71-72
defined, 64
parasympathomimetic, 70-71
response, parasympathomimetic, cholinergic agents, defined, 64
chronotropic, defined, 64
classification of, 65
dromotropic, defined, 64
ganglionic blockers, 69-70
inotropic, defined, 64</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b">B<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Barbiturates, 81-82, 129-130</p>
<p>Baths, as dermatologic agents, 277</p>
<p>Benzodiazepines, 83-84, 130-131</p>
<p>Beta (β) adrenergic blockers, 68-69, 155-158, 164</p>
<p>Beta (β) blockers, clinical, uses for, 157</p>
<p>Birth control pill, 316-317</p>
<p>Blocking agents, neuromuscular, 88-89</p>
<p>Body surface area, defined, 57</p>
<p>Brand name, defined, 20</p>
<p>Bronchodilators, 238-241
classification, 238
methylxanthines, 240-241
sympathomimetics, 238-240
xanthine derivatives, 240-241</p>
<p>BSA. see Body surface area</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c">C<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Calcium channel blockers, 158, 164-165
clinical uses for, 157</p>
<p>Calculation, dosage calculation, formulas, 57-58</p>
<p>Cancer, 251-259
antineoplastic agents
actions, 254-255
classification, 254-255
side effects, 254-255
uses of, 254-255</p>
<p>antineoplastics, 252-256
administration, 253
classification of agents, 254
nursing implications, 253-254
overview, 252-253
preparation, 253
side effects, 253-254</p>
<p>Carbonic anhydrase inhibitors, 184-185</p>
<p>Cardiac glycosides, 150-153
adenosine triphosphatase, inhibition, with calcium, increase of, 150-151</p>
<p>Cardiac terminology, defined, 64</p>
<p>Cardiovascular system, 149-177, 150-169
adenosine triphosphate
common individual drugs, 153
nursing implications, 152-153
prescription/over-the-counter medications, interactions with, 153
side effects, 151-152
subaortic stenosis, idiopathic hypertrophic, contraindicated in, 153
uses of, 151</p>
<p>afterload, defined, 150</p>
<p>360 ▼ INDEX</p>
<p>Cardiovascular system—cont’d
antianginals
beta (β) adrenergic blockers, 155-158
calcium channel blockers, 158
classification, drugs used to treat angina, 153
nitrates, 153-155
antidysrhythmics, 159, 160-162
actions of, 159
defined, 150
nursing implications, 159
side effects, 159
antihyperlipidemia agents, 168-169
cholesterol levels, and triglyceride levels, 168
cholesterol-lowering agents, 168-169
triglyceride-lowering agents, fibric acid derivatives, 169
antihypertensives, 159-168
adrenergic blocking agents, 166-167
angiotensin antagonists, 165-166
beta (β) adrenergic blockers, 164
calcium channel blockers, 164-165
classification, 163
direct vasodilating agents, 167-168
diuretics, 163-164
nursing implications, 168
stepped-care approach, high blood pressure sleep, drugs affecting, 159-163
antilipidemics, defined, 150
automaticity, defined, 150
beta (β) blockers and calcium channel blockers, clinical uses for, 157
cardiac glycosides, 150-153
adenosine triphosphatase, inhibition, with calcium, increase of, 150-151
dietary consideration, potassium sources, 166
digitalis toxicity, defined, 150
effect, on heart, 151
mechanisms of action, from ACE inhibitors in relation to normal physiology, 165
preload, defined, 150
stepped-care approach, 163
Cathartic, defined, 288
Cathartic laxatives, 293-295
Central nervous system, 99-114, 115-118
amphetamines, defined, 98
analeptics, defined, 98
anesthesia, 100-101
concentration levels, 100
general, 100-102
local, 102-104
action of, 103
drugs, 104
Central nervous system—cont’d
anesthesia—cont’d
nursing implications of, 103
overview, 102-103
side effects of, 103
uses of, 103
three phases of, 100
anesthetics, 100
inhalation, 101
intravenous, 102
anorexiant, 98
defined, 98
depressant, defined, 98
drugs affecting, 97-125
monoamine oxidase, 98, 111
muscle relaxants, skeletal, 113-114
centrally acting, 113-114
classifications, 113
overview, 113
peripherally-acting agents, 114
peripheral nervous system, defined, 98
photosensitivity, defined, 98
preanesthetics, 99-100
psychotropics, 107-113
antianxiety, 108-109
antipsychotic agents, 107-108
classifications, 107
defined, 98
monoamine oxidase inhibitors, 110-111
mood stabilizers, 112-113
serotonin reuptake inhibitors, 111-112
tricyclic antidepressants, 109-110
serotonin, defined, 98
stimulants, 104-107
amphetamines, 104-105
analeptics, 106-107
anorexiant agents, 106
overview, 104
tyramine, defined, 98
Cephalosporins, 264-265
Ceruminolytics
defined, 302
ear, 307
Chemicals
name of, defined, 20
Chewing, of drug, contraindicated, 25
Cholesterol
levels, antihyperlipidemia agents, 168
lowering agents, antihyperlipidemia agents, 168-169
Cholinergic agonists, direct-acting, 70
Cholinergic blocking agents, 71-72
Cholinergic response, defined, 64</p>
<p>INDEX ▼ 361</p>
<p>Cholinergics
defined, 64
parasympathomimetic, 70-71</p>
<p>Chronotropic, defined, 64</p>
<p>Cleansers, as dermatologic agents, 277-278</p>
<p>Client
assessments, education, 8-9
education, 2, 7-13
defined, 2
special needs, 9-10</p>
<p>CNS. see Central nervous system</p>
<p>Contraceptives, 317
oral, 316-317, 318-319t</p>
<p>Controlled substance, 22
defined, 20</p>
<p>Conversion, for dosage systems, 57, 58</p>
<p>Convulsive seizures, 81</p>
<p>Corticosteroids, 245</p>
<p>Corticotropin, defined, 218</p>
<p>Cough, 242-244
antitussives, 244
diluents, 242
expectorants, 243-244
mycolytic drugs, 242-243</p>
<p>Crushing, of drug, contraindicated, 25</p>
<p>Cubic centimeter, defined, 57</p>
<p>Cycloplegic, defined, 302</p>
<p>D</p>
<p>DA. see Dimensional analysis</p>
<p>Dawn phenomenon, defined, 218</p>
<p>Debriding agent, 283
defined, 276</p>
<p>Decongestant, 241
defined, 238</p>
<p>Deltoid muscle, injection site, 50</p>
<p>Dependence, defined, 128</p>
<p>Depolarizing agents, 89</p>
<p>Depressant, defined, 98</p>
<p>Dermatologic agents, 275-286, 276-283, 284
antiinfectives, topical, 280-281
antiinflammatory agents, 281-282
antiparasitic, 282
defined, 276
antiseptic, 276-277
defined, 276
astringent, 279
defined, 276
baths, 277
cleansers, 277-278
debriding agent, 283
defined, 276</p>
<p>Dermatologic agents—cont’d
disinfectant, 276-277
defined, 276
emollient, 278
defined, 276
keratolytics, 282-283
defined, 276
liniments, 279-280
defined, 276
lotions, 278-279
PABA, defined, 276
protectives, 280
rubs, 279-280
skin protectants, 279
soaps, 277-278
solutions, 278-279</p>
<p>Deterioration, end-of-dose, defined, 80</p>
<p>Diabetes, 227-231
hyperglycemic agents, 230-231
hypoglycemic agents, 227-230</p>
<p>Digestants, 291</p>
<p>Digitalis toxicity, defined, 150</p>
<p>Diluents, 242</p>
<p>Dimensional analysis, dosage calculation, defined, 57</p>
<p>Disinfectant, 276-277
defined, 276</p>
<p>Diuretic, 163-164
defined, 180
loop, 182-183</p>
<p>Dorsogluteal injection site, methods for defining, 51</p>
<p>Dosage calculation, 57-58
body surface area, defined, 57
calculation, formulas, 57-58
conversion, 57, 58
cubic centimeter, defined, 57
dimensional analysis, defined, 57
equipment drop factors, defined, 57
microdrop, defined, 57
nomogram, defined, 57</p>
<p>Dromotropic, defined, 64</p>
<p>E</p>
<p>Ear
administration, of medication, 308
agents used in, 307-309
anesthetic agents, 309
antiinfective agents, 307-309
antiinflammatory agents, 309
ceruminolytic agents, 309</p>
<p>Edema, defined, 180</p>
<p>362 INDEX</p>
<p>Education</p>
<ul>
<li>of client, 2</li>
<li>special needs, 9-10</li>
<li>client assessments, 8-9</li>
</ul>
<p>Emetics, 293</p>
<ul>
<li>defined, 288</li>
</ul>
<p>Emollient, 278</p>
<ul>
<li>defined, 276</li>
</ul>
<p>Endocrine system, 217-236, 219-231</p>
<ul>
<li>adrenal hormones, 225-227</li>
<li>glucocorticoids, 225-226</li>
<li>mineralcorticoids, 226-227</li>
<li>anterior pituitary hormones, 219</li>
<li>corticotropin, defined, 218</li>
<li>dawn phenomenon, defined, 218</li>
<li>diabetes, 227-231</li>
<li>hyperglycemic agents, 230-231</li>
<li>hypoglycemic agents, 227-230</li>
<li>hormones, with influence on overall function, 222</li>
<li>hyperfunction of, defined, 218</li>
<li>hypofunction of, defined, 218</li>
<li>insulin preparations, 228-229</li>
<li>iodism, defined, 218</li>
<li>myxedema, defined, 218</li>
<li>parathyroid hormone, 222-223, 222-225</li>
<li>pituitary hormone, 219-222</li>
<li>anterior pituitary hormones, 219-220</li>
<li>posterior pituitary hormone, 220-222</li>
<li>somogyi effect, defined, 218</li>
<li>T₃, defined, 218</li>
<li>T₄, defined, 218</li>
<li>thyroid</li>
<li>hormones, 222-225, 223-225</li>
<li>storm, defined, 218</li>
</ul>
<p>End-of-dose deterioration, defined, 80</p>
<p>Enteral route, defined, 20</p>
<p>Epilepsy, 81</p>
<p>Equipment drop factors, dosage calculation, defined, 57</p>
<p>Estrogens, 314-315</p>
<p>Expectorant, 243-244</p>
<ul>
<li>defined, 238</li>
</ul>
<p>Extrapyramidal effect, defined, 32, 80</p>
<p>Extravasation, defined, 48</p>
<p>Eye, 302-307</p>
<ul>
<li>anesthetic agents, 305-306</li>
<li>antiinfectives, 306-307</li>
<li>antiinflammatory agents, 306</li>
<li>cycloplegics, 302-303</li>
<li>drops, 304</li>
<li>eye drops, 304</li>
<li>intraocular pressure, lowering, 305</li>
</ul>
<p>Eye—cont'd</p>
<ul>
<li>miotics, 303</li>
<li>mydriatics, 302-303</li>
</ul>
<p>F</p>
<ul>
<li>Flora modifiers, 296</li>
<li>Follicle-stimulating hormone, defined, 314</li>
<li>FSH. see Follicle-stimulating hormone</li>
</ul>
<p>G</p>
<ul>
<li>GABA. see Gamma-amino-butyric acid</li>
<li>Gamma-amino-butyric acid, defined, 80</li>
<li>Ganglionic blockers, 69-70</li>
<li>Gastrointestinal system, 287-300, 288, 297</li>
<li>antidiarrheals, 295</li>
<li>antiemetics, 292</li>
<li>antiflatulent agents, 291</li>
<li>antispasmodics, defined, 288</li>
<li>cathartic, defined, 288</li>
<li>digestants, 291</li>
<li>emetics, 293</li>
<li>defined, 288</li>
<li>flora modifiers, 296</li>
<li>hyperacidity, 288-291</li>
<li>antacids, 288-289</li>
<li>anticholinergic agents (antispasmodics), 290-291</li>
<li>H₂ histamine receptor antagonist, 289-290</li>
<li>laxative, 293-295</li>
<li>types, 294t</li>
<li>malabsorption syndrome, defined, 288</li>
<li>antacids, 288-289</li>
<li>anticholinergic agents (antispasmodics), 290-291</li>
<li>H₂ histamine receptor antagonist, 289-290</li>
<li>peptic ulcer disease, 288-291</li>
<li>Generic name, defined, 20</li>
<li>Glucocorticoids, 225-226</li>
</ul>
<p>H</p>
<ul>
<li>H₁ histamine receptor antagonist, 289-290</li>
<li>Half-life, defined, 32</li>
<li>HBV. see Hepatitis B vaccine</li>
<li>Hematinic agents, 197-199</li>
<li>folic acid (vitamin B₆), 199</li>
<li>hydroxocobalamin (vitamin B₁₂), 198-199</li>
<li>iron products, 197-198</li>
</ul>
<p>INDEX ▼ 363</p>
<p>Hematologic system, 191-203, 192-199
activated partial thromboplastin time, defined, 192
anticoagulant, 192-195
defined, 192
oral anticoagulants, 192-194
parenteral anticoagulants, 194-195
antiplatelet agents, 196-197
folic acid (vitamin B₆), 199
hematinic agents, 197-199
folic acid (vitamin B₆), 199
hydroxocobalamin (vitamin B₁₂), 198-199
iron products, 197-198
hematuria, defined, 192
hemophilia, defined, 192
hemorrhage, defined, 192
hemostatic, defined, 192
hemostatic agents, 197
prothrombin time, defined, 192
thrombolytic agents, 195-196
Hematuria, defined, 192
Hemophilia, defined, 192
Hemophilus influenzae vaccine, defined, 206
Hemorrhage, defined, 192
Hemostatic, defined, 192
Hemostatic agents, 197
Hepatitis B vaccine, defined, 206
Hib. see Hemophilus influenzae vaccine
High blood pressure sleep, stepped-care approach, 159-163
Histamine, defined, 238
Hormones, with influence on overall function, 222
Household measures system
conversion, 57
dosage calculation, 57
Hydantoin derivatives, 81
Hydroxocobalamin (vitamin B₁₂), 198-199
Hyperacidity, gastric, 288-291
antacids, 288-289
anticholinergic agents (antispasmodics), 290-291
H₃ histamine receptor antagonist, 289-290
Hyperfunction, of endocrine system, defined, 218
Hyperglycemic agents, 230-231
Hyperkalemia, defined, 180
Hyperpyrexia, defined, 180
Hypnotics
defined, 128
overview, 128-129
Hypochloremic alkalosis, defined, 180
Hypofunction, of endocrine system, defined, 218
Hypoglycemic agents, 227-230
Hypokalemia, defined, 180
Hypomagnesemia, defined, 180</p>
<p>Iatrogenic effect, defined, 32
Idiosyncracy, defined, 32
Iminostilbenes, 82
Immune globulin, defined, 206
Immune system, 205-216, 206-212, 211, 212, 213, 214
antitoxins, defined, 206
antivenin, defined, 206
attenuated vaccine, defined, 206
hepatitis B vaccine, defined, 206
Hib (hemophilus influenzae) vaccine, defined, 206
immune globulin, defined, 206
immunity
defined, 206
sources of, 207
immunization schedule, birth to 16 years, 208
immunological agents, 206-211
active immunity agents, 210-211
overview, 206-209
passive immunity agents, 210
immunomodulating agents, 212
immunosuppressive, defined, 206
immunosuppressive agents, 211-212
vaccines, defined, 206
Immunity
defined, 206
sources of, 207
Immunization schedule, birth to 16 years, 208
Immunological agents, 206-211
active immunity agents, 210-211
overview, 206-209
passive immunity agents, 210
Immunomodulating agents, 212
Immunosuppressive, defined, 206
Immunosuppressive agents, 211-212
Implanted infusion device, 56
Infection, 261-274, 262-271, 269-271, 272
antibiotics, 262-268
aminoglycosides, 266-267
cephalosporins, 264-265
macrolides, 267
overview, 262-263
penicillins, 263-264
quinolones, 268
sulfonamides, 267-268
tetracyclines, 265-266</p>
<p>364 ▼ INDEX</p>
<p>Infection—cont'd</p>
<ul>
<li>antifungals, 270</li>
<li>antihelmintic agents, 271</li>
<li>antimalarial agents, 271</li>
<li>antitubercular agents, 269</li>
<li>actions, 269</li>
<li>nursing implications, 269</li>
<li>side effects, 269</li>
<li>uses of, 269</li>
<li>antivirals, 269-270</li>
<li>peak and trough, defined, 262</li>
<li>resistance, defined, 262</li>
<li>sensitivity, defined, 262</li>
<li>superinfection, defined, 262</li>
<li>Infertility, defined, 314</li>
<li>Infiltration, defined, 48</li>
<li>Inflammation, 142-143</li>
<li>antiinflammatory agents, 142-143</li>
<li>antipyretic agents, 142-143</li>
<li>arthritis, drugs used to treat, 143-145</li>
<li>antigout agents, 144-145</li>
<li>antirheumatic agents, 143-144</li>
<li>steroidal antiinflammatory agents, 145</li>
<li>defined, 138</li>
<li>drugs relieving, 137-148</li>
<li>inflammation, defined, 138</li>
<li>nonsteroidal antiinflammatory drug, defined, 138</li>
<li>Infusion device, implanted, 56</li>
<li>Inhalation route, defined, 20</li>
<li>Inhaler, metered-dose, 239</li>
<li>Injection, 49-52</li>
<li>site</li>
<li>deltoid muscle, 50</li>
<li>dorsogluteal, methods for defining, 51</li>
<li>subcutaneous, 51</li>
<li>ventrogluteal muscle, location of, 50</li>
<li>Inotropic, defined, 64</li>
<li>Insomnia, rebound, defined, 128</li>
<li>Insulin, 228-229</li>
<li>Intramuscular injection, Z-track, 52</li>
<li>Intraocular pressure, lowering, 305</li>
<li>Iodism, defined, 218</li>
<li>Iron products, 197-198</li>
</ul>
<p>K</p>
<ul>
<li>Keratolytics, 282-283</li>
<li>defined, 276</li>
</ul>
<p>L</p>
<ul>
<li>Laxatives</li>
<li>cathartic, 293-295</li>
<li>types of, 294t</li>
<li>Learning theory, 10-11</li>
<li>Legislation, of drugs, within United States, 22, 23</li>
<li>LH. see Luteinizing hormone</li>
<li>Life span, drug therapy across, 38-39</li>
<li>Liniments, 279-280</li>
<li>defined, 276</li>
<li>Loading dose, defined, 32</li>
<li>Loop diuretics, 182-183</li>
<li>Lotions, 278-279</li>
<li>Luteinizing hormone, defined, 314</li>
</ul>
<p>M</p>
<ul>
<li>Macrodrop, defined, 57</li>
<li>Macrolides, 267</li>
<li>Maintenance dose, defined, 32</li>
<li>Malabsorption syndrome, defined, 288</li>
<li>MAO. see Monoamine oxidase; Monoamine oxidase enzyme</li>
<li>Medication. see Pharmacology</li>
<li>Methylxanthines, 106-107, 240-241</li>
<li>Metric system</li>
<li>conversion, 57</li>
<li>dosage calculation, 57</li>
<li>Microdrop, dosage calculation, defined, 57</li>
<li>Milliliter</li>
<li>defined, 57</li>
<li>dosage calculation, defined, 57</li>
<li>Mineralcorticoids, 226-227</li>
<li>Miotic, defined, 302</li>
<li>Miotics, 303</li>
<li>Monitoring, 40-41</li>
<li>Monoamine oxidase</li>
<li>enzyme, defined, 98</li>
<li>inhibitors, 110-111</li>
<li>Mood stabilizers, 112-113</li>
<li>Mucolytic, defined, 238</li>
<li>Muscle relaxants, 113-114</li>
<li>centrally acting, 113-114</li>
<li>classifications, 113</li>
<li>direct-acting agents, 114</li>
<li>overview, 113</li>
<li>peripherally-acting agents, 114</li>
<li>Myasthenia gravis, 85-86</li>
<li>Mycolytic drugs, 242-243</li>
<li>Mydriatic, defined, 302</li>
</ul>
<p>INDEX ▼ 365</p>
<p>Mydriatics, 302-303</p>
<p>Myxedema, defined, 218</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="n">N<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Name</p>
<p>brand, of drug, defined, 20</p>
<p>chemical, of drug, defined, 20</p>
<p>generic, defined, 20</p>
<p>Narcotics, 138-140, 140-141</p>
<p>agonist-antagonist agents, mixed, 140</p>
<p>analgesics, defined, 138</p>
<p>Necrosis, of tissue, defined, 48</p>
<p>Needles, 57</p>
<p>Nervous system</p>
<p>autonomic, 63-77, 64-72, 67, 70, 73-74</p>
<p>adrenergic agents, sympathomimetic, 64-67</p>
<p>adrenergic agonists, 64-67</p>
<p>defined, 64</p>
<p>adrenergic blocking agents, 67-70</p>
<p>adrenergic receptor, defined, 64</p>
<p>adrenergic response, defined, 64</p>
<p>α adrenergic blockers, 67-68</p>
<p>antiadrenergic, defined, 64</p>
<p>anticholinergic agents, 71-72</p>
<p>anticholinesterase agents, 70-71</p>
<p>β adrenergic blockers, 68-69</p>
<p>cardiac terminology, defined, 64</p>
<p>cardiovascular medications, autonomic action of, 66</p>
<p>cholinergic, defined, 64</p>
<p>cholinergic agents, parasympathomimetic, 70-71</p>
<p>cholinergic agonists, direct-acting, 70</p>
<p>cholinergic blocking, 71-72</p>
<p>anticholinergic agents, defined, 64</p>
<p>cholinergic response,</p>
<p>parasympathomimetic, cholinergic agents, defined, 64</p>
<p>chronotropic, defined, 64</p>
<p>classification of, 65</p>
<p>dromotropic, defined, 64</p>
<p>ganglionic blockers, 69-70</p>
<p>inotropic, defined, 64</p>
<p>sympathetic, defined, 64</p>
<p>peripheral, defined, 98</p>
<p>Neuromuscular blocking agents, 88-89</p>
<p>Neuromuscular system, 80-81, 80-89, 84-85, 85, 87, 88, 90-91</p>
<p>acetylcholine, 86</p>
<p>interactions, 87</p>
<p>side effects, 87</p>
<p>Neuromuscular system—cont'd</p>
<p>acetylcholinesterase inhibitor, 87</p>
<p>anticonvulsants, 80</p>
<p>defined, 80</p>
<p>antimyasthenic agents, 85-87</p>
<p>barbiturates, 81-82</p>
<p>benzodiazepines, 83-84</p>
<p>depolarizing agents, 89</p>
<p>drugs affecting, 79-96</p>
<p>end-of-dose deterioration, defined, 80</p>
<p>epilepsy, 81</p>
<p>extrapyramidal effect, defined, 80</p>
<p>gamma-amino-butyric acid, defined, 80</p>
<p>hydantoin derivatives, 81</p>
<p>iminostilbenes, 82</p>
<p>myasthenia gravis, 85-86</p>
<p>neuromuscular blocking agents, 88-89</p>
<p>nondepolarizing agents, 88-89</p>
<p>on-off phenomenon, defined, 80</p>
<p>oxazolidinediones, 82-83</p>
<p>Parkinson's disease, 84-85</p>
<p>pyroidozine hydrochloride, interactions, 85</p>
<p>status epilepticus, defined, 80</p>
<p>succinimides, 83</p>
<p>valporic acid, 83</p>
<p>Nitrates, 153-155</p>
<p>Nomogram, dosage calculation, defined, 57</p>
<p>Nonbarbiturates, 131</p>
<p>Nondepolarizing agents, 88-89</p>
<p>Nonnarcotics, 141</p>
<p>analgesics, defined, 138</p>
<p>Nonsteroidal antiinflammatory drug, 142</p>
<p>defined, 138</p>
<p>NSAID. see Nonsteroidal antiinflammatory drug</p>
<p>Nursing process, 2-7, 20-22</p>
<p>defined, 2</p>
<p>steps in, 2</p>
<p>assessment process, initial, 3-4</p>
<p>diagnoses, selection of, 4-5</p>
<p>evaluation process, 6-7</p>
<p>intervention process, 6</p>
<p>planning process, 5-6</p>
<p>Ointment, ophthalmic, administration of, 54</p>
<p>On-off phenomenon, defined, 80</p>
<p>Ophthalmic ointment, administration of, 54</p>
<p>Oral contraceptives, 316-317, 318-319t</p>
<p>Osmotics, 185-186</p>
<p>Ototoxicity, defined, 138</p>
<p>Ovulation stimulants, 320-321</p>
<p>Oxazolidinediones, 82-83</p>
<p>366 ▼ INDEX</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="p">P<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#p" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>PABA, defined, 276</p>
<p>Pain,</p>
<ul>
<li>drugs relieving, 137-148</li>
<li>analgesic, defined, 138</li>
<li>antagonists, defined, 138</li>
<li>narcotic analgesics, defined, 138</li>
<li>nonnarcotic analgesics, defined, 138</li>
</ul>
<p>Parasympathomimetic, defined, 64</p>
<p>Parathyroid hormone, 222-223, 222-225</p>
<p>Parenteral route, defined, 20</p>
<p>Parkinson's disease, 84-85</p>
<p>Partial thromboplastin time, activated, defined, 192</p>
<p>Peak and trough, defined, 262</p>
<p>Penicillins, 263-264</p>
<p>Peptic ulcer disease, 288-291</p>
<ul>
<li>antacids, 288-289</li>
<li>anticholinergic agents (antispasmodics), 290-291</li>
<li>H₂ histamine receptor antagonist, 289-290</li>
</ul>
<p>Peripheral nervous system, defined, 98</p>
<p>Pharmacodynamics, 36</p>
<p>Pharmacokinetics, transport of drug, 33-36</p>
<p>Pharmacology, 19-30, 28, 29-30</p>
<ul>
<li>absorption, drug administration routes, comparison of, 35</li>
<li>across life span, 38-39</li>
<li>administration, 21, 52-57</li>
<li>airlock, defined, 48</li>
<li>deltoid muscle, injection site, 50</li>
<li>dorsogluteal injection site, methods for defining, 51</li>
<li>extravasation or infiltration, defined, 48</li>
<li>implanted infusion device, 56</li>
<li>injection, 49-52</li>
<li>needles, 57</li>
<li>ophthalmic ointment, administration of, 54</li>
<li>phlebitis, defined, 48</li>
<li>principles of, 48-49</li>
<li>reasons for, 32</li>
<li>rectus femoris, 49</li>
<li>routes, absorption, comparison of, 35</li>
<li>subcutaneous injection sites, 51</li>
<li>thrombophlebitis, defined, 48</li>
<li>tissue necrosis, defined, 48</li>
<li>vastus lateralis, 49</li>
<li>ventrogluteal muscle, injection site, location of, 50</li>
</ul>
<p>Z-track</p>
<ul>
<li>defined, 48</li>
<li>intramuscular injection, 52</li>
</ul>
<p>agonist, defined, 32
antagonists, defined, 32
brand name, defined, 20
chemical name, defined, 20
controlled substance, 22</p>
<ul>
<li>defined, 20
crushing, chewing, contraindicated, 25</li>
<li>drug names, 22</li>
<li>enteral route, defined, 20</li>
<li>extrapyramidal effect, defined, 32
forms of, 22-27
generic name, defined, 20
half-life, defined, 32
iatrogenic effect, defined, 32
idiosyncracy, defined, 32
inhalation route, defined, 20
legislation, within United States, 22
legislation of drugs, federal, in United States, 23
loading dose, defined, 32
maintenance dose, defined, 32
monitoring, 40-41
names, 22
nursing process, 20-22
parenteral route, defined, 20
pharmacodynamics, 36
pharmacokinetics, transport of drug, 33-36
pharmacotherapeutic phase, 36-40
response to, by clients, 36-40
side effect, defined, 32
study of, areas included, 33
target of, and response by clients, 36-37, 40
therapeutic dose, defined, 32
therapy, 31-35, 32-37, 40-41, 42-43
topical route, defined, 20
toxic effect, defined, 32
toxicity, defined, 32
transport, 33-36</li>
</ul>
<p>Phlebitis, defined, 48</p>
<p>Photosensitivity, defined, 98</p>
<p>Pituitary hormone, 219-222</p>
<ul>
<li>anterior, 219-220</li>
<li>posterior, 219, 220-222</li>
</ul>
<p>Posterior pituitary hormone, 219, 220-222</p>
<p>Potassium,</p>
<ul>
<li>sources, 166, 183</li>
<li>sparing agents, 183-184</li>
</ul>
<p>Preanesthetics, 99-100</p>
<p>Pregnancy</p>
<ul>
<li>depressants, uterine, 321-322</li>
<li>drugs used during, 321-322</li>
</ul>
<p>INDEX ▼ 367</p>
<p>Pregnancy—cont'd</p>
<ul>
<li>lactation suppressants, 322</li>
<li>stimulants, uterine, 321</li>
</ul>
<p>Preload, defined, 150</p>
<p>Premenstrual syndrome, defined, 314</p>
<p>Progestins, 315-316</p>
<p>Protectives, 280</p>
<p>Prothrombin time, defined, 192</p>
<p>Psychotropics, 107-113</p>
<ul>
<li>antianxiety, 108-109</li>
<li>antipsychotic agents, 107-108</li>
<li>anxiolytic, 108-109</li>
<li>classifications, 107</li>
<li>defined, 98</li>
<li>monoamine oxidase inhibitors, 110-111</li>
<li>mood stabilizers, 112-113</li>
<li>serotonin reuptake inhibitors, 111-112</li>
<li>tricyclic antidepressants, 109-110</li>
</ul>
<p>PT, Prothrombin time, 192</p>
<p>Pyroidozine hydrochloride, 85</p>
<ul>
<li>interactions, 85</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="q">Q<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#q" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Quinolones, 268</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="r">R<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#r" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Rapid eye movement sleep, defined, 128</p>
<p>Ratio-proportion in dosage calculation, defined, 57</p>
<p>Rebound insomnia, defined, 128</p>
<p>Relaxants, muscle, 113-114</p>
<ul>
<li>centrally acting, 113-114</li>
<li>classifications, 113</li>
<li>direct-acting agents, 114</li>
<li>overview, 113</li>
<li>peripherally-acting agents, 114</li>
</ul>
<p>REM. see Rapid eye movement</p>
<p>Renal system, 179-189, 181</p>
<ul>
<li>dietary considerations, potassium sources, 183</li>
</ul>
<p>diuretics</p>
<ul>
<li>carbonic anhydrase inhibitors, 184-185</li>
<li>classifications, 181-189</li>
<li>defined, 180</li>
<li>loop diuretics, 182-183</li>
<li>nursing implications, 186</li>
<li>osmotics, 185-186</li>
<li>potassium sparing agents, 183-184</li>
<li>thiazide/thiazide-like agents, 181-182</li>
</ul>
<p>edema, defined, 180</p>
<p>failure, defined, 180</p>
<p>Renal system—cont'd</p>
<ul>
<li>hyperkalemia, defined, 180</li>
<li>hyperpyrexia, defined, 180</li>
<li>hypochloremic alkalosis, defined, 180</li>
<li>hypokalemia, defined, 180</li>
<li>hypomagnesemia, defined, 180</li>
</ul>
<p>Reproduction, 313-325</p>
<ul>
<li>follicle-stimulating hormone, defined, 314</li>
<li>infertility, defined, 314</li>
<li>luteinizing hormone, defined, 314</li>
<li>sex hormones, 314-321</li>
<li>androgens, 317-320</li>
<li>birth control pill, 316-317</li>
<li>contraceptives, 317</li>
<li>oral, 316-317, 318-319t</li>
<li>estrogens, 314-315</li>
<li>ovulation stimulants, 320-321</li>
<li>progestins, 315-316</li>
</ul>
<p>Resistance, defined, 262</p>
<p>Respiratory system, 237-249, 238-245, 244, 245</p>
<ul>
<li>antihistamine, defined, 238</li>
<li>antiinflammatory agents, 245</li>
<li>antitussive, defined, 238</li>
<li>asthmatic drugs, prophylactic, 244-245</li>
</ul>
<p>bronchodilators, 238-241</p>
<ul>
<li>classification, 238</li>
<li>methylxanthines, 2240-241</li>
<li>sympathomimetics, 238-240</li>
<li>xanthine derivatives, 240-241</li>
</ul>
<p>corticosteroids, 245</p>
<p>cough, 242-244</p>
<ul>
<li>antitussives, 244</li>
<li>diluents, 242</li>
<li>expectorants, 243-244</li>
<li>mycolytic drugs, 242-243</li>
</ul>
<p>decongestant, defined, 238</p>
<p>expectorant, defined, 238</p>
<p>histamine, defined, 238</p>
<p>inhaler, metered-dose, 239</p>
<p>mucolytic, defined, 238</p>
<p>upper, 241-242</p>
<ul>
<li>antihistamines, 241-242</li>
<li>decongestants, 241</li>
</ul>
<p>zanthine derivative, defined, 238</p>
<p>Response to medication, by clients, 36-37, 40</p>
<p>Route</p>
<ul>
<li>enteral, defined, 20</li>
<li>inhalation, defined, 20</li>
<li>parenteral, defined, 20</li>
<li>topical, defined, 20</li>
</ul>
<p>RP. see Ratio-proportion</p>
<p>Rubs, as dermatologic agents, 279-280</p>
<p>368 INDEX</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="s">S<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sedative">Sedative<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sedative" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>alcohol, 131-132</li>
<li>barbiturates, 129-130</li>
<li>benzodiazepines, 130-131</li>
<li>defined, 128</li>
<li>nonbarbiturates, 131</li>
<li>overview, 128-129</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="seizures-convulsive-81">Seizures, convulsive, 81<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#seizures-convulsive-81" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sensitivity-defined-262">Sensitivity, defined, 262<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sensitivity-defined-262" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="serotonin">Serotonin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#serotonin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>defined, 98</li>
<li>reuptake inhibitors, 111-112</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sex-hormones-314-321">Sex hormones, 314-321<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sex-hormones-314-321" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>androgens, 317-320</li>
<li>birth control pill, 316-317</li>
<li>contraceptives, 317</li>
<li>oral, 316-317, 318-319t</li>
<li>estrogens, 314-315</li>
<li>ovulation stimulants, 320-321</li>
<li>progestins, 315-316</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sexuality-313-325">Sexuality, 313-325<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sexuality-313-325" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>premenstrual syndrome, defined, 314</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="side-effect-defined-32">Side effect, defined, 32<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effect-defined-32" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="skeletal-muscle-relaxants-113-114">Skeletal muscle relaxants, 113-114<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#skeletal-muscle-relaxants-113-114" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>centrally acting, 113-114</li>
<li>classifications, 113</li>
<li>direct-acting agents, 114</li>
<li>overview, 113</li>
<li>peripherally-acting agents, 114</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="skin-protectants-279">Skin protectants, 279<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#skin-protectants-279" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sleep-drugs-affecting-127-135">Sleep, drugs affecting, 127-135<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sleep-drugs-affecting-127-135" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>antabuse, defined, 128</li>
<li>dependence, defined, 128</li>
<li>hypnotics, defined, 128</li>
<li>rapid eye movement sleep, defined, 128</li>
<li>rebound insomnia, defined, 128</li>
<li>sedatives</li>
<li>alcohol, 131-132</li>
<li>barbiturates, 129-130</li>
<li>benzodiazepines, 130-131</li>
<li>defined, 128</li>
<li>nonbarbiturates, 131</li>
<li>overview, 128-129</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="soaps-277-278">Soaps, 277-278<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#soaps-277-278" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="somogyi-effect-defined-218">Somogyi effect, defined, 218<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#somogyi-effect-defined-218" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spasms">Spasms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spasms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>associated with Parkinson's disease, 84</li>
<li>coronary. see antianginals</li>
<li>medications, 84</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ssri-see-selective-serotonin-reuptake-inhibitors">SSRI. see Selective serotonin reuptake inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ssri-see-selective-serotonin-reuptake-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="status-epilepticus-defined-80">Status epilepticus, defined, 80<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#status-epilepticus-defined-80" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="stepped-care-approach-163">Stepped-care approach, 163<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stepped-care-approach-163" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="steroidal-antiinflammatory-agents-145">Steroidal antiinflammatory agents, 145<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#steroidal-antiinflammatory-agents-145" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="stimulants-104-107">Stimulants, 104-107<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stimulants-104-107" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>amphetamine, 104-105</li>
<li>drugs similar to, 104-105</li>
<li>analeptics, 106-107</li>
<li>anorexiant agents, 106</li>
<li>methylxanthines, 106-107</li>
<li>overview, 104</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="subcutaneous-injection-sites-51">Subcutaneous injection sites, 51<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subcutaneous-injection-sites-51" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="substance-controlled-defined-20">Substance, controlled, defined, 20<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#substance-controlled-defined-20" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="succinimides-83">Succinimides, 83<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#succinimides-83" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sulfonamides-267-268">Sulfonamides, 267-268<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sulfonamides-267-268" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="superinfection-defined-262">Superinfection, defined, 262<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#superinfection-defined-262" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sympathetic-defined-64">Sympathetic, defined, 64<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sympathetic-defined-64" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sympathomimetics-238-240">Sympathomimetics, 238-240<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sympathomimetics-238-240" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="t">T<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#t" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>T₁, thyroid hormone, defined, 218</li>
<li>T₂, thyroid hormone, defined, 218</li>
<li>Tetracyclines, 265-266</li>
<li>Therapeutic dose, defined, 32</li>
<li>Thiazide/thiazide-like agents, 181-182</li>
<li>Thrombolytic agents, 195-196</li>
<li>Thromboplastin time, partial, activated, defined, 192</li>
<li>Thyroid hormone, 222-225, 223-225</li>
<li>T₁, defined, 218</li>
<li>T₂, defined, 218</li>
<li>Thyroid storm, defined, 218</li>
<li>Thyroxine, defined, 218</li>
<li>Tinnitus, defined, 138</li>
<li>Tissue necrosis, defined, 48</li>
<li>Topical route, defined, 20</li>
<li>Toxic effect, defined, 32</li>
<li>Toxicity, defined, 32</li>
<li>Trade name, defined, 20</li>
<li>Transport, of drug, 33-36</li>
<li>Tremors, associated with Parkinson's disease, 84</li>
<li>Tricyclic antidepressants, 109-110</li>
<li>Triglyceride-lowering agents, antihyperlipidemia agents, 169</li>
<li>Triiodothyronine, defined, 218</li>
<li>Tyramine, 111</li>
<li>defined, 98</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="u">U<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#u" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ulcer-disease-peptic-288-291">Ulcer disease, peptic, 288-291<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ulcer-disease-peptic-288-291" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>antacids, 288-289</li>
<li>anticholinergic agents (antispasmodics), 290-291</li>
</ul>
<p>INDEX ▼ 369</p>
<p>Ulcer disease, peptic—cont'd
H₂ histamine receptor antagonist, 289-290</p>
<p>V</p>
<p>Vaccine
attenuated, defined, 206
defined, 206
hemophilus influenzae, defined, 206
hepatitis B, defined, 206
Valporic acid, 83
Vasodilating agents, 167-168
Vastus lateralis, 49
Ventrog luteal muscle, injection site, location of, 50</p>
<p>Vitamin B
B₂, 199
B₁₂, 198-199</p>
<p>X</p>
<p>Xanthine derivatives, 240-241</p>
<p>Z</p>
<p>Zanthine derivative, defined, 238
Z-track
defined, 48
intramuscular injection, 52</p>
<p>Instructions for Disk Start-Up</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dos-version">DOS Version<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dos-version" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="system-requirements">System Requirements<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#system-requirements" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A computer with at least 324K of RAM (Random Access Memory) available is needed for this program. This computer must be IBM PC or 100% compatible.</p>
<p>For these examples we assume that your A drive is your floppy drive, and your C drive is your hard drive. Please substitute the letter of your floppy drive for A if your floppy drive letter is different. Substitute the letter of your hard drive for C if your hard drive letter is different.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="start-up-floppy-drive">Start-up (floppy drive):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#start-up-floppy-drive" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Turn your computer on</li>
<li>At the prompt, insert the disk into your A drive</li>
<li>Type A: and press &lt;enter&gt;</li>
<li>Type MOSBY and press &lt;enter&gt;</li>
<li>Follow the instructions on the screen</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="start-up-hard-disk">Start-up (hard disk):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#start-up-hard-disk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Turn your computer on</li>
<li>At the prompt, insert the disk into your A drive</li>
<li>Type C: and press &lt;enter&gt;</li>
<li>Type MD\MOSBY and press &lt;enter&gt;</li>
<li>Type CD\MOSBY and press &lt;enter&gt;</li>
<li>Type COPY A:<em>.</em> and press &lt;enter&gt;</li>
</ol>
<p>The software is now installed on your hard drive. Once the software is installed, start the software by following these directions:</p>
<ol>
<li>Type CD\MOSBY and press &lt;enter&gt;</li>
<li>Type MOSBY and press &lt;enter&gt;</li>
<li>Follow the directions on the screen</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mac-version">MAC Version<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mac-version" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="system-requirements">System Requirements<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#system-requirements" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Mac 68XXX or Power Mac with a total of at least 1 MB of RAM is needed for this program.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="start-up">Start-up:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#start-up" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Create a new folder on your hard disk called MOSBY.</li>
<li>Insert the disk into your floppy drive and open it.</li>
<li>Drag all items from the disk to the new folder.</li>
</ol>
<p>The software is now installed on your hard drive. Once the software is installed, start the software by following these directions:</p>
<ol>
<li>Open the MOSBY folder.</li>
<li>Select the MOSBY program.</li>
<li>Follow the directions on the screen.</li>
</ol>
<p>WRITE DOWN THE PASSWORD THAT YOU HAVE SELECTED. YOUR DISK WILL BE BRANDED WITH THIS INITIAL ENTRY.&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;&lt;/enter&gt;</p>
<p>2020</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="who-else-but-mosby-the-1-nursing-publisher-could-you-trust-to-bring-you-the-best-review-series">Who else but Mosby, the #1 nursing publisher, could you trust to bring you the best review series?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#who-else-but-mosby-the-1-nursing-publisher-could-you-trust-to-bring-you-the-best-review-series" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>No other books can make studying and understanding easier for you. Check out these features:</p>
<ul>
<li>Outline review of key content</li>
<li>Nursing actions presented in order of priority</li>
<li>Chapter review questions and comprehensive exam</li>
<li>Rationales for correct and incorrect answers</li>
<li>UNIQUE! Strategies provided for working through each question</li>
<li>UNIQUE! Free disks (IBM and Mac) let you take the comprehensive exam on computer</li>
</ul>
<p>Look for these other books in <em>Mosby's Review Series</em></p>
<ul>
<li>Maternity Nursing</li>
<li>Medical-Surgical Nursing</li>
<li>Mental Health Nursing</li>
<li>Pediatric Nursing</li>
</ul>
<p>Mosby
Dedicated to Publishing Excellence
ISBN 0-8151-7245-1
9 780815 172451
24858
booksmith
2495</p></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>
